
<html lang="en"     class="pb-page"  data-request-id="8c52b517-b9b6-4569-a451-550f37517b92"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.8b01772;issue:issue:10.1021/jmcmar.2019.62.issue-9"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma" /></meta><meta name="dc.Creator" content="Dylan&#xA;J.  Kahl" /></meta><meta name="dc.Creator" content="Kim M.  Hutchings" /></meta><meta name="dc.Creator" content="Erika Mathes  Lisabeth" /></meta><meta name="dc.Creator" content="Andrew J.  Haak" /></meta><meta name="dc.Creator" content="Jeffrey R.  Leipprandt" /></meta><meta name="dc.Creator" content="Thomas  Dexheimer" /></meta><meta name="dc.Creator" content="Dinesh  Khanna" /></meta><meta name="dc.Creator" content="Pei-Suen  Tsou" /></meta><meta name="dc.Creator" content="Phillip L.  Campbell" /></meta><meta name="dc.Creator" content="David A.  Fox" /></meta><meta name="dc.Creator" content="Bo  Wen" /></meta><meta name="dc.Creator" content="Duxin  Sun" /></meta><meta name="dc.Creator" content="Marc  Bailie" /></meta><meta name="dc.Creator" content="Richard R.  Neubig" /></meta><meta name="dc.Creator" content="Scott D.  Larsen" /></meta><meta name="dc.Description" content="Through a phenotypic high-throughput screen using a serum response element luciferase promoter, we identified a novel 5-aryl-1,3,4-oxadiazol-2-ylthiopropionic acid lead inhibitor of Rho/myocardin-r..." /></meta><meta name="Description" content="Through a phenotypic high-throughput screen using a serum response element luciferase promoter, we identified a novel 5-aryl-1,3,4-oxadiazol-2-ylthiopropionic acid lead inhibitor of Rho/myocardin-r..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 5, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01772" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01772" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01772" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01772" /></link>
        
    
    

<title>5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01772" /></meta><meta property="og:title" content="5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0014.jpeg" /></meta><meta property="og:description" content="Through a phenotypic high-throughput screen using a serum response element luciferase promoter, we identified a novel 5-aryl-1,3,4-oxadiazol-2-ylthiopropionic acid lead inhibitor of Rho/myocardin-related transcription factor (MRTF)/serum response factor (SRF)-mediated gene transcription with good potency (IC50 = 180 nM). We were able to rapidly improve the cellular potency by 5 orders of magnitude guided by sharply defined and synergistic SAR. The remarkable potency and depth of the SAR, as well as the relatively low molecular weight of the series, suggests, but does not prove, that binding to the unknown molecular target may be occurring through a covalent mechanism. The series nevertheless has no observable cytotoxicity up to 100 μM. Ensuing pharmacokinetic optimization resulted in the development of two potent and orally bioavailable anti-fibrotic agents that were capable of dose-dependently reducing connective tissue growth factor gene expression in vitro as well as significantly reducing the development of bleomycin-induced dermal fibrosis in mice in vivo." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01772"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01772">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01772&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01772&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01772&amp;href=/doi/10.1021/acs.jmedchem.8b01772" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 4350-4369</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b02012" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01818" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Dylan J. Kahl</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dylan J. Kahl</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vahlteich Medicinal Chemistry Core, University of Michigan, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dylan%0AJ.++Kahl">Dylan J. Kahl</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kim M. Hutchings</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kim M. Hutchings</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vahlteich Medicinal Chemistry Core, University of Michigan, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kim+M.++Hutchings">Kim M. Hutchings</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Erika Mathes Lisabeth</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Erika Mathes Lisabeth</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan 48824, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Erika+Mathes++Lisabeth">Erika Mathes Lisabeth</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrew J. Haak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrew J. Haak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan 48824, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+J.++Haak">Andrew J. Haak</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeffrey R. Leipprandt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeffrey R. Leipprandt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan 48824, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+R.++Leipprandt">Jeffrey R. Leipprandt</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thomas Dexheimer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas Dexheimer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan 48824, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Dexheimer">Thomas Dexheimer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dinesh Khanna</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dinesh Khanna</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Internal Medicine, Division of Rheumatology and Clinical Autoimmunity Center of Excellence, University of Michigan Medical Center, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dinesh++Khanna">Dinesh Khanna</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pei-Suen Tsou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pei-Suen Tsou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Internal Medicine, Division of Rheumatology and Clinical Autoimmunity Center of Excellence, University of Michigan Medical Center, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pei-Suen++Tsou">Pei-Suen Tsou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Phillip L. Campbell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Phillip L. Campbell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Internal Medicine, Division of Rheumatology and Clinical Autoimmunity Center of Excellence, University of Michigan Medical Center, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Phillip+L.++Campbell">Phillip L. Campbell</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David A. Fox</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David A. Fox</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Internal Medicine, Division of Rheumatology and Clinical Autoimmunity Center of Excellence, University of Michigan Medical Center, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+A.++Fox">David A. Fox</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bo Wen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bo Wen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UM Pharmcokinetics Core, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bo++Wen">Bo Wen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Duxin Sun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Duxin Sun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UM Pharmcokinetics Core, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Duxin++Sun">Duxin Sun</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marc Bailie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marc Bailie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Michigan State University in Vivo Facility, East Lansing, Michigan 48824, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marc++Bailie">Marc Bailie</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard R. Neubig</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard R. Neubig</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan 48824, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard+R.++Neubig">Richard R. Neubig</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0501-0008" title="Orcid link">http://orcid.org/0000-0003-0501-0008</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Scott D. Larsen</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Scott D. Larsen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vahlteich Medicinal Chemistry Core, University of Michigan, Ann Arbor, Michigan 48109, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#2e5d4a424f5c5d4b406e434b4a005b43474d46004b4a5b"><span class="__cf_email__" data-cfemail="e5968189849796808ba5888081cb90888c868dcb808190">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Scott+D.++Larsen">Scott D. Larsen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8440-4990" title="Orcid link">http://orcid.org/0000-0001-8440-4990</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01772&amp;href=/doi/10.1021%2Facs.jmedchem.8b01772" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 4350–4369</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 5, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 November 2018</li><li><span class="item_label"><b>Published</b> online</span>5 April 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 May 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01772" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01772</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4350%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDylan%250AJ.%2BKahl%252C%2BKim%2BM.%2BHutchings%252C%2BErika%2BMathes%2BLisabeth%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D9%26contentID%3Dacs.jmedchem.8b01772%26title%3D5-Aryl-1%252C3%252C4-oxadiazol-2-ylthioalkanoic%2BAcids%253A%2BA%2BHighly%2BPotent%2BNew%2BClass%2Bof%2BInhibitors%2Bof%2BRho%252FMyocardin-Related%2BTranscription%2BFactor%2B%2528MRTF%2529%252FSerum%2BResponse%2BFactor%2B%2528SRF%2529-Mediated%2BGene%2BTranscription%2Bas%2BPotential%2BAntifibrotic%2BAgents%2Bfor%2BScleroderma%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4369%26publicationDate%3DMay%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01772"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2976</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01772" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Dylan\nJ.&quot;,&quot;last_name&quot;:&quot;Kahl&quot;},{&quot;first_name&quot;:&quot;Kim&quot;,&quot;last_name&quot;:&quot;M. Hutchings&quot;},{&quot;first_name&quot;:&quot;Erika&quot;,&quot;last_name&quot;:&quot;Mathes Lisabeth&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;J. Haak&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;R. Leipprandt&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Dexheimer&quot;},{&quot;first_name&quot;:&quot;Dinesh&quot;,&quot;last_name&quot;:&quot;Khanna&quot;},{&quot;first_name&quot;:&quot;Pei-Suen&quot;,&quot;last_name&quot;:&quot;Tsou&quot;},{&quot;first_name&quot;:&quot;Phillip&quot;,&quot;last_name&quot;:&quot;L. Campbell&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;A. Fox&quot;},{&quot;first_name&quot;:&quot;Bo&quot;,&quot;last_name&quot;:&quot;Wen&quot;},{&quot;first_name&quot;:&quot;Duxin&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;Bailie&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;R. Neubig&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;D. Larsen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;4350-4369&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01772&quot;},&quot;abstract&quot;:&quot;Through a phenotypic high-throughput screen using a serum response element luciferase promoter, we identified a novel 5-aryl-1,3,4-oxadiazol-2-ylthiopropionic acid lead inhibitor of Rho/myocardin-related transcription factor (MRTF)/serum response factor (SRF)-mediated gene transcription with good potency (IC50 = 180 nM). We were able to rapidly improve the cellular potency by 5 orders of magnitude guided by sharply defined and synergistic SAR. The remarkable potency and depth of the SAR, as well as the relatively low molecular weight of the series, suggests, but does not prove, that binding to the unknown molecular target may be occurring through a covalent mechanism. The series nevertheless has no observable cytotoxicity up to 100 μM. Ensuing pharmacokinetic optimization resulted in the development of two potent and orally bioavailable anti-fibrotic agents that were capable of dose-dependently reducing connective tissue growth factor gene expression in vitro as well as significantly reducing the development &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01772&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01772" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01772&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01772" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01772&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01772" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01772&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01772&amp;href=/doi/10.1021/acs.jmedchem.8b01772" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01772" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01772" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01772%26sid%3Dliteratum%253Aachs%26pmid%3D30951312%26genre%3Darticle%26aulast%3DKahl%26date%3D2019%26atitle%3D5-Aryl-1%252C3%252C4-oxadiazol-2-ylthioalkanoic%2BAcids%253A%2BA%2BHighly%2BPotent%2BNew%2BClass%2Bof%2BInhibitors%2Bof%2BRho%252FMyocardin-Related%2BTranscription%2BFactor%2B%2528MRTF%2529%252FSerum%2BResponse%2BFactor%2B%2528SRF%2529-Mediated%2BGene%2BTranscription%2Bas%2BPotential%2BAntifibrotic%2BAgents%2Bfor%2BScleroderma%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D9%26spage%3D4350%26epage%3D4369%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291137" title="Lipids">Lipids</a>,</li><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a>,</li><li><a href="/action/doSearch?ConceptID=291774" title="Nuclear magnetic resonance spectroscopy">Nuclear magnetic resonance spectroscopy</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/jmcmar.2019.62.issue-9/20190509/jmcmar.2019.62.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Through a phenotypic high-throughput screen using a serum response element luciferase promoter, we identified a novel 5-aryl-1,3,4-oxadiazol-2-ylthiopropionic acid lead inhibitor of Rho/myocardin-related transcription factor (MRTF)/serum response factor (SRF)-mediated gene transcription with good potency (IC<sub>50</sub> = 180 nM). We were able to rapidly improve the cellular potency by 5 orders of magnitude guided by sharply defined and synergistic SAR. The remarkable potency and depth of the SAR, as well as the relatively low molecular weight of the series, suggests, but does not prove, that binding to the unknown molecular target may be occurring through a covalent mechanism. The series nevertheless has no observable cytotoxicity up to 100 μM. Ensuing pharmacokinetic optimization resulted in the development of two potent and orally bioavailable anti-fibrotic agents that were capable of dose-dependently reducing connective tissue growth factor gene expression in vitro as well as significantly reducing the development of bleomycin-induced dermal fibrosis in mice in vivo.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18731" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18731" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Scleroderma is a chronic connective tissue disease that is characterized by thickening and fibrosis of dermal epithelial tissue and vascular abnormalities. It has been designated as an orphan disease, and, while the exact number affected is unknown, estimates suggest ∼100 000–300 000 individuals have some form of scleroderma in the U.S.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> There are two classifications of the disease: localized and systemic.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Localized scleroderma does not involve internal organs, but systemic sclerosis (SSc) is associated with pathology in multiple organs, including skin, gastrointestinal tract, lungs, kidneys, heart, etc.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> The incidence of SSc in the U.S. is 9–46 cases per million per year, and roughly 50% of these individuals have a highly aggressive form: diffuse systemic sclerosis (dSSc).<a onclick="showRef(event, 'ref1 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref5">(1,5)</a> Patients suffering with dSSc have a higher risk of developing fibrosis within the internal organs, greatly increasing the patient’s mortality risk.<a onclick="showRef(event, 'ref2 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref5">(2,5)</a> Current treatments are limited to immunosuppressants and anti-inflammatories that only address the symptoms rather than the underlying causes of the disease.<a onclick="showRef(event, 'ref2 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref5">(2,5)</a> Currently in the U.S., the only FDA-approved antifibrotics are pirfenidone and nintedanib for the treatment of idiopathic pulmonary fibrosis (IPF).<a onclick="showRef(event, 'ref3 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref6">(3,6)</a></div><div class="NLM_p">Although the etiology of fibrosis is unknown, the activation of fibroblasts and their transition to myofibroblasts are key characteristics of the fibrotic process (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> Myofibroblasts produce excess extracellular matrix (ECM) components (e.g. collagen and fibronectin) and stress fibers, for example, α-smooth muscle actin (α-SMA).<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> Many of these components undergo cross-linking and maturation, resulting in a highly stable matrix that accounts for epithelial tissue stiffness.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Dysregulation of ECM homeostasis is thought to contribute to mortality associated with SSc.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. The fibroblast-to-myofibroblast transition is tightly regulated by Rho/MRTF/SRF signaling. Both soluble and mechanical stimuli promote MRTF nuclear translocation in fibroblasts. In the resting state, actin is not polymerized, and MRTF is bound to G-actin and sequestered into the cytoplasm. When stress fibers form in response to these stimuli, G-actin polymerizes into F-actin and MRTF is released. This allows MRTF to translocate into the nucleus via binding to importins followed by MRTF/importin/nuclear pore complex (NPC) formation. The MRTF/SRF coactivator complex increases ECM and pro-fibrotic gene expression, contributing to the fibroblast-to-myofibroblast transition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">There are several known cell surface receptors involved in the fibrotic process, including various integrins, GPCRs, and growth factor receptors that activate the production of ECM components (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref9 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref11 ref12 ref13">(9,11−13)</a> These surface receptors, such as those for transforming growth factor β (TGFβ), connective tissue growth factor (CTGF), and lysophosphatidic acid (LPA), activate intracellular signaling through a common mediator (Rho GTPase), which leads to activation of Rho-associated protein kinase (ROCK).<a onclick="showRef(event, 'ref11 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref11 ref14 ref15 ref16 ref17 ref18">(11,14−18)</a> Activation of ROCK induces the polymerization of globular (G)-actin to filamentous (F)-actin, which releases, and thereby promotes, the nuclear localization of myocardin-related transcription factor (MRTF).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In the nucleus, MRTF binds to the serum response factor (SRF) on serum response elements (SREs). Binding of MRTF/SRF to these promoter regions of DNA activates expression of multiple genes associated with the fibrotic process, including: <i>COL1A1</i>, <i>CTGF</i>, and <i>ACTA2</i>.<a onclick="showRef(event, 'ref9 ref14 ref16'); return false;" href="javascript:void(0);" class="ref ref9 ref14 ref16">(9,14,16)</a></div><div class="NLM_p">While Rho/MRTF/SRF signaling plays an important role in normal wound healing, over-stimulation or dysregulation of this pathway can lead to pathological fibrosis as well as increased cancer cell migration and metastasis.<a onclick="showRef(event, 'ref7 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref7 ref19 ref20 ref21 ref22">(7,19−22)</a> Several attempts to target some of the aforementioned surface receptors for this signaling pathway have been made (e.g. STX-100 for integrins, AM152 for LPA receptors, and LY2157299 for TGFβ receptors); unfortunately, therapeutics exploiting these targets have not been successfully developed for fibrotic diseases to date.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> As an alternative approach, a MRTF-A knockout mouse model has demonstrated reduced fibrosis and scarring in heart, lung, dermal, and vascular fibrosis in response to decreased collagen production and tissue stiffness.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The development of an inhibitor that blocks the Rho/MRTF/SRF transcription pathway downstream of surface receptors, which in principle could block multiple extracellular inputs, is a promising new approach toward the treatment of SSc and other fibrotic diseases.</div><div class="NLM_p">We have previously reported the development and execution of a SRE promoter-driven luciferase (SRE.L) HTS for inhibitors of the Rho/MRTF/SRF pathway.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Although SRF responds to at least two different co-activator mechanisms, Rho/MRTF and Ras/ternary complex factor (TCF), this SRE.L luciferase assay is selective for MRTF as the TCF sites in the promoter have been eliminated.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> This led to the discovery of CCG-1423, which we subsequently optimized to CCG-203971, CCG-222740, and CCG-257081—modestly potent inhibitors that are active in multiple animal models of fibrosis.<a onclick="showRef(event, 'ref19 ref22 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref19 ref22 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32">(19,22,25−32)</a> An expanded HTS of 80 000 compounds produced a second, more potent class of Rho/MRTF/SRF inhibitors based on the confirmed hit 3-((5-(<i>m</i>-tolyl)-1,3,4-oxadiazol-2-yl)thio)propanoic acid <b>1</b> (SRE.L IC<sub>50</sub> = 180 nM, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The ensuing SAR of this class proved to be remarkably deep (over 5 orders of magnitude range of activity), suggesting that the currently unknown biological target has a very well-defined binding site. Furthermore, we report indirect evidence (from the SAR) that suggests engagement with the unknown target may be covalent; nevertheless, the series appears to have very low cytotoxicity (no impact on cell viability up to 100 μM). Herein, we report the synthesis, biological activity, pharmacokinetic profile, and initial in vivo efficacy of this structurally distinct new series of Rho/MRTF/SRF-mediated gene transcription inhibitors.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Original hit (CCG-1423) from serum response element luciferase (SRE.L) high throughput screen (HTS) and series development to CCG-257081. New chemotype hit 1 from expanded SRE.L HTS of Rho/MRTF/SRF-pathway.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47467" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47467" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The general synthesis of new 5-aryl-1,3,4-oxadiazol-2-ylthioalkanoic acids and derivatives is summarized in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Various aromatic benzoic acids (<b>2</b>) were converted to their respective methyl esters under standard Fischer esterification conditions, and then converted to the corresponding hydrazides (<b>3</b>) by refluxing in MeOH with excess hydrazine hydrate. Refluxing <b>3</b> and carbon disulfide in EtOH under basic conditions, followed by acidic workup, generated 2-mercapto-5-aryl-1,3,4-oxadiazoles (<b>4</b>). S-alkylation with either methyl, ethyl, or <i>t</i>-butyl Ω-bromoalkanoates provided the thioether esters (<b>5–7</b>). Hydrolysis of the esters was accomplished with either trifluoroacetic acid (<i>t</i>-butyl esters) or sodium hydroxide (methyl and ethyl esters) to give final carboxylic acids <b>8</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The <i>tert</i>-butyl esters became the preferred precursor when <i>n</i> = 2 because basic hydrolysis of the methyl ester intermediates resulted in competing retro-Michael elimination to regenerate the 1,3,4-oxadiazole-2-thiols <b>4</b>. Amide <b>9</b> was prepared by conversion of the corresponding acid <b>8</b> to the acid chloride with oxalyl chloride in dimethylformamide (DMF)/CH<sub>2</sub>Cl<sub>2</sub> at room temperature, followed by treatment with methylamine.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of 5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>SO<sub>4</sub>/MeOH, 85 °C 6 h. (b) H<sub>4</sub>N<sub>2</sub>·H<sub>2</sub>O, 85 °C 14 h. (c) KOH/H<sub>2</sub>O/EtOH, CS<sub>2</sub>, 95 °C 16 h. (d) 1 N HCl workup (e) acetone, K<sub>2</sub>CO<sub>3</sub>, Br–(CH<sub>2</sub>)<sub><i>n</i></sub>–CO<sub>2</sub>R′, 25 °C, 5–24 h. (f) DCM, TFA, 25 °C 3 h. (g) 1 M NaOH, THF, 25 °C 16 h. (h) Oxalyl chloride, DMF, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 2 h. (i) MeNH<sub>2</sub> in EtOH, 25 °C, 16 h.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SRE.L Activity of 5-Aryl-1,3,4-oxadiazole-2-thiopropionic Acids</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0011.gif" alt="" id="GRAPHIC-d7e602-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">R<sup>4</sup></th><th class="colsep0 rowsep0" align="center">SRE.L IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">340</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">180</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8f</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8g</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8h</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8i</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8j</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4 (2<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a>)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8k</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8l</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8m</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.02<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8n</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.23<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8o</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.32<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Inhibition of Gα12-stimulated SRE.L activity (mean of <i>n</i> = 3, SEM < 10%) in PC3 cells unless otherwise noted.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Cell viability and proliferation assay with WST-1 < 5% inhibition up to 100 μM inhibitor (mean of <i>n</i> = 3, SEM < 10%).</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">SRE.L assay performed in HEK293T cells (mean of <i>n</i> = 3, SEM < 10%).</p></div></div></div><div class="NLM_p">The syntheses of 4-((5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl)oxy)butanoic acid (<b>11</b>) and 2-(((5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl)methyl)thio)acetic acid (<b>13</b>) were accomplished starting with common intermediate <b>3j</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Intermediate <b>10</b> was produced through the cyclization/rearrangement of <b>3j</b> with propylene oxide.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> O-alkylation with <i>t</i>-butyl 4-bromobutyrate followed by acidic hydrolysis with trifluoroacetic acid provided carboxylic acid <b>11</b>. Alternatively, subjecting <b>3j</b> to bromoacetic acid and POCl<sub>3</sub> afforded intermediate <b>12</b>.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Basic S-alkylation with potassium carbonate and 2-mercaptoacetic acid produced carboxylic acid <b>13</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Thioalkanoate-Modified Analogues <b>11</b> and <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>3</sub>PO<sub>4</sub>, CS<sub>2</sub>, H<sub>2</sub>O, 106 °C, 2 h. (b) Propylene oxide, 25 °C, 16 h. (c) DMF, K<sub>2</sub>CO<sub>3</sub>, Br–(CH<sub>2</sub>)<sub>3</sub>–CO<sub>2</sub><i>t</i>Bu, 90 °C, 1 h. (d) DCM, TFA, 25 °C, 1 h. (e) POCl<sub>3</sub>, bromoacetic acid, 106 °C, 16 h. (f) 2-Mercaptoacetic acid, acetone, K<sub>2</sub>CO<sub>3</sub>, 25 °C, 2 h.</p></p></figure><div class="NLM_p">Next, alkyl, fluorinated alkyl, cycloalkyl, alkoxy, and cycloalkoxy derivatives were synthesized as shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Routes to obtain vinyl and isopropyl methyl esters <b>17a</b> and <b>17c</b> were performed as previously described.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> Alkyl methyl ester <b>17b</b> was synthesized by alkylating <b>3k</b> with two equivalents of LDA and ethyl iodide, followed by esterification. 4-(1-Fluoro)-isopropyl methyl ester <b>17d</b> was synthesized from <b>14</b> by Grignard reaction with acetone followed by fluorination of the tertiary alcohol with diethylaminosulfur trifluoride (DAST). Suzuki coupling of commercially available <b>15a–c</b> with cyclopropyl boronic acid afforded cycloalkyl methyl esters <b>17e–g</b>. 4-Alkoxy aryl derivatives were formed by O-alkylation of commercially available phenol <b>16</b> using cesium carbonate and either DMA or dimethyl sulfoxide (DMSO) (<b>17h</b> and <b>17i</b>, respectively). Reduction of vinyl intermediate <b>17a</b> with 2-nitrobenzene-1-sulfonyl chloride and hydrazine hydrate resulted in ethyl intermediate <b>17a′</b>. Using chemistry analogous to <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, the aryl methyl esters <b>17a′</b> and <b>17b–i</b> were converted to respective hydrazides, 5-aryl-2-mercapto-1,3,4-oxadiazoles (<b>18a–i</b>), thioethers, and final carboxylic acids (<b>19a–i</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route To Generate Thiobutanoate Analogues <b>19a–i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) LDA (2 equiv), THF, 0 °C, 10 min, then ethyl iodide, 0 °C, 1 h. (b) MeOH, H<sub>2</sub>SO<sub>4</sub>, 85 °C, 16 h. (c) iPrMgCl, THF, −20 °C for 1.5 h, then acetone, 25 °C for 1.5 h. (d) DAST, DCM, −78 to 25 °C 2 h. (e) MeOH, H<sub>2</sub>SO<sub>4</sub>, 85 °C, 16 h. (f) Pd(II)OAc<sub>2</sub>Cl<sub>2</sub>, K<sub>3</sub>PO<sub>4</sub>, P(Cy)<sub>3</sub>, cyclopropyl boronic acid, toluene, H<sub>2</sub>O, 100 °C, 3 h. (g) Bromocyclopropane, Cs<sub>2</sub>CO<sub>3</sub>, DMA, 155 °C, 24 h then MeOH, H<sub>2</sub>SO<sub>4</sub>, 85 °C, 16 h. (h) 3-Bromooxetane, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 105 °C, 8 h. (i) 2-Nitrobenzene-1-sulfonyl chloride, H<sub>2</sub>N<sub>4</sub>·H<sub>2</sub>O, MeCN, 0–25 °C, 16 h. (j) H<sub>4</sub>N<sub>2</sub>·H<sub>2</sub>O, MeOH, 85 °C, 16 h. (k) KOH/H<sub>2</sub>O/EtOH, CS<sub>2</sub>, 95 °C, 16 h, followed by HCl workup (l) 4-bromo-butanoate ester, K<sub>2</sub>CO<sub>3</sub>, acetone, 25 °C, 16 h. (m) 1 M NaOH, THF, 25 °C, 1 h. (n) TFA, DCM, 25 °C, 1 h.</p></p></figure><div class="NLM_p">Sulfone <b>21</b> was prepared as shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>, which also includes an alternative synthetic route for <b>8q</b>. 1,3,4-Oxadiazole thioether <b>4j</b> was converted to electrophilic sulfone <b>20</b> in two steps. First, thiol <b>4j</b> was methylated with methyl iodide and triethylamine. This thioether intermediate was oxidized to <b>20</b> using either mCPBA or ammonium molybdate tetrahydrate and hydrogen peroxide.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Nucleophilic displacement of sulfone <b>20</b> using 4-mercaptobutanoic acid efficiently produced thiobutanoic acid <b>8q</b>, which was subsequently oxidized to thiobutanoic acid sulfone analogue <b>21</b> using mCPBA.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route To Generate Thiobutanoic Acid Sulfone Analogue <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeI, Et<sub>3</sub>N, THF, 25 °C, 2 h, (b) (NH<sub>4</sub>)<sub>6</sub>Mo<sub>7</sub>O<sub>24</sub>, H<sub>2</sub>O<sub>2</sub>, EtOH, 25 °C, 2 h, (c) mCPBA, DCM, 25 °C, 2 h, (d) 4-mercaptobutanoic acid, K<sub>2</sub>CO<sub>3</sub>, acetone, 25 °C, 1 h, (e) mCPBA, DCM, 25 °C, 2 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00506" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00506" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We began our SAR investigation by probing the importance of the phenyl-substituted oxadiazole ring system and the carboxylic acid with commercially available compounds (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Pyridyl (<b>22</b> and <b>23</b>)- and furanyl (<b>24</b>)-substituted oxadiazole analogues led to complete loss in activity. Attempts to replace the oxadiazole core with other heterocycles (<b>25</b>–<b>27</b>) were similarly unsuccessful. Replacement of the carboxylic acid with an acetal isostere (<b>28</b>) also abolished activity. Based on these strongly negative results, we focused our initial synthetic SAR effort on 5-aryl-1,3,4-oxadiazaole-2-thioalkanoic acids.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Preliminary SAR investigating the importance of the heterocycle and carboxylic acid. SRE.L activity (mean of <i>n</i> = 3, SEM < 10%).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We started by systematically investigating prototype electron donating (methoxy), withdrawing (chloro), and alkyl (methyl) groups at each of the three aryl positions (<b>8a–i</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). <i>Remarkably, this revealed an over 250-fold span of potency over just these first 9 analogues</i>; SRE.L IC<sub>50</sub>s ranged from 6300 nM (<b>8h</b>) to 25 nM (<b>8g</b>). Within this small initial group, we observed several clear activity cliffs, including 2-Cl <b>8g</b> (25 nM) versus 3-Cl <b>8e</b> (1500 nM) and 4-Me <b>8c</b> (34 nM) versus 3-Me <b>1</b> (180 nM) versus 2-Me <b>8h</b> (6300 nM). We were then interested to see if the individual optimum substitutions would be synergistic. From the data in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, it is clear that, among the four substituents investigated at R<sup>1</sup>, Cl is optimum. We thus combined this substitution with all three non-H substituents at R<sup>3</sup> (<b>8j–l</b>) and observed a significant increase in potency in each case; all three of these analogues had single digit nM SRE.L activities. Despite these significant improvements in SRE.L activity, all analogues tested did not affect cell proliferation/viability up to 100 μM as measured by WST-1, highlighting the series lack of acute cytotoxicity even at high concentrations. For comparison, the clinically approved antifibrotics pirfenidone and nintedanib were tested in the SRE.L assay. Pirfenidone was inactive up to a concentration of 100 μM, above which it was cytotoxic (as determined by CellTiter-Fluor). Nintedanib had an IC<sub>50</sub> of 1.3 μM  and a CellTiter-Fluor IC<sub>50</sub> of under 30 μM.</div><div class="NLM_p">It should be noted that the phenotypic screening SRE.L assay was originally designed as a HTS for cancer therapeutics, and it was developed using PC-3 cells.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> However, to improve the throughput of the assay, the transfected cell line was switched to HEK-293T cells. To ensure equivalency in SRE.L potency from one cell line to the other, various analogues were tested under both assay conditions (e.g. <b>8j</b>, <b>8q</b>, and <b>19f</b>). We did not observe notable differences in activity between the two transfected cell lines, so the assay was permanently switched to HEK-293T cells.</div><div class="NLM_p">We were able to improve activity even further with trisubstituted analogues (<b>8m</b>–<b>o</b>) that combined the best R<sup>1</sup>/R<sup>3</sup>-disubstitution analogues (<b>8j</b> & <b>8k</b>) with the best R<sup>2</sup>/R<sup>4</sup> substituent (Me). This resulted in our first sub-nanomolar analogues with SRE.L potency as high as IC<sub>50</sub> = 20 pM (<b>8m</b>). These extremely tight and potent SAR trends suggest that these inhibitors likely interact with a very well-defined binding site on the unknown molecular target.</div><div class="NLM_p">We then focused on elucidating how the propionic acid sidechain modulated activity (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Replacing the carboxylic acid functionality with neutral methyl amide (<b>9</b>) was unsuccessful; however, ethyl ester <b>6</b> maintained activity, likely due to facile hydrolysis by non-specific esterases in the cells. This is consistent with the lack of activity of neutral acetal <b>28</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), suggesting that the acid functionality is crucial for target engagement. To determine the optimal carbon chain length between the oxadiazole and the carboxylic acid, analogues bearing linkers from one to four methylenes were synthesized (<b>8p–r</b>). We found that the optimal carbon chain length was three (<b>8q</b>) and that activity was completely lost when there was only one carbon separating the oxadiazole and carboxylic acid (<b>8p</b>). This steep SAR is further evidence of the importance of the carboxylic acid group and its position relative to the oxadiazole ring. A three-carbon chain was used for all subsequent analogues.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Carboxylic Acid Sidechain SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0012.gif" alt="" id="GRAPHIC-d7e1535-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Z</th><th class="colsep0 rowsep0" align="center">G</th><th class="colsep0 rowsep0" align="center">SRE.L IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">MLM <i>T</i><sub>1/2</sub> (min)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8j</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">4 (2<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a>)</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CONHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100 000</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8p</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">>100 000</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8q</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">1.8 (0.84<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a>)</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8r</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">43</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Inhibition of Gα12-stimulated SRE.L (mean of <i>n</i> = 3, SEM < 10%) in PC3 cells.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Cell viability and proliferation assay with WST-1 < 5% inhibition up to 100 μM inhibitor (mean of <i>n</i> = 3, SEM < 10%).</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">SRE.L assay performed in HEK293T cells (mean of <i>n</i> = 3, SEM < 10%).</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Half-life in mouse liver microsomes.</p></div></div></div><div class="NLM_p">Based on our unsuccessful attempts to replace the oxadiazole core with similar heterocycles (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), the steep SAR of the series with regard to both aryl substitution and alkanoic acid chain length, and the reported ability of 5-methylsulfonyl-1,3,4-oxadiazole probes to ligate cellular nucleophiles,<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37−39)</a> we hypothesized that the oxadiazole thioether core might be covalently engaging with a binding site nucleophile as illustrated in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. We therefore carefully selected analogues (<b>11</b>, <b>13</b>, <b>29</b>) that are structurally very similar to <b>8j</b> but predicted to be much less capable of reacting with nucleophiles (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). In support of our hypothesis, we saw an almost complete loss in activity upon replacement of the S with O or CH<sub>2</sub> (<b>11</b>, <b>29</b>) or migration of the S away from the heterocyclic core (<b>13</b>). Conversely, activity was <i>lost</i> when the system was made <i>more</i> susceptible to nucleophilic attack by oxidizing the sulfide of <b>8q</b> to the corresponding sulfone (<b>21</b>). Although the inactivity of the sulfone could be explained by poor cell permeability (due to lower Clog<i>P</i>) or rapid reaction with abundant cellular nucleophiles, this particular result certainly suggests that oxidation of our sulfide inhibitors <i>in cellulo</i> to irreversibly binding sulfones is not occurring. Furthermore, it has been reported that a non-covalent 2-benzylthio-1,3,4-oxadiazole inhibitor of glycogen synthase kinase-3β can markedly lose potency with simple changes to the thiomethyl linker analogous to what we made.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Overall, therefore, our SAR does not prove or disprove a covalent mode of binding of our compounds. Confirmation will require careful proteome labeling studies, which are underway and will be reported in due course.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hypothetical reaction of <b>8j</b> with a target nucleophile, and close structural analogues designed to be less (<b>11</b>, <b>13</b> and <b>29</b>) or more (<b>21</b>) susceptible to attack by cellular nucleophiles. Indicated below each structure is SRE.L activity (HEK293T cells, mean of <i>n</i> = 3, SEM < 10%).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Finally, we investigated the SAR on the aryl ring of the butanoic acid analogue <b>8q</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). As shown previously in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, incorporation of a small alkyl or alkoxy group at R<sup>2/4</sup> or R<sup>3</sup> led to marked improvements in potency with the propionic acid series. We therefore explored  the tolerated size limits for the alkyl group and, anticipating the potential for metabolic oxidation of the aromatic methyl group, included small cycloalkyl groups, fluoroalkyl groups, and small cycloalkoxy groups that we expected to be less prone to metabolic oxidation. Consistent with what we previously observed, replacement of the 4-Cl group of butanoic acid <b>8q</b> with Me led to a significant improvement in potency (<b>8s</b>). Larger alkyl butanoic acids (<b>19a–c</b>, <b>19f</b>) achieved even greater potency, approaching the limit of what our SRE.L assay can accurately determine (<0.1 pM). While the CF<sub>3</sub> analogues <b>8u</b>, <b>v</b>, <b>w</b> all maintained activity comparable to their corresponding methyl analogues <b>8c</b>, <b>h</b>, <b>s</b>, the larger fluoro containing derivative, 1-fluoroisopropyl <b>19d</b>, was less potent than its alkyl comparator <b>19c</b>, suggesting a possible size limit at R<sup>3</sup>. Interestingly, replacement of the 4-Cl of <b>8q</b> with 4-Br (<b>8x</b>) led to a 10-fold improvement in activity, consistent with the greater potency observed when the size of the 4-methyl group was increased. Additional evidence for the size limitation at R<sup>3</sup> was provided by 4-Ph analogue <b>8y</b>. Incorporation of oxygen (e.g. <b>8t</b>, <b>19h</b> and <b>19i</b>) also did not afford the same levels of activity as the corresponding aliphatic analogues, perhaps due to decreased permeability. The narrow SAR we had been observing was once again evident when the cyclopropyl at R<sup>3</sup> of <b>19f</b> was migrated to the R<sup>2</sup> (<b>19e</b>) or R<sup>4</sup> (<b>19g</b>) positions, leading to significant reductions in SRE.L activity. Finally, with regard to in vitro metabolic stability [as determined by half-life in the presence of mouse liver microsomes (MLM <i>T</i><sub>1/2</sub>)], replacement of the Cl at R<sup>3</sup> of <b>8q</b> with more potent Me (<b>8s</b>) was detrimental, as expected, but further replacement of the Me with c-Pr (<b>19f</b>) returned a measure of metabolic stability while improving potency 100-fold.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SRE.L Activity of 5-Aryl-1,3,4-oxadiazole-2-thiobutanoic Acids</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0013.gif" alt="" id="GRAPHIC-d7e1975-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">R<sup>4</sup></th><th class="colsep0 rowsep0" align="center">SRE.L IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">MLM <i>T</i><sub>1/2</sub> (min)<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8q</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.84</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8s</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.1<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8t</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">MeO</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.0007</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><0.0001</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19c</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.0007</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8u</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">46</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8v</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">10 000</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8w</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.06</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19d</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8x</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.07</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8y</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19e</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.019</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19f</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">c-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.001 (0.0012<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a>)</td><td class="colsep0 rowsep0" align="left">47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19g</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19h</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>O</i>-cyclopropyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19i</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>O</i>-oxetanyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">370</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Inhibition of Gα12-stimulated SRE.L activity (mean of <i>n</i> = 3, SEM < 10%) in HEK cells.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Cell viability and proliferation assay with WST-1 < 5% inhibition up to 100 μM inhibitor (mean of <i>n</i> = 3, SEM < 10%).</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">SRE.L data generated with transfected PC-3 cells (mean of <i>n</i> = 3, SEM < 10%).</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Half-life in mouse liver microsomes.</p></div></div></div><div class="NLM_p">IV and PO PK analyses were performed on representative analogues <b>8j</b>, <b>8q</b>, and <b>19f</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Propionic acid <b>8j</b> demonstrated good oral bioavailability (67%) and a moderate half-life (2 h). Rather surprisingly, the corresponding butanoic acid <b>8q</b>, despite apparently similar metabolic stability in vitro, had inferior in vivo PK properties, with a clearance rate almost 3-fold higher than <b>8j</b> and lower oral bioavailability. Butanoic acid <b>19f</b> also had a higher in vivo clearance rate, suggesting that the longer alkanoic acid moiety is a primary site of metabolism. It is interesting to note, however, that plasma exposure of <b>19f</b> was not linear with oral dose, increasing from 11% bioavailability at 3 mg/kg to 29% at 30 mg/kg, suggesting some saturation of first pass clearance.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Physical and Pharmacokinetic Parameters for Selected Rho/MRTF/SRF Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">SRE.L IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">solubility (μM)</th><th class="colsep0 rowsep0" align="center">MLM <i>T</i><sub>1/2</sub> (min)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">route, dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center">AUC (h·ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">Cl (mL/min/kg)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center">F %</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8j</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">682<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">IV, 15</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="left">47 350</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="left">88 550</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">PO, 30</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="left">63 170</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">34 050</td><td class="colsep0 rowsep0" align="left">67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8q</b></td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">841<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">IV, 10</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="left">10 716</td><td class="colsep0 rowsep0" align="char" char=".">15.5</td><td class="colsep0 rowsep0" align="left">35 650</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">PO, 20</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="left">11 140</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">23 150</td><td class="colsep0 rowsep0" align="left">52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19f</b> (CCG-232964)</td><td class="colsep0 rowsep0" align="left">0.001</td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">47</td><td class="colsep0 rowsep0" align="left">IV, 3</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="left">3255</td><td class="colsep0 rowsep0" align="char" char=".">15.4</td><td class="colsep0 rowsep0" align="left">8140</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">PO, 3</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="left">361</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">397</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">PO, 10</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="left">1826</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">1433</td><td class="colsep0 rowsep0" align="left">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">PO, 30</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="left">9496</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">10 053</td><td class="colsep0 rowsep0" align="left">29</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Thermodynamic solubility analysis was performed by Analiza Inc. using quantitative nitrogen detection (<a href="http://www.analiza.com" class="extLink">www.analiza.com</a>).</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Equilibrium solubility in PBS at 25 °C.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Half-life in mouse liver microsomes. PK parameters were estimated using non-compartmental analysis with Phoenix/WINONLIN.</p></div></div></div><div class="NLM_p">To assess direct effects on pro-fibrotic gene expression, primary human dermal fibroblasts were pre-treated with <b>8j</b> (CCG-58150) or <b>19f</b> (CCG-232964) for 48 or 72 h (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). After the pre-incubation, cells were stimulated with LPA—a direct activator or the Rho pathway through Gα12/13<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a>—for 1 h. Interestingly, after 48 h, neither <b>8j</b> nor <b>19f</b> had any significant effect on CTGF gene expression; however, after 72 h, both inhibitors dose-dependently reduced CTGF gene expression, with <b>19f</b> being ∼100× more potent than <b>8j</b>. Under the same assay conditions, nintedanib inhibited CTGF expression at 10<sup>–6</sup> M (45% of DMSO control) but not below and was cytotoxic at 10<sup>–5</sup> M. Pirfenidone did not significantly inhibit CTGF expression even at a concentration of 10<sup>–5</sup> M (91% control).</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>8j</b> and <b>19f</b> inhibit LPA-induced CTGF gene expression. Primary dermal fibroblasts from healthy donors were pre-treated with varying concentrations of <b>8j</b> (CCG-58150) and <b>19f</b> (CCG-232964) for (A) 48 h or (B) 72 h and stimulated with 1 μM LPA for 1 h. CTGF mRNA levels were measured by qPCR. Results are expressed as the mean ± SEM. *<i>p</i> < 0.05, **<i>p</i> < 0.01 vs DMSO control using one-way ANOVA; <i>n</i> > 3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We selected a mouse model of dermal fibrosis that entails inhibition of dermal thickening induced by bleomycin as our preliminary measure of in vivo efficacy of <b>8j</b> (CCG-58150) and <b>19f</b> (CCG-232964). This model has been well-described in the literature,<a onclick="showRef(event, 'ref29 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref29 ref42 ref43">(29,42,43)</a> and histopathological examination of fibrotic lung and dermal tissue induced by bleomycin treatment in mice reveals a high level of similarity to fibrotic disease progression in humans.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The protocol entails daily intracutaneous injections of bleomycin with concurrent treatment by drug or vehicle for 14 days. At the end of the dosing period, the mice are sacrificed and sections of skin at the injection site are excised and analyzed for dermal thickness and hydroxyproline—a major component of collagen and an accepted biomarker for collagen content.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p">Based on the high <i>C</i><sub>max</sub> achieved in the mouse PK study for <b>8j</b> [30 mg/kg PO dosing (107 μM) relative to the SRE.L IC<sub>50</sub> (4 nM)], we selected three lower doses for <b>8j</b> (0.1, 1 and 10 mg/kg/day) by oral gavage during bleomycin treatment. <b>8j</b> was able to dose-dependently reduce both measures of bleomycin-induced fibrotic effects (dermal thickness and hydroxyproline content), having significant effects at 10 mg/kg versus bleomycin/vehicle control (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,B). In a subsequent study, two doses were selected for the more potent but less bioavailable compound <b>19f</b> (3 and 10 mg/kg PO). The lower dose was calculated based on the single dose oral PK data (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) to achieve comparable plasma AUC: SRE.L IC<sub>50</sub> ratio as the efficacious 10 mg/kg dose of <b>8j</b>. At the conclusion of this study, <b>19f</b> significantly reduced bleomycin-induced dermal fibrosis at both doses, indicating that it is at least 3-fold more potent than <b>8j</b> in vivo (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C–E). By way of comparison, nintedanib has been reported by the Distler lab to be effective at preventing bleomycin-induced dermal thickness in mice at a minimum dose of 30 mg/kg/day,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> suggesting that our compounds are significantly more potent in this assay. To our knowledge, pirfenidone has not been tested in this assay for prevention of dermal fibrosis but has been reported to attenuate bleomycin-induced lung fibrosis in mice at a dose of 300 mg/kg.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. 5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic acids prevent bleomycin-induced dermal fibrosis. Mice treated with inhibitors displayed significantly reduced skin thickness and collagen content as compared to vehicle control. (A) Masson’s trichrome stained skin sections from PBS (left panel), bleomycin + vehicle control (middle panel), and bleomycin +10 mg/kg <b>8j</b> (right panel). <i>N</i> = 10 per group. (B) Quantification of (A), by measuring the distance between the subcutaneous fat and the epidermis. *<i>p</i> < 0.05 by using one-way ANOVA. (C) Masson’s trichrome stained skin sections for PBS (left panel), bleomycin + vehicle (middle left panel), bleomycin + 3 mg/kg <b>19f</b> (middle right panel), or bleomycin + 10 mg/kg <b>19f</b> (right panel). <i>N</i> = 7 per group. (D) Quantification of (C). ****<i>p</i> < 0.0001, using one-way ANOVA. (E) Quantification of collagen content by hydroxyproline measurement. ****<i>p</i> < 0.0001, using one-way ANOVA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33477" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33477" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In conclusion, we have developed a novel and highly potent series of inhibitors of Rho/MRTF/SRF-mediated gene transcription. The hit <b>1</b> was discovered during our previously reported phenotypic HTS utilizing a SRE.L expression readout. We systematically explored modifications to the heterocyclic core, the aromatic ring at C-5, and the alkanoic acid sidechain. During this process, we observed extremely tight SAR and multiple activity cliffs. We ultimately achieved an astonishing 150 000-fold improvement in SRE.L activity while progressing from hit <b>1</b> (SRE.L IC<sub>50</sub> = 180 nM) to lead <b>19f</b> (SRE.L IC<sub>50</sub> = 0.001 nM). Based on the structural similarity of our chemical series to previously reported in vivo probes that can label proteins, it is possible that the extreme potency we have achieved is due to the availability of a covalent mode of binding to the unknown molecular target. Our SAR, in part, supports this hypothesis by showing that simple modification of the potentially reactive thio-containing group largely abolishes activity, but confirmation will require further work to unambiguously demonstrate labeling of cellular proteins. Despite their extraordinarily high potency at inhibiting SRE.L-driven gene expression, the compounds have very low acute cytotoxicity up to 100 μM, as measured by WST-1 cell proliferation.</div><div class="NLM_p last">Selected SRE.L inhibitors <b>8j</b> and <b>19f</b> were able to reduce expression of the pro-fibrotic gene CTGF in LPA-stimulated human fibroblasts. In improving the series’ activity, we were also able to generate probes with acceptable PK profiles for in vivo studies. The potent and dose-dependent anti-fibrotic effects displayed by both <b>8j</b> (CCG-58150) and <b>19f</b> (CCG-232964) introduce orally efficacious 5-aryl-1,3,4-oxadiazol-2-ylthioalkanoic acid Rho/MRTF/SRF-mediated gene transcription inhibitors as potential therapeutics for fibrotic diseases. As part of further development of these inhibitors, identification of the biological target(s) will be key and is under active investigation.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12080" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12080" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> SRE.L Luciferase</h3><div class="NLM_p">For luciferase assays using PC3 cells, 20 000 cells/well were plated in a 96-well plate in 10% FBS + Dulbecco’s modified Eagle medium (DMEM). The next day, cells were transfected with 56 ng of SRE.L luciferase reporter and 2 ng/well of either Gα12 Q231L or pcDNA using Lipofectamine 2000 (Life Technologies) and Opti-MEM (Gibco). After 4 h of transfection, media was changed to 0.5% FBS + DMEM and cells were treated with compounds or DMSO control overnight. The next day, viability was measured using WST-1 (Roche) and absorbance was read at 450 nm. After viability was measured, cells were lysed, and luciferase was measured using the luciferase assay system (Promega).</div><div class="NLM_p last">For luciferase assays in HEK293T cells, see Hutchings et al.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> qPCR for LPA-Stimulated Expression of CTGF</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> LPA Stimulation</h4><div class="NLM_p last">Primary dermal fibroblasts isolated from healthy donors were cultured in DMEM containing 10% FBS and 1% Pen/Strep. Prior to LPA stimulation, cells were seeded in 0.5% FBS containing DMEM and pre-treated with compounds or DMSO control for 48 or 72 h. After the pre-treatment, LPA (1-oleoyl LPA, Cayman Chemical, Cat #10010093) was added at a final concentration of 10 μM for 1 h in DMEM containing 0.5% FBS and 1% Pen/Strep. After LPA stimulation, cells were lysed in iScript RT-qPCR lysis buffer (Biorad, Hercules CA, Cat #170-8898). Cells used for experiments were passaged no more than 8 times.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> qPCR</h4><div class="NLM_p last">For qPCR analysis, the iTaq Universal SYBR Green One Step Kit was used (BioRad, Hercules, CA Cat #172-5151) following the manufacturer’s instructions. 1 μL of template lysate was added to the RT-qPCR master mix. Primers used were: CTGF forward 5′-CAGAGTGGAGCGCCTGTT-3′, CTGF reverse 5′-TTGTCCGCGAGGTGAGAC-3′, GAPDH forward 5′ GAAGGTGAAGGTCGGAGTCA, and GAPDH reverse 5′-TTGAGGTCAATGAAGGGGTC-3′. Fold differences were calculated using the ΔΔCt method with GAPDH as a reference. PCR products were analyzed on a 1% agarose gel.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Metabolic Stability in Mouse Liver Microsomes</h3><div class="NLM_p last">The metabolic stability was assessed using CD-1 mouse liver microsomes. One micromolar of each compound was incubated with 0.5 mg/mL microsomes and 1.7 mM cofactor NADPH in 0.1 M phosphate buffer (pH = 7.4) containing 3.3 mM MgCl<sub>2</sub> at 37 °C. The DMSO concentration was less than 0.1% in the final incubation system. At 0, 5, 10, 15, 30, 45, and 60 min of incubation, 40 μL of reaction mixture were taken out, and the reaction is quenched by adding 3-fold excess of cold acetonitrile containing 100 ng/mL of internal standard for quantification. The collected fractions were centrifuged at 15 000 rpm for 10 min to collect the supernatant for LC–MS/MS analysis, from which the amount of compound remaining was determined. The natural log of the amount of compound remaining was plotted against time to determine the disappearance rate and the half-life of tested compounds.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Pharmacokinetic Studies in Mice</h3><div class="NLM_p last">All animal experiments in this study were approved by the University of Michigan Committee on Use and Care of Animals and Unit for Laboratory Animal Medicine. The abbreviated pharmacokinetics for <b>8j</b>, <b>8q</b>, and <b>19f</b> were determined in female CD-1 mice following intravenous (iv) and/or orally (po). Compound was dissolved in the vehicle containing 15% (v/v) DMSO, 15% (v/v) PEG-400, and 70% (v/v) phosphate-buffered saline (PBS). Four blood samples (50 μL) were collected over 7 h (at 0.5, 2, 4, and 7 h) and centrifuged at 3500 rpm for 10 min, and plasma was frozen at −80 °C for later analysis. Plasma concentrations of the compounds were determined by the LC–MS/MS method developed and validated for this study. The LC–MS/MS method consisted of a Shimadzu HPLC system, and chromatographic separation of tested compound which was achieved using a Waters Xbridge-C18 column (5 cm × 2.1 mm, 3.5 μm). An AB Sciex QTrap 4500 mass spectrometer equipped with an electrospray ionization source (ABI-Sciex, Toronto, Canada) in the positive-ion multiple reaction monitoring mode was used for detection. All pharmacokinetic parameters were calculated by non-compartmental methods using WinNonlin, version 3.2 (Pharsight Corporation, Mountain View, CA, USA).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Bleomycin-Induced Antifibrotic Effects in Mice—CCG-58150 (<b>8j</b>)</h3><div class="NLM_p last">During intradermal injections and gavage of test substance mice were anesthetized using isoflurane. The back was shaved and the injection site (∼1 cm<sup>2</sup>) cleaned with three alternating passes of chlorhexidine and warm, sterile saline or water. The periphery of the injection site was circled using a sharpie marker as a visual aid. Bleomycin was dissolved in sterile PBS at a concentration of 1 mg/mL, sterile filtered, and frozen in aliquots appropriately sized for the daily injections prior to the start of the dosing period. 100 μL of bleomycin or PBS (vehicle 1) was administered to anesthetized mice by intradermal injection using a 0.5cc TB syringe with a 27G needle. Following bleomycin or vehicle administration, test substance (<b>8j</b>, CCG-58150) or vehicle 2 (20% DMSO/30% PEG/50% PBS) was administered by oral gavage at 10 μL/g of body weight. Mice received daily clinical observations, injections of vehicle/bleomycin and oral vehicle/test substance for 14 days. Mice were weighed weekly and were euthanized on day 15. The bleomycin injection site was visually assessed, and apparent fibrosis was graded as not detectable (0), mild fibrosis (1), moderate fibrosis (2), or severe fibrosis (3), based on the appearance of lesion. A terminal blood sample was collected for the determination of serum chemistry values. The liver was collected and fixed in neutral buffered formalin, slides prepared and stained with hematoxolin and eosin (H & E). The skin at the injection site was excised to contain a few mm of normal skin around the perimeter of the fibrotic skin. A small section (∼5 × 2 mm) of the fibrotic skin was collected using a scalpel, placed in a microfuge tube, snap frozen in liquid nitrogen, and stored at −80 °C for future evaluation by the sponsor. The remaining tissue was pinned flat and fixed in 10% buffered formalin at room temperature. After fixation for at least 24 h, the skin was cut into 1–2 mm wide strips and embedded in paraffin with the tissue cross section facing up and all strips oriented in the same direction in the cassette. Slides were prepared and stained with H & E and Masson’s trichrome. All slides and frozen tissue were sent to the sponsor at study completion.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Bleomycin-Induced Antifibrotic Effects in Mice—CCG-232964 (<b>19f</b>)</h3><div class="NLM_p">C57BL/6J mice were ordered from Jackson labs for delivery at 15–16 weeks of age. Mice were preconditioned with supplemental chow for two weeks prior to start of the experiment. Mice were randomized by weight into four groups [vehicle, <b>19f</b> (3 mg/kg), <b>19f</b> (10 mg/kg), PBS]. Each group consisted of two cages with four mice per cage. Drug stock solutions were aliquoted and stored at 4 °C for the duration of the study. Aliquots were warmed to 37 °C and briefly vortexed prior to filling the gavage syringes. Vehicle and <b>19f</b> groups received daily bleomycin injections (0.1 mL, ID) each afternoon in a defined area of shaved dorsal skin. The PBS control group received daily injections (0.1 mL, ID) of PBS in the afternoon. Mice were anesthetized with ketamine/xylazine for ID injections. <b>19f</b> (3 or 10 mg/kg) and the vehicle (20% DMSO/50% PEG-400/30% PBS) were administered (po) in the morning by the University of Michigan’s Unit for Laboratory Animal Medicine in Vivo Animal Core. Mice were weighed daily to determine gavage dosage volume. Mice were euthanized after 14 days of treatment by CO<sub>2</sub> inhalation/thoracotomy. Skin from the defined area was excised for biochemical and histological analyses. A portion of the skin was fixed in neutral buffered formalin (10%), washed in 70% ethanol, and paraffin embedded for Masson’s trichrome histological staining. Another portion of the skin was snap frozen for hydroxyproline measurement.</div><div class="NLM_p">Fixed skin was paraffin embedded and sectioned at the University of Michigan Comprehensive Cancer Center Histology Core. Skin sections were stained with Masson’s trichrome (Sigma-Aldrich). Stained sections were analyzed with an Olympus BX51\DP72 microscope. Dermal thickness was determined by measuring the maximal distance between the epidermal–dermal junction and the dermal–subcutaneous fat junction. Three measurements were averaged from each skin section. The measurement was performed using the measurement tool in the cellSens imaging software package (Olympus).</div><div class="NLM_p last">Skin sections were weighed and hydrolyzed in 6 M HCl at 120 °C for 3 h. Hydrolyzed skin supernatant and hydroxyproline standards (Sigma-Aldrich) were transferred to a microplate and dried at 60 °C. Samples and standards were oxidized with chloramine T oxidation buffer for 5 min at room temperature. 4-(Dimethylamino)benzaldehyde was added to the wells and incubated at 60 °C until the standard was well defined. Absorbance was measured at 560 nm using a Synergy HT microplate reader (BioTek Instruments). Hydroxyproline values were normalized to tissue weight.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Chemistry</h3><div class="NLM_p">All reagents were used without further purification as received from commercial sources unless noted otherwise. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were taken in DMSO-<i>d</i><sub>6</sub>, MeOD-<i>d</i><sub>4</sub>, or CDCl<sub>3</sub> at room temperature on Varian Inova 400 MHz or Varian Inova 500 MHz instruments. Reported chemical shifts for the <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded in parts per million (ppm) on the δ scale from an internal standard of residual tetramethylsilane (0 ppm). Mass spectrometry data were obtained on either a Micromass LCT or Agilent Q-TOF. An Agilent 1100 series HPLC with an Agilent Zorbax Eclipse Plus-C18 column (3.5 μM, 4.6 × 100 mm) was used to determine purity of biologically tested compounds. All tested compounds were determined to be >95% pure using a 6 min gradient of 10–90% acetonitrile in water followed by a 2-min hold at 90% acetonitrile at a flow rate of 1 mL/min with detection at 254 nm. Purification was accomplished using silica gel 40–63 μm 60 Å for column chromatography. Purification of some final compounds required Waters semipreparative HPLC with a Vydac protein and peptide C18 reverse phase column, using a linear gradient of 0% solvent B (0.1% TFA in acetonitrile) in solvent A (0.1% TFA in water) to 100% solvent B in solvent A at a rate 1% per minute and monitoring UV absorbance at 230 nm.</div><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Method A: General Procedure for Fisher Esterification of Aryl Carbocyclic Acids</h4><div class="NLM_p last">The appropriate aryl acid (1.0 equiv) was dissolved in MeOH (2–4 mL/1 mmol), and 98% sulfuric acid (1 equiv) was added. The mixture was heated to reflux 4–16 h. The reaction solution was cooled to room temperature and concentrated in vacuo. The resulting crude residue was dissolved in a sat. NaHCO<sub>3(aq)</sub> solution and extracted with DCM. The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, and concentrated to afford the desired ester. Yields: 50–100%.</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Method B: General Procedure for Hydrazine Coupling of Aryl Methyl Carboxylates</h4><div class="NLM_p last">In a round-bottomed flask, the starting aryl ester (1.0 equiv) was dissolved in MeOH (2–4 mL/mmol), and hydrazine hydrate (10 equiv) was added. The solution was heated to reflux (85 °C) for overnight. The reaction was cooled to 25 °C and concentrated in vacuo. The residue was taken up in DCM and partitioned between water, and the product was extracted with DCM (3 × 20 mL). The combined organic layers were washed with brine, dried with MgSO<sub>4</sub>, and concentrated in vacuo to obtain white crystals. Yields: 70–100%.</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Method C: General Procedure for 1,3,4-Oxadiazole-thiol Cyclization of Aryl Hydrazides</h4><div class="NLM_p last">In a round-bottomed flask, the appropriate aryl hydrazide (1 equiv) was dissolved in a 0.1 M solution of KOH (1 equiv) in EtOH (2–4 mL/mol)/H<sub>2</sub>O (10 equiv) and placed under nitrogen. Carbon disulfide (1 equiv) was added and the reaction was heated to reflux (95 °C) overnight. Upon completion, most of the EtOH was evaporated in vacuo and the residue was cooled to 0 °C. The product was acidified to pH 1 with 1 N HCl, and the subsequent white precipitate was filtered and dried under vacuum. Yields: 50–90%.</div></div><div id="sec5_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Method D: General Procedure for Alkyl Bromide Coupling of 1,3,4-Oxadiazole-2-thiols</h4><div class="NLM_p last">The starting thiol (1 equiv), acetone (2–4 mL/1 mmol), and potassium carbonate (1.3 equiv) were combined in a round-bottomed flask. The alkyl bromide (1.3 equiv mmol) was added to the solution, and the reaction was stirred under nitrogen at 25 °C overnight. The crude mixture was concentrated in vacuo, and the residue was partitioned between DCM and water. The product was extracted with DCM (3 × 15 mL), washed with brine (30 mL), dried with MgSO<sub>4</sub>, and concentrated in vacuo. The oil was subjected to silica gel chromatography eluting with 30–80% EtOAc/Hex. The fractions containing the product were concentrated, and, after sitting overnight, some of the subsequent oils produced white solid. Yields: 50–95%.</div></div><div id="sec5_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Method E: General Procedure for Acidic Ester Hydrolysis of <i>t</i>-Butyl Esters</h4><div class="NLM_p last">In a round-bottomed flask, the appropriate <i>t</i>-butyl ester (1 equiv) was dissolved in DCM (2–4 mL/1 mmol). Trifluoroacetic acid (25 equiv) was added and the reaction was stirred under nitrogen at 25 °C for 3 h. The crude mixture was concentrated in vacuo and then dissolved in a minimal amount of EtOAc. The product was triturated out with Hex, and the subsequent white precipitate was filtered and dried under vacuum. Yields: 20–90%.</div></div><div id="sec5_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Method F: General Procedure for Basic Ester Hydrolysis of Methyl Esters</h4><div class="NLM_p last">In a round-bottomed flask, the starting methyl ester (1 equiv) was dissolved in THF (1–2 mL/1 mmol). 1 M NaOH (1–2 mL/1 mmol) was added to the solution, and the reaction was stirred at 25 °C for 3 h. The THF was evaporated in vacuo, and then the aqueous layer was acidified with 1 N HCl (7 mL). The product was extracted with EtOAc (3 × 15 mL), washed with brine (3 × 10 mL), dried with MgSO<sub>4</sub>, and concentrated in vacuo. The residue was dissolved in minimal EtOAc, and the product was triturated with Hex, producing a white precipitate that was filtered and dried under vacuum. Yields: 50–90%.</div></div><div id="sec5_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Method G: General Procedure for Suzuki Cross Coupling of Aryl Bromides</h4><div class="NLM_p last">The appropriate aryl bromide (1 equiv) was dissolved in toluene (2–4 mL/1 mmol) and degassed under an inert atmosphere. H<sub>2</sub>O (10 equiv), potassium phosphate dibasic (3.5 equiv), cyclopropyl boronic acid (1.2 equiv), tricyclohexylphosphine (0.1 equiv), and palladium(II) acetate (0.15 equiv) were added. The mixture was heated at reflux (100 °C) for 3 h under N<sub>2</sub>. The mixture was cooled to 25 °C and H<sub>2</sub>O was added. The product was extracted with EtOAc (3 × 15 mL), washed with brine (2 × 15 mL), dried with MgSO<sub>4</sub>, and concentrated in vacuo. The yellow residue was subjected to silica gel chromatography eluting with 2.5% EtOAc/97.5% Hex. Yields: 70–95%.</div></div><div id="sec5_7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-Chloro-4-methylbenzohydrazide (<b>3k</b>)</h4><div class="NLM_p last">Method B starting from methyl 2-chloro-4-methylbenzoate (<b>2k′</b>, 1.0 g) gave 2-chloro-4-methylbenzohydrazide as white powder (0.79 g, 73%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.63 (s, 1H), 7.55 (d, <i>J</i> = 7.9 Hz, 1H), 7.22 (d, <i>J</i> = 1.6 Hz, 1H), 7.12 (dd, <i>J</i> = 7.9, 1.6 Hz, 1H), 4.14 (br s, 2H), 2.36 (s, 3H); HPLC Ret: 3.95 min.</div></div><div id="sec5_7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-Chloro-4-methoxybenzohydrazide (<b>3l</b>)</h4><div class="NLM_p last">Method A followed by method B starting from 2-chloro-4-methoxybenzoic acid (<b>2l</b>) gave 2-chloro-4-methoxybenzohydrazide as off-white solid (2-steps, 886 mg, 82%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.43 (t, <i>J</i> = 4.1 Hz, 1H), 7.31 (d, <i>J</i> = 8.6 Hz, 1H), 7.04 (d, <i>J</i> = 2.5 Hz, 1H), 6.92 (dd, <i>J</i> = 8.5, 2.5 Hz, 1H), 4.43 (d, <i>J</i> = 4.2 Hz, 2H), 3.78 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.0, 160.9, 132.0, 130.7, 128.1, 115.4, 113.3, 56.2; MS (ESI+) <i>m</i>/<i>z</i>: 200.9 [M + H]<sup>+</sup>; HPLC Ret: 4.33 min.</div></div><div id="sec5_7_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-Chloro-3,4-dimethylbenzohydrazide (<b>3m</b>)</h4><div class="NLM_p last">Method A followed by method B starting from 2-chloro-3,4-dimethylbenzoic acid (<b>2m</b>, 0.25 g) gave 2-chloro-3,4-dimethylbenzohydrazide as white solid (2-steps, 0.27 g, 100%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.42 (br s, 1H), 7.16 (d, <i>J</i> = 7.7 Hz, 1H), 7.07 (d, <i>J</i> = 7.7 Hz, 1H), 4.43 (br s, 2H), 2.32 (s, 3H), 2.29 (s, 3H); HRMS (ESI+) <i>m</i>/<i>z</i>: 199.0633 [M + H]<sup>+</sup> (expected 199.0638); HPLC Ret: 4.33 min.</div></div><div id="sec5_7_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-Chloro-4,5-dimethylbenzohydrazide (<b>3n</b>)</h4><div class="NLM_p last">Method A followed by method B starting from 2-chloro-4,5-dimethylbenzoic acid (<b>2n</b>, 0.25 g) gave 2-chloro-4,5-dimethylbenzohydrazide as white solid (2-steps, 0.24 g, 90%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.43 (br s, 1H), 7.26 (s, 1H), 7.16 (s, 1H), 4.44 (br s, 2H), 2.23 (s, 3H), 2.19 (s, 3H); HRMS (ESI+) <i>m</i>/<i>z</i>: 199.0635 [M + H]<sup>+</sup> (expected 199.0638); HPLC Ret: 4.41 min.</div></div><div id="sec5_7_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2,4-Dichloro-5-methylbenzohydrazide (<b>3o</b>)</h4><div class="NLM_p last">Method A followed by method B starting from 2,4-dichloro-5-methylbenzoic acid (<b>2o</b>, 0.09 g) gave 2,4-dichloro-5-methylbenzohydrazide as white solid (2-steps, 0.07 g, 72%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.56 (br s, 1H), 7.63 (s, 1H), 7.40 (s, 1H), 4.49 (br s, 2H), 2.32 (s, 3H); HRMS (ESI+) <i>m</i>/<i>z</i>: 219.0087 [M + H]<sup>+</sup> (expected 219.0092); HPLC Ret: 4.74 min.</div></div><div id="sec5_7_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-(Trifluoromethyl)benzohydrazide (<b>3v</b>)</h4><div class="NLM_p last">Method B starting from methyl 2-(trifluoromethyl)benzoate (<b>2v′</b>, 0.5 g) gave 2-(trifluoromethyl)benzohydrazide as white solid (0.38 g, 76%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.73 (dd, <i>J</i> = 7.7, 1.3 Hz, 1H), 7.65–7.48 (m, 3H), 6.98 (br s, 1H), 4.12 (br s, 2H); HRMS (ESI+) <i>m</i>/<i>z</i>: 205.0585 [M + H]<sup>+</sup> (expected 205.0589); HPLC Ret: 3.25 min.</div></div><div id="sec5_7_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-Chloro-4-(trifluoromethyl)benzohydrazide (<b>3w</b>)</h4><div class="NLM_p last">Method B starting from methyl 2-chloro-4-(trifluoromethyl)benzoate (<b>2w′</b>, 0.5 g) gave 2-chloro-4-(trifluoromethyl)benzohydrazide as white solid (0.48 g, 98%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.75 (d, <i>J</i> = 8.1 Hz, 1H), 7.70 (d, <i>J</i> = 1.7 Hz, 1H), 7.60 (dd, <i>J</i> = 8.0, 1.7 Hz, 1H), 7.50 (br s, 1H), 3.94 (br s, 2H); MS (ESI+) <i>m</i>/<i>z</i>: 239.0 [M + H]<sup>+</sup>; HPLC Ret: 4.48 min.</div></div><div id="sec5_7_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 4-Bromo-2-chlorobenzohydrazide (<b>3x</b>)</h4><div class="NLM_p last">Method B starting from methyl 4-bromo-2-chlorobenzoate (<b>2x′</b>, 0.5 g) gave 4-bromo-2-chlorobenzohydrazide as white solid (0.46 g, 97%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.42 (d, <i>J</i> = 8.2 Hz, 1H), 7.31 (s, 1H), 7.19 (dd, <i>J</i> = 8.2, 1.9 Hz, 1H); MS (ESI+) <i>m</i>/<i>z</i>: 249.0 [M + H]<sup>+</sup>; HPLC Ret: 4.48 min.</div></div><div id="sec5_7_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-Chloro-[1,1′-biphenyl]-4-carbohydrazide (<b>3y</b>)</h4><div class="NLM_p last">Method B starting from methyl 3-chloro-[1,1′-biphenyl]-4-carboxylate (<b>2x′</b>, 0.42 g) gave 3-chloro-[1,1′-biphenyl]-4-carbohydrazide as white solid (0.36 g, 94%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.62 (d, <i>J</i> = 26.9 Hz, 1H), 7.87–7.61 (m, 3H), 7.57–7.34 (m, 5H), 4.53 (d, <i>J</i> = 24.8 Hz, 2H); MS (ESI+) <i>m</i>/<i>z</i>: 247.0 [M + H]<sup>+</sup>; HPLC Ret: 5.36 min.</div></div><div id="sec5_7_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 5-(2-Chloro-4-methylphenyl)-1,3,4-oxadiaole-2-thiol (<b>4k</b>)</h4><div class="NLM_p last">Method C starting from 2-chloro-4-methylbenzohydrazide (<b>3k</b>, 0.3 g) gave 5-(2-chloro-4-methylphenyl)-1,3,4-oxadiaole-2-thiol as white powder (0.29 g, 77%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.80 (d, <i>J</i> = 8.0 Hz, 1H), 7.55 (s, 1H), 7.37 (d, <i>J</i> = 8.1 Hz, 1H), 2.39 (s, 3H); HPLC Ret: 6.70 min.</div></div><div id="sec5_7_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 5-(2-Chloro-4-methoxyphenyl)-1,3,4-oxadiazole-2-thiol (<b>4l</b>)</h4><div class="NLM_p last">Method C starting from 2-chloro-4-methoxybenzohydrazide (886 mg, <b>3l</b>) gave 5-(2-chloro-4-methoxyphenyl)-1,3,4-oxadiazole-2-thiol as white solid (912 mg, 85%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.80 (d, <i>J</i> = 8.8 Hz, 1H), 7.24 (d, <i>J</i> = 2.5 Hz, 1H), 7.09 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 3.85 (s, 3H); MS (ESI+) <i>m</i>/<i>z</i>: 242.9 [M + H]<sup>+</sup>; HPLC Ret: 6.30 min.</div></div><div id="sec5_7_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 5-(2-Chloro-3,4-dimethylphenyl)-1,3,4-oxadiazole-2-thiol (<b>4m</b>)</h4><div class="NLM_p last">Method C starting from 2-chloro-3,4-dimethylbenzohydrazide (<b>3m</b>, 0.27 g) gave 5-(2-chloro-3,4-dimethylphenyl)-1,3,4-oxadiazole-2-thiol as white solid (0.28 g, 86%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.71 (br s, 1H), 7.62 (d, <i>J</i> = 7.7 Hz, 1H), 7.21 (d, <i>J</i> = 8.0 Hz, 1H), 2.41 (br s, 6H); HRMS (ESI+) <i>m</i>/<i>z</i>: 241.0192 [M + H]<sup>+</sup> (expected 241.0202); HPLC Ret: 6.97 min.</div></div><div id="sec5_7_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 5-(2-Chloro-4,5-dimethylphenyl)-1,3,4-oxadiazole-2-thiol (<b>4n</b>)</h4><div class="NLM_p last">Method C starting from 2-chloro-4,5-dimethylbenzohydrazide (<b>3n</b>, 0.24 g) gave 5-(2-chloro-4,5-dimethylphenyl)-1,3,4-oxadiazole-2-thiol as white solild (0.22 g, 76%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 11.03 (br s, 1H), 7.69 (s, 1H), 7.32 (s, 1H), 2.32 (br s, 6H); MS (ESI+) <i>m</i>/<i>z</i>: 241.0194 [M + H]<sup>+</sup> (expected 241.0202); HPLC Ret: 7.00 min.</div></div><div id="sec5_7_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 5-(2,4-Dichloro-5-methylphenyl)-1,3,4-oxadiazole-2-thiol (<b>4o</b>)</h4><div class="NLM_p last">Method C starting from 2,4-dichloro-5-methylbenzohydrazide (<b>3o</b>, 0.07 g) gave 5-(2,4-dichloro-5-methylphenyl)-1,3,4-oxadiazole-2-thiol as yellow solid (0.07 g, 85%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.30 (br s, 1H), 7.80 (s, 1H), 7.57 (s, 1H), 2.42 (s, 3H); HRMS (ESI+) <i>m</i>/<i>z</i>: 260.9656 [M + H]<sup>+</sup> (expected 260.9656); HPLC Ret: 7.23 min.</div></div><div id="sec5_7_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 5-(4-(Trifluoromethyl)phenyl)-1,3,4-oxadiazole-2-thiol (<b>4u</b>)</h4><div class="NLM_p last">Method C starting from 4-(trifluoromethyl)benzohydrazide (<b>3u</b>, 0.25 g) gave 5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazole-2-thiol as white solid (0.26 g, 86%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.66 (br s, 1H), 8.07 (d, <i>J</i> = 8.1 Hz, 2H), 7.79 (d, <i>J</i> = 8.1 Hz, 2H); HRMS (ESI−) <i>m</i>/<i>z</i>: 244.9999 [M – H]<sup>−</sup> (expected 244.9996); HPLC Ret: 6.92 min.</div></div><div id="sec5_7_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 5-(2-(Trifluoromethyl)phenyl)-1,3,4-oxadiazole-2-thiol (<b>4v</b>)</h4><div class="NLM_p last">Method C starting from 2-(trifluoromethyl)benzohydrazide (<b>3v</b>, 0.38 g) gave 5-(2-(trifluoromethyl)phenyl)-1,3,4-oxadiazole-2-thiol as white powder (0.41 g, 90%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.64 (br s, 1H), 7.98–7.85 (m, 2H), 7.77–7.70 (m, 2H); HPLC Ret: 6.49 min.</div></div><div id="sec5_7_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 5-(2-Chloro-4-(trifluoromethyl)phenyl)-1,3,4-oxadiazole-2-thiol (<b>4w</b>)</h4><div class="NLM_p last">Method C starting from 2-chloro-4-(trifluoromethyl)benzohydrazide (<b>3w</b>, 0.48 g) gave 5-(2-chloro-4-(trifluoromethyl)phenyl)-1,3,4-oxadiazole-2-thiol as white powder (0.26 g, 59%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.16–8.09 (m, 2H), 7.95–7.89 (m, 1H); MS (ESI+) <i>m</i>/<i>z</i>: 280.1 [M + H]<sup>+</sup>; HPLC Ret: 7.14 min.</div></div><div id="sec5_7_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 5-(4-Bromo-2-chlorophenyl)-1,3,4-oxadiazole-2-thiol (<b>4x</b>)</h4><div class="NLM_p last">Method C starting from 4-bromo-2-chlorobenzohydrazide (<b>3x</b>, 0.46 g) gave 5-(4-bromo-2-chlorophenyl)-1,3,4-oxadiazole-2-thiol as white solid (0.37 g, 81%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.99 (d, <i>J</i> = 8.2 Hz, 1H), 7.84–7.72 (m, 2H); MS (ESI+) <i>m</i>/<i>z</i>: 292.9 [M + Na]<sup>+</sup>; HPLC Ret: 7.06 min.</div></div><div id="sec5_7_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 5-(3-Chloro-[1,1′-biphenyl]-4-yl)-1,3,4-oxadiazole-2-thiol (<b>4y</b>)</h4><div class="NLM_p last">Method C starting from 3-chloro-[1,1′-biphenyl]-4-carbohydrazide (<b>3y</b>, 0.36 g) gave 5-(3-chloro-[1,1′-biphenyl]-4-yl)-1,3,4-oxadiazole-2-thiol as white solid (0.29 g, 88%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.02–7.93 (m, 2H), 7.80–7.72 (m, 3H), 7.53–7.40 (m, 3H); MS (ESI+) <i>m</i>/<i>z</i>: 289.0 [M + H]<sup>+</sup>; HPLC Ret: 7.69 min.</div></div><div id="sec5_7_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Methyl-4-((5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>5q</b>)</h4><div class="NLM_p last">Method D starting from 5-(2,4-dichlorophenyl)-1,3,4-oxadiazole-2-thiol (<b>4j</b>, 0.2 g) gave methyl-4-((5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate as colorless oil (0.19 g, 66%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.00 (d, <i>J</i> = 8.5 Hz, 1H), 7.92 (d, <i>J</i> = 2.1 Hz, 1H), 7.66 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 3.60 (s, 3H), 3.35 (t, <i>J</i> = 7.4 Hz, 2H), 2.50 (t, <i>J</i> = 7.4 Hz, 2H), 2.12–1.97 (m, 2H); HRMS (ESI+) <i>m</i>/<i>z</i>: 368.9836 [M + Na]<sup>+</sup> (expected 368.9843); HPLC Ret: 7.94 min.</div></div><div id="sec5_7_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Methyl 5-((5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-yl)thio)pentanoate (<b>5r</b>)</h4><div class="NLM_p last">Method D starting from 5-(2,4-dichlorophenyl)-1,3,4-oxadiazole-2-thiol (<b>4j</b>, 0.27 g) gave methyl 5-((5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl)thio)pentanoate as white solid (330 g, 82%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.97 (d, <i>J</i> = 8.4 Hz, 1H), 7.90 (<i>J</i> = 2.1 Hz, 1H), 7.64 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 3.55 (s, 3H), 3.30 (t, <i>J</i> = 7.3 Hz, 2H), 2.35 (t, <i>J</i> = 7.3 Hz, 2H), 1.84–1.72 (m, 2H), 1.79–1.63 (m, 2H); MS (ESI+) <i>m</i>/<i>z</i>: 382.9 [M + Na]<sup>+</sup>; HPLC Ret: 7.95 min.</div></div><div id="sec5_7_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Methyl 4-((5-(2-Chloro-4-methylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>5s</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-chloro-4-methyl)-1,3,4-oxadiazole-2-thiol (<b>4k</b>, 0.02 g, 0.10 mmol) gave methyl 4-((5-(2-chloro-4-methylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (0.02 g, 70%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.84 (d, <i>J</i> = 8.0 Hz, 1H), 7.36 (d, <i>J</i> = 1.2 Hz, 1H), 7.18 (dd, <i>J</i> = 8.0, 1.2 Hz, 1H), 3.69 (s, 3H), 3.36 (t, <i>J</i> = 7.1 Hz, 2H), 2.53 (t, <i>J</i> = 7.2 Hz, 2H), 2.41 (s, 3H), 2.22 (p, <i>J</i> = 7.2 Hz, 2H); HRMS (ESI+) <i>m</i>/<i>z</i>: 349.0403 [M + Na]<sup>+</sup> (expected 349.0390); HPLC Ret: 7.62 min.</div></div><div id="sec5_7_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Methyl 4-((5-(2-Chloro-4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>5t</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-chloro-4-methoxyphenyl)-1,3,4-oxadiazole-2-thiol (<b>4l</b>, 0.1 g) gave methyl 4-((5-(2-chloro-4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate as colorless oil (0.12 g, 82%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.88 (d, <i>J</i> = 8.8 Hz, 1H), 7.05 (dd, <i>J</i> = 2.5 Hz, 1H), 6.92 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 3.87 (s, 3H), 3.69 (s, 3H), 3.35 (t, <i>J</i> = 7.1 Hz, 2H), 2.53 (t, <i>J</i> = 7.2 Hz, 2H), 2.20 (p, <i>J</i> = 7.2 Hz, 2H); HRMS (ESI+) <i>m</i>/<i>z</i>: 343.0525 [M + H]<sup>+</sup> (expected 343.0519); HPLC Ret: 7.31 min.</div></div><div id="sec5_7_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Methyl 4-((5-(4-(Trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>5u</b>)</h4><div class="NLM_p last">Method D starting from 5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazole-2-thiol (<b>4u</b>, 0.075 g) gave methyl 4-((5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate as white solid (0.09 g, 87%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.14 (d, <i>J</i> = 8.2 Hz, 2H), 7.77 (d, <i>J</i> = 8.2 Hz, 2H), 3.70 (s, 3H), 3.39 (t, <i>J</i> = 7.2 Hz, 2H), 2.54 (t, <i>J</i> = 7.1 Hz, 2H), 2.22 (p, <i>J</i> = 7.1 Hz, 2H); HRMS (ESI+) <i>m</i>/<i>z</i>: 347.0674 [M + H]<sup>+</sup> (expected 347.0677); HPLC Ret: 7.75 min.</div></div><div id="sec5_7_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Methyl 4-((5-(2-Chloro-4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>5w</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-chloro-4-(trifluoromethyl)phenyl)-1,3,4-oxadiazole-2-thiol (<b>4w</b>, 0.1 g) gave methyl 4-((5-(2-chloro-4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate as colorless oil (0.05 g, 47%); HPLC Ret: 7.98 min.</div></div><div id="sec5_7_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Methyl 4-((5-(3-Chloro-[1,1′-biphenyl]-4-yl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>5y</b>)</h4><div class="NLM_p last">Method D starting from 5-(3-chloro-[1,1′-biphenyl]-4-yl)-1,3,4-oxadiazole-2-thiol (<b>4y</b>, 0.1 g) gave methyl 4-((5-(3-chloro-[1,1′-biphenyl]-4-yl)-1,3,4-oxadiazol-2-yl)thio)butanoate as white solid (0.08 g, 75%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.03 (d, <i>J</i> = 8.2 Hz, 1H), 7.77 (d, <i>J</i> = 1.8 Hz, 1H), 7.64–7.58 (m, 3H), 7.52–7.39 (m, 3H), 3.70 (s, 3H), 3.38 (t, <i>J</i> = 7.1 Hz, 2H), 2.54 (t, <i>J</i> = 7.2 Hz, 2H), 2.22 (p, <i>J</i> = 7.2 Hz, 2H); MS (ESI+) <i>m</i>/<i>z</i>: 389.0 [M + H]<sup>+</sup>; HPLC Ret: 8.00 min.</div></div><div id="sec5_7_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Ethyl 3-((5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate (<b>6</b>)</h4><div class="NLM_p last">Method D starting from 5-(2,4-dichlorophenyl)-1,3,4-oxadiazole-2-thiol (<b>4j</b>, 1.2 g) gave ethyl 3-((5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate as white solid (1.6 g, 91%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.97 (d, <i>J</i> = 8.5 Hz, 1H), 7.90 (d, <i>J</i> = 2.1 Hz, 1H), 7.64 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 4.08 (q, <i>J</i> = 7.1 Hz, 2H), 3.48 (t, <i>J</i> = 6.8 Hz, 2H), 2.90 (t, <i>J</i> = 6.8 Hz, 2H), 1.17 (t, <i>J</i> = 7.1 Hz, 3H); MS (ESI+) <i>m</i>/<i>z</i>: 346.8 [M + H]<sup>+</sup>; HPLC Ret: 7.95 min; 98% pure.</div></div><div id="sec5_7_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>tert</i>-Butyl 3-((5-(<i>o</i>-Tolyl)-1,3,4-oxadiazol-2-yl)thio)propanoate (<b>7h</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-methylphenyl)-1,3,4-oxadiazole-2-thiol (<b>4h</b>) gave <i>tert</i>-butyl 3-((5-(<i>o</i>-tolyl)-1,3,4-oxadiazol-2-yl)thio)propanoate as colorless oil (313 mg, 94%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.87 (dd, <i>J</i> = 7.9, 1.4 Hz, 1H), 7.40 (td, <i>J</i> = 7.5, 1.4 Hz, 1H), 7.36–7.27 (m, 2H), 3.50 (t, <i>J</i> = 6.8 Hz, 2H), 2.87 (t, <i>J</i> = 6.8 Hz, 2H), 2.69 (s, 3H), 1.46 (s, 9H).</div></div><div id="sec5_7_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>tert</i>-Butyl 3-((5-(2-Methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate (<b>7i</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-methoxyphenyl)-1,3,4-oxadiazole-2-thiol (<b>4i</b>) gave <i>tert</i>-butyl 3-((5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate as colorless oil (310 mg, 96%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.77 (dd, <i>J</i> = 7.9, 1.8 Hz), 7.39 (ddd, <i>J</i> = 8.9, 7.5, 1.8 Hz, 1H), 6.95 (dd, <i>J</i> = 8.3, 6.2 Hz, 2H), 3.85 (s, 3H), 3.39 (t, <i>J</i> = 6.9 Hz, 2H), 2.78 (t, <i>J</i> = 6.9 Hz, 2H), 1.38 (s, 9H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.3, 164.5, 163.6, 157.6, 133.0, 130.0, 120.6, 112.6, 111.9, 81.2, 55.9, 35.3, 28.0, 27.5; MS (ESI+) <i>m</i>/<i>z</i>: 337.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_7_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>tert</i>-Butyl-3-((5-(2-chloro-4-methylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate (<b>7k</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-chloro-4-methyl)-1,3,4-oxadiazole-2-thiol (<b>4k</b>, 0.25 g) gave <i>tert</i>-butyl-3-((5-(2-chloro-4-methylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate as white solid (0.27 g, 70%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.86 (d, <i>J</i> = 8.1 Hz, 1H), 7.56 (d, <i>J</i> = 1.5 Hz, 1H), 7.37 (d, <i>J</i> = 8.2 Hz, 1H), 3.45 (t, <i>J</i> = 6.8 Hz, 2H), 2.82 (t, <i>J</i> = 6.8 Hz, 2H), 2.40 (s, 3H), 1.41 (s, 9H); MS (ESI+) <i>m</i>/<i>z</i>: 354.0 [M + H]<sup>+</sup>; HPLC Ret: 8.66 min.</div></div><div id="sec5_7_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>tert</i>-Butyl 3-((5-(2-Chloro-4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate (<b>7l</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-chloro-4-methoxyphenyl)-1,3,4-oxadiazole-2-thiol (250 mg, <b>4l</b>) gave <i>tert</i>-butyl 3-((5-(2-chloro-4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate as colorless oil (276 mg, 90%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.87 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 7.26 (d, <i>J</i> = 2.5 Hz, 1H), 7.11 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 3.85 (s, 3H), 3.42 (t, <i>J</i> = 6.8 Hz, 2H), 2.79 (t, <i>J</i> = 6.8 Hz, 2H), 1.39 (s, 9H).</div></div><div id="sec5_7_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>tert</i>-Butyl 3-((5-(2-Chloro-3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate (<b>7m</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-chloro-3,4-dimethylphenyl)-1,3,4-oxadiazole-2-thiol (<b>4m</b>, 0.14 g) gave <i>tert</i>-butyl 3-((5-(2-chloro-3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate as colorless oil (0.17 g, 80%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.61 (d, <i>J</i> = 7.9 Hz, 1H), 7.18 (d, <i>J</i> = 7.9 Hz, 1H), 3.49 (t, <i>J</i> = 6.8 Hz, 2H), 3.42 (s, 3H), 2.86 (t, <i>J</i> = 6.9 Hz, 2H), 2.38 (s, 3H), 1.47 (s, 9H); HRMS (ESI+) <i>m</i>/<i>z</i>: 369.1035 [M + H]<sup>+</sup> (expected 369.1040); HPLC Ret: 7.63 min.</div></div><div id="sec5_7_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>tert</i>-Butyl 3-((5-(2-Chloro-4,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate (<b>7n</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-chloro-4,5-dimethylphenyl)-1,3,4-oxadiazole-2-thiol (<b>4n</b>, 0.11 g) gave <i>tert</i>-butyl 3-((5-(2-chloro-4,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate as colorless oil (0.13 g, 77%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.71 (s, 1H), 7.30 (s, 1H), 3.49 (t, <i>J</i> = 6.9 Hz, 2H), 3.32 (s, 3H), 2.86 (t, <i>J</i> = 6.8 Hz, 2H), 2.28 (s, 3H), 1.47 (s, 9H); HRMS (ESI+) <i>m</i>/<i>z</i>: 369.1034 [M + H]<sup>+</sup> (expected 369.1040); HPLC Ret: 7.81 min.</div></div><div id="sec5_7_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>tert</i>-Butyl 3-((5-(2,4-Dichloro-5-methylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate (<b>7o</b>)</h4><div class="NLM_p last">Method D starting from 5-(2,4-dichloro-5-methylphenyl)-1,3,4-oxadiazole-2-thiol (<b>4o</b>, 0.07 g) gave <i>tert</i>-butyl 3-((5-(2,4-dichloro-5-methylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate as green oil (0.09 g, 82%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.84 (s, 1H), 7.55 (s, 1H), 3.51 (t, <i>J</i> = 6.8 Hz, 2H), 2.86 (t, <i>J</i> = 6.8 Hz, 2H), 2.42 (s, 3H), 1.47 (s, 9H); HRMS (ESI+) <i>m</i>/<i>z</i>: 389.0494 [M + H]<sup>+</sup> (expected 389.0493); HPLC Ret: 8.95 min.</div></div><div id="sec5_7_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>tert</i>-Butyl 4-((5-(2-(Trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>7v</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-(trifluoromethyl)phenyl)-1,3,4-oxadiazole-2-thiol (<b>4v</b>, 0.1 g) gave <i>tert</i>-butyl 4-((5-(2-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate as colorless oil (0.14 g, 88%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.06–8.00 (m, 1H), 7.85 (dd, <i>J</i> = 7.1, 1.9 Hz, 1H), 7.74–7.64 (m, 2H), 3.34 (t, <i>J</i> = 7.2 Hz, 2H), 2.43 (t, <i>J</i> = 7.2 Hz, 2H), 2.15 (p, <i>J</i> = 7.2 Hz, 2H), 1.45 (s, 9H); HRMS (ESI+) <i>m</i>/<i>z</i>: 389.1173 [M + H]<sup>+</sup> (expected 389.1147); HPLC Ret: 8.46 min.</div></div><div id="sec5_7_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>t</i>-Butyl 4-((5-(4-Bromo-2-chlorophenyl)-1,3,4-oxadiazole-2-yl)thio)butanoate (<b>7x</b>)</h4><div class="NLM_p last">Method D starting from 5-(4-bromo-2-chlorophenyl)-1,3,4-oxadiazole-2-thiol (<b>4x</b>, 0.1 g) gave <i>t</i>-butyl 4-((5-(4-bromo-2-chlorophenyl)-1,3,4-oxadiazole-2-yl)thio)butanoate as colorless oil (0.12 g, 84%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.83 (d, <i>J</i> = 8.4 Hz, 1H), 7.73 (d, <i>J</i> = 1.9 Hz, 1H), 7.54 (dd, <i>J</i> = 8.4, 1.9 Hz, 2H), 3.36 (t, <i>J</i> = 7.2 Hz, 2H), 2.43 (t, <i>J</i> = 7.2 Hz, 2H), 2.16 (p, <i>J</i> = 7.2 Hz, 2H), 1.45 (s, 9H); MS (ESI+) <i>m</i>/<i>z</i>: 434.9 [M + H]<sup>+</sup>; HPLC Ret: 9.22 min.</div></div><div id="sec5_7_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 3-((5-(<i>o</i>-Tolyl)-1,3,4-oxadiazol-2-yl)thio)propanoic Acid (<b>8h</b>)</h4><div class="NLM_p last">Method E starting from <i>tert</i>-butyl 3-((5-(<i>o</i>-tolyl)-1,3,4-oxadiazol-2-yl)thio)propanoate (313 mg, <b>7h</b>) gave 3-((5-(<i>o</i>-tolyl)-1,3,4-oxadiazol-2-yl)thio)propanoic acid as off-white solid (248 mg, 96%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.52 (s, 1H), 7.83 (dd, <i>J</i> = 7.8, 1.5 Hz, 1H), 7.47 (td, <i>J</i> = 7.4, 1.5 Hz, 1H), 7.42–7.31 (m, 2H), 3.43 (t, <i>J</i> = 6.8 Hz, 2H), 2.82 (t, <i>J</i> = 6.8 Hz, 2H), 2.57 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 172.9, 165.7, 163.6, 137.9, 132.1, 131.8, 129.1, 126.9, 122.7, 34.3, 27.9, 21.9; HRMS (ESI+) <i>m</i>/<i>z</i>: 265.0640 [M + H]<sup>+</sup> (expected 265.0647); HPLC Ret: 6.08 min; 97% pure.</div></div><div id="sec5_7_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 3-((5-(2-Methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoic Acid (<b>8i</b>)</h4><div class="NLM_p last">Method E starting from <i>tert</i>-butyl 3-((5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate (310 mg, <b>7i</b>) gave 3-((5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoic acid as white solid (103 mg, 50%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.56 (s, 1H), 7.79 (dd, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.58 (ddd, <i>J</i> = 8.9, 7.4, 1.8 Hz, 1H), 7.24 (d, <i>J</i> = 8.4 Hz, 1H), 7.10 (t, <i>J</i> = 7.5 Hz, 1H), 3.87 (s, 3H), 3.41 (t, <i>J</i> = 6.8 Hz, 2H), 2.81 (t, <i>J</i> = 6.8 Hz, 2H); HRMS (ESI+) <i>m</i>/<i>z</i>: 281.0592 [M + H]<sup>+</sup> (expected 281.0596); HPLC Ret: 5.37 min; 99% pure.</div></div><div id="sec5_7_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 3-((5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-yl)thio)propanoic Acid (<b>8j</b>)</h4><div class="NLM_p last">2-(2,4-Dichlorophenyl)-5-(methylsulfonyl)-1,3,4-oxadiazole (<b>20</b>, 0.05 g, 0.171 mmol) was dissolved in 2 mL acetone. K<sub>2</sub>CO<sub>3</sub> (0.028 g, 0.205 mmol) and 3-mercaptopropanoic acid (0.022 g, 0.018 mL, 0.205 mmol) were added and the mixture was stirred at 25 °C for 1 h. The acetone was removed in vacuo, and the remaining residue was partitioned between water (5 mL) and DCM (5 mL). The product was extracted with DCM (3 × 10 mL), washed with brine (10 mL), dried with MgSO<sub>4</sub>, and concentrated in vacuo. The residue was dissolved in minimal EtOAc, and the product was triturated with Hex, producing a white precipitate that was filtered and dried under vacuum. Yield = 51%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ ppm 7.90 (d, <i>J</i> = 8.5 Hz, 1H), 7.57 (d, <i>J</i> = 2.0 Hz 1H), 7.39 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 3.55 (t, <i>J</i> = 6.7 Hz, 2H), 3.05 (t, <i>J</i> = 6.7 Hz, 2H); MS (ESI+) <i>m</i>/<i>z</i>: 318.9 [M + H]<sup>+</sup>; HPLC Ret: 6.64 min.</div></div><div id="sec5_7_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 3-((5-(2-Chloro-4-methylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoic Acid (<b>8k</b>)</h4><div class="NLM_p last">Method E starting from <i>t</i>-butyl-3-((5-(2-chloro-4-methylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate (<b>7k</b>, 0.27 g) gave 3-((5-(2-chloro-4-methylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoic acid as white powder (0.13 g, 57%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.45 (br s, 1H), 7.85 (d, <i>J</i> = 8.0 Hz, 1H), 7.55 (s, 1H), 7.37 (d, <i>J</i> = 8.1 Hz, 1H), 3.46 (t, <i>J</i> = 6.8 Hz, 2H), 2.84 (t, <i>J</i> = 6.8 Hz, 2H), 2.40 (s, 3H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 172.88, 164.42, 163.75, 144.35, 131.77, 131.26, 128.98, 119.78, 34.26, 27.99, 21.05; HRMS (ESI+) <i>m</i>/<i>z</i>: 321.0070 [M + Na]<sup>+</sup> (expected 321.0077); HPLC Ret: 6.31 min; 98% pure.</div></div><div id="sec5_7_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 3-((5-(2-Chloro-4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoic Acid (<b>8l</b>)</h4><div class="NLM_p last">Method E starting from <i>tert</i>-butyl 3-((5-(2-chloro-4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate (<b>7l</b>) gave 3-((5-(2-chloro-4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoic acid as white solid (130 mg, 75%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.55 (s, 1H), 7.87 (d, <i>J</i> = 8.8, 1H), 7.26 (d, <i>J</i> = 2.5 Hz, 1H), 7.10 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 3.85 (s, 3H), 3.42 (t, <i>J</i> = 6.8 Hz, 2H), 2.81 (t, <i>J</i> = 6.8 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 172.9, 164.0, 163.7, 162.6, 133.3, 132.7, 116.6, 114.9, 114.6, 56.5, 34.3, 28.0; HRMS (ESI+) <i>m</i>/<i>z</i>: 315.0201 [M + H]<sup>+</sup> (expected 315.0206); HPLC Ret: 5.91 min; 95% pure.</div></div><div id="sec5_7_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 3-((5-(2-Chloro-3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoic Acid (<b>8m</b>)</h4><div class="NLM_p last">Method E starting from <i>tert</i>-butyl 3-((5-(2-chloro-3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate (<b>7m</b>, 0.17 g) gave 3-((5-(2-chloro-3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoic acid as white powder (0.11 g, 80%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.59 (br s, 1H), 7.60 (d, <i>J</i> = 7.9 Hz, 1H), 7.17 (d, <i>J</i> = 7.9 Hz, 1H), 3.53 (t, <i>J</i> = 6.8 Hz, 2H), 3.32 (s, 3H), 3.04 (t, <i>J</i> = 6.8 Hz, 2H), 2.28 (s, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 176.37, 165.02, 164.19, 142.27, 136.67, 133.15, 128.14, 120.93, 34.00, 26.99, 21.37, 16.72; HRMS (ESI−) <i>m</i>/<i>z</i>: 311.0258 [M – H]<sup>−</sup> (expected 311.0257); HPLC Ret: 5.83 min; 95% pure.</div></div><div id="sec5_7_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 3-((5-(2-Chloro-4,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoic Acid (<b>8n</b>)</h4><div class="NLM_p last">Method E starting from <i>tert</i>-butyl 3-((5-(2-chloro-4,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate (<b>7n</b>, 0.13 g) gave 3-((5-(2-chloro-4,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoic acid as white powder (0.08 g, 75%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 11.00 (br s, 1H), 7.71 (s, 1H), 7.29 (s, 1H), 3.54 (t, <i>J</i> = 6.8 Hz, 2H), 3.32 (s, 3H), 3.04 (t, <i>J</i> = 6.8 Hz, 2H), 2.28 (s, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 176.49, 164.54, 164.10, 142.24, 135.99, 131.95, 131.52, 129.77, 119.69, 33.99, 27.00, 19.70, 19.06; HRMS (ESI−) <i>m</i>/<i>z</i>: 311.0259 [M – H]<sup>−</sup> (expected 311.0257); HPLC Ret: 5.91 min; 99% pure.</div></div><div id="sec5_7_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 3-((5-(2,4-Dichloro-5-methylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoic Acid (<b>8o</b>)</h4><div class="NLM_p last">Method E starting from <i>tert</i>-butyl 3-((5-(2,4-dichloro-5-methylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoate (<b>7o</b>, 0.09 g) gave 3-((5-(2,4-dichloro-5-methylphenyl)-1,3,4-oxadiazol-2-yl)thio)propanoic acid as white powder (0.04 g, 65%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.83 (s, 1H), 7.54 (s, 1H), 3.55 (t, <i>J</i> = 6.8 Hz, 2H), 3.04 (t, <i>J</i> = 6.8 Hz, 2H), 2.41 (s, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 175.94, 164.62, 163.72, 138.29, 135.72, 132.36, 131.31, 130.62, 129.34, 120.94, 33.84, 27.05, 19.46; HRMS (ESI−) <i>m</i>/<i>z</i>: 330.9710 [M – H]<sup>−</sup> (expected 330.9711); HPLC Ret: 6.81 min; 95% pure.</div></div><div id="sec5_7_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 4-((5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic Acid (<b>8q</b>)</h4><div class="NLM_p last">Method F starting from methyl-4-((5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>5q</b>, 0.19 g) gave 4-((5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic acid as white powder (0.06 g, 35%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 12.21 (br s, 1H), 8.00 (d, <i>J</i> = 8.6 Hz, 1H), 7.93 (d, <i>J</i> = 2.1 Hz, 1H), 7.66 (dd, <i>J</i> = 8.6, 2.1 Hz, 1H), 3.34 (t, <i>J</i> = 7.3 Hz, 2H), 2.40 (t, <i>J</i> = 7.3 Hz, 2H), 2.11–1.95 (m, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 174.15, 164.95, 162.95, 137.54, 133.14, 132.75, 131.19, 128.64, 121.70, 32.62, 31.96, 24.96; HRMS (ESI+) <i>m</i>/<i>z</i>: 354.9677 [M + Na]<sup>+</sup> (expected 354.9687); HPLC Ret: 6.82 min; 98% pure.</div></div><div id="sec5_7_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 5-((5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-yl)thio)pentanoic Acid (<b>8r</b>)</h4><div class="NLM_p last">Modified method F (product required silica gel column chromatography eluting with 2% MeOH/98% DCM and semi-prep to obtain >95% purity) starting from methyl 5-((5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl)thio)pentanoate (<b>5r</b>, 0.33 g) gave 5-((5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl)thio)pentanoic acid as white solid (109 mg, 34%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.05 (s, 1H), 7.97 (d, <i>J</i> = 8.5 Hz, 1H), 7.90 (d, <i>J</i> = 2.1 Hz, 1H), 7.64, (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 3.30 (t, <i>J</i> = 7.3 Hz, 2H), 2.25 (t, <i>J</i> = 7.3 Hz, 2H), 1.86–1.69 (m, 2H), 1.80–1.60 (m, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.6, 165.1, 162.9, 137.5, 133.1, 132.7, 131.2, 128.6, 121.7, 33.4, 32.2, 28.9, 23.8; MS (ESI−) <i>m</i>/<i>z</i>: 345.0 [M – H]<sup>−</sup>; HPLC Ret: 7.01 min; 98% pure.</div></div><div id="sec5_7_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 4-((5-(2-Chloro-4-methylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic Acid (<b>8s</b>)</h4><div class="NLM_p last">Method F starting from methyl 4-((5-(2-chloro-4-methylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (0.15 g, 0.46 mmol) gave 4-((5-(2-chloro-4-methylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic acid (0.10 g, 69%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.67 (br s, 1H), 7.82 (d, <i>J</i> = 8.0 Hz, 1H), 7.35 (s, 1H), 7.19 (d, <i>J</i> = 7.9 Hz, 1H), 3.38 (t, <i>J</i> = 7.1 Hz, 2H), 2.59 (t, <i>J</i> = 7.1 Hz, 2H), 2.40 (s, 3H), 2.21 (q, <i>J</i> = 7.1 Hz, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 178.02, 164.39, 164.28, 143.42, 132.64, 131.68, 130.67, 127.96, 119.89, 32.31, 31.60, 24.34, 21.24; HRMS (ESI+) <i>m</i>/<i>z</i>: 335.0244 [M + Na]<sup>+</sup> (expected 335.0233); HPLC Ret: 6.53 min; 96% pure.</div></div><div id="sec5_7_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 4-((5-(2-Chloro-4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic Acid (<b>8t</b>)</h4><div class="NLM_p last">Method F starting from methyl 4-((5-(2-chloro-4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>5t</b>, 0.1 g) gave 4-((5-(2-chloro-4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic acid as white solid (0.09 g, 94%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.78 (br s, 1H), 7.87 (d, <i>J</i> = 8.8 Hz, 1H), 7.04 (d, <i>J</i> = 2.5 Hz, 1H), 6.91 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 3.87 (s, 3H), 3.37 (t, <i>J</i> = 7.2 Hz, 2H), 2.59 (t, <i>J</i> = 7.1 Hz, 2H), 2.21 (p, <i>J</i> = 7.1 Hz, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 178.05, 164.18, 164.03, 162.21, 134.12, 131.96, 116.34, 115.12, 113.38, 55.76, 32.32, 31.60, 24.34; HRMS (ESI+) <i>m</i>/<i>z</i>: 329.0386 [M + H]<sup>+</sup> (expected 329.0363); HPLC Ret: 6.27 min; 99% pure.</div></div><div id="sec5_7_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 4-((5-(4-(Trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic Acid (<b>8u</b>)</h4><div class="NLM_p last">Method F starting from methyl 4-((5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>5u</b>, 0.09 g) gave 4-((5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic acid as white powder (0.06 g, 68%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.41 (br s, 1H), 8.14 (d, <i>J</i> = 8.2 Hz, 2H), 7.77 (d, <i>J</i> = 8.2 Hz, 2H), 3.41 (t, <i>J</i> = 7.2 Hz, 2H), 2.60 (t, <i>J</i> = 7.1 Hz, 2H), 2.22 (p, <i>J</i> = 7.1 Hz, 2H); <sup>19</sup>F NMR (500 MHz, CDCl<sub>3</sub>): δ ppm −63.16 (s, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 177.97, 165.00, 164.64, 133.41, 126.97, 126.13, 124.59, 121.90, 32.22, 31.57, 24.22; HRMS (ESI+) <i>m</i>/<i>z</i>: 333.0352 [M + H]<sup>+</sup> (expected 333.0521); HPLC Ret: 6.76 min; 99% pure.</div></div><div id="sec5_7_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 4-((5-(2-(Trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic Acid (<b>8v</b>)</h4><div class="NLM_p last">Modified method E (product required column chromatography eluting with 45% EtOAc/55% Hex/0.1% AcOH to obtain >95% purity) starting from <i>tert</i>-butyl 4-((5-(2-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>7v</b>, 0.13 g) gave 4-((5-(2-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic acid as colorless oil (0.10 g, 93%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.45 (br s, 1H), 8.07–8.00 (m, 1H), 7.85 (dd, <i>J</i> = 7.1, 2.0 Hz, 1H), 7.75–7.65 (m, 2H), 3.37 (t, <i>J</i> = 7.2 Hz, 2H), 2.59 (t, <i>J</i> = 7.1 Hz, 2H), 2.21 (p, <i>J</i> = 7.1 Hz, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 178.29, 165.45, 164.05, 132.18, 131.65, 128.78, 127.06, 126.98, 124.19, 122.01, 32.28, 31.55, 24.34; HRMS (ESI+) <i>m</i>/<i>z</i>: 333.0547 [M + H]<sup>+</sup> (expected 333.0521); HPLC Ret: 6.31 min; 97% pure.</div></div><div id="sec5_7_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 4-((5-(2-Chloro-4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic Acid (<b>8w</b>)</h4><div class="NLM_p last">Method F starting from methyl 4-((5-(2-chloro-4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>5w</b>, 0.05 g) gave 4-((5-(2-chloro-4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic acid as white powder (0.03 g, 81%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.12 (d, <i>J</i> = 8.2 Hz, 1H), 7.82 (d, <i>J</i> = 1.6 Hz, 1H), 7.66 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 3.41 (t, <i>J</i> = 7.2 Hz, 2H), 2.60 (t, <i>J</i> = 7.1 Hz, 2H), 2.24 (p, <i>J</i> = 7.1 Hz, 2H); <sup>19</sup>F NMR (500 MHz, CDCl<sub>3</sub>): δ −63.24 (s, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 177.45, 165.54, 163.05, 133.60, 131.35, 128.38, 125.99, 123.94, 123.91, 32.16, 31.62, 24.28; HRMS (ESI+) <i>m</i>/<i>z</i>: 367.0022 [M + H]<sup>+</sup> (expected 367.0131); HPLC Ret: 6.99 min; 97% pure.</div></div><div id="sec5_7_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 4-((5-(4-Bromo-2-chlorophenyl)-1,3,4-oxadiazole-2-yl)thio)butanoic Acid (<b>8x</b>)</h4><div class="NLM_p last">Method E starting from <i>t</i>-butyl 4-((5-(4-bromo-2-chlorophenyl)-1,3,4-oxadiazole-2-yl)thio)butanoate (<b>7</b> × 0.12 g) gave 4-((5-(4-bromo-2-chlorophenyl)-1,3,4-oxadiazole-2-yl)thio)butanoic acid as white solid (0.1 g, 94%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.83 (d, <i>J</i> = 8.4 Hz, 1H), 7.73 (d, <i>J</i> = 1.9 Hz, 1H), 7.54 (dd, <i>J</i> = 8.5, 1.9 Hz, 2H), 3.39 (t, <i>J</i> = 7.2 Hz, 2H), 2.59 (t, <i>J</i> = 7.1 Hz, 2H), 2.22 (p, <i>J</i> = 7.1 Hz, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 176.35, 164.99, 163.50, 134.00, 133.78, 131.66, 130.54, 126.15, 121.75, 32.23, 31.60, 24.31; HRMS (ESI+) <i>m</i>/<i>z</i>: 376.9455 [M + H]<sup>+</sup> (expected 376.9362); HPLC Ret: 6.91 min; 95% pure.</div></div><div id="sec5_7_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 4-((5-(3-Chloro-[1,1′-biphenyl]-4-yl)-1,3,4-oxadiazol-2-yl)thio)butanoic Acid (<b>8y</b>)</h4><div class="NLM_p last">Method F starting from methyl 4-((5-(3-chloro-[1,1′-biphenyl]-4-yl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>5y</b>, 0.08 g) gave 4-((5-(3-chloro-[1,1′-biphenyl]-4-yl)-1,3,4-oxadiazol-2-yl)thio)butanoic acid (0.05 g, 82%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.03 (d, <i>J</i> = 8.1 Hz, 1H), 7.77 (d, <i>J</i> = 1.8 Hz, 1H), 7.63–7.60 (m, 3H), 7.52–7.39 (m, 3H), 3.40 (t, <i>J</i> = 7.2 Hz, 2H), 2.60 (t, <i>J</i> = 7.1 Hz, 2H), 2.24 (p, <i>J</i> = 7.1 Hz, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 177.29, 164.63, 164.11, 145.45, 138.32, 133.28, 131.16, 129.64, 129.10, 128.75, 127.11, 125.64, 121.23, 32.16, 31.63, 24.37; HRMS (ESI+) <i>m</i>/<i>z</i>: 333.0489 [M + H]<sup>+</sup> (expected 375.0570); HPLC Ret: 7.43 min; 98% pure.</div></div><div id="sec5_7_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 3-((5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-yl)thio)-<i>N</i>-methylpropanamide (<b>9</b>)</h4><div class="NLM_p last">To a solution of 3-((5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl)thio)propanoic acid (<b>8j</b>, 200 mg, 0.63 mmol) in dichloromethane (5 mL) was added oxalyl chloride (0.060 mL, 0.69 mmol) followed by one drop of DMF. After 2 h, the reaction was concentrated and taken into the next step without further purification. 3-((5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-yl)thio)propanoyl chloride was dissolved in 2 mL of 33% methylamine in ethanol. The reaction was stirred overnight in a sealed tube. The reaction was concentrated. The crude reaction mixture was purified by column chromatography eluting with 50–80% ethylacetate in hexanes. Isolated 69 mg of a white solid. Yield = 66%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.89 (d, <i>J</i> = 8.5 Hz, 1H), 7.57 (d, <i>J</i> = 2.0 Hz, 1H), 7.39 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 5.65 (s, 1H), 3.57 (t, <i>J</i> = 6.8 Hz, 2H), 2.82 (m, 5H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.4, 165.1, 162.9, 137.5, 133.1, 132.7, 131.2, 128.6, 121.7, 35.1, 28.7, 25.9; HRMS (ESI+) <i>m</i>/<i>z</i>: 353.9838 [M + Na]<sup>+</sup> (expected 353.9847); HPLC Ret: 6.20 min; 96% pure.</div></div><div id="sec5_7_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-ol (<b>10</b>)</h4><div class="NLM_p last">In a 50 mL round bottomed flask, 2,4-dichlorobenzohydrazide (<b>3j</b>, 0.5 g, 2.44 mmol), K<sub>3</sub>PO<sub>4</sub> (0.52, 2.44 mmol), and CS<sub>2</sub> (0.19 g, 0.15 mL, 2.44 mmol) were stirred in 10 mL of H<sub>2</sub>O for 10 min at 25 °C. The reaction was then stirred at reflux (106 °C) for 2 h and then cooled to 25 °C. Propylene oxide (0.14 g, 2.44 mmol, 0.17 mL) was added and the reaction was stirred at 25 °C for 16 h. The product was extracted with EtOAc (3 × 15 mL), washed with brine, dried with MgSO<sub>4</sub>, and the solvent was evaporated. The residue was subjected to silica gel chromatography eluting with 20% EtOAc/80% Hex. The fractions containing product were concentrated in vacuo to produce white solid. Yield = 23% (2 steps); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.18 (br s, 1H), 7.83–7.73 (m, 1H), 7.57–7.55 (m, 1H), 7.41–7.38 (m, 1H); MS (ESI−) <i>m</i>/<i>z</i>: 228.9 [M – H]<sup>−</sup>; HPLC Ret: 6.39 min.</div></div><div id="sec5_7_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> <i>tert</i>-Butyl 4-((5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-yl)oxy)butanoate (<b>10′</b>)</h4><div class="NLM_p last">5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-ol (<b>10</b>, 0.06 g, 0.251 mmol) was dissolved in DMF (2 mL). K<sub>2</sub>CO<sub>3</sub> (0.045 g, 0.33 mmol) and <i>tert</i>-butyl 4-bromobutanoate (0.07 g, 0.33 mmol, 0.06 mL) were added and the reaction was stirred at 90 °C for 1 h. The reaction was cooled to room temperature and the solvent was removed in vacuo. The residue was partitioned between H<sub>2</sub>O (10 mL) and DCM (10 mL), and the product was extracted with DCM (3 × 10 mL), washed with brine, dried with MgSO<sub>4</sub>, and the solvents removed in vacuo. The oil was subjected to silica gel chromatography eluting with 10% EtOAc/90% Hex. The fractions containing the product were concentrated in vacuo to produce white solid. Yield = 62%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.75 (d, <i>J</i> = 8.5 Hz, 1H), 7.54 (d, <i>J</i> = 2.1 Hz, 1H), 7.37 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 3.88 (t, <i>J</i> = 6.8 Hz, 2H), 2.36 (t, <i>J</i> = 7.3 Hz, 2H), 2.10 (p, <i>J</i> = 7.1 Hz, 2H), 1.45 (s, 9H); MS (ESI+) <i>m</i>/<i>z</i>: 396.9 [M + Na]<sup>+</sup>; HPLC Ret: 8.72 min.</div></div><div id="sec5_7_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 4-((5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-yl)oxy)butanoic Acid (<b>11</b>)</h4><div class="NLM_p last">Modified method E (crystallization not needed) starting from <i>tert</i>-butyl 4-((5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl)oxy)butanoate (<b>10′</b>, 0.06 g, 0.16 mmol) gave 4-((5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl)oxy)butanoic acid (0.04 g, 89%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.75 (d, <i>J</i> = 8.5 Hz, 1H), 7.59 (br s, 1H), 7.54 (d, <i>J</i> = 2.1 Hz, 1H), 7.37 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 3.93 (t, <i>J</i> = 6.7 Hz, 2H), 2.53 (t, <i>J</i> = 7.2 Hz, 2H), 2.17 (p, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 177.90, 153.08, 150.84, 137.89, 133.40, 131.38, 130.53, 127.56, 121.02, 45.15, 30.61, 23.22; HRMS (ESI+) <i>m</i>/<i>z</i>: 338.9912 [M + Na]<sup>+</sup> (expected 338.9915); HPLC Ret: 6.52 min.</div></div><div id="sec5_7_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 2-(Bromomethyl)-5-(2,4-dichlorophenyl)-1,3,4-oxadiazole (<b>12</b>)</h4><div class="NLM_p last">In a 100 mL round bottomed flask, 2,4-dichlorobenzohydrazide (<b>3j</b>, 0.5 g, 2.44 mmol) and bromoacetic acid (0.34 g, 2.44 mmol) were combined under an inert atmosphere. The reagents were dissolved in POCl<sub>3</sub> (5.0 mL) and stirred at reflux (106 °C) for 16 h. The reaction was cooled to room temperature and poured over ice water (5 mL). The solution was neutralized to pH ≈ 9 with NaHCO<sub>3</sub> (20% to sat), causing a yellow precipitate to form. The product was extracted with EtOAc (3 × 25 mL), washed with brine, dried with MgSO<sub>4</sub>, and the solvents were evaporated in vacuo producing brown oil. The impurities were triturated with EtOAc/Hex (tan solid), and the mother liquor was evaporated to provide the desired product as white/tan solid. Yield = 49%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.97 (d, <i>J</i> = 8.3, 1H), 7.60 (s, 1H), 7.42 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 4.62 (s, 2H); MS (ESI+) <i>m</i>/<i>z</i>: 359.9 [M + MeOH + Na]<sup>+</sup>; HPLC Ret: 7.42 min.</div></div><div id="sec5_7_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 2-(((5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-yl)methyl)thio)acetic Acid (<b>13</b>)</h4><div class="NLM_p last">2-Mercaptoacetic acid (0.13 g, 1.36 mmol, 0.10 mL) was dissolved in acetone (5 mL), and K<sub>2</sub>CO<sub>3</sub> (0.19 g, 1.36 mmol) and 2-(bromomethyl)-5-(2,4-dichlorophenyl)-1,3,4-oxadiazole (<b>12</b>, 0.35 g, 1.14 mmol) were added. The reaction was stirred at 25 °C for 24 h, and then the solvent was removed in vacuo. The residue was diluted with H<sub>2</sub>O (2 mL) and acidified to pH ≈ 1 with 1 N HCl (3 mL). The product was extracted with DCM (3 × 15 mL), washed with brine, and dried with MgSO<sub>4</sub>, and the solvent was evaporated in vacuo. The residue was subjected to silica gel chromatography eluting with 5% MeOH/95% DCM/0.1% AcOH. The fractions containing product were concentrated and the residue was crystalized with DCM. The product was filtered, producing white crystals. Yield = 20%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.73 (br s, 1 H), 7.96 (d, <i>J</i> = 8.4 Hz, 1H), 7.89 (d, <i>J</i> = 2.1 Hz, 1H), 7.65 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 4.62 (s, 2H), 3.46 (s, 2H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.17, 165.24, 162.28, 137.57, 133.27, 132.91, 131.20, 128.81, 121.93, 33.93, 24.95; HRMS (ESI+) <i>m</i>/<i>z</i>: 340.9524 [M + Na]<sup>+</sup> (expected 340.9530); HPLC Ret: 6.13 min.</div></div><div id="sec5_7_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Methyl 2-Chloro-4-(2-hydroxypropan-2-yl)benzoate (<b>14′</b>)</h4><div class="NLM_p last">In a 100 mL round-bottomed flask, methyl 2-chloro-4-iodobenzoate (<b>14</b>, 1.0 g, 3.4 mmol) was dissolved in 10 mL THF and cooled to −20 °C. 2 M iPrMgCl in THF (1.7 mL, 3.4 mmol) was added dropwise and the reaction was stirred at −20 °C for 1.5 h. Acetone (0.29 g, 0.37 mL, 5.1 mmol) was then added and the reaction was stirred at 25 °C for 1.5 h. The reaction was quenched with MeOH and then diluted with H<sub>2</sub>O. The product was extracted with EtOAc (3 × 15 mL), and the organic layers were combined, washed with brine, dried with MgSO<sub>4</sub>, and concentrated in vacuo. The subsequent oil was subjected to silica gel chromatography eluting with 30% EtOAc/70% Hex. The fractions containing product were concentrated in vacuo to produce colorless oil. Yield = 53%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.81 (d, <i>J</i> = 8.2 Hz, 1H), 7.59 (d, <i>J</i> = 1.7 Hz, 1H), 7.41 (dd, <i>J</i> = 8.2, 1.8 Hz, 1H), 3.93 (s, 3H), 1.58 (s, 6H); HPLC Ret: 6.09 min.</div></div><div id="sec5_7_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Methyl 3-Bromo-2-chlorobenzoate (<b>15a′</b>)</h4><div class="NLM_p last">Method A starting from 3-bromo-2-chlorobenzoic acid (0.5 g) gave methyl 3-bromo-2-chlorobenzoate as colorless oil (<b>15a</b>, 0.52 g, 98%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.77 (dd, <i>J</i> = 8.0, 0.8 Hz, 1H), 7.68 (dd, <i>J</i> = 7.7, 0.8, 1H), 7.19 (td, <i>J</i> = 7.9, 0.8 Hz, 1H), 3.94 (s, 3H); HPLC Ret: 7.44 min.</div></div><div id="sec5_7_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Methyl 4-Bromo-2-chlorobenzoate (<b>15b′</b>)</h4><div class="NLM_p last">Method A starting from 4-bromo-2-chlorobenzoic acid (<b>15b</b>, 1.0 g) gave methyl 4-bromo-2-chlorobenzoate as yellow oil (0.93 g, 87%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.72 (dd, <i>J</i> = 8.4, 1.1 Hz, 1H), 7.64 (s, 1H), 7.46 (dd, <i>J</i> = 8.4, 1.6 Hz, 1H), 3.93 (s, 3H); HPLC Ret: 7.71 min.</div></div><div id="sec5_7_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> Methyl 2-Chloro-4-ethylbenzoate (<b>17a′</b>)</h4><div class="NLM_p last">In a flamed dried 25 mL round bottomed flask, freshly prepared methyl 2-chloro-4-vinylbenzoate (<b>17a</b>, 0.12 g, 0.59 mmol) as previously described<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and 2-nitrobenzene-1-sulfonyl chloride (0.26 g, 1.19 mmol) were dissolved in 3 mL dry MeCN. The solution was cooled to 0 °C and hydrazine hydrate (0.08 g, 0.07 mL, 2.4 mmol) was slowly added. The reaction was warmed to 25 °C and stirred vigorously for 16 h under N<sub>2</sub>. Upon completion, the reaction was quenched with water (15 mL) and the product was extracted with EtOAc (4 × 20 mL). The layers were combined, dried with MgSO<sub>4</sub>, and concentrated in vacuo. The yellow residue was subjected to silica gel chromatography eluting with 2.5% EtOAc/97.5% Hex. The fractions containing product were concentrated in vacuo to produce yellow oil. Yield = 66%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ ppm 7.78 (dd, <i>J</i> = 8.0, 1.0 Hz, 1H), 7.29 (d, <i>J</i> = 1.6 Hz, 1H), 7.13 (dd, <i>J</i> = 8.2, 1.3 Hz, 1H), 3.92 (s, 3H), 2.66 (q, <i>J</i> = 7.6 Hz, 2H), 1.25 (t, <i>J</i> = 7.6 Hz, 3 Hz); HRMS (ESI+) <i>m</i>/<i>z</i>: 199.0691 [M + H]<sup>+</sup> (expected 199.0526); HPLC Ret: 7.73 min.</div></div><div id="sec5_7_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 2-Chloro-4-methylbenzohydrazide (<b>17a″</b>)</h4><div class="NLM_p last">Method B starting from methyl 2-chloro-4-ethylbenzoate (<b>17a′</b>, 0.08 g) gave 2-chloro-4-ethylbenzohydrazide as white solid (0.075 g, 98%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.61 (dd, <i>J</i> = 7.9, 1.1 Hz, 1H), 7.45 (br s, 1H), 7.26 (d, <i>J</i> = 1.1 Hz, 1H), 7.17 (dd, <i>J</i> = 8.4, 1.4 Hz, 1H), 4.13 (br s, 2H), 2.66 (q, <i>J</i> = 7.6 Hz, 2H), 1.24 (t, <i>J</i> = 7.6 Hz, 3H); HRMS (ESI+) <i>m</i>/<i>z</i>: 199.0633 [M + H]<sup>+</sup> (expected 199.0638); HPLC Ret: 4.61 min.</div></div><div id="sec5_7_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> Methyl 2-Chloro-4-propylbenzoate (<b>17b</b>)</h4><div class="NLM_p last">In a flame dried 25 mL round-bottomed flask, 2-chloro-4-methylbenzoic acid (<b>3k</b>, 0.1 g, 0.59 mmol) was dissolved in THF (1.0 mL). The solution was cooled to 0 °C and freshly prepared LDA (0.13 g, 1.2 mmol, 2.5 mL) was added. The reaction was stirred at 0 °C for 10 min, and then ethyl iodide (0.14 g, 0.88 mmol, 0.07 mL) was added. After stirring at 0 °C for 1 h, the reaction was quenched with 1 N HCl (10 mL). The product was extracted with EtOAc (3 × 20 mL), washed with brine, dried with MgSO<sub>4</sub>, and concentrated in vacuo to produce white solid. HPLC Ret: 6.87 min. The subsequent oil was subjected to method A to produce methyl 2-chloro-4-propylbenzoate as colorless oil (0.03 g, 25%, 2-steps) after silica gel chromatography eluting with 2% EtOAc/98% Hex; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.77 (d, <i>J</i> = 8.0 Hz, 1H), 7.27 (d, <i>J</i> = 1.6 Hz, 1H), 7.11 (dd, <i>J</i> = 8.1, 1.6 Hz, 1H), 3.92 (s, 3H), 2.59 (t, <i>J</i> = 7.4 Hz, 2H), 1.65 (h, <i>J</i> = 7.4 Hz, 2H), 0.94 (t, <i>J</i> = 7.4 Hz, 3H); HPLC Ret: 8.22 min.</div></div><div id="sec5_7_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 2-Chloro-4-propylbenzohydrazide (<b>17b′</b>)</h4><div class="NLM_p last">Method B starting from methyl 2-chloro-4-propylbenzoate (<b>17b</b>, 0.03 g) gave 2-chloro-4-propylbenzohydrazide as white solid (0.03 g, quant.); HPLC Ret: 5.00 min.</div></div><div id="sec5_7_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> Methyl 2-Chloro-4-(2-fluoropropan-2-yl)benzoate (<b>17d</b>)</h4><div class="NLM_p last">In a flame dried 25 mL round bottomed flask, methyl 2-chloro-4-(2-hydroxypropan-2-yl)benzoate (<b>14′</b>, 0.11 g, 0.48 mmol) was dissolved in DCM (2 mL) and cooled to −78 °C. DAST (0.08 g, 0.06 mL, 0.48 mmol) was added and the solution was stirred at 25 °C for 2 h. The reaction was diluted with H<sub>2</sub>O and the product was extracted with DCM (3 × 20 mL). The organic layers were combined, washed with brine (2 × 15 mL), dried with MgSO<sub>4</sub>, and concentrated in vacuo. The oil was subjected to silica gel chromatography eluting with 2.5% EtOAc/97.5% Hex to 5% EtOAc/95% Hex. The fractions containing product were concentrated to produce colorless oil. Yield = 51%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.83 (d, <i>J</i> = 8.2 Hz, 1H), 7.47 (d, <i>J</i> = 1.7 Hz, 1H), 7.30 (dd, <i>J</i> = 8.2, 1.7 Hz, 1H), 3.93 (s, 3H), 1.70 (d, <i>J</i> = 1.5 Hz, 3H), 1.65 (d, <i>J</i> = 1.5 Hz, 3H); <sup>19</sup>F NMR (100 MHz, CDCl<sub>3</sub>): δ −139.4 (hept, 1H); HRMS (ESI+) <i>m</i>/<i>z</i>: 231.0583 [M + H]<sup>+</sup> (expected 231.0588); HPLC Ret: 8.02 min.</div></div><div id="sec5_7_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 2-Chloro-4-(2-fluoropropan-2-yl)benzohydrazide (<b>17d′</b>)</h4><div class="NLM_p last">Method B starting from methyl 2-chloro-4-(2-fluoropropan-2-yl)benzoate (<b>17d</b>, 0.25 g) gave 2-chloro-4-(2-fluoropropan-2-yl)benzohydrazide as white solid (0.24 g, 96%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.67 (d, 8.1 Hz, 1H), 7.47–7.42 (m, 2H), 7.32 (dd, <i>J</i> = 8.1, 1.7 Hz, 1H), 4.15 (d, <i>J</i> = 4.3 Hz, 2H), 1.69 (s, 3H), 1.65 (s, 3H); HRMS (ESI+) <i>m</i>/<i>z</i>: 231.0697 [M + H]<sup>+</sup> (expected 231.0700); HPLC Ret: 4.76 min.</div></div><div id="sec5_7_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> Methyl 2-Chloro-3-cyclopropylbenzoate (<b>17e</b>)</h4><div class="NLM_p last">Method G starting from methyl 3-bromo-2-chlorobenzoate (<b>15a′</b>, 0.52 g) gave methyl 2-chloro-3-cyclopropylbenzoate as yellow oil (0.43 g, 97%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.51 (dd, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.21 (t, <i>J</i> = 7.7 Hz, 1H), 7.10 (dd, <i>J</i> = 7.8, 1.6 Hz, 1H), 3.94 (s, 3H), 2.29–2.21 (m, 1H), 1.09–0.96 (m, 2H), 0.71–0.66 (m, 2H); HRMS (ESI+) <i>m</i>/<i>z</i>: 211.0521 [M + H]<sup>+</sup> (expected 211.0526); HPLC Ret: 7.31 min.</div></div><div id="sec5_7_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 2-Chloro-3-cyclopropylbenzohydrazide (<b>17e′</b>)</h4><div class="NLM_p last">Method B starting from methyl 2-chloro-3-cyclopropylbenzoate (<b>17e</b>, 0.43 g) gave 2-chloro-3-cyclopropylbenzohydrazide as white solid (0.41 g, 95%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.33 (dd, <i>J</i> = 7.3, 1.4 Hz, 1H), 7.24 (t, <i>J</i> = 7.5 Hz, 1H), 7.06 (dd, <i>J</i> = 7.8, 1.6 Hz, 1H), 4.14 (d, <i>J</i> = 4.2 Hz, 2H), 2.20 (tt, <i>J</i> = 8.6, 5.3 Hz, 1H), 1.09–0.96 (m, 2H), 0.74–0.63 (m, 2H); HRMS (ESI+) <i>m</i>/<i>z</i>: 211.0641 [M + H]<sup>+</sup> (expected 211.0638); HPLC Ret: 4.55 min.</div></div><div id="sec5_7_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> Methyl 2-Chloro-4-cyclopropylbenzoate (<b>17f</b>)</h4><div class="NLM_p last">Method G starting from methyl 4-bromo-2-chlorobenzoate (<b>15b′</b>, 0.27 g) gave methyl 2-chloro-4-cyclopropylbenzoate as yellow oil (0.18 g, 51%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.81–7.70 (m, 1H), 7.15–7.12 (m, 1H), 7.03–6.94 (m, 1H), 3.90 (s, 3H), 1.95–1.84 (m, 1H), 1.11–1.00 (m, 2H), 0.81–0.70 (m, 2H); MS (ESI+) <i>m</i>/<i>z</i>: 211.0 [M + H]<sup>+</sup>; HPLC Ret: 7.29 min.</div></div><div id="sec5_7_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> 2-Chloro-4-cyclopropylbenzohydrazide (<b>17f′</b>)</h4><div class="NLM_p last">Method B starting from methyl 2-chloro-4-cyclopropylbenzoate (<b>17f</b>, 0.12 g) gave 2-chloro-4-cyclopropylbenzohydrazide as white solid (0.10 g, 85%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.63–7.52 (m, 1H), 7.09 (s, 1H), 7.02–7.00 (m, 1H), 4.12 (br s, 2H), 1.93–1.84 (m, 1H), 1.05 (dtd, <i>J</i> = 6.4, 4.8, 1.3 Hz, 2H), 0.74 (dtd, <i>J</i> = 6.4, 4.8, 1.3 Hz, 2H); MS (ESI+) <i>m</i>/<i>z</i>: 211.0 [M + H]<sup>+</sup>; HPLC Ret: 4.64 min.</div></div><div id="sec5_7_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> Methyl 2-Chloro-5-cyclopropylbenzoate (<b>17g</b>)</h4><div class="NLM_p last">Method G starting from methyl 5-bromo-2-chlorobenzoate (<b>15c′</b>, 0.5 g) gave methyl 2-chloro-5-cyclopropylbenzoate as yellow oil (0.35 g, 83%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.51 (d, <i>J</i> = 1.6 Hz, 1H), 7.33 (d, <i>J</i> = 8.2 Hz, 1H), 7.11 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 3.93 (s, 3H), 1.93–1.86 (m, 1H), 1.05–0.98 (m, 2H), 0.73–0.68 (m, 2H); HRMS (ESI+) <i>m</i>/<i>z</i>: 211.0521 [M + H]<sup>+</sup> (expected 211.0526); HPLC Ret: 7.31 min.</div></div><div id="sec5_7_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> 2-Chloro-5-cyclopropylbenzohydrazide (<b>17g′</b>)</h4><div class="NLM_p last">Method B starting from methyl 2-chloro-5-cyclopropylbenzoate (<b>17g</b>, 0.35 g) gave 2-chloro-5-cyclopropylbenzohydrazide as white solid (0.33 g, 96%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.41 (br s, 1H), 7.36 (d, <i>J</i> = 2.3 Hz, 1H), 7.28 (dd, <i>J</i> = 8.3, 0.8 Hz, 1H), 7.08 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 1.89 (tt, <i>J</i> = 8.6, 5.0 Hz, 1H), 1.08–0.94 (m, 2H), 0.76–0.64 (m, 2H); HRMS (ESI+) <i>m</i>/<i>z</i>: 211.0646 [M + H]<sup>+</sup> (expected 211.0638); HPLC Ret: 4.59 min.</div></div><div id="sec5_7_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> Methyl 2-Chloro-4-cyclopropoxybenzoate (<b>17h</b>)</h4><div class="NLM_p last">Methyl 2-chloro-4-hydroxybenzoate (<b>16</b>, 0.25 g, 1.34 mmol) was dissolved in 2.0 mL DMA. Bromocyclopropane (0.54 g, 4.42 mmol) along with Cs<sub>2</sub>CO<sub>3</sub> (1.4 g, 4.42 mmol) were added and the reaction was stirred at 155 °C for 24 h. The reaction was diluted with 10 mL H<sub>2</sub>O and washed with EtOAc (3 × 10 mL). The aqueous layer was acidified to pH ∼1 with 1 N HCl and the product was extracted with EtOAc (3 × 15 mL). The organic layers were combined, washed with brine (3 × 10 mL), dried with MgSO<sub>4</sub>, and evaporated in vacuo. The subsequent oil was subjected to silica gel chromatography eluting with 45% EtOAc/55% Hex/0.1% AcOH. The fractions containing product were concentrated in vacuo to produce white solid. Yield = 65%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.00 (br s, 1H), 7.84 (d, 8.7 Hz, 1H), 7.20 (d, <i>J</i> = 2.5 Hz, 1H), 6.99 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 3.98 (tt, <i>J</i> = 6.1, 2.9 Hz, 1H), 0.87–0.79 (m, 2H), 0.70 (tdd, <i>J</i> = 5.9, 3.0, 1.5, 2H); MS (ESI+) <i>m</i>/<i>z</i>: 213.0 [M + H]<sup>+</sup>; HPLC Ret: 6.33 min. Method A starting from 2-chloro-4-cyclopropoxybenzoic acid (0.3 g) gave methyl 2-chloro-4-cyclopropoxybenzoate as colorless oil (<b>17h</b>, 0.21 g, 66%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.86 (d, 8.5 Hz, 1H), 7.14 (d, <i>J</i> = 2.5 Hz, 1H), 6.94 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 3.90 (s, 3H), 3.77 (tt, <i>J</i> = 6.4, 3.0 Hz, 1H), 0.88–0.75 (m, 4H); MS (ESI+) <i>m</i>/<i>z</i>: 226.1 [M + H]<sup>+</sup>; HPLC Ret: 7.67 min.</div></div><div id="sec5_7_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> 2-Chloro-4-cyclopropoxybenzohydrazide (<b>17h′</b>)</h4><div class="NLM_p last">Method B starting from methyl 2-chloro-4-cyclopropoxybenzoate (<b>17h</b>, 0.21 g) gave 2-chloro-4-cyclopropoxybenzohydrazide as white solid (0.21 g, 98%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.69 (d, 8.7 Hz, 1H), 7.54 (br s, 1H), 7.09 (d, <i>J</i> = 2.4 Hz, 1H), 6.99 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 4.13 (br s, 2H), 3.80–3.72 (m, 1H), 0.88–0.73 (m, 4H); HRMS (ESI+) <i>m</i>/<i>z</i>: 227.0581 [M + H]<sup>+</sup> (expected 227.0587); HPLC Ret: 4.57 min.</div></div><div id="sec5_7_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> Methyl 2-Chloro-4-(oxetan-3-yloxy)benzoate (<b>17i</b>)</h4><div class="NLM_p last">In a 50 mL round-bottomed flask, methyl 2-chloro-4-hydroxybenzoate (<b>16</b>, 0.3 g, 1.6 mmol) was dissolved in 6 mL anhydrous DMSO. Cs<sub>2</sub>CO<sub>3</sub> (0.68 g, 2.09 mmol) and 3-bromooxetane (0.29 g, 0.17 mL, 2.09 mmol) were added, and the reaction was heated at 105 °C for 8 h. The reaction was cooled, diluted with H<sub>2</sub>O, and extracted with EtOAc (3 × 20 mL). The organic layers were combined, washed with brine, and concentrated in vacuo. The yellow residue was subjected to silica gel chromatography eluting with 30% EtOAc/70% Hex. The fractions containing product were concentrated in vacuo to produce yellow solid. Yield = 70%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.87 (d, <i>J</i> = 8.7 Hz, 1H), 6.76 (d, <i>J</i> = 2.5 Hz, 1H), 6.64 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 5.28–5.20 (m, 2H), 5.02–4.95 (m, 2H), 4.78–4.72 (m, 2H), 3.90 (s, 3H); HPLC Ret: 6.39 min.</div></div><div id="sec5_7_85" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> 2-Chloro-4-(oxetan-3-yloxy)benzohydrazide (<b>17i′</b>)</h4><div class="NLM_p last">Method B starting from methyl 2-chloro-4-(oxetan-3-yloxy)benzoate (<b>17i</b>, 0.27 g) gave 2-chloro-4-(oxetan-3-yloxy)benzohydrazide as white solid (0.20 g, 72%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.69 (d, 8.7 Hz, 1H), 7.51 (br s, 1H), 6.74 (d, <i>J</i> = 2.5 Hz, 1H), 6.67 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 5.22 (pd, 6.0, 1.0 Hz, 1H), 4.98 (t, <i>J</i> = 7.1 Hz, 2H), 4.74 (dd, <i>J</i> = 7.3, 5.1 Hz, 2H), 4.12 (d, <i>J</i> = 4.1 Hz, 2H); HRMS (ESI+) <i>m</i>/<i>z</i>: 243.0533 [M + H]<sup>+</sup> (expected 243.0536); HPLC Ret: 3.10 min.</div></div><div id="sec5_7_86" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 5-(2-Chloro-4-ethylphenyl)-1,3,4-oxadiazole-2-thiol (<b>18a</b>)</h4><div class="NLM_p last">Method C starting from 2-chloro-4-ethylbenzohydrazide (<b>17a″</b>, 0.075 g) gave 5-(2-chloro-4-ethylphenyl)-1,3,4-oxadiaole-2-thiol as white powder (0.08 g, 87%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.44 (br s, 1H), 7.83 (dd, <i>J</i> = 8.1, 1.5 Hz, 1H), 7.40 (d, <i>J</i> = 1.5 Hz, 1H), 7.25 (dd, <i>J</i> = 8.1, 1.3 Hz, 1H), 2.71 (q, <i>J</i> = 7.6 Hz, 2H), 1.28 (t, <i>J</i> = 7.6 Hz, 3H); HPLC Ret: 7.16 min.</div></div><div id="sec5_7_87" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> <i>tert</i>-Butyl 4-((5-(2-Chloro-4-ethylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>18a′</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-chloro-4-ethylphenyl)-1,3,4-oxadiazole-2-thiol (<b>18a</b>, 0.05 g) gave <i>tert</i>-butyl 4-((5-(2-chloro-4-ethylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate as colorless oil (0.07 g, 85%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.85 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.37 (d, <i>J</i> = 1.5 Hz, 1H), 7.22 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 3.34 (t, <i>J</i> = 7.2 Hz, 2H), 2.70 (q, <i>J</i> = 7.6 Hz, 2H), 2.43 (t, <i>J</i> = 7.2 Hz, 2H), 2.15 (p, <i>J</i> = 7.2 Hz, 2H), 1.45 (s, 9H), 1.27 (t, <i>J</i> = 7.6 Hz, 3H); HRMS (ESI+) <i>m</i>/<i>z</i>: 405.1009 [M + Na]<sup>+</sup> (expected 405.1016); HPLC Ret: 9.28 min.</div></div><div id="sec5_7_88" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> 5-(2-Chloro-4-propylphenyl)-1,3,4-oxadiazole-2-thiol (<b>18b</b>)</h4><div class="NLM_p last">Modified method C (post acidification, product was extracted with EtOAc (3 × 15 mL), washed with brine, dried with MgSO<sub>4</sub>, concentrated in vacuo) starting from 2-chloro-4-propylbenzohydrazide (<b>17b′</b>, 0.03 g) gave 5-(2-chloro-4-propylphenyl)-1,3,4-oxadiazole-2-thiol as white solid (0.03 g, 71%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.36 (br s, 1H), 7.82 (d, <i>J</i> = 8.1 Hz, 1H), 7.37 (d, <i>J</i> = 1.5 Hz, 1H), 7.26 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 2.64 (t, <i>J</i> = 7.6 Hz, 2H), 1.66 (h, <i>J</i> = 7.4 Hz, 2H), 0.96 (t, <i>J</i> = 7.5 Hz, 3H); HRMS (ESI+) <i>m</i>/<i>z</i>: 255.0349 [M + H]<sup>+</sup> (expected 255.0359); HPLC Ret: 7.63 min.</div></div><div id="sec5_7_89" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> <i>tert</i>-Butyl 4-((5-(2-Chloro-4-propylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>18b′</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-chloro-4-propylphenyl)-1,3,4-oxadiazole-2-thiol (<b>18b</b>, 0.03 g) gave <i>tert</i>-butyl 4-((5-(2-chloro-4-propylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate as colorless oil (0.03 g, 62%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.85 (dd, <i>J</i> = 8.0, 1.3 Hz, 1H), 7.27 (s, 1H), 7.20 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 3.34 (t, <i>J</i> = 7.2 Hz, 2H), 2.63 (t, <i>J</i> = 7.6 Hz, 2H), 2.43 (t, <i>J</i> = 7.3 Hz, 2H), 2.16 (p, <i>J</i> = 7.3 Hz, 2H), 1.68 (h, <i>J</i> = 7.5 Hz, 2H), 1.46 (s, 9H), 0.96 (t, <i>J</i> = 7.5 Hz, 3H); HRMS (ESI+) <i>m</i>/<i>z</i>: 397.1359 [M + H]<sup>+</sup> (expected 397.1353); HPLC Ret: 9.81 min.</div></div><div id="sec5_7_90" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> 5-(2-Chloro-4-isopropylphenyl)-1,3,4-oxadiazole-2-thiol (<b>18c</b>)</h4><div class="NLM_p last">Method B starting from mixture of methyl 2-chloro-4-isopropylbenzoate (<b>17c</b>) and methyl-butyl 4-isopropylbenzoate (0.05 g) prepared as previously described<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> gave the mixture of 2-chloro-4-isopropylbenzohydrazide and 4-isopropylbenzohydrazide as white solid (0.05 g, quant.) followed by modified method C (post acidification, product was extracted with EtOAc (3 × 15 mL), washed with brine, dried with MgSO<sub>4</sub>, concentrated in vacuo) gave 5-(2-chloro-4-isopropylphenyl)-1,3,4-oxadiazole-2-thiol and 5-(4-isopropylphenyl)-1,3,4-oxadiazole-2-thiol as yellow solid (0.04 g, 88%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.43 (br s, 2H), 7.88–7.82 (m, 3H), 7.43–7.26 (m, 4H), 3.03–2.91 (m, 2H), 1.29–1.25 (m, 12H); HRMS (ESI+) <i>m</i>/<i>z</i>: 255.0351 and 221.0749 [M + H]<sup>+</sup> (expected 255.0359 and 221.0749); HPLC Ret: 7.53 & 7.31 min.</div></div><div id="sec5_7_91" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> <i>tert</i>-Butyl 4-((5-(2-Chloro-4-isopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>18c′</b>)</h4><div class="NLM_p last">Method D starting from a mixture of 5-(2-chloro-4-isopropylphenyl)-1,3,4-oxadiazole-2-thiol (<b>18c</b>) and 5-(4-isopropylphenyl)-1,3,4-oxadiazole-2-thiol (0.04 g) gave the mixture of <i>tert</i>-butyl 4-((5-(2-chloro-4-isopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate and <i>tert</i>-butyl 4-((5-(4-isopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate as colorless oil (0.03 g, 60%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.92 (d, <i>J</i> = 8.3 Hz, 2H), 7.86 (d, <i>J</i> = 8.0 Hz, 0.5H), 7.41–7.32 (m, 2.5H), 7.25 (dd, <i>J</i> = 8.0, 1.6 Hz, 0.5H), 3.34 (t, <i>J</i> = 7.2 Hz, 3H), 3.02–2.90 (m, 1.5H), 2.43 (t, <i>J</i> = 7.2 Hz, 3H), 2.15 (p, <i>J</i> = 7.2 Hz, 3H), 1.45 (s, 13.5H), 1.30–1.26 (m, 9H); HRMS (ESI+) <i>m</i>/<i>z</i>: 397.1355 & 363.1757 [M + H]<sup>+</sup> (expected 397.1353 and 363.1742); HPLC Ret: 9.70 & 9.40 min.</div></div><div id="sec5_7_92" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> 5-(2-Chloro-4-(2-fluoropropan-2-yl)phenyl)-1,3,4-oxadiazole-2-thiol (<b>18d</b>)</h4><div class="NLM_p last">Method C starting from 2-chloro-4-(2-fluoropropan-2-yl)benzohydrazide (<b>17d′</b>, 0.24 g) gave 5-(2-chloro-4-(2-fluoropropan-2-yl)phenyl)-1,3,4-oxadiazole-2-thiol as white solid (0.25 g, 88%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.62 (br s, 1H), 7.91 (d, 8.3 Hz, 1H), 7.59 (d, <i>J</i> = 1.4 Hz, 1H), 7.41 (dd, <i>J</i> = 8.3, 1.4 Hz, 1H), 1.73 (d, <i>J</i> = 1.1 Hz, 3H), 1.68 (d, <i>J</i> = 1.1 Hz, 3H); HRMS (ESI−) <i>m</i>/<i>z</i>: 271.0110 [M – H]<sup>−</sup> (expected 271.0108); HPLC Ret: 7.15 min.</div></div><div id="sec5_7_93" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> Methyl 4-((5-(2-Chloro-4-(2-fluoropropan-2-yl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>18d′</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-chloro-4-(2-fluoropropan-2-yl)phenyl)-1,3,4-oxadiazole-2-thiol (<b>18d</b>, 0.08 g) gave methyl 4-((5-(2-chloro-4-(2-fluoropropan-2-yl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate as colorless oil (0.09 g, 86%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.94 (d, <i>J</i> = 8.2 Hz, 1H), 7.56 (d, <i>J</i> = 1.7 Hz, 1H), 7.38 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 3.70 (s, 3H), 3.37 (t, <i>J</i> = 7.1 Hz, 2H), 2.54 (t, <i>J</i> = 7.2 Hz, 2H), 2.22 (p, <i>J</i> = 7.2 Hz, 2H), 1.72 (s, 3H), 1.68 (s, 3H); HRMS (ESI+) <i>m</i>/<i>z</i>: 373.0785 [M + H]<sup>+</sup> (expected 373.0789); HPLC Ret: 7.96 min.</div></div><div id="sec5_7_94" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> 5-(2-Chloro-3-cyclopropylphenyl)-1,3,4-oxadiazole-2-thiol (<b>18e</b>)</h4><div class="NLM_p last">Method C starting from 2-chloro-3-cyclopropylbenzohydrazide (<b>17e′</b>, 0.2 g) gave 5-(2-chloro-3-cyclopropylphenyl)-1,3,4-oxadiazole-2-thiol as yellow powder (0.13 g, 55%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.56 (br s, 1H), 7.69 (dd, <i>J</i> = 7.8, 1.6 Hz, 1H), 7.32 (t, <i>J</i> = 7.8 Hz, 1H), 7.19 (dd, <i>J</i> = 7.8, 1.6 Hz, 1H), 2.27 (ddd, <i>J</i> = 13.9, 8.6, 5.4 Hz, 1H), 1.15–1.03 (m, 2H), 0.77–0.65 (m, 2H); HRMS (ESI−) <i>m</i>/<i>z</i>: 251.0050 [M – H]<sup>−</sup> (expected 251.0046); HPLC Ret: 7.16 min.</div></div><div id="sec5_7_95" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> <i>tert</i>-Butyl 4-((5-(2-Chloro-3-cyclopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>18e′</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-chloro-3-cyclopropylphenyl)-1,3,4-oxadiazole-2-thiol (<b>18e</b>, 0.05 g) gave <i>tert</i>-butyl 4-((5-(2-chloro-3-cyclopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate as colorless oil (0.06 g, 82%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.69 (dd, <i>J</i> = 7.7, 1.6 Hz, 1H), 7.29 (t, <i>J</i> = 7.8 Hz, 1H), 7.15 (dd, <i>J</i> = 7.9, 1.6 Hz, 1H), 3.35 (t, <i>J</i> = 7.2 Hz, 2H), 2.43 (t, <i>J</i> = 7.2 Hz, 2H), 2.26 (tt, <i>J</i> = 8.6, 5.4 Hz, 1H), 2.16 (p, <i>J</i> = 7.2 Hz, 2H), 1.46 (s, 9H), 1.13–1.02 (m, 2H), 0.77–0.66 (m, 2H); HRMS (ESI+) <i>m</i>/<i>z</i>: 395.1208 [M + H]<sup>+</sup> (expected 395.1196); HPLC Ret: 9.19 min.</div></div><div id="sec5_7_96" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> 5-(2-Chloro-4-cyclopropylphenyl)-1,3,4-oxadiazole-2-thiol (<b>18f</b>)</h4><div class="NLM_p last">Method C starting from 2-chloro-4-cyclopropylbenzohydrazide (<b>17f′</b>, 0.1 g) gave 5-(2-chloro-4-cyclopropylphenyl)-1,3,4-oxadiazole-2-thiol as yellow powder (0.08 g, 70%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.53 (br s, 1H), 7.81–7.73 (m, 1H), 7.23 (s, 1H), 7.08 (dd, <i>J</i> = 8.2, 1.8 Hz, 1H), 1.96–1.91 (m, 1H), 1.12 (dt, <i>J</i> = 6.8, 4.8, Hz, 2H), 0.81 (dt, <i>J</i> = 6.8, 4.8, Hz, 2H); MS (ESI+) <i>m</i>/<i>z</i>: 253.0 [M + H]<sup>+</sup>; HPLC Ret: 7.14 min.</div></div><div id="sec5_7_97" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> Methyl 4-((5-(2-Chloro-4-cyclopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>18f′</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-chloro-4-cyclopropylphenyl)-1,3,4-oxadiazole-2-thiol (<b>18f</b>, 0.08 g) gave methyl 4-((5-(2-chloro-4-cyclopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate as white oil (0.07 g, 64%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.81 (d, <i>J</i> = 8.2 Hz, 1H), 7.19 (s, 1H), 7.05 (dd, <i>J</i> = 8.2, 1.7 Hz, 1H), 3.69 (s, 3H), 2.37 (t, <i>J</i> = 7.2 Hz, 2H), 2.58 (t, <i>J</i> = 7.1 Hz, 2H), 2.20 (p, <i>J</i> = 7.2 Hz, 2H), 1.96–1.91 (tt, <i>J</i> = 8.4, 5.0 Hz, 1H), 1.08 (dt, <i>J</i> = 6.9, 4.9 Hz, 2H), 0.78 (dt, <i>J</i> = 6.9, 4.9 Hz, 2H); HRMS (ESI+) <i>m</i>/<i>z</i>: 375.0540 [M + Na]<sup>+</sup> (expected 375.0546); HPLC Ret: 8.01 min.</div></div><div id="sec5_7_98" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> 5-(2-Chloro-5-cyclopropylphenyl)-1,3,4-oxadiazole-2-thiol (<b>18g</b>)</h4><div class="NLM_p last">Method C starting from 2-chloro-5-cyclopropylbenzohydrazide (<b>17g′</b>, 0.15 g) gave 5-(2-chloro-5-cyclopropylphenyl)-1,3,4-oxadiazole-2-thiol as white solid (0.15 g, 81%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.58 (br s, 1H), 7.59 (d, <i>J</i> = 2.3 Hz, 1H), 7.42 (d, <i>J</i> = 8.3 Hz, 1H), 7.18 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 1.94 (ddd, <i>J</i> = 13.4, 8.4, 5.1 Hz, 1H), 1.11–0.99 (m, 2H), 0.79–0.68 (m, 2H); HRMS (ESI−) <i>m</i>/<i>z</i>: 251.0053 [M – H]<sup>−</sup> (expected 251.0046); HPLC Ret: 7.19 min.</div></div><div id="sec5_7_99" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> <i>tert</i>-Butyl 4-((5-(2-Chloro-5-cyclopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>18g′</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-chloro-5-cyclopropylphenyl)-1,3,4-oxadiazole-2-thiol (<b>18g</b>, 0.05 g) gave <i>tert</i>-butyl 4-((5-(2-chloro-5-cyclopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate as colorless oil (0.07 g, 90%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.63 (d, <i>J</i> = 2.3 Hz, 1H), 7.39 (d, <i>J</i> = 8.4 Hz, 1H), 7.14 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 3.35 (t, <i>J</i> = 7.2 Hz, 2H), 2.43 (t, <i>J</i> = 7.2 Hz, 2H), 2.16 (p, <i>J</i> = 7.2 Hz, 2H), 1.93 (ddd, <i>J</i> = 13.5, 8.6, 5.1 Hz, 1H), 1.45 (s, 9H), 1.07–0.98 (m, 2H), 0.75–0.64 (m, 2H); HRMS (ESI+) <i>m</i>/<i>z</i>: 395.1208 [M + H]<sup>+</sup> (expected 395.1196); HPLC Ret: 9.21 min.</div></div><div id="sec5_7_100" class="NLM_sec NLM_sec_level_3"><div id="ac_i123" class="anchor-spacer"></div><h4 class="article-section__title" id="_i123"> 5-(2-Chloro-4-cyclopropoxyphenyl)-1,3,4-oxadiazole-2-thiol (<b>18h</b>)</h4><div class="NLM_p last">Method C starting from 2-chloro-4-cyclopropoxybenzohydrazide (<b>17h′</b>, 0.2 g) gave 5-(2-chloro-4-cyclopropoxyphenyl)-1,3,4-oxadiazole-2-thiol as yellow solid (0.18 g, 78%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.36 (br s, 1H), 7.84 (d, 8.8 Hz, 1H), 7.24 (d, <i>J</i> = 2.5 Hz, 1H), 7.06 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 3.85–3.77 (m, 1H), 0.92–0.79 (m, 4H); HRMS (ESI+) <i>m</i>/<i>z</i>: 269.0149 [M + H]<sup>+</sup> (expected 269.0152); HPLC Ret: 7.13 min.</div></div><div id="sec5_7_101" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124"> Methyl 4-((5-(2-Chloro-4-cyclopropoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>18h′</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-chloro-4-cyclopropoxyphenyl)-1,3,4-oxadiazole-2-thiol (<b>18h</b>, 0.1 g) gave methyl 4-((5-(2-chloro-4-cyclopropoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate as colorless oil (0.11 g, 78%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.86 (d, 8.8 Hz, 1H), 7.24 (d, <i>J</i> = 2.5 Hz, 1H), 7.04 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 3.83–3.76 (m, 1H), 3.69 (s, 3H), 3.35 (t, <i>J</i> = 7.2 Hz, 2H), 2.53 (t, <i>J</i> = 7.2 Hz, 2H), 2.20 (p, <i>J</i> = 7.2 Hz, 2H), 0.90–0.78 (m, 4H); HRMS (ESI+) <i>m</i>/<i>z</i>: 369.0674 [M + H]<sup>+</sup> (expected 369.0676); HPLC Ret: 7.94 min.</div></div><div id="sec5_7_102" class="NLM_sec NLM_sec_level_3"><div id="ac_i125" class="anchor-spacer"></div><h4 class="article-section__title" id="_i125"> 5-(2-Chloro-4-(oxetan-3-yloxy)phenyl)-1,3,4-oxadiazole-2-thiol (<b>18i</b>)</h4><div class="NLM_p last">Method C starting from 2-chloro-4-(oxetan-3-yloxy)benzohydrazide (<b>17i′</b>, 0.2 g) gave 5-(2-chloro-4-(oxetan-3-yloxy)phenyl)-1,3,4-oxadiazole-2-thiol as white solid (0.19 g, 81%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.61 (br s, 1H), 7.85 (d, 8.8 Hz, 1H), 6.87 (d, <i>J</i> = 2.5 Hz, 1H), 6.74 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 5.27 (pd, 6.0, 1.0 Hz, 1H), 5.02 (t, <i>J</i> = 7.1 Hz, 2H), 4.78 (dd, <i>J</i> = 7.3, 5.1 Hz, 2H); HRMS (ESI−) <i>m</i>/<i>z</i>: 282.9945 [M – H]<sup>−</sup> (expected 282.9944); HPLC Ret: 6.03 min.</div></div><div id="sec5_7_103" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126"> Methyl 4-((5-(2-Chloro-4-(oxetan-3-yloxy)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>18i′</b>)</h4><div class="NLM_p last">Method D starting from 5-(2-chloro-4-(oxetan-3-yloxy)phenyl)-1,3,4-oxadiazole-2-thiol (<b>18i</b>, 0.08 g) gave methyl 4-((5-(2-chloro-4-(oxetan-3-yloxy)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate as colorless oil (0.07 g, 70%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.88 (d, 8.8 Hz, 1H), 6.85 (d, <i>J</i> = 2.6 Hz, 1H), 6.73 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 5.26 (pd, 6.0, 1.0 Hz, 1H), 5.01 (t, <i>J</i> = 7.1 Hz, 2H), 4.77 (dd, <i>J</i> = 7.3, 5.1 Hz, 2H), 3.69 (s, 3H), 3.35 (t, <i>J</i> = 7.2 Hz, 2H), 2.53 (t, <i>J</i> = 7.2 Hz, 2H), 2.20 (p, <i>J</i> = 7.2 Hz, 2H); HRMS (ESI+) <i>m</i>/<i>z</i>: 285.0621 [M + H]<sup>+</sup> (expected 385.0625); HPLC Ret: 6.03 min.</div></div><div id="sec5_7_104" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> 4-((5-(2-Chloro-4-ethylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic Acid (<b>19a</b>)</h4><div class="NLM_p last">Method E starting from <i>tert</i>-butyl 4-((5-(2-chloro-4-ethylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>18a′</b>, 0.07 g) gave 4-((5-(2-chloro-4-ethylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic acid as white solid (0.05 g, 83%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.52 (br s, 1H), 7.85 (d, <i>J</i> = 8.0, 1H), 7.37 (d, <i>J</i> = 1.6 Hz, 1H), 7.22 (dd, <i>J</i> = 8.1, 1.6 Hz, 1H), 3.38 (t, <i>J</i> = 7.1 Hz, 2H), 2.70 (q, <i>J</i> = 7.6 Hz, 2H), 2.59 (t, <i>J</i> = 7.1 Hz, 2H), 2.23 (p, <i>J</i> = 7.2 Hz, 2H), 1.27 (t, <i>J</i> = 7.6 Hz, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 178.04, 164.39, 164.29, 149.58, 132.76, 130.81, 130.54, 126.78, 120.06, 32.32, 31.60, 28.51, 24.34, 14.87; HRMS (ESI+) <i>m</i>/<i>z</i>: 349.0385 [M + Na]<sup>+</sup> (expected 349.0390); HPLC Ret: 6.96 min; 98% pure.</div></div><div id="sec5_7_105" class="NLM_sec NLM_sec_level_3"><div id="ac_i128" class="anchor-spacer"></div><h4 class="article-section__title" id="_i128"> 4-((5-(2-Chloro-4-propylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic Acid (<b>19b</b>)</h4><div class="NLM_p last">Modified method E (product required silica gel column chromatography eluting with 2% MeOH/98% DCM and semi-prep to obtain >95% purity) starting from <i>tert</i>-butyl 4-((5-(2-chloro-4-propylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>18b′</b>, 0.03 g) gave 4-((5-(2-chloro-4-propylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic acid as colorless oil (0.01 g, 47%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.84 (d, <i>J</i> = 8.0, 1H), 7.35 (s, 1H), 7.20 (dd, <i>J</i> = 8.1, 1.6 Hz, 1H), 3.38 (t, <i>J</i> = 7.2 Hz, 2H), 2.64–2.57 (m, 4H), 2.22 (p, <i>J</i> = 7.2 Hz, 2H), 1.68 (h, <i>J</i> = 7.4 Hz, 2H), 0.96 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 177.82, 164.39, 164.31, 148.13, 132.68, 131.10, 131.06, 130.72, 127.35, 120.08, 37.52, 32.27, 31.59, 24.35, 23.95, 13.65; HRMS (ESI+) <i>m</i>/<i>z</i>: 341.0738 [M + H]<sup>+</sup> (expected 341.0727); HPLC Ret: 7.43 min; 97% pure.</div></div><div id="sec5_7_106" class="NLM_sec NLM_sec_level_3"><div id="ac_i129" class="anchor-spacer"></div><h4 class="article-section__title" id="_i129"> 4-((5-(2-Chloro-4-isopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic Acid (<b>19c</b>)</h4><div class="NLM_p last">Modified method E (product required semi-prep to obtain >95% purity) starting from a mixture of <i>tert</i>-butyl 4-((5-(2-chloro-4-isopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>19c′</b>) and <i>tert</i>-butyl 4-((5-(4-isopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (0.03 g) gave 4-((5-(2-chloro-4-isopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic acid as white oil (0.01 g, 36%); <sup>1</sup>H NMR (500 MHz, MeOH-<i>d</i><sub>4</sub>): δ 7.86 (d, <i>J</i> = 8.1 Hz, 1H), 7.49 (d, <i>J</i> = 1.7 Hz, 1H), 7.38 (dd, <i>J</i> = 8.1, 1.7 Hz, 1H), 3.38 (t, <i>J</i> = 7.2 Hz, 2H), 2.99 (hept, <i>J</i> = 7.0 Hz, 1H), 2.51 (t, <i>J</i> = 7.2 Hz, 2H), 2.14 (p, <i>J</i> = 7.2 Hz, 2H), 1.29 (d, <i>J</i> = 6.9 Hz, 6H); <sup>13</sup>C NMR (125 MHz, MeOH-<i>d</i><sub>4</sub>): δ 174.11, 165.07, 164.11, 154.83, 132.45, 130.74, 128.88, 125.45, 119.83, 33.80, 31.86, 31.34, 24.65, 22.39; HRMS (ESI+) <i>m</i>/<i>z</i>: 341.0902 [M + H]<sup>+</sup> (expected 341.0727); HPLC Ret: 7.32 min; 99% pure.</div></div><div id="sec5_7_107" class="NLM_sec NLM_sec_level_3"><div id="ac_i130" class="anchor-spacer"></div><h4 class="article-section__title" id="_i130"> 4-((5-(2-Chloro-4-(2-fluoropropan-2-yl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic Acid (<b>19d</b>)</h4><div class="NLM_p last">Modified method F (product required column chromatography eluting with 50% EtOAc/50% Hex/0.1% AcOH to obtain >95% purity) starting from methyl 4-((5-(2-chloro-4-(2-fluoropropan-2-yl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>18d′</b>, 0.09 g) gave 4-((5-(2-chloro-4-(2-fluoropropan-2-yl)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic acid as colorless oil (0.06 g, 76%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.94 (d, <i>J</i> = 8.2 Hz, 1H), 7.56 (d, <i>J</i> = 1.7 Hz, 1H), 7.38 (dd, <i>J</i> = 8.3, 1.7 Hz, 1H), 3.39 (t, <i>J</i> = 7.1 Hz, 2H), 2.60 (t, <i>J</i> = 7.1 Hz, 2H), 2.23 (p, <i>J</i> = 7.1 Hz, 2H), 1.72 (s, 3H), 1.68 (s, 3H); <sup>19</sup>F NMR (100 MHz, CDCl<sub>3</sub>): δ −139.2 (hept, 1H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 178.08, 164.73, 163.90, 150.88, 133.03, 130.94, 126.80, 122.72, 121.58, 32.30, 31.60, 29.05, 28.85, 24.31; HRMS (ESI+) <i>m</i>/<i>z</i>: 359.0627 [M + H]<sup>+</sup> (expected 359.0632); HPLC Ret: 6.95 min; 98% pure.</div></div><div id="sec5_7_108" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> 4-((5-(2-Chloro-3-cyclopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic Acid (<b>19e</b>)</h4><div class="NLM_p last">Modified method E (product required column chromatography eluting with 5% MeOH/95% DCM to obtain >95% purity) starting from <i>tert</i>-butyl-4-((5-(2-chloro-3-cyclopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>18e′</b>, 0.06 g) gave 4-((5-(2-chloro-3-cyclopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic acid as white oil (0.02 g, 39%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.68 (dd, <i>J</i> = 7.7, 1.6 Hz, 1H), 7.29 (t, <i>J</i> = 7.8 Hz, 1H), 7.15 (dd, <i>J</i> = 7.8, 1.6 Hz, 1H), 3.39 (t, <i>J</i> = 7.2 Hz, 2H), 2.59 (t, <i>J</i> = 7.1 Hz, 2H), 2.31–2.18 (m, 3H), 1.13–0.98 (m, 2H), 0.77–0.66 (m, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 175.45, 164.64, 143.05, 134.30, 129.45, 128.56, 126.72, 123.34, 109.99, 32.30, 31.60, 24.37, 14.02, 8.05; HRMS (ESI+) <i>m</i>/<i>z</i>: 339.0571 [M + H]<sup>+</sup> (expected 339.0570); HPLC Ret: 6.94 min; 95% pure.</div></div><div id="sec5_7_109" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> 4-((5-(2-Chloro-4-cyclopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic Acid (<b>19f</b>)</h4><div class="NLM_p last">Modified method F (product required column chromatography eluting with 5% MeOH/95% DCM to obtain >95% purity) starting from methyl-4-((5-(2-chloro-4-cyclopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>18f′</b>, 0.07 g) gave 4-((5-(2-chloro-4-cyclopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic acid as colorless oil (0.07 g, 92%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.11 (br s, 1H), 7.81 (d, <i>J</i> = 8.2 Hz, 1H), 7.19 (s, 1H), 7.05 (dd, <i>J</i> = 8.2, 1.7 Hz, 1H), 2.58 (t, <i>J</i> = 7.1 Hz, 2H), 2.37 (t, <i>J</i> = 7.2 Hz, 2H), 2.20 (p, <i>J</i> = 7.2 Hz, 2H), 1.96–1.91 (tt, <i>J</i> = 8.4, 5.0 Hz, 1H), 1.08 (dt, <i>J</i> = 6.9, 4.9 Hz, 2H), 0.78 (dt, <i>J</i> = 6.9, 4.9 Hz, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 177.84, 164.36, 164.26, 150.10, 132.77, 130.66, 128.12, 124.27, 119.43, 32.36, 31.61, 24.37, 15.40, 10.41; HRMS (ESI+) <i>m</i>/<i>z</i>: 361.0383 [M + Na]<sup>+</sup> (expected 361.0390); HPLC Ret: 6.93 min; 97% pure.</div></div><div id="sec5_7_110" class="NLM_sec NLM_sec_level_3"><div id="ac_i133" class="anchor-spacer"></div><h4 class="article-section__title" id="_i133"> 4-((5-(2-Chloro-5-cyclopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic Acid (<b>19g</b>)</h4><div class="NLM_p last">Modified method E (product required column chromatography eluting with 5% MeOH/95% DCM to obtain >95% purity) starting from <i>tert</i>-butyl-4-((5-(2-chloro-5-cyclopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>18g′</b>, 0.07 g) gave 4-((5-(2-chloro-5-cyclopropylphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic acid as white oil (0.03 g, 55%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.90 (br s, 1H), 7.63 (d, <i>J</i> = 2.2 Hz, 1H), 7.39 (d, <i>J</i> = 8.3 Hz, 1H), 7.14 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 3.38 (t, <i>J</i> = 7.1 Hz, 2H), 2.59 (t, <i>J</i> = 7.1 Hz, 2H), 2.22 (p, <i>J</i> = 7.1 Hz, 2H), 1.93 (tt, <i>J</i> = 8.4, 5.0 Hz, 1H), 1.08–0.98 (m, 2H), 0.73 (dt, 6.8, 4.9 Hz, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 177.92, 164.64, 164.35, 143.59, 130.93, 129.86, 129.51, 128.16, 122.37, 32.32, 31.62, 24.35, 14.89, 9.56; HRMS (ESI+) <i>m</i>/<i>z</i>: 339.0573 [M + H]<sup>+</sup> (expected 339.0570); HPLC Ret: 6.98 min; 97% pure.</div></div><div id="sec5_7_111" class="NLM_sec NLM_sec_level_3"><div id="ac_i134" class="anchor-spacer"></div><h4 class="article-section__title" id="_i134"> 4-((5-(2-Chloro-4-cyclopropoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic Acid (<b>19h</b>)</h4><div class="NLM_p last">Method F starting from methyl 4-((5-(2-chloro-4-cyclopropoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>18h′</b>, 0.1 g) gave 4-((5-(2-chloro-4-cyclopropoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic acid as white powder (0.07 g, 75%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 11.07 (br s, 1H), 7.86 (d, <i>J</i> = 8.8 Hz, 1H), 7.22 (d, <i>J</i> = 2.4 Hz, 1H), 7.04 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 3.80 (tt, <i>J</i> = 6.2, 3.0 Hz, 1H), 3.37 (t, <i>J</i> = 7.1 Hz, 2H), 2.59 (t, <i>J</i> = 7.1 Hz, 2H), 2.21 (p, <i>J</i> = 7.1 Hz, 2H), 0.92–0.77 (m, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 177.72, 164.22, 164.01, 133.99, 131.86, 131.78, 117.37, 115.47, 114.41, 51.62, 32.22, 31.60, 24.35, 6.28; HRMS (ESI+) <i>m</i>/<i>z</i>: 355.0555 [M + H]<sup>+</sup> (expected 355.0519); HPLC Ret: 6.90 min; 97% pure.</div></div><div id="sec5_7_112" class="NLM_sec NLM_sec_level_3"><div id="ac_i135" class="anchor-spacer"></div><h4 class="article-section__title" id="_i135"> 4-((5-(2-Chloro-4-(oxetan-3-yloxy)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic Acid (<b>19i</b>)</h4><div class="NLM_p last">Method F starting from methyl 4-((5-(2-chloro-4-(oxetan-3-yloxy)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoate (<b>18i′</b>, 0.07 g) gave 4-((5-(2-chloro-4-(oxetan-3-yloxy)phenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic acid as white powder (0.05 g, 79%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.88 (d, 8.8 Hz, 1H), 6.85 (d, <i>J</i> = 2.5 Hz, 1H), 6.73 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 5.27 (p, 6.0 Hz, 1H), 5.02 (t, <i>J</i> = 7.1 Hz, 2H), 4.78 (dd, <i>J</i> = 7.3, 5.1 Hz, 2H), 3.37 (t, <i>J</i> = 7.1 Hz, 2H), 2.58 (t, <i>J</i> = 7.1 Hz, 2H), 2.21 (p, <i>J</i> = 7.1 Hz, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 177.64, 164.26, 163.89, 159.11, 134.38, 132.27, 117.00, 116.16, 113.67, 77.44, 70.69, 32.25, 31.60, 24.33; HRMS (ESI+) <i>m</i>/<i>z</i>: 371.0307 [M + H]<sup>+</sup> (expected 371.0468); HPLC Ret: 5.85 min; 98% pure.</div></div><div id="sec5_7_113" class="NLM_sec NLM_sec_level_3"><div id="ac_i136" class="anchor-spacer"></div><h4 class="article-section__title" id="_i136"> 2-(2,4-Dichlorophenyl)-5-(methylthio)-1,3,4-oxadiazole (<b>20′</b>)</h4><div class="NLM_p last">5-(2,4-Dichlorophenyl)-1,3,4-oxadiazole-2-thiol (<b>4j</b>, 0.25 g, 1.01 mmol) was dissolved in 5 mL THF. Triethylamine (0.12 g, 0.17 mL, 1.21 mmol) and iodomethane (0.16 g, 0.07 mL, 1.11 mmol) were added and the mixture was stirred at 25 °C for 2 h. The reaction was quenched with 5 mL H<sub>2</sub>O. The product was extracted with EtOAc (3×, 15 mL), washed with brine (20 mL), dried with MgSO<sub>4</sub>, and concentrated in vacuo. The residue was dissolved in minimal EtOAc and the product was triturated with Hex, producing a white precipitate that was filtered and dried under vacuum. Yield = 81%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 7.91 (d, <i>J</i> = 8.5 Hz, 1H), 7.57 (d, <i>J</i> = 2.1 Hz, 1H), 7.39 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 2.79 (s, 3H); MS (ESI+) <i>m</i>/<i>z</i>: 260.9 [M + H]<sup>+</sup>; HPLC Ret: 7.57 min.</div></div><div id="sec5_7_114" class="NLM_sec NLM_sec_level_3"><div id="ac_i137" class="anchor-spacer"></div><h4 class="article-section__title" id="_i137"> 2-(2,4-Dichlorophenyl)-5-(methylsulfonyl)-1,3,4-oxadiazole (<b>20</b>)</h4><div class="NLM_p">Route 1: 2-(2,4-dichlorophenyl)-5-(methylthio)-1,3,4-oxadiazole (<b>20′</b>, 0.22 g, 0.823 mmol) was dissolved in 5 mL EtOH and cooled to 0 °C. Ammonium molybdate tetrahydrate (0.20 g, 0.165 mmol) and hydrogen peroxide (0.28 g, 0.25 mL, 2.47 mmol) were added and stirred at 25 °C for 2 h. The reaction was quenched with 10% sodium thiosulfate (10 mL). The product was extracted with EtOAc (3×, 15 mL), washed with brine (20 mL), dried with MgSO<sub>4</sub>, and concentrated in vacuo. The yellow residue was subjected to silica gel chromatography eluting with 20% EtOAc/80% Hex. The fractions containing the product were concentrated in vacuo to produce white solid. Yield = 54%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 8.02 (d, <i>J</i> = 8.5 Hz 1H), 7.64 (d, <i>J</i> = 2.0 Hz 1H), 7.47 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 3.55 (s, 3H); MS (ESI+) <i>m</i>/<i>z</i>: 292.9 [M + H]<sup>+</sup>; HPLC Ret: 6.96 min.</div><div class="NLM_p last">Route 2: 2-(2,4-dichlorophenyl)-5-(methylthio)-1,3,4-oxadiazole (<b>20′</b>, 0.3 g, 1.15 mmol) was dissolved in 5 mL DCM. mCPBA (0.57 g, 2.30 mmol) was added and the reaction was stirred at 25 °C for 2 h. The solvent was evaporated, and the yellow residue was subjected to silica gel chromatography eluting with 20% EtOAc/80% Hex. The fractions containing the product were concentrated in vacuo to produce white solid. Yield = 64%.</div></div><div id="sec5_7_115" class="NLM_sec NLM_sec_level_3"><div id="ac_i138" class="anchor-spacer"></div><h4 class="article-section__title" id="_i138"> 4-((5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-yl)sulfonyl)butanoic Acid (<b>21</b>)</h4><div class="NLM_p last">4-((5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-yl)thio)butanoic acid (<b>8q</b>, 0.05 g, 0.15 mmol) was dissolved in 1 mL DCM. 70% mCPBA (0.08 g, 0.33 mmol) was added and the reaction was stirred at 25 °C for 4 h. The solvent was evaporated, and the yellow residue was subjected to silica gel chromatography eluting with 5% MeOH/95% DCM. The fractions containing product were concentrated in vacuo to produce white solid. The solid was crystalized with EtOAc/Hex to produce white powder. Yield = 58%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 12.31 (br s, 1H), 8.10 (d, <i>J</i> = 8.5 Hz, 1H), 8.00 (<i>J</i> = 2.0 Hz, 1H), 7.74 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 3.83 (t, <i>J</i> = 7.3 Hz, 2H), 2.43 (t, <i>J</i> = 7.3 Hz, 2H), 2.01 (p, <i>J</i> = 7.5 Hz, 2H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 173.73, 164.02, 161.87, 138.74, 133.93, 133.60, 131.45, 128.83, 120.84, 54.32, 31.71, 17.93; HRMS (ESI−) <i>m</i>/<i>z</i>: 362.9609 [M – H]<sup>−</sup> (expected 362.9609); HPLC Ret: 6.56 min; 99% pure.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i139"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01772" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01772" class="ext-link">10.1021/acs.jmedchem.8b01772</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01772/suppl_file/jm8b01772_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01772/suppl_file/jm8b01772_si_001.csv">jm8b01772_si_001.csv (2.43 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01772" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36270" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36270" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott D. Larsen</span> - <span class="hlFld-Affiliation affiliation">Vahlteich
Medicinal Chemistry Core and , University of Michigan, Ann Arbor, Michigan 48109, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8440-4990" title="Orcid link">http://orcid.org/0000-0001-8440-4990</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#14677078756667717a547971703a61797d777c3a717061"><span class="__cf_email__" data-cfemail="cebdaaa2afbcbdaba08ea3abaae0bba3a7ada6e0abaabb">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dylan
J. Kahl</span> - <span class="hlFld-Affiliation affiliation">Vahlteich
Medicinal Chemistry Core and , University of Michigan, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kim M. Hutchings</span> - <span class="hlFld-Affiliation affiliation">Vahlteich
Medicinal Chemistry Core and , University of Michigan, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erika Mathes Lisabeth</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Toxicology, Michigan
State University, East Lansing, Michigan 48824, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew J. Haak</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Toxicology, Michigan
State University, East Lansing, Michigan 48824, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey R. Leipprandt</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Toxicology, Michigan
State University, East Lansing, Michigan 48824, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Dexheimer</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Toxicology, Michigan
State University, East Lansing, Michigan 48824, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dinesh Khanna</span> - <span class="hlFld-Affiliation affiliation">Department
of Internal Medicine, Division of Rheumatology and Clinical Autoimmunity
Center of Excellence, University of Michigan
Medical Center, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pei-Suen Tsou</span> - <span class="hlFld-Affiliation affiliation">Department
of Internal Medicine, Division of Rheumatology and Clinical Autoimmunity
Center of Excellence, University of Michigan
Medical Center, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Phillip L. Campbell</span> - <span class="hlFld-Affiliation affiliation">Department
of Internal Medicine, Division of Rheumatology and Clinical Autoimmunity
Center of Excellence, University of Michigan
Medical Center, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David A. Fox</span> - <span class="hlFld-Affiliation affiliation">Department
of Internal Medicine, Division of Rheumatology and Clinical Autoimmunity
Center of Excellence, University of Michigan
Medical Center, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bo Wen</span> - <span class="hlFld-Affiliation affiliation">UM Pharmcokinetics Core, College
of Pharmacy and , University of Michigan, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Duxin Sun</span> - <span class="hlFld-Affiliation affiliation">UM Pharmcokinetics Core, College
of Pharmacy and , University of Michigan, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc Bailie</span> - <span class="hlFld-Affiliation affiliation">Michigan
State University in Vivo Facility, East Lansing, Michigan 48824, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard R. Neubig</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Toxicology, Michigan
State University, East Lansing, Michigan 48824, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0501-0008" title="Orcid link">http://orcid.org/0000-0003-0501-0008</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i140">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42550" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42550" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by NIH NIAMS award R01AR066049 (S.D.L.) and NIH NIGMS award R01GM115459-01A1 (R.R.N.). Support was also provided in part by a University of Michigan Mi-TRAC award (S.D.L. and R.R.N.) sponsored by the Michigan Economic Development Corporation.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">SSc</td><td class="NLM_def"><p class="first last">scleroderma</p></td></tr><tr><td class="NLM_term">MRTF</td><td class="NLM_def"><p class="first last">myocardin-related transcription factor</p></td></tr><tr><td class="NLM_term">SRF</td><td class="NLM_def"><p class="first last">serum response factor</p></td></tr><tr><td class="NLM_term">SRE</td><td class="NLM_def"><p class="first last">serum response element</p></td></tr><tr><td class="NLM_term">CTGF</td><td class="NLM_def"><p class="first last">connective tissue growth factor</p></td></tr><tr><td class="NLM_term">LPA</td><td class="NLM_def"><p class="first last">lysophosphatidic acid</p></td></tr><tr><td class="NLM_term">dSSc</td><td class="NLM_def"><p class="first last">diffuse scleroderma</p></td></tr><tr><td class="NLM_term">IPF</td><td class="NLM_def"><p class="first last">idiopathic pulmonary fibrosis</p></td></tr><tr><td class="NLM_term">ECM</td><td class="NLM_def"><p class="first last">extracellular matrix</p></td></tr><tr><td class="NLM_term">α-SMA</td><td class="NLM_def"><p class="first last">α-smooth muscle actin</p></td></tr><tr><td class="NLM_term">TGFβ</td><td class="NLM_def"><p class="first last">transforming growth factor β</p></td></tr><tr><td class="NLM_term">ROCK</td><td class="NLM_def"><p class="first last">Rho-associated protein kinase</p></td></tr><tr><td class="NLM_term">G</td><td class="NLM_def"><p class="first last">globular</p></td></tr><tr><td class="NLM_term">F</td><td class="NLM_def"><p class="first last">filamentous</p></td></tr><tr><td class="NLM_term">NPC</td><td class="NLM_def"><p class="first last">nuclear pore complex</p></td></tr><tr><td class="NLM_term">DAST</td><td class="NLM_def"><p class="first last">diethylaminosulfur trifluoride</p></td></tr><tr><td class="NLM_term">mCPBA</td><td class="NLM_def"><p class="first last"><i>m</i>-chloroperoxybenzoic acid</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle medium</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i142">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15572" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15572" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 47 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varga, J.</span></span> <span> </span><span class="NLM_article-title">Systemic Sclerosis (Scleroderma) and Related Disorders</span>. In  <i>Harrison’s Principles of Internal Medicine, 20e</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jameson, J. L.</span>, <span class="NLM_string-name">Fauci, A. S.</span>, <span class="NLM_string-name">Kasper, D. L.</span>, <span class="NLM_string-name">Hauser, S. L.</span>, <span class="NLM_string-name">Longo, D. L.</span>, <span class="NLM_string-name">Loscalzo, J.</span></span>, Eds.; <span class="NLM_publisher-name">McGraw-Hill Education</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+Vargaauthor=J.+L.+Jameson&author=A.+S.+Fauci&author=D.+L.+Kasper&author=S.+L.+Hauser&author=D.+L.+Longo&author=J.+Loscalzo&title=Harrison%E2%80%99s+Principles+of+Internal+Medicine%2C+20e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVarga%26aufirst%3DJ.%26atitle%3DSystemic%2520Sclerosis%2520%2528Scleroderma%2529%2520and%2520Related%2520Disorders%26btitle%3DHarrison%25E2%2580%2599s%2520Principles%2520of%2520Internal%2520Medicine%252C%252020e%26aulast%3DJameson%26aufirst%3DJ.%2BL.%26pub%3DMcGraw-Hill%2520Education%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Distler, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozzio, A.</span></span> <span> </span><span class="NLM_article-title">Systemic sclerosis and localized scleroderma-current concepts and novel targets for therapy</span>. <i>Semin. Immunopathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1007/s00281-015-0551-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1007%2Fs00281-015-0551-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=26577237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyhsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2016&pages=87-95&author=O.+Distlerauthor=A.+Cozzio&title=Systemic+sclerosis+and+localized+scleroderma-current+concepts+and+novel+targets+for+therapy&doi=10.1007%2Fs00281-015-0551-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic sclerosis and localized scleroderma-current concepts and novel targets for therapy</span></div><div class="casAuthors">Distler, Oliver; Cozzio, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunopathology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-95</span>CODEN:
                <span class="NLM_cas:coden">SIEMB7</span>;
        ISSN:<span class="NLM_cas:issn">1863-2297</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Systemic sclerosis (SSc) is a chronic autoimmune disease with a high morbidity and mortality.  Skin and organ fibrosis are key manifestations of SSc, for which no generally accepted therapy is available.  Thus, there is a high unmet need for novel anti-fibrotic therapeutic strategies in SSc.  At the same time, important progress has been made in the identification and characterization of potential mol. targets in fibrotic diseases over the recent years.  In this review, we have selected four targeted therapies, which are tested in clin. trials in SSc, for in depths discussion of their preclin. characterization.  Sol. guanylate cyclase (sGC) stimulators such as riociguat might target both vascular remodeling and tissue fibrosis.  Blockade of interleukin-6 might be particularly promising for early inflammatory stages of SSc.  Inhibition of serotonin receptor 2b signaling links platelet activation to tissue fibrosis.  Targeting simultaneously multiple key mols. with the multityrosine kinase-inhibitor nintedanib might be a promising approach in complex fibrotic diseases such as SSc, in which many partially independent pathways are activated.  Herein, we also give a state of the art overview of the current classification, clin. presentation, diagnostic approach, and treatment options of localized scleroderma.  Finally, we discuss whether the novel targeted therapies currently tested in SSc could be used for localized scleroderma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPf4GPB7WcPrVg90H21EOLACvtfcHk0lhHz5IYLMhW0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyhsL%252FE&md5=2ffb658a09e6a69a526a10ff6bd168c2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00281-015-0551-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00281-015-0551-z%26sid%3Dliteratum%253Aachs%26aulast%3DDistler%26aufirst%3DO.%26aulast%3DCozzio%26aufirst%3DA.%26atitle%3DSystemic%2520sclerosis%2520and%2520localized%2520scleroderma-current%2520concepts%2520and%2520novel%2520targets%2520for%2520therapy%26jtitle%3DSemin.%2520Immunopathol.%26date%3D2016%26volume%3D38%26spage%3D87%26epage%3D95%26doi%3D10.1007%2Fs00281-015-0551-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allanore, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simms, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distler, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pope, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denton, CP</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varga, J.</span></span> <span> </span><span class="NLM_article-title">Systemic sclerosis</span>. <i>Nat. Rev. Dis. Prim.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">15002</span>, <span class="refDoi"> DOI: 10.1038/nrdp.2015.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1038%2Fnrdp.2015.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=27189141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252Fgs1SqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=15002&author=Y.+Allanoreauthor=R.+Simmsauthor=O.+Distlerauthor=M.+Trojanowskaauthor=J.+Popeauthor=CP+Dentonauthor=J.+Varga&title=Systemic+sclerosis&doi=10.1038%2Fnrdp.2015.2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic sclerosis</span></div><div class="casAuthors">Allanore Yannick; Simms Robert; Trojanowska Maria; Distler Oliver; Pope Janet; Denton Christopher P; Varga John</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Disease primers</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15002</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Systemic sclerosis is a complex autoimmune disease characterized by a chronic and frequently progressive course and by extensive patient-to-patient variability.  Like other autoimmune diseases, systemic sclerosis occurs more frequently in women, with a peak of onset in the fifth decade of life.  The exact cause of systemic sclerosis remains elusive but is likely to involve environmental factors in a genetically primed individual.  Pathogenesis is dominated by vascular changes; evidence of autoimmunity with distinct autoantibodies and activation of both innate and adaptive immunity; and fibrosis of the skin and visceral organs that results in irreversible scarring and organ failure.  Intractable progression of vascular and fibrotic organ damage accounts for the chronic morbidity and high mortality.  Early and accurate diagnosis and classification might improve patient outcomes.  Screening strategies facilitate timely recognition of life-threatening complications and initiation of targeted therapies to halt their progression.  Effective treatments of organ-based complications are now within reach.  Discovery of biomarkers - including autoantibodies that identify patient subsets at high risk for particular disease complications or rapid progression - is a research priority.  Understanding the key pathogenetic pathways, cell types and mediators underlying disease manifestations opens the door for the development of targeted therapies with true disease-modifying potential.  For an illustrated summary of this Primer, visit: http://go.nature.com/lchkcA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcrna7Vp9c5ENoizSOkG_FfW6udTcc2eYpEZbMp6jFX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252Fgs1SqsA%253D%253D&md5=7ebb2c370d7a36dfa3c8fe9e4b7a6ad3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrdp.2015.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrdp.2015.2%26sid%3Dliteratum%253Aachs%26aulast%3DAllanore%26aufirst%3DY.%26aulast%3DSimms%26aufirst%3DR.%26aulast%3DDistler%26aufirst%3DO.%26aulast%3DTrojanowska%26aufirst%3DM.%26aulast%3DPope%26aufirst%3DJ.%26aulast%3DDenton%26aufirst%3DCP%26aulast%3DVarga%26aufirst%3DJ.%26atitle%3DSystemic%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Dis.%2520Prim.%26date%3D2015%26volume%3D1%26spage%3D15002%26doi%3D10.1038%2Fnrdp.2015.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Careta, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romiti, R.</span></span> <span> </span><span class="NLM_article-title">Localized scleroderma: clinical spectrum and therapeutic update</span>. <i>An. Bras. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1590/abd1806-4841.20152890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1590%2Fabd1806-4841.20152890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=25672301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A280%3ADC%252BC2MrkvVCktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2015&pages=62-73&author=M.+F.+Caretaauthor=R.+Romiti&title=Localized+scleroderma%3A+clinical+spectrum+and+therapeutic+update&doi=10.1590%2Fabd1806-4841.20152890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Localized scleroderma: clinical spectrum and therapeutic update</span></div><div class="casAuthors">Careta Mariana Figueiroa; Romiti Ricardo</div><div class="citationInfo"><span class="NLM_cas:title">Anais brasileiros de dermatologia</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement.  Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues.  Localized scleroderma is a rare disease of unknown etiology.  Recent studies show that the localized form may affect internal organs and have variable morbidity.  Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.  In this review, we report the most important aspects and particularities in the treatment of patients diagnosed with localized scleroderma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRbXEFktKP1cq91pGlMMoT5fW6udTcc2ea9oTVQBmY7a7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MrkvVCktQ%253D%253D&md5=79c0809794795760c0d6f2de223fa312</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1590%2Fabd1806-4841.20152890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252Fabd1806-4841.20152890%26sid%3Dliteratum%253Aachs%26aulast%3DCareta%26aufirst%3DM.%2BF.%26aulast%3DRomiti%26aufirst%3DR.%26atitle%3DLocalized%2520scleroderma%253A%2520clinical%2520spectrum%2520and%2520therapeutic%2520update%26jtitle%3DAn.%2520Bras.%2520Dermatol.%26date%3D2015%26volume%3D90%26spage%3D62%26epage%3D73%26doi%3D10.1590%2Fabd1806-4841.20152890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pattanaik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postlethwaitel, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postlethwaite, A. E.</span></span> <span> </span><span class="NLM_article-title">Pathogenesis of systemic sclerosis</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">272</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2015.00272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.3389%2Ffimmu.2015.00272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=26106387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A280%3ADC%252BC2Mbmslaluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=272&author=D.+Pattanaikauthor=M.+Brownauthor=B.+C.+Postlethwaitelauthor=A.+E.+Postlethwaite&title=Pathogenesis+of+systemic+sclerosis&doi=10.3389%2Ffimmu.2015.00272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of Systemic Sclerosis</span></div><div class="casAuthors">Pattanaik Debendra; Postlethwaite Arnold E; Brown Monica; Postlethwaite Bradley C</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">272</span>
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    </div><div class="casAbstract">Systemic scleroderma (SSc) is one of the most complex systemic autoimmune diseases.  It targets the vasculature, connective tissue-producing cells (namely fibroblasts/myofibroblasts), and components of the innate and adaptive immune systems.  Clinical and pathologic manifestations of SSc are the result of: (1) innate/adaptive immune system abnormalities leading to production of autoantibodies and cell-mediated autoimmunity, (2) microvascular endothelial cell/small vessel fibroproliferative vasculopathy, and (3) fibroblast dysfunction generating excessive accumulation of collagen and other matrix components in skin and internal organs.  All three of these processes interact and affect each other.  The disease is heterogeneous in its clinical presentation that likely reflects different genetic or triggering factor (i.e., infection or environmental toxin) influences on the immune system, vasculature, and connective tissue cells.  The roles played by other ubiquitous molecular entities (such as lysophospholipids, endocannabinoids, and their diverse receptors and vitamin D) in influencing the immune system, vasculature, and connective tissue cells are just beginning to be realized and studied and may provide insights into new therapeutic approaches to treat SSc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThQWXPjMQFggxyojvcjibhfW6udTcc2ea9oTVQBmY7a7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mbmslaluw%253D%253D&md5=4ad63f92276c9aa96a0d3e60e0c76c11</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2015.00272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2015.00272%26sid%3Dliteratum%253Aachs%26aulast%3DPattanaik%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DPostlethwaitel%26aufirst%3DB.%2BC.%26aulast%3DPostlethwaite%26aufirst%3DA.%2BE.%26atitle%3DPathogenesis%2520of%2520systemic%2520sclerosis%26jtitle%3DFront.%2520Immunol.%26date%3D2015%26volume%3D6%26spage%3D272%26doi%3D10.3389%2Ffimmu.2015.00272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fala, L.</span></span> <span> </span><span class="NLM_article-title">Ofev (Nintedanib): First tyrosine kinase inhibitor approved for the treatment of patients with Idiopathic Pulmonary Fibrosis</span>. <i>Am. Health Drug Benefits</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=26629273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A280%3ADC%252BC28rgvVygsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=101&author=L.+Fala&title=Ofev+%28Nintedanib%29%3A+First+tyrosine+kinase+inhibitor+approved+for+the+treatment+of+patients+with+Idiopathic+Pulmonary+Fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Ofev (Nintedanib): First Tyrosine Kinase Inhibitor Approved for the Treatment of Patients with Idiopathic Pulmonary Fibrosis</span></div><div class="casAuthors">Fala Loretta</div><div class="citationInfo"><span class="NLM_cas:title">American health & drug benefits</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">Spec Feature</span>),
    <span class="NLM_cas:pages">101-4</span>
        ISSN:<span class="NLM_cas:issn">1942-2962</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGt-9WtWJAKoNpW7w2tapOfW6udTcc2eZ__y83ZYA8OLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgvVygsA%253D%253D&md5=f7b482b635809e521de973704c16282a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFala%26aufirst%3DL.%26atitle%3DOfev%2520%2528Nintedanib%2529%253A%2520First%2520tyrosine%2520kinase%2520inhibitor%2520approved%2520for%2520the%2520treatment%2520of%2520patients%2520with%2520Idiopathic%2520Pulmonary%2520Fibrosis%26jtitle%3DAm.%2520Health%2520Drug%2520Benefits%26date%3D2015%26volume%3D8%26spage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nanthakumar, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatley, R. J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauldie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J. F.</span></span> <span> </span><span class="NLM_article-title">Dissecting fibrosis: therapeutic insights from the small-molecule toolbox</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">720</span>, <span class="refDoi"> DOI: 10.1038/nrd4592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1038%2Fnrd4592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=26338155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrt7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=693-720&author=C.+B.+Nanthakumarauthor=R.+J.+D.+Hatleyauthor=S.+Lemmaauthor=J.+Gauldieauthor=R.+P.+Marshallauthor=S.+J.+F.+Macdonald&title=Dissecting+fibrosis%3A+therapeutic+insights+from+the+small-molecule+toolbox&doi=10.1038%2Fnrd4592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting fibrosis: therapeutic insights from the small-molecule toolbox</span></div><div class="casAuthors">Nanthakumar, Carmel B.; Hatley, Richard J. D.; Lemma, Seble; Gauldie, Jack; Marshall, Richard P.; MacDonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">693-720</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Fibrosis, which leads to progressive loss of tissue function and eventual organ failure, has been estd. to contribute to ∼45% of deaths in the developed world, and so new therapeutics to modulate fibrosis are urgently needed.  Major advances in our understanding of the mechanisms underlying pathol. fibrosis are supporting the search for such therapeutics, and the recent approval of two anti-fibrotic drugs for idiopathic pulmonary fibrosis has demonstrated the tractability of this area for drug discovery.  This Review examines the pharmacol. and structural information for small mols. being evaluated for lung, liver, kidney and skin fibrosis.  In particular, we discuss the insights gained from the use of these pharmacol. tools, and how these entities can inform, and probe, emerging insights into disease mechanisms, including the potential for future drug combinations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk6pfSk3gsCrVg90H21EOLACvtfcHk0lgmSR2mwv0CQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrt7rJ&md5=b05a37db6ede2acc0f5c65826aa344f3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd4592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4592%26sid%3Dliteratum%253Aachs%26aulast%3DNanthakumar%26aufirst%3DC.%2BB.%26aulast%3DHatley%26aufirst%3DR.%2BJ.%2BD.%26aulast%3DLemma%26aufirst%3DS.%26aulast%3DGauldie%26aufirst%3DJ.%26aulast%3DMarshall%26aufirst%3DR.%2BP.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26atitle%3DDissecting%2520fibrosis%253A%2520therapeutic%2520insights%2520from%2520the%2520small-molecule%2520toolbox%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D693%26epage%3D720%26doi%3D10.1038%2Fnrd4592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thannickal, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henke, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horowitz, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sime, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschumperlin, D. J.</span></span> <span> </span><span class="NLM_article-title">Matrix Biology of Idiopathic Pulmonary Fibrosis</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">1643</span>– <span class="NLM_lpage">1651</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2014.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.ajpath.2014.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=24726499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosFalurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2014&pages=1643-1651&author=V.+J.+Thannickalauthor=C.+A.+Henkeauthor=J.+C.+Horowitzauthor=P.+W.+Nobleauthor=J.+Romanauthor=P.+J.+Simeauthor=Y.+Zhouauthor=R.+G.+Wellsauthor=E.+S.+Whiteauthor=D.+J.+Tschumperlin&title=Matrix+Biology+of+Idiopathic+Pulmonary+Fibrosis&doi=10.1016%2Fj.ajpath.2014.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix Biology of Idiopathic Pulmonary Fibrosis</span></div><div class="casAuthors">Thannickal, Victor J.; Henke, Craig A.; Horowitz, Jeffrey C.; Noble, Paul W.; Roman, Jesse; Sime, Patricia J.; Zhou, Yong; Wells, Rebecca G.; White, Eric S.; Tschumperlin, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1643-1651</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A hallmark of idiopathic pulmonary fibrosis (IPF) is excessive and disordered deposition of extracellular matrix.  Although the lung extracellular matrix normally plays an essential role in development and maintenance of lung tissue through reciprocal interactions with resident cells, the disordered matrix in the diseased lung is increasingly recognized as an active and important contributor to IPF pathogenesis.  This working group summary from a recently conducted National Heart, Lung, and Blood Institute strategic planning workshop for IPF research highlights recent advances, challenges, and opportunities in the study of matrix biol. in IPF.  Particular attention is given to the compn. and mech. properties of the matrix in normal and diseased lungs, and the biochem. and biomech. influences exerted by pathol. matrix.  Recently developed model systems are also summarized as key tools for advancing our understanding of matrix biol. in IPF.  Emerging approaches to therapeutically target the matrix in preclin. and clin. settings are discussed, as are important concepts, such as alterations of the matrix with aging and the potential for the resoln. of fibrosis.  Specific recommendations for future studies in matrix biol. of IPF are also proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPiyE0Bm7rkLVg90H21EOLACvtfcHk0lgmSR2mwv0CQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosFalurc%253D&md5=447165289e84837f940dd0e0ae7cf932</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2014.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2014.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DThannickal%26aufirst%3DV.%2BJ.%26aulast%3DHenke%26aufirst%3DC.%2BA.%26aulast%3DHorowitz%26aufirst%3DJ.%2BC.%26aulast%3DNoble%26aufirst%3DP.%2BW.%26aulast%3DRoman%26aufirst%3DJ.%26aulast%3DSime%26aufirst%3DP.%2BJ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWells%26aufirst%3DR.%2BG.%26aulast%3DWhite%26aufirst%3DE.%2BS.%26aulast%3DTschumperlin%26aufirst%3DD.%2BJ.%26atitle%3DMatrix%2520Biology%2520of%2520Idiopathic%2520Pulmonary%2520Fibrosis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2014%26volume%3D184%26spage%3D1643%26epage%3D1651%26doi%3D10.1016%2Fj.ajpath.2014.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thannickal, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prunotto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desmoulière, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Wever, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mareel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabbiani, G.</span></span> <span> </span><span class="NLM_article-title">Recent Developments in Myofibroblast Biology</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">1340</span>– <span class="NLM_lpage">1355</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2012.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.ajpath.2012.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=22387320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFCju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2012&pages=1340-1355&author=B.+Hinzauthor=S.+H.+Phanauthor=V.+J.+Thannickalauthor=M.+Prunottoauthor=A.+Desmouli%C3%A8reauthor=J.+Vargaauthor=O.+De+Weverauthor=M.+Mareelauthor=G.+Gabbiani&title=Recent+Developments+in+Myofibroblast+Biology&doi=10.1016%2Fj.ajpath.2012.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in myofibroblast biology: paradigms for connective tissue remodeling</span></div><div class="casAuthors">Hinz, Boris; Phan, Sem H.; Thannickal, Victor J.; Prunotto, Marco; Desmouliere, Alexis; Varga, John; De Wever, Olivier; Mareel, Marc; Gabbiani, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1340-1355</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The discovery of the myofibroblast has opened new perspectives for the comprehension of the biol. mechanisms involved in wound healing and fibrotic diseases.  In recent years, many advances have been made in understanding important aspects of myofibroblast basic biol. characteristics.  This review summarizes such advances in several fields, such as the following: i) force prodn. by the myofibroblast and mechanisms of connective tissue remodeling; ii) factors controlling the expression of α-smooth muscle actin, the most used marker of myofibroblastic phenotype and, more important, involved in force generation by the myofibroblast; and iii) factors affecting genesis of the myofibroblast and its differentiation from precursor cells, in particular epigenetic factors, such as DNA methylation, microRNAs, and histone modification.  We also review the origin and the specific features of the myofibroblast in diverse fibrotic lesions, such as systemic sclerosis; kidney, liver, and lung fibrosis; and the stromal reaction to certain epithelial tumors.  Finally, we summarize the emerging strategies for influencing myofibroblast behavior in vitro and in vivo, with the ultimate goal of an effective therapeutic approach for myofibroblast-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTXMejvqx9WbVg90H21EOLACvtfcHk0lifh8EVUl2rkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFCju70%253D&md5=e714aedffec0af2b64537d4fefa3dd96</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2012.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2012.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DHinz%26aufirst%3DB.%26aulast%3DPhan%26aufirst%3DS.%2BH.%26aulast%3DThannickal%26aufirst%3DV.%2BJ.%26aulast%3DPrunotto%26aufirst%3DM.%26aulast%3DDesmouli%25C3%25A8re%26aufirst%3DA.%26aulast%3DVarga%26aufirst%3DJ.%26aulast%3DDe%2BWever%26aufirst%3DO.%26aulast%3DMareel%26aufirst%3DM.%26aulast%3DGabbiani%26aufirst%3DG.%26atitle%3DRecent%2520Developments%2520in%2520Myofibroblast%2520Biology%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2012%26volume%3D180%26spage%3D1340%26epage%3D1355%26doi%3D10.1016%2Fj.ajpath.2012.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiore, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thannickal, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span> <span> </span><span class="NLM_article-title">Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1165/rcmb.2012-0050oc</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1165%2Frcmb.2012-0050oc" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=22461426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCjsrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=340-348&author=X.+Huangauthor=N.+Yangauthor=V.+F.+Fioreauthor=T.+H.+Barkerauthor=Y.+Sunauthor=S.+W.+Morrisauthor=Q.+Dingauthor=V.+J.+Thannickalauthor=Y.+Zhou&title=Matrix+stiffness-induced+myofibroblast+differentiation+is+mediated+by+intrinsic+mechanotransduction&doi=10.1165%2Frcmb.2012-0050oc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction</span></div><div class="casAuthors">Huang, Xiangwei; Yang, Naiheng; Fiore, Vincent F.; Barker, Thomas H.; Sun, Yi; Morris, Stephan W.; Ding, Qiang; Thannickal, Victor J.; Zhou, Yong</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">340-348</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">The mech. properties of the extracellular matrix have recently been shown to promote myofibroblast differentiation and lung fibrosis.  Mechanisms by which matrix stiffness regulates myofibroblast differentiation are not fully understood.  The goal of this study was to det. the intrinsic mechanisms of mechanotransduction in the regulation of matrix stiffness-induced myofibroblast differentiation.  A well established polyacrylamide gel system with tunable substrate stiffness was used in this study.  Megakaryoblastic leukemia factor-1 (MKL1) nuclear translocation was imaged by confocal immunofluorescent microscopy.  The binding of MKL1 to the α-smooth muscle actin (α-SMA) gene promoter was quantified by quant. chromatin immunopptn. assay.  Normal human lung fibroblasts responded to matrix stiffening with changes in actin dynamics that favor filamentous actin polymn.  Actin polymn. resulted in nuclear translocation of MKL1, a serum response factor coactivator that plays a central role in regulating the expression of fibrotic genes, including α-SMA, a marker for myofibroblast differentiation.  Mouse lung fibroblasts deficient in Mkl1 did not respond to matrix stiffening with increased α-SMA expression, whereas ectopic expression of human MKL1 cDNA restored the ability of Mkl1 null lung fibroblasts to express α-SMA.  Furthermore, matrix stiffening promoted prodn. and activation of the small GTPase RhoA, increased Rho kinase (ROCK) activity, and enhanced fibroblast contractility.  Inhibition of RhoA/ROCK abrogated stiff matrix-induced actin cytoskeletal reorganization, MKL1 nuclear translocation, and myofibroblast differentiation.  This study indicates that actin cytoskeletal remodeling-mediated activation of MKL1 transduces mech. stimuli from the extracellular matrix to a fibrogenic program that promotes myofibroblast differentiation, suggesting an intrinsic mechanotransduction mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjRSk-_Wigb7Vg90H21EOLACvtfcHk0ljkZ5iIv5lN5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCjsrvP&md5=d040de24d75c0dbd3912d9e6e50a95b2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2012-0050oc&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2012-0050oc%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DFiore%26aufirst%3DV.%2BF.%26aulast%3DBarker%26aufirst%3DT.%2BH.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DThannickal%26aufirst%3DV.%2BJ.%26aulast%3DZhou%26aufirst%3DY.%26atitle%3DMatrix%2520stiffness-induced%2520myofibroblast%2520differentiation%2520is%2520mediated%2520by%2520intrinsic%2520mechanotransduction%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D47%26spage%3D340%26epage%3D348%26doi%3D10.1165%2Frcmb.2012-0050oc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsou, P.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haak, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span> <span> </span><span class="NLM_article-title">Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription</span>. <i>Am. J. Physiol.: Cell Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">C2</span>– <span class="NLM_lpage">C13</span>, <span class="refDoi"> DOI: 10.1152/ajpcell.00060.2014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1152%2Fajpcell.00060.2014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=24740541" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2014&pages=C2-C13&author=P.-S.+Tsouauthor=A.+J.+Haakauthor=D.+Khannaauthor=R.+R.+Neubig&title=Cellular+mechanisms+of+tissue+fibrosis.+8.+Current+and+future+drug+targets+in+fibrosis%3A+focus+on+Rho+GTPase-regulated+gene+transcription&doi=10.1152%2Fajpcell.00060.2014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00060.2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00060.2014%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DP.-S.%26aulast%3DHaak%26aufirst%3DA.%2BJ.%26aulast%3DKhanna%26aufirst%3DD.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26atitle%3DCellular%2520mechanisms%2520of%2520tissue%2520fibrosis.%25208.%2520Current%2520and%2520future%2520drug%2520targets%2520in%2520fibrosis%253A%2520focus%2520on%2520Rho%2520GTPase-regulated%2520gene%2520transcription%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Cell%2520Physiol.%26date%3D2014%26volume%3D307%26spage%3DC2%26epage%3DC13%26doi%3D10.1152%2Fajpcell.00060.2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wipff, P.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rifkin, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, B.</span></span> <span> </span><span class="NLM_article-title">Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>179</i></span>,  <span class="NLM_fpage">1311</span>– <span class="NLM_lpage">1323</span>, <span class="refDoi"> DOI: 10.1083/jcb.200704042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1083%2Fjcb.200704042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2007&pages=1311-1323&author=P.-J.+Wipffauthor=D.+B.+Rifkinauthor=J.-J.+Meisterauthor=B.+Hinz&title=Myofibroblast+contraction+activates+latent+TGF-beta1+from+the+extracellular+matrix&doi=10.1083%2Fjcb.200704042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200704042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200704042%26sid%3Dliteratum%253Aachs%26aulast%3DWipff%26aufirst%3DP.-J.%26aulast%3DRifkin%26aufirst%3DD.%2BB.%26aulast%3DMeister%26aufirst%3DJ.-J.%26aulast%3DHinz%26aufirst%3DB.%26atitle%3DMyofibroblast%2520contraction%2520activates%2520latent%2520TGF-beta1%2520from%2520the%2520extracellular%2520matrix%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2007%26volume%3D179%26spage%3D1311%26epage%3D1323%26doi%3D10.1083%2Fjcb.200704042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wynn, T. A.</span></span> <span> </span><span class="NLM_article-title">Cellular and molecular mechanisms of fibrosis</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>214</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1002/path.2277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1002%2Fpath.2277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=18161745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvFCkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=2008&pages=199-210&author=T.+A.+Wynn&title=Cellular+and+molecular+mechanisms+of+fibrosis&doi=10.1002%2Fpath.2277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular and molecular mechanisms of fibrosis</span></div><div class="casAuthors">Wynn, T. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-210</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Fibrosis is defined by the overgrowth, hardening, and/or scarring of various tissues and is attributed to excess deposition of extracellular matrix components including collagen.  Fibrosis is the end result of chronic inflammatory reactions induced by a variety of stimuli including persistent infections, autoimmune reactions, allergic responses, chem. insults, radiation, and tissue injury.  Although current treatments for fibrotic diseases such as idiopathic pulmonary fibrosis, liver cirrhosis, systemic sclerosis, progressive kidney disease, and cardiovascular fibrosis typically target the inflammatory response, there is accumulating evidence that the mechanisms driving fibrogenesis are distinct from those regulating inflammation.  In fact, some studies have suggested that ongoing inflammation is needed to reverse established and progressive fibrosis.  The key cellular mediator of fibrosis is the myofibroblast, which when activated serves as the primary collagen-producing cell.  Myofibroblasts are generated from a variety of sources including resident mesenchymal cells, epithelial and endothelial cells in processes termed epithelial/endothelial-mesenchymal (EMT/EndMT) transition, as well as from circulating fibroblast-like cells called fibrocytes that are derived from bone-marrow stem cells.  Myofibroblasts are activated by a variety of mechanisms, including paracrine signals derived from lymphocytes and macrophages, autocrine factors secreted by myofibroblasts, and pathogen-assocd. mol. patterns (PAMPS) produced by pathogenic organisms that interact with pattern recognition receptors (i.e. TLRs) on fibroblasts.  Cytokines (IL-13, IL-21, TGF-β1), chemokines (MCP-1, MIP-1β), angiogenic factors (VEGF), growth factors (PDGF), peroxisome proliferator-activated receptors (PPARs), acute phase proteins (SAP), caspases, and components of the renin-angiotensin-aldosterone system (ANG II) have been identified as important regulators of fibrosis and are being investigated as potential targets of antifibrotic drugs.  This review explores our current understanding of the cellular and mol. mechanisms of fibrogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0w_vXtFhJmrVg90H21EOLACvtfcHk0liWjv16ocj1kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvFCkt7w%253D&md5=a6b143a20d478d96bc60b816f23370f1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fpath.2277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.2277%26sid%3Dliteratum%253Aachs%26aulast%3DWynn%26aufirst%3DT.%2BA.%26atitle%3DCellular%2520and%2520molecular%2520mechanisms%2520of%2520fibrosis%26jtitle%3DJ.%2520Pathol.%26date%3D2008%26volume%3D214%26spage%3D199%26epage%3D210%26doi%3D10.1002%2Fpath.2277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandbo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulin, N.</span></span> <span> </span><span class="NLM_article-title">Actin cytoskeleton in myofibroblast differentiation: ultrastructure defining form and driving function</span>. <i>Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1016/j.trsl.2011.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.trsl.2011.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=21925115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2jtrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2011&pages=181-196&author=N.+Sandboauthor=N.+Dulin&title=Actin+cytoskeleton+in+myofibroblast+differentiation%3A+ultrastructure+defining+form+and+driving+function&doi=10.1016%2Fj.trsl.2011.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Actin cytoskeleton in myofibroblast differentiation: Ultrastructure defining form and driving function</span></div><div class="casAuthors">Sandbo, Nathan; Dulin, Nickolai</div><div class="citationInfo"><span class="NLM_cas:title">Translational Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">181-196</span>CODEN:
                <span class="NLM_cas:coden">TRRECL</span>;
        ISSN:<span class="NLM_cas:issn">1931-5244</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Myofibroblasts are modified fibroblasts characterized by the presence of a well-developed contractile app. and the formation of robust actin stress fibers.  These mech. active cells are thought to orchestrate extracellular matrix remodeling during normal wound healing in response to tissue injury; these cells are found also in aberrant tissue remodeling in fibrosing disorders.  This review surveys the understanding of the role of actin stress fibers in myofibroblast biol.  Actin stress fibers are discussed as a defining ultrastructural and morphol. feature and well-accepted observations demonstrating its participation in contraction, focal adhesion maturation, and extracellular matrix reorganization are presented.  Finally, more recent observations are reviewed, demonstrating its role in transducing mech. force into biochem. signals, transcriptional control of genes involved in locomotion, contraction, and matrix reorganization, as well as the localized regulation of mRNA (mRNA) translation.  This breadth of functionality of the actin stress fiber serves to reinforce and amplify its mech. function, via induced expression of proteins that themselves augment contraction, focal adhesion formation, and matrix remodeling.  In composite, the functions of the actin cytoskeleton are most often aligned, allowing for the integration and amplification of signals promoting both myofibroblast differentiation and matrix remodeling during fibrogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRSjy1ABM_37Vg90H21EOLACvtfcHk0liWjv16ocj1kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2jtrrN&md5=6ff2e2661440bb1546b5eba63ea1f252</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.trsl.2011.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trsl.2011.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DSandbo%26aufirst%3DN.%26aulast%3DDulin%26aufirst%3DN.%26atitle%3DActin%2520cytoskeleton%2520in%2520myofibroblast%2520differentiation%253A%2520ultrastructure%2520defining%2520form%2520and%2520driving%2520function%26jtitle%3DTransl.%2520Res.%26date%3D2011%26volume%3D158%26spage%3D181%26epage%3D196%26doi%3D10.1016%2Fj.trsl.2011.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandbo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulin, N. O.</span></span> <span> </span><span class="NLM_article-title">Delayed stress fiber formation mediates pulmonary myofibroblast differentiation in response to TGF-β</span>. <i>Am. J. Physiol.: Lung Cell. Mol. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>301</i></span>,  <span class="NLM_fpage">L656</span>– <span class="NLM_lpage">L666</span>, <span class="refDoi"> DOI: 10.1152/ajplung.00166.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1152%2Fajplung.00166.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=21856814" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2011&pages=L656-L666&author=N.+Sandboauthor=A.+Lauauthor=J.+Kachauthor=C.+Ngamauthor=D.+Yauauthor=N.+O.+Dulin&title=Delayed+stress+fiber+formation+mediates+pulmonary+myofibroblast+differentiation+in+response+to+TGF-%CE%B2&doi=10.1152%2Fajplung.00166.2011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00166.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00166.2011%26sid%3Dliteratum%253Aachs%26aulast%3DSandbo%26aufirst%3DN.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DKach%26aufirst%3DJ.%26aulast%3DNgam%26aufirst%3DC.%26aulast%3DYau%26aufirst%3DD.%26aulast%3DDulin%26aufirst%3DN.%2BO.%26atitle%3DDelayed%2520stress%2520fiber%2520formation%2520mediates%2520pulmonary%2520myofibroblast%2520differentiation%2520in%2520response%2520to%2520TGF-%25CE%25B2%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Lung%2520Cell.%2520Mol.%2520Physiol.%26date%3D2011%26volume%3D301%26spage%3DL656%26epage%3DL666%26doi%3D10.1152%2Fajplung.00166.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandbo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torr, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kregel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulin, N.</span></span> <span> </span><span class="NLM_article-title">Control of myofibroblast differentiation by microtubule dynamics through a regulated localization of mDia2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">15466</span>– <span class="NLM_lpage">15473</span>, <span class="refDoi"> DOI: 10.1074/jbc.m113.464461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1074%2Fjbc.m113.464461" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=15466-15473&author=N.+Sandboauthor=C.+Ngamauthor=E.+Torrauthor=S.+Kregelauthor=J.+Kachauthor=N.+Dulin&title=Control+of+myofibroblast+differentiation+by+microtubule+dynamics+through+a+regulated+localization+of+mDia2&doi=10.1074%2Fjbc.m113.464461"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m113.464461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m113.464461%26sid%3Dliteratum%253Aachs%26aulast%3DSandbo%26aufirst%3DN.%26aulast%3DNgam%26aufirst%3DC.%26aulast%3DTorr%26aufirst%3DE.%26aulast%3DKregel%26aufirst%3DS.%26aulast%3DKach%26aufirst%3DJ.%26aulast%3DDulin%26aufirst%3DN.%26atitle%3DControl%2520of%2520myofibroblast%2520differentiation%2520by%2520microtubule%2520dynamics%2520through%2520a%2520regulated%2520localization%2520of%2520mDia2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D15466%26epage%3D15473%26doi%3D10.1074%2Fjbc.m113.464461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomasek, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaughan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropp, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabbiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haaksma, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, B.</span></span> <span> </span><span class="NLM_article-title">Contraction of myofibroblasts in granulation tissue is dependent on Rho/Rho kinase/myosin light chain phosphatase activity</span>. <i>Wound Repair Regen.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1111/j.1743-6109.2006.00126.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1111%2Fj.1743-6109.2006.00126.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=16808810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A280%3ADC%252BD28zpt1ymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=313-320&author=J.+J.+Tomasekauthor=M.+B.+Vaughanauthor=B.+P.+Kroppauthor=G.+Gabbianiauthor=M.+D.+Martinauthor=C.+J.+Haaksmaauthor=B.+Hinz&title=Contraction+of+myofibroblasts+in+granulation+tissue+is+dependent+on+Rho%2FRho+kinase%2Fmyosin+light+chain+phosphatase+activity&doi=10.1111%2Fj.1743-6109.2006.00126.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Contraction of myofibroblasts in granulation tissue is dependent on Rho/Rho kinase/myosin light chain phosphatase activity</span></div><div class="casAuthors">Tomasek James J; Vaughan Melville B; Kropp Bradley P; Gabbiani Giulio; Martin Michael D; Haaksma Carol J; Hinz Boris</div><div class="citationInfo"><span class="NLM_cas:title">Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">313-20</span>
        ISSN:<span class="NLM_cas:issn">1067-1927</span>.
    </div><div class="casAbstract">During wound healing and fibrocontractive diseases fibroblasts acquire a smooth muscle cell-like phenotype by differentiating into contractile force generating myofibroblasts.  We examined whether regulation of myofibroblast contraction in granulation tissue is dominated by Ca2+-induced phosphorylation of myosin light chain kinase or by Rho/Rho kinase (ROCK)-mediated inhibition of myosin light chain phosphatase, similar to that of cultured myofibroblasts.  Strips of granulation tissue obtained from rat granuloma pouches were stimulated with endothelin-1 (ET-1), serotonin, and angiotensin-II and isometric force generation was measured.  We here investigated ET-1 in depth, because it was the only agonist that produced a long-lasting and strong response.  The ROCK inhibitor Y27632 completely inhibited ET-1-promoted contraction and the phosphatase inhibitor calyculin elicited contraction in the absence of any other agonists, suggesting that activation of the Rho/ROCK/myosn light chain phosphatase pathway is critical in regulating in vivo myofibroblast contraction.  Membrane depolarization with K+ also stimulated a long-lasting contraction of granulation tissue; however, the amount of force generated was significantly less compared to ET-1.  Moreover, K+-induced contraction was inhibited by Y27632.  These results are consistent with inhibition of myosin light chain phosphatase by the Rho/ROCK signaling pathway, which would account for the long-duration contraction of myofibroblasts necessary for wound closure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpvR3flZYusFQKX3ooHxWjfW6udTcc2eYgnDNUf9DhBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zpt1ymtQ%253D%253D&md5=9aa34dce3088966cadfd4b3ba01bd569</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1743-6109.2006.00126.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1743-6109.2006.00126.x%26sid%3Dliteratum%253Aachs%26aulast%3DTomasek%26aufirst%3DJ.%2BJ.%26aulast%3DVaughan%26aufirst%3DM.%2BB.%26aulast%3DKropp%26aufirst%3DB.%2BP.%26aulast%3DGabbiani%26aufirst%3DG.%26aulast%3DMartin%26aufirst%3DM.%2BD.%26aulast%3DHaaksma%26aufirst%3DC.%2BJ.%26aulast%3DHinz%26aufirst%3DB.%26atitle%3DContraction%2520of%2520myofibroblasts%2520in%2520granulation%2520tissue%2520is%2520dependent%2520on%2520Rho%252FRho%2520kinase%252Fmyosin%2520light%2520chain%2520phosphatase%2520activity%26jtitle%3DWound%2520Repair%2520Regen.%26date%3D2006%26volume%3D14%26spage%3D313%26epage%3D320%26doi%3D10.1111%2Fj.1743-6109.2006.00126.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurundkar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurundkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thannickal, V. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">1096</span>– <span class="NLM_lpage">1108</span>, <span class="refDoi"> DOI: 10.1172/jci66700</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1172%2Fjci66700" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=1096-1108&author=Y.+Zhouauthor=X.+Huangauthor=L.+Heckerauthor=D.+Kurundkarauthor=A.+Kurundkarauthor=H.+Liuauthor=T.-H.+Jinauthor=L.+Desaiauthor=K.+Bernardauthor=V.+J.+Thannickal&title=Inhibition+of+mechanosensitive+signaling+in+myofibroblasts+ameliorates+experimental+pulmonary+fibrosis&doi=10.1172%2Fjci66700"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1172%2Fjci66700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252Fjci66700%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHecker%26aufirst%3DL.%26aulast%3DKurundkar%26aufirst%3DD.%26aulast%3DKurundkar%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DT.-H.%26aulast%3DDesai%26aufirst%3DL.%26aulast%3DBernard%26aufirst%3DK.%26aulast%3DThannickal%26aufirst%3DV.%2BJ.%26atitle%3DInhibition%2520of%2520mechanosensitive%2520signaling%2520in%2520myofibroblasts%2520ameliorates%2520experimental%2520pulmonary%2520fibrosis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D1096%26epage%3D1108%26doi%3D10.1172%2Fjci66700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evelyn, C.
R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iniguez-Lluhi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merajver, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span> <span> </span><span class="NLM_article-title">CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2249</span>– <span class="NLM_lpage">2260</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-06-0782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1158%2F1535-7163.mct-06-0782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=17699722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVGltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=2249-2260&author=C.%0AR.+Evelynauthor=S.+M.+Wadeauthor=Q.+Wangauthor=M.+Wuauthor=J.+A.+Iniguez-Lluhiauthor=S.+D.+Merajverauthor=R.+R.+Neubig&title=CCG-1423%3A+a+small-molecule+inhibitor+of+RhoA+transcriptional+signaling&doi=10.1158%2F1535-7163.mct-06-0782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling</span></div><div class="casAuthors">Evelyn, Chris R.; Wade, Susan M.; Wang, Qin; Wu, Mei; Iniguez-Lluhi, Jorge A.; Merajver, Sofia D.; Neubig, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2249-2260</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Lysophosphatidic acid receptors stimulate a Gα12/13/RhoA-dependent gene transcription program involving the serum response factor (SRF) and its coactivator and oncogene, megakaryoblastic leukemia 1 (MKL1).  Inhibitors of this pathway could serve as useful biol. probes and potential cancer therapeutic agents.  Through a transcription-based high-throughput serum response element-luciferase screening assay, we identified two small-mol. inhibitors of this pathway.  Mechanistic studies on the more potent CCG-1423 show that it acts downstream of Rho because it blocks SRE.L-driven transcription stimulated by Gα12Q231L, Gα13Q226L, RhoA-G14V, and RhoC-G14V.  The ability of CCG-1423 to block transcription activated by MKL1, but not that induced by SRF-VP16 or GAL4-VP16, suggests a mechanism targeting MKL/SRF-dependent transcriptional activation that does not involve alterations in DNA binding.  Consistent with its role as a Rho/SRF pathway inhibitor, CCG-1423 displays activity in several in vitro cancer cell functional assays.  CCG-1423 potently (<1 μmol/L) inhibits lysophosphatidic acid-induced DNA synthesis in PC-3 prostate cancer cells, and whereas it inhibits the growth of RhoC-overexpressing melanoma lines (A375M2 and SK-Mel-147) at nanomolar concns., it is less active on related lines (A375 and SK-Mel-28) that express lower levels of Rho.  Similarly, CCG-1423 selectively stimulates apoptosis of the metastasis-prone, RhoC-overexpressing melanoma cell line (A375M2) compared with the parental cell line (A375).  CCG-1423 inhibited Rho-dependent invasion by PC-3 prostate cancer cells, whereas it did not affect the Gαi-dependent invasion by the SKOV-3 ovarian cancer cell line.  Thus, based on its profile, CCG-1423 is a promising lead compd. for the development of novel pharmacol. tools to disrupt transcriptional responses of the Rho pathway in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovpixrnu35wLVg90H21EOLACvtfcHk0ljKqpsC0frZ0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVGltbs%253D&md5=6b58f9ac8c9f45e8efc1572d21b358bf</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.mct-06-0782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.mct-06-0782%26sid%3Dliteratum%253Aachs%26aulast%3DEvelyn%26aufirst%3DC.%2BR.%26aulast%3DWade%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DIniguez-Lluhi%26aufirst%3DJ.%2BA.%26aulast%3DMerajver%26aufirst%3DS.%2BD.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26atitle%3DCCG-1423%253A%2520a%2520small-molecule%2520inhibitor%2520of%2520RhoA%2520transcriptional%2520signaling%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D2249%26epage%3D2260%26doi%3D10.1158%2F1535-7163.mct-06-0782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcucci, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stassi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maria, R.</span></span> <span> </span><span class="NLM_article-title">Epithelial-mesenchymal transition: a new target in anticancer drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1038/nrd.2015.13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1038%2Fnrd.2015.13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=26822829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs12ht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=311-325&author=F.+Marcucciauthor=G.+Stassiauthor=R.+De+Maria&title=Epithelial-mesenchymal+transition%3A+a+new+target+in+anticancer+drug+discovery&doi=10.1038%2Fnrd.2015.13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Epithelial-mesenchymal transition: a new target in anticancer drug discovery</span></div><div class="casAuthors">Marcucci, Fabrizio; Stassi, Giorgio; De Maria, Ruggero</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">311-325</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The conversion of cells with an epithelial phenotype into cells with a mesenchymal phenotype, referred to as epithelial-mesenchymal transition, is a crit. process for embryonic development that also occurs in adult life, particularly during tumor progression.  Tumor cells undergoing epithelial-mesenchymal transition acquire the capacity to disarm the body's antitumor defences, resist apoptosis and anticancer drugs, disseminate throughout the organism, and act as a reservoir that replenishes and expands the tumor cell population.  Epithelial-mesenchymal transition is therefore becoming a target of prime interest for anticancer therapy.  Here, we discuss the screening and classification of compds. that affect epithelial-mesenchymal transition, highlight some compds. of particular interest, and address issues related to their clin. application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryjKwYq-FVDrVg90H21EOLACvtfcHk0ljKqpsC0frZ0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs12ht7o%253D&md5=dd4ecd416aaeb73ba477836449079fb0</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2015.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2015.13%26sid%3Dliteratum%253Aachs%26aulast%3DMarcucci%26aufirst%3DF.%26aulast%3DStassi%26aufirst%3DG.%26aulast%3DDe%2BMaria%26aufirst%3DR.%26atitle%3DEpithelial-mesenchymal%2520transition%253A%2520a%2520new%2520target%2520in%2520anticancer%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D311%26epage%3D325%26doi%3D10.1038%2Fnrd.2015.13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbloom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez, S. A.</span></span> <span> </span><span class="NLM_article-title">Strategies for anti-fibrotic therapies</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1832</i></span>,  <span class="NLM_fpage">1088</span>– <span class="NLM_lpage">1103</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2012.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.bbadis.2012.12.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1832&publication_year=2013&pages=1088-1103&author=J.+Rosenbloomauthor=F.+A.+Mendozaauthor=S.+A.+Jimenez&title=Strategies+for+anti-fibrotic+therapies&doi=10.1016%2Fj.bbadis.2012.12.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2012.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2012.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DRosenbloom%26aufirst%3DJ.%26aulast%3DMendoza%26aufirst%3DF.%2BA.%26aulast%3DJimenez%26aufirst%3DS.%2BA.%26atitle%3DStrategies%2520for%2520anti-fibrotic%2520therapies%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2013%26volume%3D1832%26spage%3D1088%26epage%3D1103%26doi%3D10.1016%2Fj.bbadis.2012.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sisson, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajayi, I. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subbotina, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodi, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodansky, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibucos, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keshamouni, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, P. D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horowitz, J. C.</span></span> <span> </span><span class="NLM_article-title">Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">969</span>– <span class="NLM_lpage">986</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2014.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.ajpath.2014.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=25681733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2MXis1Smt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2015&pages=969-986&author=T.+H.+Sissonauthor=I.+O.+Ajayiauthor=N.+Subbotinaauthor=A.+E.+Dodiauthor=E.+S.+Rodanskyauthor=L.+N.+Chibucosauthor=K.+K.+Kimauthor=V.+G.+Keshamouniauthor=E.+S.+Whiteauthor=Y.+Zhouauthor=P.+D.+R.+Higginsauthor=S.+D.+Larsenauthor=R.+R.+Neubigauthor=J.+C.+Horowitz&title=Inhibition+of+myocardin-related+transcription+factor%2Fserum+response+factor+signaling+decreases+lung+fibrosis+and+promotes+mesenchymal+cell+apoptosis&doi=10.1016%2Fj.ajpath.2014.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Myocardin-Related Transcription Factor/Serum Response Factor Signaling Decreases Lung Fibrosis and Promotes Mesenchymal Cell Apoptosis</span></div><div class="casAuthors">Sisson, Thomas H.; Ajayi, Iyabode O.; Subbotina, Natalya; Dodi, Amos E.; Rodansky, Eva S.; Chibucos, Lauren N.; Kim, Kevin K.; Keshamouni, Venkateshwar G.; White, Eric S.; Zhou, Yong; Higgins, Peter D. R.; Larsen, Scott D.; Neubig, Richard R.; Horowitz, Jeffrey C.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">969-986</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Myofibroblasts are crucial to the pathogenesis of tissue fibrosis.  Their formation of stress fibers results in the release of myocardin-related transcription factor (MRTF), a transcriptional coactivator of serum response factor (SRF).  MRTF-A (Mkl1)-deficient mice are protected from lung fibrosis.  We hypothesized that the SRF/MRTF pathway inhibitor CCG-203971 would modulate myofibroblast function in vitro and limit lung fibrosis in vivo.  Normal and idiopathic pulmonary fibrosis lung fibroblasts were treated with/without CCG-203971 (N-[4-chlorophenyl]-1-[3-(2-furanyl)benzoyl]-3-piperidine carboxamide) and/or Fas-activating antibody in the presence/absence of transforming growth factor (TGF)-β1, and apoptosis was assessed.  In vivo studies examd. the effect of therapeutically administered CCG-203971 on lung fibrosis in two distinct murine models of fibrosis induced by bleomycin or targeted type II alveolar epithelial injury.  In vitro, CCG-203971 prevented nuclear localization of MRTF-A; increased the apoptotic susceptibility of normal and idiopathic pulmonary fibrosis fibroblasts; blocked TGF-β1-induced myofibroblast differentiation; and inhibited TGF-β1-induced expression of fibronectin, X-linked inhibitor of apoptosis, and plasminogen activator inhibitor-1.  TGF-β1 did not protect fibroblasts or myofibroblasts from apoptosis in the presence of CCG-203971.  In vivo, CCG-203971 significantly reduced lung collagen content in both murine models while decreasing alveolar plasminogen activator inhibitor-1 and promoting myofibroblast apoptosis.  These data support a central role of the SRF/MRTF pathway in the pathobiol. of lung fibrosis and suggest that its inhibition can help resolve lung fibrosis by promoting fibroblast apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG7V8_ausIX7Vg90H21EOLACvtfcHk0lgnHgljrlGOHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXis1Smt7g%253D&md5=147984195b8821c88aefd8cc21c9ea10</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2014.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2014.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DSisson%26aufirst%3DT.%2BH.%26aulast%3DAjayi%26aufirst%3DI.%2BO.%26aulast%3DSubbotina%26aufirst%3DN.%26aulast%3DDodi%26aufirst%3DA.%2BE.%26aulast%3DRodansky%26aufirst%3DE.%2BS.%26aulast%3DChibucos%26aufirst%3DL.%2BN.%26aulast%3DKim%26aufirst%3DK.%2BK.%26aulast%3DKeshamouni%26aufirst%3DV.%2BG.%26aulast%3DWhite%26aufirst%3DE.%2BS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DHiggins%26aufirst%3DP.%2BD.%2BR.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DHorowitz%26aufirst%3DJ.%2BC.%26atitle%3DInhibition%2520of%2520myocardin-related%2520transcription%2520factor%252Fserum%2520response%2520factor%2520signaling%2520decreases%2520lung%2520fibrosis%2520and%2520promotes%2520mesenchymal%2520cell%2520apoptosis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2015%26volume%3D185%26spage%3D969%26epage%3D986%26doi%3D10.1016%2Fj.ajpath.2014.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiwen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikitorowicz-Buniak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed-Abdi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponticos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suki, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layne, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafyatis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. D.</span></span> <span> </span><span class="NLM_article-title">A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related Fibrosis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0126015</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0126015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1371%2Fjournal.pone.0126015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=25955164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Oju7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=X.+Shiwenauthor=R.+Strattonauthor=J.+Nikitorowicz-Buniakauthor=B.+Ahmed-Abdiauthor=M.+Ponticosauthor=C.+Dentonauthor=D.+Abrahamauthor=A.+Takahashiauthor=B.+Sukiauthor=M.+D.+Layneauthor=R.+Lafyatisauthor=B.+D.+Smith&title=A+Role+of+Myocardin+Related+Transcription+Factor-A+%28MRTF-A%29+in+Scleroderma+Related+Fibrosis&doi=10.1371%2Fjournal.pone.0126015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A role of myocardin related transcription factor-A (MRTF-A) in scleroderma related fibrosis</span></div><div class="casAuthors">Shiwen, Xu; Stratton, Richard; Nikitorowicz-Buniak, Joanna; Ahmed-Abdi, Bahja; Ponticos, Markella; Denton, Christopher; Abraham, David; Takahashi, Ayuko; Suki, Bela; Layne, Matthew D.; Lafyatis, Robert; Smith, Barbara D.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0126015/1-e0126015/20</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">In scleroderma (systemic sclerosis, SSc), persistent activation of myofibroblast leads to severe skin and organ fibrosis resistant to therapy.  Increased mech. stiffness in the involved fibrotic tissues is a hallmark clin. feature and a cause of disabling symptoms.  Myocardin Related Transcription Factor-A (MRTF-A) is a transcriptional co-activator that is sequestered in the cytoplasm and translocates to the nucleus under mech. stress or growth factor stimulation.  Our objective was to det. if MRTF-A is activated in the disease microenvironment to produce more extracellular matrix in progressive SSc.  Immunohistochem. studies demonstrate that nuclear translocation of MRTF-A in scleroderma tissues occurs in keratinocytes, endothelial cells, infiltrating inflammatory cells, and dermal fibroblasts, consistent with enhanced signaling in multiple cell lineages exposed to the stiff extracellular matrix.  Inhibition of MRTF-A nuclear translocation or knockdown of MRTF-A synthesis abolishes the SSc myofibroblast enhanced basal contractility and synthesis of type I collagen and inhibits the matricellular profibrotic protein, connective tissue growth factor (CCN2/CTGF).  In MRTF-A null mice, basal skin and lung stiffness was abnormally reduced and assocd. with altered fibrillar collagen.  MRTF-A has a role in SSc fibrosis acting as a central regulator linking mech. cues to adverse remodeling of the extracellular matrix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE_DfciSC9I7Vg90H21EOLACvtfcHk0ljdHoexZz7O6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Oju7bI&md5=e737b5705f7a08db7f95d9bea9e0b968</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0126015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0126015%26sid%3Dliteratum%253Aachs%26aulast%3DShiwen%26aufirst%3DX.%26aulast%3DStratton%26aufirst%3DR.%26aulast%3DNikitorowicz-Buniak%26aufirst%3DJ.%26aulast%3DAhmed-Abdi%26aufirst%3DB.%26aulast%3DPonticos%26aufirst%3DM.%26aulast%3DDenton%26aufirst%3DC.%26aulast%3DAbraham%26aufirst%3DD.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DSuki%26aufirst%3DB.%26aulast%3DLayne%26aufirst%3DM.%2BD.%26aulast%3DLafyatis%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DB.%2BD.%26atitle%3DA%2520Role%2520of%2520Myocardin%2520Related%2520Transcription%2520Factor-A%2520%2528MRTF-A%2529%2520in%2520Scleroderma%2520Related%2520Fibrosis%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0126015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treisman, R.</span></span> <span> </span><span class="NLM_article-title">Serum-regulated transcription by serum response factor (SRF): a novel role for the DNA binding domain</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">5421</span>– <span class="NLM_lpage">5432</span>, <span class="refDoi"> DOI: 10.1002/j.1460-2075.1994.tb06877.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1002%2Fj.1460-2075.1994.tb06877.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1994&pages=5421-5432&author=C.+S.+Hillauthor=J.+Wynneauthor=R.+Treisman&title=Serum-regulated+transcription+by+serum+response+factor+%28SRF%29%3A+a+novel+role+for+the+DNA+binding+domain&doi=10.1002%2Fj.1460-2075.1994.tb06877.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fj.1460-2075.1994.tb06877.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fj.1460-2075.1994.tb06877.x%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DC.%2BS.%26aulast%3DWynne%26aufirst%3DJ.%26aulast%3DTreisman%26aufirst%3DR.%26atitle%3DSerum-regulated%2520transcription%2520by%2520serum%2520response%2520factor%2520%2528SRF%2529%253A%2520a%2520novel%2520role%2520for%2520the%2520DNA%2520binding%2520domain%26jtitle%3DEMBO%2520J.%26date%3D1994%26volume%3D13%26spage%3D5421%26epage%3D5432%26doi%3D10.1002%2Fj.1460-2075.1994.tb06877.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutchings, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisabeth, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajeswaran, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorenson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruth, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsou, P.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leipprandt, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. D.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1744</span>– <span class="NLM_lpage">1749</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.02.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.bmcl.2017.02.070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1744-1749&author=K.+M.+Hutchingsauthor=E.+M.+Lisabethauthor=W.+Rajeswaranauthor=M.+W.+Wilsonauthor=R.+J.+Sorensonauthor=P.+L.+Campbellauthor=J.+H.+Ruthauthor=A.+Aminauthor=P.-S.+Tsouauthor=J.+R.+Leipprandtauthor=S.+R.+Olsonauthor=B.+Wenauthor=T.+Zhaoauthor=D.+Sunauthor=D.+Khannaauthor=D.+A.+Foxauthor=R.+R.+Neubigauthor=S.+D.+Larsen&title=Pharmacokinetic+optimitzation+of+CCG-203971%3A+Novel+inhibitors+of+the+Rho%2FMRTF%2FSRF+transcriptional+pathway+as+potential+antifibrotic+therapeutics+for+systemic+scleroderma&doi=10.1016%2Fj.bmcl.2017.02.070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.02.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.02.070%26sid%3Dliteratum%253Aachs%26aulast%3DHutchings%26aufirst%3DK.%2BM.%26aulast%3DLisabeth%26aufirst%3DE.%2BM.%26aulast%3DRajeswaran%26aufirst%3DW.%26aulast%3DWilson%26aufirst%3DM.%2BW.%26aulast%3DSorenson%26aufirst%3DR.%2BJ.%26aulast%3DCampbell%26aufirst%3DP.%2BL.%26aulast%3DRuth%26aufirst%3DJ.%2BH.%26aulast%3DAmin%26aufirst%3DA.%26aulast%3DTsou%26aufirst%3DP.-S.%26aulast%3DLeipprandt%26aufirst%3DJ.%2BR.%26aulast%3DOlson%26aufirst%3DS.%2BR.%26aulast%3DWen%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DKhanna%26aufirst%3DD.%26aulast%3DFox%26aufirst%3DD.%2BA.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26atitle%3DPharmacokinetic%2520optimitzation%2520of%2520CCG-203971%253A%2520Novel%2520inhibitors%2520of%2520the%2520Rho%252FMRTF%252FSRF%2520transcriptional%2520pathway%2520as%2520potential%2520antifibrotic%2520therapeutics%2520for%2520systemic%2520scleroderma%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D1744%26epage%3D1749%26doi%3D10.1016%2Fj.bmcl.2017.02.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haak, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchhoff, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. D.</span></span> <span> </span><span class="NLM_article-title">Optimization of novel nipecotic bis(amide) inhibitors of the Rho/MKL1/SRF transcriptional pathway as potential anti-metastasis agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3826</span>– <span class="NLM_lpage">3832</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.04.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.bmcl.2013.04.080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3826-3832&author=J.+L.+Bellauthor=A.+J.+Haakauthor=S.+M.+Wadeauthor=P.+D.+Kirchhoffauthor=R.+R.+Neubigauthor=S.+D.+Larsen&title=Optimization+of+novel+nipecotic+bis%28amide%29+inhibitors+of+the+Rho%2FMKL1%2FSRF+transcriptional+pathway+as+potential+anti-metastasis+agents&doi=10.1016%2Fj.bmcl.2013.04.080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.04.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.04.080%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DJ.%2BL.%26aulast%3DHaak%26aufirst%3DA.%2BJ.%26aulast%3DWade%26aufirst%3DS.%2BM.%26aulast%3DKirchhoff%26aufirst%3DP.%2BD.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26atitle%3DOptimization%2520of%2520novel%2520nipecotic%2520bis%2528amide%2529%2520inhibitors%2520of%2520the%2520Rho%252FMKL1%252FSRF%2520transcriptional%2520pathway%2520as%2520potential%2520anti-metastasis%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3826%26epage%3D3832%26doi%3D10.1016%2Fj.bmcl.2013.04.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evelyn, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocab, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harzdorf, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis
Showalter, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. D.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and prostate cancer cell-based studies of analogs of the Rho/MKL1 transcriptional pathway inhibitor, CCG-1423</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">665</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.bmcl.2009.11.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=19963382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2iur%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=665-672&author=C.+R.+Evelynauthor=J.+L.+Bellauthor=J.+G.+Ryuauthor=S.+M.+Wadeauthor=A.+Kocabauthor=N.+L.+Harzdorfauthor=H.+D.+Hollis%0AShowalterauthor=R.+R.+Neubigauthor=S.+D.+Larsen&title=Design%2C+synthesis+and+prostate+cancer+cell-based+studies+of+analogs+of+the+Rho%2FMKL1+transcriptional+pathway+inhibitor%2C+CCG-1423&doi=10.1016%2Fj.bmcl.2009.11.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and prostate cancer cell-based studies of analogs of the Rho/MKL1 transcriptional pathway inhibitor, CCG-1423</span></div><div class="casAuthors">Evelyn, Chris R.; Bell, Jessica L.; Ryu, Jenny G.; Wade, Susan M.; Kocab, Andrew; Harzdorf, Nicole L.; Showalter, H. D. Hollis; Neubig, Richard R.; Larsen, Scott D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">665-672</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We recently identified bis(amide) CCG-1423 (1) as a novel inhibitor of RhoA/C-mediated gene transcription that is capable of inhibiting invasion of PC-3 prostate cancer cells in a Matrigel model of metastasis.  An initial structure-activity relationship study focusing on bioisosteric replacement of the amides and conformational restriction identified two compds., 4g and 8, with improved selectivity for inhibition of RhoA/C-mediated gene transcription and attenuated cytotoxicity relative to 1.  Both compds. were also capable of inhibiting cell invasion with equal efficacy to 1 but with less attendant cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDgSeS9pYMp7Vg90H21EOLACvtfcHk0ljaRzbqXSQmaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2iur%252FO&md5=e931712238b9376b45c6e40daac3fda8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.056%26sid%3Dliteratum%253Aachs%26aulast%3DEvelyn%26aufirst%3DC.%2BR.%26aulast%3DBell%26aufirst%3DJ.%2BL.%26aulast%3DRyu%26aufirst%3DJ.%2BG.%26aulast%3DWade%26aufirst%3DS.%2BM.%26aulast%3DKocab%26aufirst%3DA.%26aulast%3DHarzdorf%26aufirst%3DN.%2BL.%26aulast%3DHollis%2BShowalter%26aufirst%3DH.%2BD.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26atitle%3DDesign%252C%2520synthesis%2520and%2520prostate%2520cancer%2520cell-based%2520studies%2520of%2520analogs%2520of%2520the%2520Rho%252FMKL1%2520transcriptional%2520pathway%2520inhibitor%252C%2520CCG-1423%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D665%26epage%3D672%26doi%3D10.1016%2Fj.bmcl.2009.11.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haak, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleton, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisabeth, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misek, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockwell, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Airik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krook, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhaegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawlor, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of Myocardin-related Transcription Factor pathway blocks bung metastases of RhoC-overexpressing melanoma</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-16-0482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1158%2F1535-7163.mct-16-0482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=27837031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsF2jtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=193-204&author=A.+J.+Haakauthor=K.+M.+Appletonauthor=E.+M.+Lisabethauthor=S.+A.+Misekauthor=Y.+Jiauthor=S.+M.+Wadeauthor=J.+L.+Bellauthor=C.+E.+Rockwellauthor=M.+Airikauthor=M.+A.+Krookauthor=S.+D.+Larsenauthor=M.+Verhaegenauthor=E.+R.+Lawlorauthor=R.+R.+Neubig&title=Pharmacological+inhibition+of+Myocardin-related+Transcription+Factor+pathway+blocks+bung+metastases+of+RhoC-overexpressing+melanoma&doi=10.1158%2F1535-7163.mct-16-0482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma</span></div><div class="casAuthors">Haak, Andrew J.; Appleton, Kathryn M.; Lisabeth, Erika M.; Misek, Sean A.; Ji, Yajing; Wade, Susan M.; Bell, Jessica L.; Rockwell, Cheryl E.; Airik, Merlin; Krook, Melanie A.; Larsen, Scott D.; Verhaegen, Monique; Lawlor, Elizabeth R.; Neubig, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-204</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Melanoma is the most dangerous form of skin cancer with the majority of deaths arising from metastatic disease.  Evidence implicates Rho-activated gene transcription in melanoma metastasis mediated by the nuclear localization of the transcriptional coactivator, myocardin-related transcription factor (MRTF).  Here, we highlight a role for Rho and MRTF signaling and its reversal by pharmacol. inhibition using in vitro and in vivo models of human melanoma growth and metastasis.  Using two cellular models of melanoma, we clearly show that one cell type, SK-Mel-147, is highly metastatic, has high RhoC expression, and MRTF nuclear localization and activity.  Conversely, SK-Mel-19 melanoma cells have low RhoC expression, and decreased levels of MRTF-regulated genes.  To probe the dependence of melanoma aggressiveness to MRTF transcription, we use a previously developed small-mol. inhibitor, CCG-203971, which at low micromolar concns. blocks nuclear localization and activity of MRTF-A.  In SK-Mel-147 cells, CCG-203971 inhibits cellular migration and invasion, and decreases MRTF target gene expression.  In addn., CCG-203971-mediated inhibition of the Rho/MRTF pathway significantly reduces cell growth and clonogenicity and causes G1 cell-cycle arrest.  In an exptl. model of melanoma lung metastasis, the RhoC-overexpressing melanoma cells (SK-Mel-147) exhibited pronounced lung colonization compared with the low RhoC-expressing SK-Mel-19.  Furthermore, pharmacol. inhibition of the MRTF pathway reduced both the no. and size of lung metastasis resulting in a marked redn. of total lung tumor burden.  These data link Rho and MRTF-mediated signaling with aggressive phenotypes and support targeting the MRTF transcriptional pathway as a novel approach to melanoma therapeutics.  Mol Cancer Ther; 16(1); 193-204. cpr2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNd4iHo1dIebVg90H21EOLACvtfcHk0ljaRzbqXSQmaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsF2jtw%253D%253D&md5=d26db3a495452bda8477c576239f5dbe</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.mct-16-0482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.mct-16-0482%26sid%3Dliteratum%253Aachs%26aulast%3DHaak%26aufirst%3DA.%2BJ.%26aulast%3DAppleton%26aufirst%3DK.%2BM.%26aulast%3DLisabeth%26aufirst%3DE.%2BM.%26aulast%3DMisek%26aufirst%3DS.%2BA.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DWade%26aufirst%3DS.%2BM.%26aulast%3DBell%26aufirst%3DJ.%2BL.%26aulast%3DRockwell%26aufirst%3DC.%2BE.%26aulast%3DAirik%26aufirst%3DM.%26aulast%3DKrook%26aufirst%3DM.%2BA.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26aulast%3DVerhaegen%26aufirst%3DM.%26aulast%3DLawlor%26aufirst%3DE.%2BR.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26atitle%3DPharmacological%2520inhibition%2520of%2520Myocardin-related%2520Transcription%2520Factor%2520pathway%2520blocks%2520bung%2520metastases%2520of%2520RhoC-overexpressing%2520melanoma%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2017%26volume%3D16%26spage%3D193%26epage%3D204%26doi%3D10.1158%2F1535-7163.mct-16-0482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haak, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsou, P.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruth, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span> <span> </span><span class="NLM_article-title">Targeting the myofibroblast genetic switch: inhibitors of Myocardin-Related Transcription Factor/Serum Response Factor-regulated gene transcription prevent fibrosis in a murine model of skin injury</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">480</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1124/jpet.114.213520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1124%2Fjpet.114.213520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=24706986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGltbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2014&pages=480-486&author=A.+J.+Haakauthor=P.-S.+Tsouauthor=M.+A.+Aminauthor=J.+H.+Ruthauthor=P.+Campbellauthor=D.+A.+Foxauthor=D.+Khannaauthor=S.+D.+Larsenauthor=R.+R.+Neubig&title=Targeting+the+myofibroblast+genetic+switch%3A+inhibitors+of+Myocardin-Related+Transcription+Factor%2FSerum+Response+Factor-regulated+gene+transcription+prevent+fibrosis+in+a+murine+model+of+skin+injury&doi=10.1124%2Fjpet.114.213520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury</span></div><div class="casAuthors">Haak, Andrew J.; Tsou, Pei-Suen; Amin, Mohammad A.; Ruth, Jeffrey H.; Campbell, Phillip; Fox, David A.; Khanna, Dinesh; Larsen, Scott D.; Neubig, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">480-486, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Systemic sclerosis (SSc), or scleroderma, similar to many fibrotic disorders, lacks effective therapies.  Current trials focus on anti-inflammatory drugs or targeted approaches aimed at one of the many receptor mechanisms initiating fibrosis.  In light of evidence that a myocardin-related transcription factor (MRTF)-and serum response factor (SRF)-regulated gene transcriptional program induced by Rho GTPases is essential for myofibroblast activation, we explored the hypothesis that inhibitors of this pathway may represent novel antifibrotics.  MRTF/SRF-regulated genes show spontaneously increased expression in primary dermal fibroblasts from patients with diffuse cutaneous SSc.  A novel small-mol. inhibitor of MRTF/SRF-regulated transcription (CCG-203971) inhibits expression of connective tissue growth factor (CTGF), α-smooth muscle actin (α-SMA), and collagen 1 (COL1A2) in both SSc fibroblasts and in lysophosphatidic acid (LPA)- and transforming growth factor β (TGFβ)-stimulated fibroblasts.  In vivo treatment with CCG-203971 also prevented bleomycin-induced skin thickening and collagen deposition.  Thus, targeting the MRTF/SRF gene transcription pathway could provide an efficacious new approach to therapy for SSc and other fibrotic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolPwXDfCVZd7Vg90H21EOLACvtfcHk0liW0049v_wMqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGltbvM&md5=182922f94ffc7a990a3ed96d1d915db2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.213520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.213520%26sid%3Dliteratum%253Aachs%26aulast%3DHaak%26aufirst%3DA.%2BJ.%26aulast%3DTsou%26aufirst%3DP.-S.%26aulast%3DAmin%26aufirst%3DM.%2BA.%26aulast%3DRuth%26aufirst%3DJ.%2BH.%26aulast%3DCampbell%26aufirst%3DP.%26aulast%3DFox%26aufirst%3DD.%2BA.%26aulast%3DKhanna%26aufirst%3DD.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26atitle%3DTargeting%2520the%2520myofibroblast%2520genetic%2520switch%253A%2520inhibitors%2520of%2520Myocardin-Related%2520Transcription%2520Factor%252FSerum%2520Response%2520Factor-regulated%2520gene%2520transcription%2520prevent%2520fibrosis%2520in%2520a%2520murine%2520model%2520of%2520skin%2520injury%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D349%26spage%3D480%26epage%3D486%26doi%3D10.1124%2Fjpet.114.213520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldfine, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciaraldi, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emecan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzpatrick, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vokes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Chillaron, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patti, M.-E.</span></span> <span> </span><span class="NLM_article-title">Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">918</span>– <span class="NLM_lpage">929</span>, <span class="refDoi"> DOI: 10.1172/jci41940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1172%2Fjci41940" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=918-929&author=W.+Jinauthor=A.+B.+Goldfineauthor=T.+Boesauthor=R.+R.+Henryauthor=T.+P.+Ciaraldiauthor=E.-Y.+Kimauthor=M.+Emecanauthor=C.+Fitzpatrickauthor=A.+Senauthor=A.+Shahauthor=E.+Munauthor=M.+Vokesauthor=J.+Schroederauthor=E.+Tatroauthor=J.+Jimenez-Chillaronauthor=M.-E.+Patti&title=Increased+SRF+transcriptional+activity+in+human+and+mouse+skeletal+muscle+is+a+signature+of+insulin+resistance&doi=10.1172%2Fjci41940"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1172%2Fjci41940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252Fjci41940%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DW.%26aulast%3DGoldfine%26aufirst%3DA.%2BB.%26aulast%3DBoes%26aufirst%3DT.%26aulast%3DHenry%26aufirst%3DR.%2BR.%26aulast%3DCiaraldi%26aufirst%3DT.%2BP.%26aulast%3DKim%26aufirst%3DE.-Y.%26aulast%3DEmecan%26aufirst%3DM.%26aulast%3DFitzpatrick%26aufirst%3DC.%26aulast%3DSen%26aufirst%3DA.%26aulast%3DShah%26aufirst%3DA.%26aulast%3DMun%26aufirst%3DE.%26aulast%3DVokes%26aufirst%3DM.%26aulast%3DSchroeder%26aufirst%3DJ.%26aulast%3DTatro%26aufirst%3DE.%26aulast%3DJimenez-Chillaron%26aufirst%3DJ.%26aulast%3DPatti%26aufirst%3DM.-E.%26atitle%3DIncreased%2520SRF%2520transcriptional%2520activity%2520in%2520human%2520and%2520mouse%2520skeletal%2520muscle%2520is%2520a%2520signature%2520of%2520insulin%2520resistance%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26spage%3D918%26epage%3D929%26doi%3D10.1172%2Fjci41940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffield, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luster, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tager, A. M.</span></span> <span> </span><span class="NLM_article-title">LPA(1)-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1830</span>– <span class="NLM_lpage">1846</span>, <span class="refDoi"> DOI: 10.1096/fj.12-219378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1096%2Ffj.12-219378" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=1830-1846&author=N.+Sakaiauthor=J.+Chunauthor=J.+S.+Duffieldauthor=T.+Wadaauthor=A.+D.+Lusterauthor=A.+M.+Tager&title=LPA%281%29-induced+cytoskeleton+reorganization+drives+fibrosis+through+CTGF-dependent+fibroblast+proliferation&doi=10.1096%2Ffj.12-219378"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1096%2Ffj.12-219378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.12-219378%26sid%3Dliteratum%253Aachs%26aulast%3DSakai%26aufirst%3DN.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DDuffield%26aufirst%3DJ.%2BS.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26aulast%3DTager%26aufirst%3DA.%2BM.%26atitle%3DLPA%25281%2529-induced%2520cytoskeleton%2520reorganization%2520drives%2520fibrosis%2520through%2520CTGF-dependent%2520fibroblast%2520proliferation%26jtitle%3DFASEB%2520J.%26date%3D2013%26volume%3D27%26spage%3D1830%26epage%3D1846%26doi%3D10.1096%2Ffj.12-219378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu-Wai-Man, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer-Dene, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchings, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisabeth, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treisman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaw, P. T.</span></span> <span> </span><span class="NLM_article-title">Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">518</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-00212-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1038%2Fs41598-017-00212-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=28364121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A280%3ADC%252BC1cvjt12qsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=518&author=C.+Yu-Wai-Manauthor=B.+Spencer-Deneauthor=R.+M.+H.+Leeauthor=K.+Hutchingsauthor=E.+M.+Lisabethauthor=R.+Treismanauthor=M.+Baillyauthor=S.+D.+Larsenauthor=R.+R.+Neubigauthor=P.+T.+Khaw&title=Local+delivery+of+novel+MRTF%2FSRF+inhibitors+prevents+scar+tissue+formation+in+a+preclinical+model+of+fibrosis&doi=10.1038%2Fs41598-017-00212-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis</span></div><div class="casAuthors">Yu-Wai-Man Cynthia; Bailly Maryse; Yu-Wai-Man Cynthia; Lee Richard M H; Khaw Peng T; Yu-Wai-Man Cynthia; Treisman Richard; Spencer-Dene Bradley; Hutchings Kim; Larsen Scott D; Lisabeth Erika M; Neubig Richard R</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">518</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The myocardin-related transcription factor/serum response factor (MRTF/SRF) pathway represents a promising therapeutic target to prevent fibrosis.  We have tested the effects of new pharmacological inhibitors of MRTF/SRF signalling in a preclinical model of fibrosis.  CCG-222740, a novel MRTF/SRF inhibitor, markedly decreased SRF reporter gene activity and showed a greater inhibitory effect on MRTF/SRF target genes than the previously described MRTF-A inhibitor CCG-203971.  CCG-222740 was also five times more potent, with an IC50 of 5 μM, in a fibroblast-mediated collagen contraction assay, was less cytotoxic, and a more potent inhibitor of alpha-smooth muscle actin protein expression than CCG-203971.  Local delivery of CCG-222740 and CCG-203971 in a validated and clinically relevant rabbit model of scar tissue formation after glaucoma filtration surgery increased the long-term success of the surgery by 67% (P < 0.0005) and 33% (P < 0.01), respectively, and significantly decreased fibrosis and scarring histologically.  Unlike mitomycin-C, neither CCG-222740 nor CCG-203971 caused any detectable epithelial toxicity or systemic side effects with very low drug levels measured in the aqueous, vitreous, and serum.  We conclude that inhibitors of MRTF/SRF-regulated gene transcription such as CCG-222740, potentially represent a new therapeutic strategy to prevent scar tissue formation in the eye and other tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQWJMd8-qWYjNyzdcP07UmufW6udTcc2eba4lTXJR6uF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvjt12qsg%253D%253D&md5=3eb899dd07f924253de149588b01e17d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-00212-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-00212-w%26sid%3Dliteratum%253Aachs%26aulast%3DYu-Wai-Man%26aufirst%3DC.%26aulast%3DSpencer-Dene%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DR.%2BM.%2BH.%26aulast%3DHutchings%26aufirst%3DK.%26aulast%3DLisabeth%26aufirst%3DE.%2BM.%26aulast%3DTreisman%26aufirst%3DR.%26aulast%3DBailly%26aufirst%3DM.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DKhaw%26aufirst%3DP.%2BT.%26atitle%3DLocal%2520delivery%2520of%2520novel%2520MRTF%252FSRF%2520inhibitors%2520prevents%2520scar%2520tissue%2520formation%2520in%2520a%2520preclinical%2520model%2520of%2520fibrosis%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D518%26doi%3D10.1038%2Fs41598-017-00212-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span> <span> </span><span class="NLM_article-title">Propylene oxide assisted one-pot, tandem synthesis of substituted-1,3,4-oxadiazole-2(3H)-ones in water</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">7978</span>– <span class="NLM_lpage">7983</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2012.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.tet.2012.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyjs77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=7978-7983&author=X.+Yanauthor=S.+Zhouauthor=Y.+Wangauthor=Z.+Geauthor=T.+Chengauthor=R.+Li&title=Propylene+oxide+assisted+one-pot%2C+tandem+synthesis+of+substituted-1%2C3%2C4-oxadiazole-2%283H%29-ones+in+water&doi=10.1016%2Fj.tet.2012.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Propylene oxide assisted one-pot, tandem synthesis of substituted-1,3,4-oxadiazole-2(3H)-ones in water</span></div><div class="casAuthors">Yan, Xu; Zhou, Shuo; Wang, Yuanqiang; Ge, Zemei; Cheng, Tieming; Li, Runtao</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">7978-7983</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">It has been developed for the synthesis of substituted-1,3,4-oxadiazole-2(3H)-one derivs. via a novel one-pot, tandem procedure assisted by propylene oxide.  The 5-substituted-1,3,4-oxadiazole-2(3H)-ones and 3,5-disubstituted-1,3,4-oxadiazole-2(3H)-ones were, resp., obtained from three-component reaction of acylhydrazines, carbon disulfide, and propylene oxide, and four-component reaction of acylhydrazines, carbon disulfide, propylene oxide, and org. halides.  The reactions were carried out using water as solvent in the presence of potassium phosphate to afford the expected products in good to excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRTfZSG8k9B7Vg90H21EOLACvtfcHk0lh0kQvOA8zkrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyjs77N&md5=331acc507f763c89a7bdeeba4c2d6afc</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2012.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2012.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGe%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DR.%26atitle%3DPropylene%2520oxide%2520assisted%2520one-pot%252C%2520tandem%2520synthesis%2520of%2520substituted-1%252C3%252C4-oxadiazole-2%25283H%2529-ones%2520in%2520water%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D7978%26epage%3D7983%26doi%3D10.1016%2Fj.tet.2012.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.-L.</span></span> <span> </span><span class="NLM_article-title">Oxadiazole derivatives containing 1,4-benzodioxan as potential immunosuppressive agents against RAW264.7 cells</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4895</span>– <span class="NLM_lpage">4902</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.06.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.bmc.2011.06.061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=4895-4902&author=J.+Sunauthor=N.+Caoauthor=X.-M.+Zhangauthor=Y.-S.+Yangauthor=Y.-B.+Zhangauthor=X.-M.+Wangauthor=H.-L.+Zhu&title=Oxadiazole+derivatives+containing+1%2C4-benzodioxan+as+potential+immunosuppressive+agents+against+RAW264.7+cells&doi=10.1016%2Fj.bmc.2011.06.061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.06.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.06.061%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DX.-M.%26aulast%3DYang%26aufirst%3DY.-S.%26aulast%3DZhang%26aufirst%3DY.-B.%26aulast%3DWang%26aufirst%3DX.-M.%26aulast%3DZhu%26aufirst%3DH.-L.%26atitle%3DOxadiazole%2520derivatives%2520containing%25201%252C4-benzodioxan%2520as%2520potential%2520immunosuppressive%2520agents%2520against%2520RAW264.7%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D4895%26epage%3D4902%26doi%3D10.1016%2Fj.bmc.2011.06.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, B. K.</span>; <span class="NLM_string-name">Audia, J. E.</span>; <span class="NLM_string-name">Gagnon, A.</span>; <span class="NLM_string-name">Harmange, J.-C.</span>; <span class="NLM_string-name">Naveschuk, C. G.</span></span> <span> </span><span class="NLM_article-title">Modulators of methyl modifying enzymes, compositions and uses thereof</span>. WO <span class="NLM_patent">2013075084 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=B.+K.+Albrecht&author=J.+E.+Audia&author=A.+Gagnon&author=J.-C.+Harmange&author=C.+G.+Naveschuk&title=Modulators+of+methyl+modifying+enzymes%2C+compositions+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DModulators%2520of%2520methyl%2520modifying%2520enzymes%252C%2520compositions%2520and%2520uses%2520thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D.-M.</span>; <span class="NLM_string-name">Sinz, C. J.</span>; <span class="NLM_string-name">Crespo, A.</span>; <span class="NLM_string-name">Wilson, J. E.</span>; <span class="NLM_string-name">McCracken, T.</span>; <span class="NLM_string-name">Xu, S.</span>; <span class="NLM_string-name">Li, H.</span></span> <span> </span><span class="NLM_article-title">Triazolyl pyrimidinone compounds as PDE2 inhibitors</span>. WO <span class="NLM_patent">2016145614 A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=D.-M.+Shen&author=C.+J.+Sinz&author=A.+Crespo&author=J.+E.+Wilson&author=T.+McCracken&author=S.+Xu&author=H.+Li&title=Triazolyl+pyrimidinone+compounds+as+PDE2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DD.-M.%26atitle%3DTriazolyl%2520pyrimidinone%2520compounds%2520as%2520PDE2%2520inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbas, C. F.</span></span> <span> </span><span class="NLM_article-title">Rapid, stable, chemoselective labeling of thiols with Julia-Kocienski-like reagents: A serum-stable alternative to maleimide-based protein conjugation</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">12592</span>– <span class="NLM_lpage">12596</span>, <span class="refDoi"> DOI: 10.1002/anie.201306241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1002%2Fanie.201306241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Wms7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=12592-12596&author=N.+Todaauthor=S.+Asanoauthor=C.+F.+Barbas&title=Rapid%2C+stable%2C+chemoselective+labeling+of+thiols+with+Julia-Kocienski-like+reagents%3A+A+serum-stable+alternative+to+maleimide-based+protein+conjugation&doi=10.1002%2Fanie.201306241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid, stable, chemoselective labeling of thiols with Julia-Kocienski-like reagents: A serum-stable alternative to maleimide-based protein conjugation</span></div><div class="casAuthors">Toda, Narihiro; Asano, Shigehiro; Barbas, Carlos F., III</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">12592-12596</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have developed a class of sulfone derivs. for applications in protein conjugation chem., and we have compared the newly synthesized conjugates to maleimide conjugates.  Methylsulfonyl-functionalized five-membered cyclic compds., such as phenyltetrazole or phenyloxadiazole, reacted rapidly and specifically with thiols in small mols. and proteins with exquisite chemoselectivity at biol. relevant pH values (pH 5.8 - 8.0).  Designer heteroarom. sulfones allowed for the selective introduction of a fluorophore and poly(ethylene) glycol chains (PEGylation), and provided protein conjugates with superior stability compared to maleimide-conjugated proteins in human plasma.  Given the speed, selectivity, and stability of the sulfone-cysteine reactions described herein, we anticipate that this "thiol-Click" approach will find broad application in peptide and protein chem. and for the development of antibody drug conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowJzWgExtAGLVg90H21EOLACvtfcHk0lgl-LsVAdSsDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Wms7%252FF&md5=ef91e1e933d116482b9e886c94c6cdd0</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fanie.201306241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201306241%26sid%3Dliteratum%253Aachs%26aulast%3DToda%26aufirst%3DN.%26aulast%3DAsano%26aufirst%3DS.%26aulast%3DBarbas%26aufirst%3DC.%2BF.%26atitle%3DRapid%252C%2520stable%252C%2520chemoselective%2520labeling%2520of%2520thiols%2520with%2520Julia-Kocienski-like%2520reagents%253A%2520A%2520serum-stable%2520alternative%2520to%2520maleimide-based%2520protein%2520conjugation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D12592%26epage%3D12596%26doi%3D10.1002%2Fanie.201306241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adumeau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davydova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeglis, B. M.</span></span> <span> </span><span class="NLM_article-title">Thiol-reactive bifunctional chelators for the creation of site-selectively modified radioimmunoconjugates with improved stability</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1364</span>– <span class="NLM_lpage">1372</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.8b00081</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.8b00081" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvVKrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=1364-1372&author=P.+Adumeauauthor=M.+Davydovaauthor=B.+M.+Zeglis&title=Thiol-reactive+bifunctional+chelators+for+the+creation+of+site-selectively+modified+radioimmunoconjugates+with+improved+stability&doi=10.1021%2Facs.bioconjchem.8b00081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Thiol-Reactive Bifunctional Chelators for the Creation of Site-Selectively Modified Radioimmunoconjugates with Improved Stability</span></div><div class="casAuthors">Adumeau, Pierre; Davydova, Maria; Zeglis, Brian M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1364-1372</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Maleimide-bearing bifunctional chelators have been used extensively for the site-selective bioconjugation and radiolabeling of peptides and proteins.  However, bioconjugates obtained using these constructs inevitably suffer from limited stability in vivo, a trait that translates into suboptimal activity concns. in target tissues and higher uptake levels in healthy, nontarget tissues.  To circumvent this issue, phenyloxadiazolyl methylsulfones have previously been reported as alternatives to maleimides for thiol-based ligations, but these constructs have scarcely been used in the field of radiochem.  In this report, we describe the synthesis of two thiol-reactive bifunctional chelators for 89Zr and 177Lu based on a new, easy-to-make phenyloxadiazolyl methylsulfone reagent, PODS.  Radioimmunoconjugates created using these novel bifunctional chelators displayed in vitro stability that was higher than that of their maleimide-derived cousins.  More importantly, positron emission tomog. imaging in murine models of cancer revealed that a 89Zr-labeled radioimmunoconjugate created using a PODS-bearing bifunctional chelator produced a rate of uptake in nontarget tissues that is significantly lower than that of its analogous maleimide-based counterpart.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPceA_fJIlKrVg90H21EOLACvtfcHk0liX27uMoXdYVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvVKrtbc%253D&md5=08abd0933d4965449c2bb8ed6f123544</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.8b00081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.8b00081%26sid%3Dliteratum%253Aachs%26aulast%3DAdumeau%26aufirst%3DP.%26aulast%3DDavydova%26aufirst%3DM.%26aulast%3DZeglis%26aufirst%3DB.%2BM.%26atitle%3DThiol-reactive%2520bifunctional%2520chelators%2520for%2520the%2520creation%2520of%2520site-selectively%2520modified%2520radioimmunoconjugates%2520with%2520improved%2520stability%26jtitle%3DBioconjugate%2520Chem.%26date%3D2018%26volume%3D29%26spage%3D1364%26epage%3D1372%26doi%3D10.1021%2Facs.bioconjchem.8b00081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farrukh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paez, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salierno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berninger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Campo, A.</span></span> <span> </span><span class="NLM_article-title">Bifunctional poly(acrylamide) hydrogels through orthogonal coupling chemistries</span>. <i>Biomacromolecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">906</span>– <span class="NLM_lpage">913</span>, <span class="refDoi"> DOI: 10.1021/acs.biomac.6b01784</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biomac.6b01784" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=906-913&author=A.+Farrukhauthor=J.+I.+Paezauthor=M.+Saliernoauthor=W.+Fanauthor=B.+Berningerauthor=A.+Del+Campo&title=Bifunctional+poly%28acrylamide%29+hydrogels+through+orthogonal+coupling+chemistries&doi=10.1021%2Facs.biomac.6b01784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Bifunctional Poly(acrylamide) Hydrogels through Orthogonal Coupling Chemistries</span></div><div class="casAuthors">Farrukh, Aleeza; Paez, Julieta I.; Salierno, Marcelo; Fan, Wenqiang; Berninger, Benedikt; del Campo, Aranzazu</div><div class="citationInfo"><span class="NLM_cas:title">Biomacromolecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">906-913</span>CODEN:
                <span class="NLM_cas:coden">BOMAF6</span>;
        ISSN:<span class="NLM_cas:issn">1525-7797</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Biomaterials for cell culture allowing simple and quant. presentation of instructive cues enable rationalization of the interplay between cells and their surrounding microenvironment.  Poly(acrylamide) (PAAm) hydrogels are popular 2D-model substrates for this purpose.  However, quant. and reproducible biofunctionalization of PAAm hydrogels with multiple ligands in a trustable, controlled, and independent fashion is not trivial.  Here, we describe a method for bifunctional modification of PAAm hydrogels with thiol- and amine- contg. biomols. with controlled densities in an independent, orthogonal manner.  We developed copolymer networks of AAm with 9% acrylic acid and 2% N-(4-(5-(methylsulfonyl)-1,3,4-oxadiazol-2-yl)phenyl)acrylamide.  The covalent binding of thiol- and amine-contg. chromophores at tunable concns. was demonstrated and quantified by UV spectroscopy.  The morphol., mech. properties, and homogeneity of the copolymd. hydrogels were characterized by SEM, dynamic mech. anal., and confocal microscopy studies.  Our copolymer hydrogels were bifunctionalized with polylysine and a laminin-mimetic peptide using the specific chemistries.  We analyzed the effect of binding protocol of the two components in the maturation of cultured postmitotic cortical neurons.  Our substrates supported neuronal attachment, proliferation, and neuronal differentiation.  We found that neurons cultured on our hydrogels bifunctionalized with ligand-specific chemistries in a sequential fashion exhibited higher maturation at comparable culture times than using a simultaneous bifunctionalization strategy, displaying a higher no. of neurites, branches, and dendritic filopodia.  These results demonstrate the relevance of quant. and optimized coupling chemistries for the performance of simple biomaterials and with sensitive cell types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9e33oc9sXt7Vg90H21EOLACvtfcHk0liX27uMoXdYVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWksrs%253D&md5=e783b4dc21ccbae4926f6c5905a0b524</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.biomac.6b01784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biomac.6b01784%26sid%3Dliteratum%253Aachs%26aulast%3DFarrukh%26aufirst%3DA.%26aulast%3DPaez%26aufirst%3DJ.%2BI.%26aulast%3DSalierno%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DBerninger%26aufirst%3DB.%26aulast%3DDel%2BCampo%26aufirst%3DA.%26atitle%3DBifunctional%2520poly%2528acrylamide%2529%2520hydrogels%2520through%2520orthogonal%2520coupling%2520chemistries%26jtitle%3DBiomacromolecules%26date%3D2017%26volume%3D18%26spage%3D906%26epage%3D913%26doi%3D10.1021%2Facs.biomac.6b01784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saitoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunitomo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mol, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Textor, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, F.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and structure-activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3β</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2017</span>– <span class="NLM_lpage">2029</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.01.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.bmc.2009.01.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=2017-2029&author=M.+Saitohauthor=J.+Kunitomoauthor=E.+Kimuraauthor=Y.+Hayaseauthor=H.+Kobayashiauthor=N.+Uchiyamaauthor=T.+Kawamotoauthor=T.+Tanakaauthor=C.+D.+Molauthor=D.+R.+Douganauthor=G.+S.+Textorauthor=G.+P.+Snellauthor=F.+Itoh&title=Design%2C+synthesis+and+structure-activity+relationships+of+1%2C3%2C4-oxadiazole+derivatives+as+novel+inhibitors+of+glycogen+synthase+kinase-3%CE%B2&doi=10.1016%2Fj.bmc.2009.01.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.01.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.01.019%26sid%3Dliteratum%253Aachs%26aulast%3DSaitoh%26aufirst%3DM.%26aulast%3DKunitomo%26aufirst%3DJ.%26aulast%3DKimura%26aufirst%3DE.%26aulast%3DHayase%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DUchiyama%26aufirst%3DN.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DMol%26aufirst%3DC.%2BD.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DTextor%26aufirst%3DG.%2BS.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DItoh%26aufirst%3DF.%26atitle%3DDesign%252C%2520synthesis%2520and%2520structure-activity%2520relationships%2520of%25201%252C3%252C4-oxadiazole%2520derivatives%2520as%2520novel%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%25CE%25B2%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D2017%26epage%3D2029%26doi%3D10.1016%2Fj.bmc.2009.01.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajicek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozasa, T.</span></span> <span> </span><span class="NLM_article-title">Regulation and physiological functions of G12/13-mediated signaling pathways</span>. <i>Neurosignals</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1159/000186690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1159%2F000186690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=19212140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhslyit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=55-70&author=N.+Suzukiauthor=N.+Hajicekauthor=T.+Kozasa&title=Regulation+and+physiological+functions+of+G12%2F13-mediated+signaling+pathways&doi=10.1159%2F000186690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation and Physiological Functions of G12/13-Mediated Signaling Pathways</span></div><div class="casAuthors">Suzuki, Nobuchika; Hajicek, Nicole; Kozasa, Tohru</div><div class="citationInfo"><span class="NLM_cas:title">Neurosignals</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-70</span>CODEN:
                <span class="NLM_cas:coden">NEURIQ</span>;
        ISSN:<span class="NLM_cas:issn">1424-862X</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Accumulating data indicate that G12 subfamily (Gα12/13)-mediated signaling pathways play pivotal roles in a variety of physiol. processes, while aberrant regulation of this pathway has been identified in various human diseases.  It has been demonstrated that Gα12/13-mediated signals form networks with other signaling proteins at various levels, from cell surface receptors to transcription factors, to regulate cellular responses.  Gα12/13 have slow rates of nucleotide exchange and GTP hydrolysis, and specifically target RhoGEFs contg. an amino-terminal RGS homol. domain (RH-RhoGEFs), which uniquely function both as a GAP and an effector for Gα12/13.  In this review, we will focus on the mechanisms regulating the Gα12/13 signaling system, particularly the Gα12/13-RH-RhoGEF-Rho pathway, which can regulate a wide variety of cellular functions from migration to transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod4qKQ3wyEQ7Vg90H21EOLACvtfcHk0lj_iN2eYYwO4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhslyit7o%253D&md5=d57e621114e8e4f0ca58d2c89c2ed29d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1159%2F000186690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000186690%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DHajicek%26aufirst%3DN.%26aulast%3DKozasa%26aufirst%3DT.%26atitle%3DRegulation%2520and%2520physiological%2520functions%2520of%2520G12%252F13-mediated%2520signaling%2520pathways%26jtitle%3DNeurosignals%26date%3D2009%26volume%3D17%26spage%3D55%26epage%3D70%26doi%3D10.1159%2F000186690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span> <span> </span><span class="NLM_article-title">A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis</span>. <i>Lab. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">342</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1038/labinvest.2014.145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1038%2Flabinvest.2014.145" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=342-350&author=M.+Liangauthor=J.+Lvauthor=L.+Zouauthor=W.+Yangauthor=Y.+Xiongauthor=X.+Chenauthor=M.+Guanauthor=R.+Heauthor=H.+Zou&title=A+modified+murine+model+of+systemic+sclerosis%3A+bleomycin+given+by+pump+infusion+induced+skin+and+pulmonary+inflammation+and+fibrosis&doi=10.1038%2Flabinvest.2014.145"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.2014.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.2014.145%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DM.%26aulast%3DLv%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DR.%26aulast%3DZou%26aufirst%3DH.%26atitle%3DA%2520modified%2520murine%2520model%2520of%2520systemic%2520sclerosis%253A%2520bleomycin%2520given%2520by%2520pump%2520infusion%2520induced%2520skin%2520and%2520pulmonary%2520inflammation%2520and%2520fibrosis%26jtitle%3DLab.%2520Invest.%26date%3D2015%26volume%3D95%26spage%3D342%26epage%3D350%26doi%3D10.1038%2Flabinvest.2014.145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batteux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavian, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Servettaz, A.</span></span> <span> </span><span class="NLM_article-title">New insights on chemically induced animal models of systemic sclerosis</span>. <i>Curr. Opin. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">518</span>, <span class="refDoi"> DOI: 10.1097/bor.0b013e32834b1606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1097%2Fbor.0b013e32834b1606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=21857225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Ghu7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2011&pages=511-518&author=F.+Batteuxauthor=N.+Kavianauthor=A.+Servettaz&title=New+insights+on+chemically+induced+animal+models+of+systemic+sclerosis&doi=10.1097%2Fbor.0b013e32834b1606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">New insights on chemically induced animal models of systemic sclerosis</span></div><div class="casAuthors">Batteux, Frederic; Kavian, Niloufar; Servettaz, Amelie</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Rheumatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">511-518</span>CODEN:
                <span class="NLM_cas:coden">CORHES</span>;
        ISSN:<span class="NLM_cas:issn">1040-8711</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: To discuss the most recent published studies on chem.-induced animal models of systemic sclerosis (SSc) and to precise the important signalling pathways that lead to the initiation and progression of the disease in these models.  Recent findings: Environmental factors undoubtedly contribute to the initiation and the development of SSc.  Among those factors, bleomycin has been identified as a possible SSc-inducing substance in mice.  The bleomycin model mimics the inflammatory changes obsd. in the early phase of the disease.  This model has been extensively studied and has allowed identification of several key pathways activated in the human disease.  More recently, a new chem.-induced model of scleroderma has been developed in mice using daily intradermal injections of a soln. generating hypochlorous acid (HOCl)-model.  This HOCl-model recapitulates the whole spectrum of the human disease, as fibrosis, inflammation, autoimmunity and vasculopathy can be obsd. in mice and brought new arguments for a major role of reactive oxygen species in the induction of local and systemic fibrosis.  Summary: Chem. induced models truly develop a SSc-like disease and argue for a crucial role of ROS in SSc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXe1ozOLnA5rVg90H21EOLACvtfcHk0lg-v8YeMaShGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Ghu7zE&md5=cd1d6fb1f8e903c2b5688e028d241b5e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1097%2Fbor.0b013e32834b1606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fbor.0b013e32834b1606%26sid%3Dliteratum%253Aachs%26aulast%3DBatteux%26aufirst%3DF.%26aulast%3DKavian%26aufirst%3DN.%26aulast%3DServettaz%26aufirst%3DA.%26atitle%3DNew%2520insights%2520on%2520chemically%2520induced%2520animal%2520models%2520of%2520systemic%2520sclerosis%26jtitle%3DCurr.%2520Opin.%2520Rheumatol.%26date%3D2011%26volume%3D23%26spage%3D511%26epage%3D518%26doi%3D10.1097%2Fbor.0b013e32834b1606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avouac, J.</span></span> <span> </span><span class="NLM_article-title">Mouse model of experimental dermal fibrosis: The bleomycin-induced dermal fibrosis</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1142</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-0404-4_11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1007%2F978-1-4939-0404-4_11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=24706279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns1yqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1142&publication_year=2014&pages=91-98&author=J.+Avouac&title=Mouse+model+of+experimental+dermal+fibrosis%3A+The+bleomycin-induced+dermal+fibrosis&doi=10.1007%2F978-1-4939-0404-4_11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse Model of Experimental Dermal Fibrosis: The Bleomycin-Induced Dermal Fibrosis</span></div><div class="casAuthors">Avouac, Jerome</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1142</span>
        (<span class="NLM_cas:issue">Arthritis Research</span>),
    <span class="NLM_cas:pages">91-98</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Relevant animal models are essential tools to investigate in depth the pathogenesis of autoimmune disease.  Systemic sclerosis (SSc) is an autoimmune connective tissue disorder that affects particularly the skin.  SSc is characterized by vasculopathy, immune disturbances, and fibrosis.  Expression of each of the three pathol. features varies among SSc patients leading to disease heterogeneity and variable organ manifestations.  Several animal models of SSc are available; however, some models display inflammation followed by fibrosis, whether some others primarily mimic autonomous fibroblast activation.  Here, we describe the mouse model of bleomycin-induced dermal fibrosis, which mimics early and inflammatory stages of SSc, and is widely used in SSc research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkovRIOPHT1LVg90H21EOLACvtfcHk0lg-v8YeMaShGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns1yqt7w%253D&md5=b65f2e9afd44a63eeca75be498d6ac3d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-0404-4_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-0404-4_11%26sid%3Dliteratum%253Aachs%26aulast%3DAvouac%26aufirst%3DJ.%26atitle%3DMouse%2520model%2520of%2520experimental%2520dermal%2520fibrosis%253A%2520The%2520bleomycin-induced%2520dermal%2520fibrosis%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2014%26volume%3D1142%26spage%3D91%26epage%3D98%26doi%3D10.1007%2F978-1-4939-0404-4_11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khare, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghuwanshi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, R.</span></span> <span> </span><span class="NLM_article-title">Hydroxyproline: A potential biochemical marker and its role in the pathogenesis of different diseases</span>. <i>Curr. Protein Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">602</span>, <span class="refDoi"> DOI: 10.2174/1389203717666151201192247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.2174%2F1389203717666151201192247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=26916157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Grt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=596-602&author=A.+K.+Srivastavaauthor=P.+Khareauthor=H.+K.+Nagarauthor=N.+Raghuwanshiauthor=R.+Srivastava&title=Hydroxyproline%3A+A+potential+biochemical+marker+and+its+role+in+the+pathogenesis+of+different+diseases&doi=10.2174%2F1389203717666151201192247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxyproline: A Potential Biochemical Marker and Its Role in the Pathogenesis of Different Diseases</span></div><div class="casAuthors">Srivastava, Amit Kumar; Khare, Piush; Nagar, Hemant Kumar; Raghuwanshi, Navdeep; Srivastava, Rajnish</div><div class="citationInfo"><span class="NLM_cas:title">Current Protein and Peptide Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">596-602</span>CODEN:
                <span class="NLM_cas:coden">CPPSCM</span>;
        ISSN:<span class="NLM_cas:issn">1389-2037</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Hydroxyproline is a non-essential amino acid found in collagen and few other extracellular animal proteins.  It's two isomeric forms trans-4-hydroxy-L-proline and trans-3-hydroxy-L-proline play a crucial role in collagen synthesis and thermodn. stability of the triple-helical conformation of collagen and assocd. tissues.  Various abnormalities in hydroxyproline metab. have been shown to play key roles in the pathophysiol. and pathogenesis of different diseases.  The elevated level of hydroxyproline is obsd. in several disorders, e.g., graft vs. host disease, keloids, and vitiligo while its decreased level is a marker of poor wound-healing.  This review explores the potential of using hydroxyproline as a biochem. marker to understand the pathogenesis, mol. pathophysiol. and treatment of these diseases.  The review concludes with an outlook on the scope and challenges in the clin. implementation of hydroxyproline as a biomarker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC1dbwZRxvsrVg90H21EOLACvtfcHk0ljayWKh2JR_Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Grt7%252FK&md5=ebb92a208f9d6b2992949942ed6a138f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.2174%2F1389203717666151201192247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389203717666151201192247%26sid%3Dliteratum%253Aachs%26aulast%3DSrivastava%26aufirst%3DA.%2BK.%26aulast%3DKhare%26aufirst%3DP.%26aulast%3DNagar%26aufirst%3DH.%2BK.%26aulast%3DRaghuwanshi%26aufirst%3DN.%26aulast%3DSrivastava%26aufirst%3DR.%26atitle%3DHydroxyproline%253A%2520A%2520potential%2520biochemical%2520marker%2520and%2520its%2520role%2520in%2520the%2520pathogenesis%2520of%2520different%2520diseases%26jtitle%3DCurr.%2520Protein%2520Pept.%2520Sci.%26date%3D2016%26volume%3D17%26spage%3D596%26epage%3D602%26doi%3D10.2174%2F1389203717666151201192247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palumbo-Zerr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramming, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelse, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distler, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schett, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distler, J. H. W.</span></span> <span> </span><span class="NLM_article-title">Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis</span>. <i>Ann. Rheum. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1136/annrheumdis-2014-207109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1136%2Fannrheumdis-2014-207109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=25858641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivV2ru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2016&pages=883-890&author=J.+Huangauthor=C.+Beyerauthor=K.+Palumbo-Zerrauthor=Y.+Zhangauthor=A.+Rammingauthor=A.+Distlerauthor=K.+Gelseauthor=O.+Distlerauthor=G.+Schettauthor=L.+Wollinauthor=J.+H.+W.+Distler&title=Nintedanib+inhibits+fibroblast+activation+and+ameliorates+fibrosis+in+preclinical+models+of+systemic+sclerosis&doi=10.1136%2Fannrheumdis-2014-207109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis</span></div><div class="casAuthors">Huang, Jingang; Beyer, Christian; Palumbo-Zerr, Katrin; Zhang, Yun; Ramming, Andreas; Distler, Alfiya; Gelse, Kolja; Distler, Oliver; Schett, Georg; Wollin, Lutz; Distler, Joerg H. W.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">883-890</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Background Nintedanib is a tyrosine kinase inhibitor that has recently been shown to slow disease progression in idiopathic pulmonary fibrosis in two replicate phase III clin. trials.  The aim of this study was to analyze the antifibrotic effects of nintedanib in preclin. models of systemic sclerosis (SSc) and to provide a scientific background for clin. trials in SSc.  Methods The effects of nintedanib on migration, proliferation, myofibroblast differentiation and release of extracellular matrix of dermal fibroblasts were analyzed by microtitre tetrazolium and scratch assays, stress fiber staining, qPCR and SirCol assays.  The antifibrotic effects of nintedanib were evaluated in bleomycin-induced skin fibrosis, in a murine sclerodermatous chronic graft-vs.-host disease model and in tight-skin-1 mice.  Results Nintedanib dose-dependently reduced platelet derived growth factor-induced and transforming growth factor-β-induced proliferation and migration as well as myofibroblast differentiation and collagen release of dermal fibroblasts from patients with and healthy individuals.  Nintedanib also inhibited the endogenous activation of SSc fibroblasts.  Nintedanib prevented bleomycin-induced skin fibrosis in a dose-dependent manner and was also effective in the treatment of established fibrosis.  Moreover, treatment with nintedanib ameliorated fibrosis in the chronic graft-vs.-host disease model and in tight-skin-1 mice in well-tolerated doses.  Conclusions We demonstrate that nintedanib effectively inhibits the endogenous as well as cytokine induced activation of SSc fibroblasts and exerts potent antifibrotic effects in different complementary mouse models of SSc.  These data have direct translational implications for clin. trials with nintedanib in SSc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDEbmgLqW_5LVg90H21EOLACvtfcHk0lhYQrRsAL9DBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivV2ru7o%253D&md5=d8b6a3c431064917cb72c4f839aa55f4</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2014-207109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2014-207109%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DBeyer%26aufirst%3DC.%26aulast%3DPalumbo-Zerr%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DRamming%26aufirst%3DA.%26aulast%3DDistler%26aufirst%3DA.%26aulast%3DGelse%26aufirst%3DK.%26aulast%3DDistler%26aufirst%3DO.%26aulast%3DSchett%26aufirst%3DG.%26aulast%3DWollin%26aufirst%3DL.%26aulast%3DDistler%26aufirst%3DJ.%2BH.%2BW.%26atitle%3DNintedanib%2520inhibits%2520fibroblast%2520activation%2520and%2520ameliorates%2520fibrosis%2520in%2520preclinical%2520models%2520of%2520systemic%2520sclerosis%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2016%26volume%3D75%26spage%3D883%26epage%3D890%26doi%3D10.1136%2Fannrheumdis-2014-207109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium</span>. <i>BMC Pulm. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">63</span>, <span class="refDoi"> DOI: 10.1186/s12890-017-0405-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1186%2Fs12890-017-0405-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=28420366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsl2qu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=63&author=Y.+Liuauthor=F.+Luauthor=L.+Kangauthor=Z.+Wangauthor=Y.+Wang&title=Pirfenidone+attenuates+bleomycin-induced+pulmonary+fibrosis+in+mice+by+regulating+Nrf2%2FBach1+equilibrium&doi=10.1186%2Fs12890-017-0405-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium</span></div><div class="casAuthors">Liu, Yuan; Lu, Fuai; Kang, Lirong; Wang, Zhihua; Wang, Yongfu</div><div class="citationInfo"><span class="NLM_cas:title">BMC Pulmonary Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63/1-63/11</span>CODEN:
                <span class="NLM_cas:coden">BPMMBB</span>;
        ISSN:<span class="NLM_cas:issn">1471-2466</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Oxidative stress is one of the important factors involved in the pathogenesis of idiopathic pulmonary fibrosis (IPF).  The equil. of Nuclear factor-erythroid-related factor 2 (Nrf2)/[BTB (broad-complex, tramtrack and bric-a-brac) and CNC (cap'n'collar protein) homol. 1, Bach1] dets. the expression level of antioxidant factors, further regulating the function of oxidn./antioxidn. capacity.  Pirfenidone (PFD) is one of two currently for IPF therapy approved drugs.  PFD regulates intracellular antioxidants, inhibits secretion of inflammatory cytokines and collagen synthesis.  However the mechanisms of its antioxidant effects remain elusive.  Methods: Effects of PFD treatment were studied in mouse lung fibroblasts (MLF) following induction by transforminggrowth factor beta 1 (TGF-β1) and in mice following bleomycin-induced lung fibrosis.  The mRNA and protein levels of oxidative stress-related factors Nrf2/Bach1 and their downstream antioxidant factors heme oxygenase-1 (Ho-1) and glutathione peroxidase 1 (Gpx1) were detd. by RT-PCR and Western blot.  Fibrosis-related cytokines interleukin-6 (IL-6) and myofibroblast markers type 1 collagen a1 (COL1A1) levels in supernate of MLF, serum, and bronchoalveolar lavage fluid (BALF) as well as malondialdehyde (MDA) in serum and BALF were detected by ELISA, reactive oxygen species (ROS) generation was measured by 2',7'- dichlorofluorescin diacetate (DCFH-DA) assay and lung pathol./morphol. alterations in mice were obsd. by HE and Masson to assess the antioxidant mechanism and therapeutic effects on pulmonary fibrosis induced by bleomycin.  Results: PFD inhibited Bach1 mRNA and protein expressions in mouse lung fibroblasts induced by TGF-β1 and lung tissues with pulmonary fibrosis induced by bleomycin.  Furthermore, it improved Nrf2, Ho-1 and Gpx1 mRNA and protein expressions.  After PFD treatment, COL1A1and IL-6 levels in supernate of MLF, serum, and BALF as well as ROS in lung tissues and MDA in serum and BALF from a mouse with pulmonary fibrosis were significantly decreased, and the infiltration of lung inflammatory cells and fibrosis degree were alleviated.  Conclusions: Theraputic effects of PFD for IPF were involved in Nrf2/Bach1 equil. which regulated the capacity of oxidative stress.  The study provided new insights into the antioxidant mechanism of PFD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4lesxVU9HjLVg90H21EOLACvtfcHk0lj9HYdBsEllnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsl2qu7g%253D&md5=23fb783bf5bdde2afe2ebeb7c196d447</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1186%2Fs12890-017-0405-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12890-017-0405-7%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DF.%26aulast%3DKang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DPirfenidone%2520attenuates%2520bleomycin-induced%2520pulmonary%2520fibrosis%2520in%2520mice%2520by%2520regulating%2520Nrf2%252FBach1%2520equilibrium%26jtitle%3DBMC%2520Pulm.%2520Med.%26date%3D2017%26volume%3D17%26spage%3D63%26doi%3D10.1186%2Fs12890-017-0405-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Hashim F. Motiwala, Yu-Hsuan Kuo, Brittany L. Stinger, Bruce A. Palfey, <span class="NLM_string-name hlFld-ContribAuthor">Brent R. Martin</span>. </span><span class="cited-content_cbyCitation_article-title">Tunable Heteroaromatic Sulfones Enhance in-Cell Cysteine Profiling. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (4)
                                     , 1801-1810. <a href="https://doi.org/10.1021/jacs.9b08831" title="DOI URL">https://doi.org/10.1021/jacs.9b08831</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b08831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b08831%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DTunable%252BHeteroaromatic%252BSulfones%252BEnhance%252Bin-Cell%252BCysteine%252BProfiling%26aulast%3DMotiwala%26aufirst%3DHashim%2BF.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D22082019%26date%3D13012020%26date%3D27122019%26volume%3D142%26issue%3D4%26spage%3D1801%26epage%3D1810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marya D.  Semenova</span>, <span class="hlFld-ContribAuthor ">Sergey A.  Popov</span>, <span class="hlFld-ContribAuthor ">Tatiana S.  Golubeva</span>, <span class="hlFld-ContribAuthor ">Dmitry S.  Baev</span>, <span class="hlFld-ContribAuthor ">Elvira E.  Shults</span>, <span class="hlFld-ContribAuthor ">Māris  Turks</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Cytotoxicity of Sulfanyl, Sulfinyl and Sulfonyl Group Containing Ursane Conjugates with 1,3,4‐Oxadiazoles and 1,2,4‐Triazoles. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (25)
                                     , 6472-6477. <a href="https://doi.org/10.1002/slct.202101594" title="DOI URL">https://doi.org/10.1002/slct.202101594</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202101594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202101594%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Band%252BCytotoxicity%252Bof%252BSulfanyl%25252C%252BSulfinyl%252Band%252BSulfonyl%252BGroup%252BContaining%252BUrsane%252BConjugates%252Bwith%252B1%25252C3%25252C4%2525E2%252580%252590Oxadiazoles%252Band%252B1%25252C2%25252C4%2525E2%252580%252590Triazoles%26aulast%3DSemenova%26aufirst%3DMarya%2BD.%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D25%26spage%3D6472%26epage%3D6477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eloisa  Romano</span>, <span class="hlFld-ContribAuthor ">Irene  Rosa</span>, <span class="hlFld-ContribAuthor ">Bianca Saveria  Fioretto</span>, <span class="hlFld-ContribAuthor ">Marco  Matucci-Cerinic</span>, <span class="hlFld-ContribAuthor ">Mirko  Manetti</span>. </span><span class="cited-content_cbyCitation_article-title">New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy. </span><span class="cited-content_cbyCitation_journal-name">Life</span><span> <strong>2021,</strong> <em>11 </em>
                                    (7)
                                     , 610. <a href="https://doi.org/10.3390/life11070610" title="DOI URL">https://doi.org/10.3390/life11070610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/life11070610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Flife11070610%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%26atitle%3DNew%252BInsights%252Binto%252BProfibrotic%252BMyofibroblast%252BFormation%252Bin%252BSystemic%252BSclerosis%25253A%252BWhen%252Bthe%252BVascular%252BWall%252BBecomes%252Bthe%252BEnemy%26aulast%3DRomano%26aufirst%3DEloisa%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D7%26spage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alain  Lescoat</span>, <span class="hlFld-ContribAuthor ">John  Varga</span>, <span class="hlFld-ContribAuthor ">Marco  Matucci-Cerinic</span>, <span class="hlFld-ContribAuthor ">Dinesh  Khanna</span>. </span><span class="cited-content_cbyCitation_article-title">New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2021,</strong> <em>30 </em>
                                    (6)
                                     , 635-652. <a href="https://doi.org/10.1080/13543784.2021.1923693" title="DOI URL">https://doi.org/10.1080/13543784.2021.1923693</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2021.1923693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2021.1923693%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DNew%252Bpromising%252Bdrugs%252Bfor%252Bthe%252Btreatment%252Bof%252Bsystemic%252Bsclerosis%25253A%252Bpathogenic%252Bconsiderations%25252C%252Benhanced%252Bclassifications%25252C%252Band%252Bpersonalized%252Bmedicine%26aulast%3DLescoat%26aufirst%3DAlain%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D6%26spage%3D635%26epage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Zena  Miranda</span>, <span class="hlFld-ContribAuthor ">Zsuzsanna  Lichner</span>, <span class="hlFld-ContribAuthor ">Katalin  Szászi</span>, <span class="hlFld-ContribAuthor ">András  Kapus</span>. </span><span class="cited-content_cbyCitation_article-title">MRTF: Basic Biology and Role in Kidney Disease. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (11)
                                     , 6040. <a href="https://doi.org/10.3390/ijms22116040" title="DOI URL">https://doi.org/10.3390/ijms22116040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22116040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22116040%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DMRTF%25253A%252BBasic%252BBiology%252Band%252BRole%252Bin%252BKidney%252BDisease%26aulast%3DMiranda%26aufirst%3DMaria%2BZena%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D11%26spage%3D6040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcel G.  Clerc</span>, <span class="hlFld-ContribAuthor ">Gregorio  González-Cortés</span>, <span class="hlFld-ContribAuthor ">Paulina I.  Hidalgo</span>, <span class="hlFld-ContribAuthor ">Lucciano A.  Letelier</span>, <span class="hlFld-ContribAuthor ">Mauricio J.  Morel</span>, <span class="hlFld-ContribAuthor ">Jorge  Vergara</span>. </span><span class="cited-content_cbyCitation_article-title">Light-Induced Ring Pattern in a Dye-Doped Nematic Liquid Crystal. </span><span class="cited-content_cbyCitation_journal-name">Applied Sciences</span><span> <strong>2021,</strong> <em>11 </em>
                                    (11)
                                     , 5285. <a href="https://doi.org/10.3390/app11115285" title="DOI URL">https://doi.org/10.3390/app11115285</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/app11115285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fapp11115285%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Sciences%26atitle%3DLight-Induced%252BRing%252BPattern%252Bin%252Ba%252BDye-Doped%252BNematic%252BLiquid%252BCrystal%26aulast%3DClerc%26aufirst%3DMarcel%2BG.%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D11%26spage%3D5285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenjuan  Zhou</span>, <span class="hlFld-ContribAuthor ">Chenhao  Xu</span>, <span class="hlFld-ContribAuthor ">Guanjun  Dong</span>, <span class="hlFld-ContribAuthor ">Hui  Qiao</span>, <span class="hlFld-ContribAuthor ">Jing  Yang</span>, <span class="hlFld-ContribAuthor ">Hongmin  Liu</span>, <span class="hlFld-ContribAuthor ">Lina  Ding</span>, <span class="hlFld-ContribAuthor ">Kai  Sun</span>, <span class="hlFld-ContribAuthor ">Wen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Development of phenyltriazole thiol-based derivatives as highly potent inhibitors of DCN1-UBC12 interaction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>217 </em>, 113326. <a href="https://doi.org/10.1016/j.ejmech.2021.113326" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113326</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113326%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bphenyltriazole%252Bthiol-based%252Bderivatives%252Bas%252Bhighly%252Bpotent%252Binhibitors%252Bof%252BDCN1-UBC12%252Binteraction%26aulast%3DZhou%26aufirst%3DWenjuan%26date%3D2021%26volume%3D217%26spage%3D113326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuai  Yang</span>, <span class="hlFld-ContribAuthor ">Qiuqin  Lai</span>, <span class="hlFld-ContribAuthor ">Fengwen  Lai</span>, <span class="hlFld-ContribAuthor ">Xunyuan  Jiang</span>, <span class="hlFld-ContribAuthor ">Chen  Zhao</span>, <span class="hlFld-ContribAuthor ">Hanhong  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and insecticidal activities of novel
              5‐substituted
              4,
              5‐dihydropyrazolo
              [1,5‐
              a
              ]quinazoline derivatives. </span><span class="cited-content_cbyCitation_journal-name">Pest Management Science</span><span> <strong>2021,</strong> <em>77 </em>
                                    (2)
                                     , 1013-1022. <a href="https://doi.org/10.1002/ps.6113" title="DOI URL">https://doi.org/10.1002/ps.6113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ps.6113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fps.6113%26sid%3Dliteratum%253Aachs%26jtitle%3DPest%2520Management%2520Science%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Binsecticidal%252Bactivities%252Bof%252Bnovel%252B5%2525E2%252580%252590substituted%252B4%25252C%252B5%2525E2%252580%252590dihydropyrazolo%252B%25255B1%25252C5%2525E2%252580%252590%252Ba%252B%25255Dquinazoline%252Bderivatives%26aulast%3DYang%26aufirst%3DShuai%26date%3D2021%26date%3D2020%26volume%3D77%26issue%3D2%26spage%3D1013%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yitao  Li</span>, <span class="hlFld-ContribAuthor ">Wenqiang  Yao</span>, <span class="hlFld-ContribAuthor ">Jian  Lin</span>, <span class="hlFld-ContribAuthor ">Guoliang  Gao</span>, <span class="hlFld-ContribAuthor ">Chang  Huang</span>, <span class="hlFld-ContribAuthor ">Yang  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of phenyloxadiazole derivatives as potential antifungal agents against phytopathogenic fungi. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2021,</strong> <em>152 </em>
                                    (1)
                                     , 121-135. <a href="https://doi.org/10.1007/s00706-020-02717-z" title="DOI URL">https://doi.org/10.1007/s00706-020-02717-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-020-02717-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-020-02717-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bphenyloxadiazole%252Bderivatives%252Bas%252Bpotential%252Bantifungal%252Bagents%252Bagainst%252Bphytopathogenic%252Bfungi%26aulast%3DLi%26aufirst%3DYitao%26date%3D2021%26date%3D2021%26volume%3D152%26issue%3D1%26spage%3D121%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elahe  Yarmohammadi</span>, <span class="hlFld-ContribAuthor ">Hamid  Beyzaei</span>, <span class="hlFld-ContribAuthor ">Reza  Aryan</span>, <span class="hlFld-ContribAuthor ">Ashraf  Moradi</span>. </span><span class="cited-content_cbyCitation_article-title">Ultrasound-assisted, low-solvent and acid/base-free synthesis of 5-substituted 1,3,4-oxadiazole-2-thiols as potent antimicrobial and antioxidant agents. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2020,</strong> <em>69 </em><a href="https://doi.org/10.1007/s11030-020-10125-y" title="DOI URL">https://doi.org/10.1007/s11030-020-10125-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-020-10125-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-020-10125-y%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DUltrasound-assisted%25252C%252Blow-solvent%252Band%252Bacid%25252Fbase-free%252Bsynthesis%252Bof%252B5-substituted%252B1%25252C3%25252C4-oxadiazole-2-thiols%252Bas%252Bpotent%252Bantimicrobial%252Band%252Bantioxidant%252Bagents%26aulast%3DYarmohammadi%26aufirst%3DElahe%26date%3D2020%26date%3D2020%26volume%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna M.  Schoepf</span>, <span class="hlFld-ContribAuthor ">Stefan  Salcher</span>, <span class="hlFld-ContribAuthor ">Petra  Obexer</span>, <span class="hlFld-ContribAuthor ">Ronald  Gust</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and development of non-cytotoxic cell death modulators: Impact of sartans and derivatives on PPARγ activation and on growth of imatinib-resistant chronic myelogenous leukemia cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>195 </em>, 112258. <a href="https://doi.org/10.1016/j.ejmech.2020.112258" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112258%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Band%252Bdevelopment%252Bof%252Bnon-cytotoxic%252Bcell%252Bdeath%252Bmodulators%25253A%252BImpact%252Bof%252Bsartans%252Band%252Bderivatives%252Bon%252BPPAR%2525CE%2525B3%252Bactivation%252Band%252Bon%252Bgrowth%252Bof%252Bimatinib-resistant%252Bchronic%252Bmyelogenous%252Bleukemia%252Bcells%26aulast%3DSchoepf%26aufirst%3DAnna%2BM.%26date%3D2020%26volume%3D195%26spage%3D112258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serena  Diazzi</span>, <span class="hlFld-ContribAuthor ">Sophie  Tartare-Deckert</span>, <span class="hlFld-ContribAuthor ">Marcel  Deckert</span>. </span><span class="cited-content_cbyCitation_article-title">Bad Neighborhood: Fibrotic Stroma as a New Player in Melanoma Resistance to Targeted Therapies. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (6)
                                     , 1364. <a href="https://doi.org/10.3390/cancers12061364" title="DOI URL">https://doi.org/10.3390/cancers12061364</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12061364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12061364%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DBad%252BNeighborhood%25253A%252BFibrotic%252BStroma%252Bas%252Ba%252BNew%252BPlayer%252Bin%252BMelanoma%252BResistance%252Bto%252BTargeted%252BTherapies%26aulast%3DDiazzi%26aufirst%3DSerena%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D6%26spage%3D1364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew J.  Haak</span>, <span class="hlFld-ContribAuthor ">Merrick T.  Ducharme</span>, <span class="hlFld-ContribAuthor ">Ana M.  Diaz Espinosa</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Tschumperlin</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting GPCR Signaling for Idiopathic Pulmonary Fibrosis Therapies. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2020,</strong> <em>41 </em>
                                    (3)
                                     , 172-182. <a href="https://doi.org/10.1016/j.tips.2019.12.008" title="DOI URL">https://doi.org/10.1016/j.tips.2019.12.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2019.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2019.12.008%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DTargeting%252BGPCR%252BSignaling%252Bfor%252BIdiopathic%252BPulmonary%252BFibrosis%252BTherapies%26aulast%3DHaak%26aufirst%3DAndrew%2BJ.%26date%3D2020%26volume%3D41%26issue%3D3%26spage%3D172%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alain  Lescoat</span>, <span class="hlFld-ContribAuthor ">Alice  Ballerie</span>, <span class="hlFld-ContribAuthor ">Marie  Lelong</span>, <span class="hlFld-ContribAuthor ">Yu  Augagneur</span>, <span class="hlFld-ContribAuthor ">Claudie  Morzadec</span>, <span class="hlFld-ContribAuthor ">Stéphane  Jouneau</span>, <span class="hlFld-ContribAuthor ">Patrick  Jégo</span>, <span class="hlFld-ContribAuthor ">Olivier  Fardel</span>, <span class="hlFld-ContribAuthor ">Laurent  Vernhet</span>, <span class="hlFld-ContribAuthor ">Valérie  Lecureur</span>. </span><span class="cited-content_cbyCitation_article-title">Crystalline Silica Impairs Efferocytosis Abilities of Human and Mouse Macrophages: Implication for Silica-Associated Systemic Sclerosis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fimmu.2020.00219" title="DOI URL">https://doi.org/10.3389/fimmu.2020.00219</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2020.00219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2020.00219%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DCrystalline%252BSilica%252BImpairs%252BEfferocytosis%252BAbilities%252Bof%252BHuman%252Band%252BMouse%252BMacrophages%25253A%252BImplication%252Bfor%252BSilica-Associated%252BSystemic%252BSclerosis%26aulast%3DLescoat%26aufirst%3DAlain%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ebtesam A.  Basiony</span>, <span class="hlFld-ContribAuthor ">Allam A.  Hassan</span>, <span class="hlFld-ContribAuthor ">Zahra M.  Al-Amshany</span>, <span class="hlFld-ContribAuthor ">Ahmed A.  Abd-Rabou</span>, <span class="hlFld-ContribAuthor ">Adel A.-H.  Abdel-Rahman</span>, <span class="hlFld-ContribAuthor ">Nasser A.  Hassan</span>, <span class="hlFld-ContribAuthor ">Wael A.  El-Sayed</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Cytotoxic Activity of New Thiazolopyrimidine Sugar Hydrazones and Their Derived Acyclic Nucleoside Analogues. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (2)
                                     , 399. <a href="https://doi.org/10.3390/molecules25020399" title="DOI URL">https://doi.org/10.3390/molecules25020399</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25020399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25020399%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BCytotoxic%252BActivity%252Bof%252BNew%252BThiazolopyrimidine%252BSugar%252BHydrazones%252Band%252BTheir%252BDerived%252BAcyclic%252BNucleoside%252BAnalogues%26aulast%3DBasiony%26aufirst%3DEbtesam%2BA.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D2%26spage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. The fibroblast-to-myofibroblast transition is tightly regulated by Rho/MRTF/SRF signaling. Both soluble and mechanical stimuli promote MRTF nuclear translocation in fibroblasts. In the resting state, actin is not polymerized, and MRTF is bound to G-actin and sequestered into the cytoplasm. When stress fibers form in response to these stimuli, G-actin polymerizes into F-actin and MRTF is released. This allows MRTF to translocate into the nucleus via binding to importins followed by MRTF/importin/nuclear pore complex (NPC) formation. The MRTF/SRF coactivator complex increases ECM and pro-fibrotic gene expression, contributing to the fibroblast-to-myofibroblast transition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Original hit (CCG-1423) from serum response element luciferase (SRE.L) high throughput screen (HTS) and series development to CCG-257081. New chemotype hit 1 from expanded SRE.L HTS of Rho/MRTF/SRF-pathway.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of 5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>SO<sub>4</sub>/MeOH, 85 °C 6 h. (b) H<sub>4</sub>N<sub>2</sub>·H<sub>2</sub>O, 85 °C 14 h. (c) KOH/H<sub>2</sub>O/EtOH, CS<sub>2</sub>, 95 °C 16 h. (d) 1 N HCl workup (e) acetone, K<sub>2</sub>CO<sub>3</sub>, Br–(CH<sub>2</sub>)<sub><i>n</i></sub>–CO<sub>2</sub>R′, 25 °C, 5–24 h. (f) DCM, TFA, 25 °C 3 h. (g) 1 M NaOH, THF, 25 °C 16 h. (h) Oxalyl chloride, DMF, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 2 h. (i) MeNH<sub>2</sub> in EtOH, 25 °C, 16 h.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Thioalkanoate-Modified Analogues <b>11</b> and <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>3</sub>PO<sub>4</sub>, CS<sub>2</sub>, H<sub>2</sub>O, 106 °C, 2 h. (b) Propylene oxide, 25 °C, 16 h. (c) DMF, K<sub>2</sub>CO<sub>3</sub>, Br–(CH<sub>2</sub>)<sub>3</sub>–CO<sub>2</sub><i>t</i>Bu, 90 °C, 1 h. (d) DCM, TFA, 25 °C, 1 h. (e) POCl<sub>3</sub>, bromoacetic acid, 106 °C, 16 h. (f) 2-Mercaptoacetic acid, acetone, K<sub>2</sub>CO<sub>3</sub>, 25 °C, 2 h.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route To Generate Thiobutanoate Analogues <b>19a–i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) LDA (2 equiv), THF, 0 °C, 10 min, then ethyl iodide, 0 °C, 1 h. (b) MeOH, H<sub>2</sub>SO<sub>4</sub>, 85 °C, 16 h. (c) iPrMgCl, THF, −20 °C for 1.5 h, then acetone, 25 °C for 1.5 h. (d) DAST, DCM, −78 to 25 °C 2 h. (e) MeOH, H<sub>2</sub>SO<sub>4</sub>, 85 °C, 16 h. (f) Pd(II)OAc<sub>2</sub>Cl<sub>2</sub>, K<sub>3</sub>PO<sub>4</sub>, P(Cy)<sub>3</sub>, cyclopropyl boronic acid, toluene, H<sub>2</sub>O, 100 °C, 3 h. (g) Bromocyclopropane, Cs<sub>2</sub>CO<sub>3</sub>, DMA, 155 °C, 24 h then MeOH, H<sub>2</sub>SO<sub>4</sub>, 85 °C, 16 h. (h) 3-Bromooxetane, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 105 °C, 8 h. (i) 2-Nitrobenzene-1-sulfonyl chloride, H<sub>2</sub>N<sub>4</sub>·H<sub>2</sub>O, MeCN, 0–25 °C, 16 h. (j) H<sub>4</sub>N<sub>2</sub>·H<sub>2</sub>O, MeOH, 85 °C, 16 h. (k) KOH/H<sub>2</sub>O/EtOH, CS<sub>2</sub>, 95 °C, 16 h, followed by HCl workup (l) 4-bromo-butanoate ester, K<sub>2</sub>CO<sub>3</sub>, acetone, 25 °C, 16 h. (m) 1 M NaOH, THF, 25 °C, 1 h. (n) TFA, DCM, 25 °C, 1 h.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route To Generate Thiobutanoic Acid Sulfone Analogue <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeI, Et<sub>3</sub>N, THF, 25 °C, 2 h, (b) (NH<sub>4</sub>)<sub>6</sub>Mo<sub>7</sub>O<sub>24</sub>, H<sub>2</sub>O<sub>2</sub>, EtOH, 25 °C, 2 h, (c) mCPBA, DCM, 25 °C, 2 h, (d) 4-mercaptobutanoic acid, K<sub>2</sub>CO<sub>3</sub>, acetone, 25 °C, 1 h, (e) mCPBA, DCM, 25 °C, 2 h.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Preliminary SAR investigating the importance of the heterocycle and carboxylic acid. SRE.L activity (mean of <i>n</i> = 3, SEM < 10%).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hypothetical reaction of <b>8j</b> with a target nucleophile, and close structural analogues designed to be less (<b>11</b>, <b>13</b> and <b>29</b>) or more (<b>21</b>) susceptible to attack by cellular nucleophiles. Indicated below each structure is SRE.L activity (HEK293T cells, mean of <i>n</i> = 3, SEM < 10%).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>8j</b> and <b>19f</b> inhibit LPA-induced CTGF gene expression. Primary dermal fibroblasts from healthy donors were pre-treated with varying concentrations of <b>8j</b> (CCG-58150) and <b>19f</b> (CCG-232964) for (A) 48 h or (B) 72 h and stimulated with 1 μM LPA for 1 h. CTGF mRNA levels were measured by qPCR. Results are expressed as the mean ± SEM. *<i>p</i> < 0.05, **<i>p</i> < 0.01 vs DMSO control using one-way ANOVA; <i>n</i> > 3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/medium/jm-2018-01772n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. 5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic acids prevent bleomycin-induced dermal fibrosis. Mice treated with inhibitors displayed significantly reduced skin thickness and collagen content as compared to vehicle control. (A) Masson’s trichrome stained skin sections from PBS (left panel), bleomycin + vehicle control (middle panel), and bleomycin +10 mg/kg <b>8j</b> (right panel). <i>N</i> = 10 per group. (B) Quantification of (A), by measuring the distance between the subcutaneous fat and the epidermis. *<i>p</i> < 0.05 by using one-way ANOVA. (C) Masson’s trichrome stained skin sections for PBS (left panel), bleomycin + vehicle (middle left panel), bleomycin + 3 mg/kg <b>19f</b> (middle right panel), or bleomycin + 10 mg/kg <b>19f</b> (right panel). <i>N</i> = 7 per group. (D) Quantification of (C). ****<i>p</i> < 0.0001, using one-way ANOVA. (E) Quantification of collagen content by hydroxyproline measurement. ****<i>p</i> < 0.0001, using one-way ANOVA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01772/20190502/images/large/jm-2018-01772n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01772&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i142">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 47 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varga, J.</span></span> <span> </span><span class="NLM_article-title">Systemic Sclerosis (Scleroderma) and Related Disorders</span>. In  <i>Harrison’s Principles of Internal Medicine, 20e</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jameson, J. L.</span>, <span class="NLM_string-name">Fauci, A. S.</span>, <span class="NLM_string-name">Kasper, D. L.</span>, <span class="NLM_string-name">Hauser, S. L.</span>, <span class="NLM_string-name">Longo, D. L.</span>, <span class="NLM_string-name">Loscalzo, J.</span></span>, Eds.; <span class="NLM_publisher-name">McGraw-Hill Education</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+Vargaauthor=J.+L.+Jameson&author=A.+S.+Fauci&author=D.+L.+Kasper&author=S.+L.+Hauser&author=D.+L.+Longo&author=J.+Loscalzo&title=Harrison%E2%80%99s+Principles+of+Internal+Medicine%2C+20e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVarga%26aufirst%3DJ.%26atitle%3DSystemic%2520Sclerosis%2520%2528Scleroderma%2529%2520and%2520Related%2520Disorders%26btitle%3DHarrison%25E2%2580%2599s%2520Principles%2520of%2520Internal%2520Medicine%252C%252020e%26aulast%3DJameson%26aufirst%3DJ.%2BL.%26pub%3DMcGraw-Hill%2520Education%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Distler, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozzio, A.</span></span> <span> </span><span class="NLM_article-title">Systemic sclerosis and localized scleroderma-current concepts and novel targets for therapy</span>. <i>Semin. Immunopathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1007/s00281-015-0551-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1007%2Fs00281-015-0551-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=26577237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyhsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2016&pages=87-95&author=O.+Distlerauthor=A.+Cozzio&title=Systemic+sclerosis+and+localized+scleroderma-current+concepts+and+novel+targets+for+therapy&doi=10.1007%2Fs00281-015-0551-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic sclerosis and localized scleroderma-current concepts and novel targets for therapy</span></div><div class="casAuthors">Distler, Oliver; Cozzio, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunopathology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-95</span>CODEN:
                <span class="NLM_cas:coden">SIEMB7</span>;
        ISSN:<span class="NLM_cas:issn">1863-2297</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Systemic sclerosis (SSc) is a chronic autoimmune disease with a high morbidity and mortality.  Skin and organ fibrosis are key manifestations of SSc, for which no generally accepted therapy is available.  Thus, there is a high unmet need for novel anti-fibrotic therapeutic strategies in SSc.  At the same time, important progress has been made in the identification and characterization of potential mol. targets in fibrotic diseases over the recent years.  In this review, we have selected four targeted therapies, which are tested in clin. trials in SSc, for in depths discussion of their preclin. characterization.  Sol. guanylate cyclase (sGC) stimulators such as riociguat might target both vascular remodeling and tissue fibrosis.  Blockade of interleukin-6 might be particularly promising for early inflammatory stages of SSc.  Inhibition of serotonin receptor 2b signaling links platelet activation to tissue fibrosis.  Targeting simultaneously multiple key mols. with the multityrosine kinase-inhibitor nintedanib might be a promising approach in complex fibrotic diseases such as SSc, in which many partially independent pathways are activated.  Herein, we also give a state of the art overview of the current classification, clin. presentation, diagnostic approach, and treatment options of localized scleroderma.  Finally, we discuss whether the novel targeted therapies currently tested in SSc could be used for localized scleroderma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPf4GPB7WcPrVg90H21EOLACvtfcHk0lgxg54iEUBmnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyhsL%252FE&md5=2ffb658a09e6a69a526a10ff6bd168c2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00281-015-0551-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00281-015-0551-z%26sid%3Dliteratum%253Aachs%26aulast%3DDistler%26aufirst%3DO.%26aulast%3DCozzio%26aufirst%3DA.%26atitle%3DSystemic%2520sclerosis%2520and%2520localized%2520scleroderma-current%2520concepts%2520and%2520novel%2520targets%2520for%2520therapy%26jtitle%3DSemin.%2520Immunopathol.%26date%3D2016%26volume%3D38%26spage%3D87%26epage%3D95%26doi%3D10.1007%2Fs00281-015-0551-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allanore, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simms, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distler, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pope, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denton, CP</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varga, J.</span></span> <span> </span><span class="NLM_article-title">Systemic sclerosis</span>. <i>Nat. Rev. Dis. Prim.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">15002</span>, <span class="refDoi"> DOI: 10.1038/nrdp.2015.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1038%2Fnrdp.2015.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=27189141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252Fgs1SqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=15002&author=Y.+Allanoreauthor=R.+Simmsauthor=O.+Distlerauthor=M.+Trojanowskaauthor=J.+Popeauthor=CP+Dentonauthor=J.+Varga&title=Systemic+sclerosis&doi=10.1038%2Fnrdp.2015.2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic sclerosis</span></div><div class="casAuthors">Allanore Yannick; Simms Robert; Trojanowska Maria; Distler Oliver; Pope Janet; Denton Christopher P; Varga John</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Disease primers</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15002</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Systemic sclerosis is a complex autoimmune disease characterized by a chronic and frequently progressive course and by extensive patient-to-patient variability.  Like other autoimmune diseases, systemic sclerosis occurs more frequently in women, with a peak of onset in the fifth decade of life.  The exact cause of systemic sclerosis remains elusive but is likely to involve environmental factors in a genetically primed individual.  Pathogenesis is dominated by vascular changes; evidence of autoimmunity with distinct autoantibodies and activation of both innate and adaptive immunity; and fibrosis of the skin and visceral organs that results in irreversible scarring and organ failure.  Intractable progression of vascular and fibrotic organ damage accounts for the chronic morbidity and high mortality.  Early and accurate diagnosis and classification might improve patient outcomes.  Screening strategies facilitate timely recognition of life-threatening complications and initiation of targeted therapies to halt their progression.  Effective treatments of organ-based complications are now within reach.  Discovery of biomarkers - including autoantibodies that identify patient subsets at high risk for particular disease complications or rapid progression - is a research priority.  Understanding the key pathogenetic pathways, cell types and mediators underlying disease manifestations opens the door for the development of targeted therapies with true disease-modifying potential.  For an illustrated summary of this Primer, visit: http://go.nature.com/lchkcA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcrna7Vp9c5ENoizSOkG_FfW6udTcc2eakR_DY4zsGXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252Fgs1SqsA%253D%253D&md5=7ebb2c370d7a36dfa3c8fe9e4b7a6ad3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrdp.2015.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrdp.2015.2%26sid%3Dliteratum%253Aachs%26aulast%3DAllanore%26aufirst%3DY.%26aulast%3DSimms%26aufirst%3DR.%26aulast%3DDistler%26aufirst%3DO.%26aulast%3DTrojanowska%26aufirst%3DM.%26aulast%3DPope%26aufirst%3DJ.%26aulast%3DDenton%26aufirst%3DCP%26aulast%3DVarga%26aufirst%3DJ.%26atitle%3DSystemic%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Dis.%2520Prim.%26date%3D2015%26volume%3D1%26spage%3D15002%26doi%3D10.1038%2Fnrdp.2015.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Careta, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romiti, R.</span></span> <span> </span><span class="NLM_article-title">Localized scleroderma: clinical spectrum and therapeutic update</span>. <i>An. Bras. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1590/abd1806-4841.20152890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1590%2Fabd1806-4841.20152890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=25672301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A280%3ADC%252BC2MrkvVCktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2015&pages=62-73&author=M.+F.+Caretaauthor=R.+Romiti&title=Localized+scleroderma%3A+clinical+spectrum+and+therapeutic+update&doi=10.1590%2Fabd1806-4841.20152890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Localized scleroderma: clinical spectrum and therapeutic update</span></div><div class="casAuthors">Careta Mariana Figueiroa; Romiti Ricardo</div><div class="citationInfo"><span class="NLM_cas:title">Anais brasileiros de dermatologia</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement.  Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues.  Localized scleroderma is a rare disease of unknown etiology.  Recent studies show that the localized form may affect internal organs and have variable morbidity.  Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.  In this review, we report the most important aspects and particularities in the treatment of patients diagnosed with localized scleroderma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRbXEFktKP1cq91pGlMMoT5fW6udTcc2ea2LnW1WKno_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MrkvVCktQ%253D%253D&md5=79c0809794795760c0d6f2de223fa312</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1590%2Fabd1806-4841.20152890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252Fabd1806-4841.20152890%26sid%3Dliteratum%253Aachs%26aulast%3DCareta%26aufirst%3DM.%2BF.%26aulast%3DRomiti%26aufirst%3DR.%26atitle%3DLocalized%2520scleroderma%253A%2520clinical%2520spectrum%2520and%2520therapeutic%2520update%26jtitle%3DAn.%2520Bras.%2520Dermatol.%26date%3D2015%26volume%3D90%26spage%3D62%26epage%3D73%26doi%3D10.1590%2Fabd1806-4841.20152890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pattanaik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postlethwaitel, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postlethwaite, A. E.</span></span> <span> </span><span class="NLM_article-title">Pathogenesis of systemic sclerosis</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">272</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2015.00272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.3389%2Ffimmu.2015.00272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=26106387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A280%3ADC%252BC2Mbmslaluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=272&author=D.+Pattanaikauthor=M.+Brownauthor=B.+C.+Postlethwaitelauthor=A.+E.+Postlethwaite&title=Pathogenesis+of+systemic+sclerosis&doi=10.3389%2Ffimmu.2015.00272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of Systemic Sclerosis</span></div><div class="casAuthors">Pattanaik Debendra; Postlethwaite Arnold E; Brown Monica; Postlethwaite Bradley C</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">272</span>
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    </div><div class="casAbstract">Systemic scleroderma (SSc) is one of the most complex systemic autoimmune diseases.  It targets the vasculature, connective tissue-producing cells (namely fibroblasts/myofibroblasts), and components of the innate and adaptive immune systems.  Clinical and pathologic manifestations of SSc are the result of: (1) innate/adaptive immune system abnormalities leading to production of autoantibodies and cell-mediated autoimmunity, (2) microvascular endothelial cell/small vessel fibroproliferative vasculopathy, and (3) fibroblast dysfunction generating excessive accumulation of collagen and other matrix components in skin and internal organs.  All three of these processes interact and affect each other.  The disease is heterogeneous in its clinical presentation that likely reflects different genetic or triggering factor (i.e., infection or environmental toxin) influences on the immune system, vasculature, and connective tissue cells.  The roles played by other ubiquitous molecular entities (such as lysophospholipids, endocannabinoids, and their diverse receptors and vitamin D) in influencing the immune system, vasculature, and connective tissue cells are just beginning to be realized and studied and may provide insights into new therapeutic approaches to treat SSc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThQWXPjMQFggxyojvcjibhfW6udTcc2ea2LnW1WKno_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mbmslaluw%253D%253D&md5=4ad63f92276c9aa96a0d3e60e0c76c11</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2015.00272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2015.00272%26sid%3Dliteratum%253Aachs%26aulast%3DPattanaik%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DPostlethwaitel%26aufirst%3DB.%2BC.%26aulast%3DPostlethwaite%26aufirst%3DA.%2BE.%26atitle%3DPathogenesis%2520of%2520systemic%2520sclerosis%26jtitle%3DFront.%2520Immunol.%26date%3D2015%26volume%3D6%26spage%3D272%26doi%3D10.3389%2Ffimmu.2015.00272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fala, L.</span></span> <span> </span><span class="NLM_article-title">Ofev (Nintedanib): First tyrosine kinase inhibitor approved for the treatment of patients with Idiopathic Pulmonary Fibrosis</span>. <i>Am. Health Drug Benefits</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=26629273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A280%3ADC%252BC28rgvVygsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=101&author=L.+Fala&title=Ofev+%28Nintedanib%29%3A+First+tyrosine+kinase+inhibitor+approved+for+the+treatment+of+patients+with+Idiopathic+Pulmonary+Fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Ofev (Nintedanib): First Tyrosine Kinase Inhibitor Approved for the Treatment of Patients with Idiopathic Pulmonary Fibrosis</span></div><div class="casAuthors">Fala Loretta</div><div class="citationInfo"><span class="NLM_cas:title">American health & drug benefits</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">Spec Feature</span>),
    <span class="NLM_cas:pages">101-4</span>
        ISSN:<span class="NLM_cas:issn">1942-2962</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGt-9WtWJAKoNpW7w2tapOfW6udTcc2ea2LnW1WKno_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgvVygsA%253D%253D&md5=f7b482b635809e521de973704c16282a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFala%26aufirst%3DL.%26atitle%3DOfev%2520%2528Nintedanib%2529%253A%2520First%2520tyrosine%2520kinase%2520inhibitor%2520approved%2520for%2520the%2520treatment%2520of%2520patients%2520with%2520Idiopathic%2520Pulmonary%2520Fibrosis%26jtitle%3DAm.%2520Health%2520Drug%2520Benefits%26date%3D2015%26volume%3D8%26spage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nanthakumar, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatley, R. J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauldie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J. F.</span></span> <span> </span><span class="NLM_article-title">Dissecting fibrosis: therapeutic insights from the small-molecule toolbox</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">720</span>, <span class="refDoi"> DOI: 10.1038/nrd4592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1038%2Fnrd4592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=26338155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrt7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=693-720&author=C.+B.+Nanthakumarauthor=R.+J.+D.+Hatleyauthor=S.+Lemmaauthor=J.+Gauldieauthor=R.+P.+Marshallauthor=S.+J.+F.+Macdonald&title=Dissecting+fibrosis%3A+therapeutic+insights+from+the+small-molecule+toolbox&doi=10.1038%2Fnrd4592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting fibrosis: therapeutic insights from the small-molecule toolbox</span></div><div class="casAuthors">Nanthakumar, Carmel B.; Hatley, Richard J. D.; Lemma, Seble; Gauldie, Jack; Marshall, Richard P.; MacDonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">693-720</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Fibrosis, which leads to progressive loss of tissue function and eventual organ failure, has been estd. to contribute to ∼45% of deaths in the developed world, and so new therapeutics to modulate fibrosis are urgently needed.  Major advances in our understanding of the mechanisms underlying pathol. fibrosis are supporting the search for such therapeutics, and the recent approval of two anti-fibrotic drugs for idiopathic pulmonary fibrosis has demonstrated the tractability of this area for drug discovery.  This Review examines the pharmacol. and structural information for small mols. being evaluated for lung, liver, kidney and skin fibrosis.  In particular, we discuss the insights gained from the use of these pharmacol. tools, and how these entities can inform, and probe, emerging insights into disease mechanisms, including the potential for future drug combinations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk6pfSk3gsCrVg90H21EOLACvtfcHk0lg6EySqugVJaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrt7rJ&md5=b05a37db6ede2acc0f5c65826aa344f3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd4592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4592%26sid%3Dliteratum%253Aachs%26aulast%3DNanthakumar%26aufirst%3DC.%2BB.%26aulast%3DHatley%26aufirst%3DR.%2BJ.%2BD.%26aulast%3DLemma%26aufirst%3DS.%26aulast%3DGauldie%26aufirst%3DJ.%26aulast%3DMarshall%26aufirst%3DR.%2BP.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26atitle%3DDissecting%2520fibrosis%253A%2520therapeutic%2520insights%2520from%2520the%2520small-molecule%2520toolbox%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D693%26epage%3D720%26doi%3D10.1038%2Fnrd4592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thannickal, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henke, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horowitz, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sime, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschumperlin, D. J.</span></span> <span> </span><span class="NLM_article-title">Matrix Biology of Idiopathic Pulmonary Fibrosis</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">1643</span>– <span class="NLM_lpage">1651</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2014.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.ajpath.2014.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=24726499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosFalurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2014&pages=1643-1651&author=V.+J.+Thannickalauthor=C.+A.+Henkeauthor=J.+C.+Horowitzauthor=P.+W.+Nobleauthor=J.+Romanauthor=P.+J.+Simeauthor=Y.+Zhouauthor=R.+G.+Wellsauthor=E.+S.+Whiteauthor=D.+J.+Tschumperlin&title=Matrix+Biology+of+Idiopathic+Pulmonary+Fibrosis&doi=10.1016%2Fj.ajpath.2014.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix Biology of Idiopathic Pulmonary Fibrosis</span></div><div class="casAuthors">Thannickal, Victor J.; Henke, Craig A.; Horowitz, Jeffrey C.; Noble, Paul W.; Roman, Jesse; Sime, Patricia J.; Zhou, Yong; Wells, Rebecca G.; White, Eric S.; Tschumperlin, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1643-1651</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A hallmark of idiopathic pulmonary fibrosis (IPF) is excessive and disordered deposition of extracellular matrix.  Although the lung extracellular matrix normally plays an essential role in development and maintenance of lung tissue through reciprocal interactions with resident cells, the disordered matrix in the diseased lung is increasingly recognized as an active and important contributor to IPF pathogenesis.  This working group summary from a recently conducted National Heart, Lung, and Blood Institute strategic planning workshop for IPF research highlights recent advances, challenges, and opportunities in the study of matrix biol. in IPF.  Particular attention is given to the compn. and mech. properties of the matrix in normal and diseased lungs, and the biochem. and biomech. influences exerted by pathol. matrix.  Recently developed model systems are also summarized as key tools for advancing our understanding of matrix biol. in IPF.  Emerging approaches to therapeutically target the matrix in preclin. and clin. settings are discussed, as are important concepts, such as alterations of the matrix with aging and the potential for the resoln. of fibrosis.  Specific recommendations for future studies in matrix biol. of IPF are also proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPiyE0Bm7rkLVg90H21EOLACvtfcHk0ljfXiw7a6q_mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosFalurc%253D&md5=447165289e84837f940dd0e0ae7cf932</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2014.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2014.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DThannickal%26aufirst%3DV.%2BJ.%26aulast%3DHenke%26aufirst%3DC.%2BA.%26aulast%3DHorowitz%26aufirst%3DJ.%2BC.%26aulast%3DNoble%26aufirst%3DP.%2BW.%26aulast%3DRoman%26aufirst%3DJ.%26aulast%3DSime%26aufirst%3DP.%2BJ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWells%26aufirst%3DR.%2BG.%26aulast%3DWhite%26aufirst%3DE.%2BS.%26aulast%3DTschumperlin%26aufirst%3DD.%2BJ.%26atitle%3DMatrix%2520Biology%2520of%2520Idiopathic%2520Pulmonary%2520Fibrosis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2014%26volume%3D184%26spage%3D1643%26epage%3D1651%26doi%3D10.1016%2Fj.ajpath.2014.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thannickal, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prunotto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desmoulière, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Wever, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mareel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabbiani, G.</span></span> <span> </span><span class="NLM_article-title">Recent Developments in Myofibroblast Biology</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">1340</span>– <span class="NLM_lpage">1355</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2012.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.ajpath.2012.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=22387320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFCju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2012&pages=1340-1355&author=B.+Hinzauthor=S.+H.+Phanauthor=V.+J.+Thannickalauthor=M.+Prunottoauthor=A.+Desmouli%C3%A8reauthor=J.+Vargaauthor=O.+De+Weverauthor=M.+Mareelauthor=G.+Gabbiani&title=Recent+Developments+in+Myofibroblast+Biology&doi=10.1016%2Fj.ajpath.2012.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in myofibroblast biology: paradigms for connective tissue remodeling</span></div><div class="casAuthors">Hinz, Boris; Phan, Sem H.; Thannickal, Victor J.; Prunotto, Marco; Desmouliere, Alexis; Varga, John; De Wever, Olivier; Mareel, Marc; Gabbiani, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1340-1355</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The discovery of the myofibroblast has opened new perspectives for the comprehension of the biol. mechanisms involved in wound healing and fibrotic diseases.  In recent years, many advances have been made in understanding important aspects of myofibroblast basic biol. characteristics.  This review summarizes such advances in several fields, such as the following: i) force prodn. by the myofibroblast and mechanisms of connective tissue remodeling; ii) factors controlling the expression of α-smooth muscle actin, the most used marker of myofibroblastic phenotype and, more important, involved in force generation by the myofibroblast; and iii) factors affecting genesis of the myofibroblast and its differentiation from precursor cells, in particular epigenetic factors, such as DNA methylation, microRNAs, and histone modification.  We also review the origin and the specific features of the myofibroblast in diverse fibrotic lesions, such as systemic sclerosis; kidney, liver, and lung fibrosis; and the stromal reaction to certain epithelial tumors.  Finally, we summarize the emerging strategies for influencing myofibroblast behavior in vitro and in vivo, with the ultimate goal of an effective therapeutic approach for myofibroblast-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTXMejvqx9WbVg90H21EOLACvtfcHk0ljfXiw7a6q_mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFCju70%253D&md5=e714aedffec0af2b64537d4fefa3dd96</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2012.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2012.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DHinz%26aufirst%3DB.%26aulast%3DPhan%26aufirst%3DS.%2BH.%26aulast%3DThannickal%26aufirst%3DV.%2BJ.%26aulast%3DPrunotto%26aufirst%3DM.%26aulast%3DDesmouli%25C3%25A8re%26aufirst%3DA.%26aulast%3DVarga%26aufirst%3DJ.%26aulast%3DDe%2BWever%26aufirst%3DO.%26aulast%3DMareel%26aufirst%3DM.%26aulast%3DGabbiani%26aufirst%3DG.%26atitle%3DRecent%2520Developments%2520in%2520Myofibroblast%2520Biology%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2012%26volume%3D180%26spage%3D1340%26epage%3D1355%26doi%3D10.1016%2Fj.ajpath.2012.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiore, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thannickal, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span> <span> </span><span class="NLM_article-title">Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1165/rcmb.2012-0050oc</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1165%2Frcmb.2012-0050oc" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=22461426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCjsrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=340-348&author=X.+Huangauthor=N.+Yangauthor=V.+F.+Fioreauthor=T.+H.+Barkerauthor=Y.+Sunauthor=S.+W.+Morrisauthor=Q.+Dingauthor=V.+J.+Thannickalauthor=Y.+Zhou&title=Matrix+stiffness-induced+myofibroblast+differentiation+is+mediated+by+intrinsic+mechanotransduction&doi=10.1165%2Frcmb.2012-0050oc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction</span></div><div class="casAuthors">Huang, Xiangwei; Yang, Naiheng; Fiore, Vincent F.; Barker, Thomas H.; Sun, Yi; Morris, Stephan W.; Ding, Qiang; Thannickal, Victor J.; Zhou, Yong</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">340-348</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">The mech. properties of the extracellular matrix have recently been shown to promote myofibroblast differentiation and lung fibrosis.  Mechanisms by which matrix stiffness regulates myofibroblast differentiation are not fully understood.  The goal of this study was to det. the intrinsic mechanisms of mechanotransduction in the regulation of matrix stiffness-induced myofibroblast differentiation.  A well established polyacrylamide gel system with tunable substrate stiffness was used in this study.  Megakaryoblastic leukemia factor-1 (MKL1) nuclear translocation was imaged by confocal immunofluorescent microscopy.  The binding of MKL1 to the α-smooth muscle actin (α-SMA) gene promoter was quantified by quant. chromatin immunopptn. assay.  Normal human lung fibroblasts responded to matrix stiffening with changes in actin dynamics that favor filamentous actin polymn.  Actin polymn. resulted in nuclear translocation of MKL1, a serum response factor coactivator that plays a central role in regulating the expression of fibrotic genes, including α-SMA, a marker for myofibroblast differentiation.  Mouse lung fibroblasts deficient in Mkl1 did not respond to matrix stiffening with increased α-SMA expression, whereas ectopic expression of human MKL1 cDNA restored the ability of Mkl1 null lung fibroblasts to express α-SMA.  Furthermore, matrix stiffening promoted prodn. and activation of the small GTPase RhoA, increased Rho kinase (ROCK) activity, and enhanced fibroblast contractility.  Inhibition of RhoA/ROCK abrogated stiff matrix-induced actin cytoskeletal reorganization, MKL1 nuclear translocation, and myofibroblast differentiation.  This study indicates that actin cytoskeletal remodeling-mediated activation of MKL1 transduces mech. stimuli from the extracellular matrix to a fibrogenic program that promotes myofibroblast differentiation, suggesting an intrinsic mechanotransduction mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjRSk-_Wigb7Vg90H21EOLACvtfcHk0lhde7Zq6wEnHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCjsrvP&md5=d040de24d75c0dbd3912d9e6e50a95b2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2012-0050oc&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2012-0050oc%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DFiore%26aufirst%3DV.%2BF.%26aulast%3DBarker%26aufirst%3DT.%2BH.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DThannickal%26aufirst%3DV.%2BJ.%26aulast%3DZhou%26aufirst%3DY.%26atitle%3DMatrix%2520stiffness-induced%2520myofibroblast%2520differentiation%2520is%2520mediated%2520by%2520intrinsic%2520mechanotransduction%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D47%26spage%3D340%26epage%3D348%26doi%3D10.1165%2Frcmb.2012-0050oc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsou, P.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haak, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span> <span> </span><span class="NLM_article-title">Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription</span>. <i>Am. J. Physiol.: Cell Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">C2</span>– <span class="NLM_lpage">C13</span>, <span class="refDoi"> DOI: 10.1152/ajpcell.00060.2014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1152%2Fajpcell.00060.2014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=24740541" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2014&pages=C2-C13&author=P.-S.+Tsouauthor=A.+J.+Haakauthor=D.+Khannaauthor=R.+R.+Neubig&title=Cellular+mechanisms+of+tissue+fibrosis.+8.+Current+and+future+drug+targets+in+fibrosis%3A+focus+on+Rho+GTPase-regulated+gene+transcription&doi=10.1152%2Fajpcell.00060.2014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00060.2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00060.2014%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DP.-S.%26aulast%3DHaak%26aufirst%3DA.%2BJ.%26aulast%3DKhanna%26aufirst%3DD.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26atitle%3DCellular%2520mechanisms%2520of%2520tissue%2520fibrosis.%25208.%2520Current%2520and%2520future%2520drug%2520targets%2520in%2520fibrosis%253A%2520focus%2520on%2520Rho%2520GTPase-regulated%2520gene%2520transcription%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Cell%2520Physiol.%26date%3D2014%26volume%3D307%26spage%3DC2%26epage%3DC13%26doi%3D10.1152%2Fajpcell.00060.2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wipff, P.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rifkin, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, B.</span></span> <span> </span><span class="NLM_article-title">Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>179</i></span>,  <span class="NLM_fpage">1311</span>– <span class="NLM_lpage">1323</span>, <span class="refDoi"> DOI: 10.1083/jcb.200704042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1083%2Fjcb.200704042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2007&pages=1311-1323&author=P.-J.+Wipffauthor=D.+B.+Rifkinauthor=J.-J.+Meisterauthor=B.+Hinz&title=Myofibroblast+contraction+activates+latent+TGF-beta1+from+the+extracellular+matrix&doi=10.1083%2Fjcb.200704042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200704042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200704042%26sid%3Dliteratum%253Aachs%26aulast%3DWipff%26aufirst%3DP.-J.%26aulast%3DRifkin%26aufirst%3DD.%2BB.%26aulast%3DMeister%26aufirst%3DJ.-J.%26aulast%3DHinz%26aufirst%3DB.%26atitle%3DMyofibroblast%2520contraction%2520activates%2520latent%2520TGF-beta1%2520from%2520the%2520extracellular%2520matrix%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2007%26volume%3D179%26spage%3D1311%26epage%3D1323%26doi%3D10.1083%2Fjcb.200704042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wynn, T. A.</span></span> <span> </span><span class="NLM_article-title">Cellular and molecular mechanisms of fibrosis</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>214</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1002/path.2277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1002%2Fpath.2277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=18161745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvFCkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=2008&pages=199-210&author=T.+A.+Wynn&title=Cellular+and+molecular+mechanisms+of+fibrosis&doi=10.1002%2Fpath.2277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular and molecular mechanisms of fibrosis</span></div><div class="casAuthors">Wynn, T. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-210</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Fibrosis is defined by the overgrowth, hardening, and/or scarring of various tissues and is attributed to excess deposition of extracellular matrix components including collagen.  Fibrosis is the end result of chronic inflammatory reactions induced by a variety of stimuli including persistent infections, autoimmune reactions, allergic responses, chem. insults, radiation, and tissue injury.  Although current treatments for fibrotic diseases such as idiopathic pulmonary fibrosis, liver cirrhosis, systemic sclerosis, progressive kidney disease, and cardiovascular fibrosis typically target the inflammatory response, there is accumulating evidence that the mechanisms driving fibrogenesis are distinct from those regulating inflammation.  In fact, some studies have suggested that ongoing inflammation is needed to reverse established and progressive fibrosis.  The key cellular mediator of fibrosis is the myofibroblast, which when activated serves as the primary collagen-producing cell.  Myofibroblasts are generated from a variety of sources including resident mesenchymal cells, epithelial and endothelial cells in processes termed epithelial/endothelial-mesenchymal (EMT/EndMT) transition, as well as from circulating fibroblast-like cells called fibrocytes that are derived from bone-marrow stem cells.  Myofibroblasts are activated by a variety of mechanisms, including paracrine signals derived from lymphocytes and macrophages, autocrine factors secreted by myofibroblasts, and pathogen-assocd. mol. patterns (PAMPS) produced by pathogenic organisms that interact with pattern recognition receptors (i.e. TLRs) on fibroblasts.  Cytokines (IL-13, IL-21, TGF-β1), chemokines (MCP-1, MIP-1β), angiogenic factors (VEGF), growth factors (PDGF), peroxisome proliferator-activated receptors (PPARs), acute phase proteins (SAP), caspases, and components of the renin-angiotensin-aldosterone system (ANG II) have been identified as important regulators of fibrosis and are being investigated as potential targets of antifibrotic drugs.  This review explores our current understanding of the cellular and mol. mechanisms of fibrogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0w_vXtFhJmrVg90H21EOLACvtfcHk0ljeoyaptQabTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvFCkt7w%253D&md5=a6b143a20d478d96bc60b816f23370f1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fpath.2277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.2277%26sid%3Dliteratum%253Aachs%26aulast%3DWynn%26aufirst%3DT.%2BA.%26atitle%3DCellular%2520and%2520molecular%2520mechanisms%2520of%2520fibrosis%26jtitle%3DJ.%2520Pathol.%26date%3D2008%26volume%3D214%26spage%3D199%26epage%3D210%26doi%3D10.1002%2Fpath.2277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandbo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulin, N.</span></span> <span> </span><span class="NLM_article-title">Actin cytoskeleton in myofibroblast differentiation: ultrastructure defining form and driving function</span>. <i>Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1016/j.trsl.2011.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.trsl.2011.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=21925115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2jtrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2011&pages=181-196&author=N.+Sandboauthor=N.+Dulin&title=Actin+cytoskeleton+in+myofibroblast+differentiation%3A+ultrastructure+defining+form+and+driving+function&doi=10.1016%2Fj.trsl.2011.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Actin cytoskeleton in myofibroblast differentiation: Ultrastructure defining form and driving function</span></div><div class="casAuthors">Sandbo, Nathan; Dulin, Nickolai</div><div class="citationInfo"><span class="NLM_cas:title">Translational Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">181-196</span>CODEN:
                <span class="NLM_cas:coden">TRRECL</span>;
        ISSN:<span class="NLM_cas:issn">1931-5244</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Myofibroblasts are modified fibroblasts characterized by the presence of a well-developed contractile app. and the formation of robust actin stress fibers.  These mech. active cells are thought to orchestrate extracellular matrix remodeling during normal wound healing in response to tissue injury; these cells are found also in aberrant tissue remodeling in fibrosing disorders.  This review surveys the understanding of the role of actin stress fibers in myofibroblast biol.  Actin stress fibers are discussed as a defining ultrastructural and morphol. feature and well-accepted observations demonstrating its participation in contraction, focal adhesion maturation, and extracellular matrix reorganization are presented.  Finally, more recent observations are reviewed, demonstrating its role in transducing mech. force into biochem. signals, transcriptional control of genes involved in locomotion, contraction, and matrix reorganization, as well as the localized regulation of mRNA (mRNA) translation.  This breadth of functionality of the actin stress fiber serves to reinforce and amplify its mech. function, via induced expression of proteins that themselves augment contraction, focal adhesion formation, and matrix remodeling.  In composite, the functions of the actin cytoskeleton are most often aligned, allowing for the integration and amplification of signals promoting both myofibroblast differentiation and matrix remodeling during fibrogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRSjy1ABM_37Vg90H21EOLACvtfcHk0ljeoyaptQabTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2jtrrN&md5=6ff2e2661440bb1546b5eba63ea1f252</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.trsl.2011.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trsl.2011.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DSandbo%26aufirst%3DN.%26aulast%3DDulin%26aufirst%3DN.%26atitle%3DActin%2520cytoskeleton%2520in%2520myofibroblast%2520differentiation%253A%2520ultrastructure%2520defining%2520form%2520and%2520driving%2520function%26jtitle%3DTransl.%2520Res.%26date%3D2011%26volume%3D158%26spage%3D181%26epage%3D196%26doi%3D10.1016%2Fj.trsl.2011.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandbo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulin, N. O.</span></span> <span> </span><span class="NLM_article-title">Delayed stress fiber formation mediates pulmonary myofibroblast differentiation in response to TGF-β</span>. <i>Am. J. Physiol.: Lung Cell. Mol. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>301</i></span>,  <span class="NLM_fpage">L656</span>– <span class="NLM_lpage">L666</span>, <span class="refDoi"> DOI: 10.1152/ajplung.00166.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1152%2Fajplung.00166.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=21856814" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2011&pages=L656-L666&author=N.+Sandboauthor=A.+Lauauthor=J.+Kachauthor=C.+Ngamauthor=D.+Yauauthor=N.+O.+Dulin&title=Delayed+stress+fiber+formation+mediates+pulmonary+myofibroblast+differentiation+in+response+to+TGF-%CE%B2&doi=10.1152%2Fajplung.00166.2011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00166.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00166.2011%26sid%3Dliteratum%253Aachs%26aulast%3DSandbo%26aufirst%3DN.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DKach%26aufirst%3DJ.%26aulast%3DNgam%26aufirst%3DC.%26aulast%3DYau%26aufirst%3DD.%26aulast%3DDulin%26aufirst%3DN.%2BO.%26atitle%3DDelayed%2520stress%2520fiber%2520formation%2520mediates%2520pulmonary%2520myofibroblast%2520differentiation%2520in%2520response%2520to%2520TGF-%25CE%25B2%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Lung%2520Cell.%2520Mol.%2520Physiol.%26date%3D2011%26volume%3D301%26spage%3DL656%26epage%3DL666%26doi%3D10.1152%2Fajplung.00166.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandbo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torr, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kregel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulin, N.</span></span> <span> </span><span class="NLM_article-title">Control of myofibroblast differentiation by microtubule dynamics through a regulated localization of mDia2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">15466</span>– <span class="NLM_lpage">15473</span>, <span class="refDoi"> DOI: 10.1074/jbc.m113.464461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1074%2Fjbc.m113.464461" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=15466-15473&author=N.+Sandboauthor=C.+Ngamauthor=E.+Torrauthor=S.+Kregelauthor=J.+Kachauthor=N.+Dulin&title=Control+of+myofibroblast+differentiation+by+microtubule+dynamics+through+a+regulated+localization+of+mDia2&doi=10.1074%2Fjbc.m113.464461"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m113.464461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m113.464461%26sid%3Dliteratum%253Aachs%26aulast%3DSandbo%26aufirst%3DN.%26aulast%3DNgam%26aufirst%3DC.%26aulast%3DTorr%26aufirst%3DE.%26aulast%3DKregel%26aufirst%3DS.%26aulast%3DKach%26aufirst%3DJ.%26aulast%3DDulin%26aufirst%3DN.%26atitle%3DControl%2520of%2520myofibroblast%2520differentiation%2520by%2520microtubule%2520dynamics%2520through%2520a%2520regulated%2520localization%2520of%2520mDia2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D15466%26epage%3D15473%26doi%3D10.1074%2Fjbc.m113.464461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomasek, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaughan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropp, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabbiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haaksma, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, B.</span></span> <span> </span><span class="NLM_article-title">Contraction of myofibroblasts in granulation tissue is dependent on Rho/Rho kinase/myosin light chain phosphatase activity</span>. <i>Wound Repair Regen.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1111/j.1743-6109.2006.00126.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1111%2Fj.1743-6109.2006.00126.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=16808810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A280%3ADC%252BD28zpt1ymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=313-320&author=J.+J.+Tomasekauthor=M.+B.+Vaughanauthor=B.+P.+Kroppauthor=G.+Gabbianiauthor=M.+D.+Martinauthor=C.+J.+Haaksmaauthor=B.+Hinz&title=Contraction+of+myofibroblasts+in+granulation+tissue+is+dependent+on+Rho%2FRho+kinase%2Fmyosin+light+chain+phosphatase+activity&doi=10.1111%2Fj.1743-6109.2006.00126.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Contraction of myofibroblasts in granulation tissue is dependent on Rho/Rho kinase/myosin light chain phosphatase activity</span></div><div class="casAuthors">Tomasek James J; Vaughan Melville B; Kropp Bradley P; Gabbiani Giulio; Martin Michael D; Haaksma Carol J; Hinz Boris</div><div class="citationInfo"><span class="NLM_cas:title">Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">313-20</span>
        ISSN:<span class="NLM_cas:issn">1067-1927</span>.
    </div><div class="casAbstract">During wound healing and fibrocontractive diseases fibroblasts acquire a smooth muscle cell-like phenotype by differentiating into contractile force generating myofibroblasts.  We examined whether regulation of myofibroblast contraction in granulation tissue is dominated by Ca2+-induced phosphorylation of myosin light chain kinase or by Rho/Rho kinase (ROCK)-mediated inhibition of myosin light chain phosphatase, similar to that of cultured myofibroblasts.  Strips of granulation tissue obtained from rat granuloma pouches were stimulated with endothelin-1 (ET-1), serotonin, and angiotensin-II and isometric force generation was measured.  We here investigated ET-1 in depth, because it was the only agonist that produced a long-lasting and strong response.  The ROCK inhibitor Y27632 completely inhibited ET-1-promoted contraction and the phosphatase inhibitor calyculin elicited contraction in the absence of any other agonists, suggesting that activation of the Rho/ROCK/myosn light chain phosphatase pathway is critical in regulating in vivo myofibroblast contraction.  Membrane depolarization with K+ also stimulated a long-lasting contraction of granulation tissue; however, the amount of force generated was significantly less compared to ET-1.  Moreover, K+-induced contraction was inhibited by Y27632.  These results are consistent with inhibition of myosin light chain phosphatase by the Rho/ROCK signaling pathway, which would account for the long-duration contraction of myofibroblasts necessary for wound closure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpvR3flZYusFQKX3ooHxWjfW6udTcc2eYJIA1yL8FJMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zpt1ymtQ%253D%253D&md5=9aa34dce3088966cadfd4b3ba01bd569</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1743-6109.2006.00126.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1743-6109.2006.00126.x%26sid%3Dliteratum%253Aachs%26aulast%3DTomasek%26aufirst%3DJ.%2BJ.%26aulast%3DVaughan%26aufirst%3DM.%2BB.%26aulast%3DKropp%26aufirst%3DB.%2BP.%26aulast%3DGabbiani%26aufirst%3DG.%26aulast%3DMartin%26aufirst%3DM.%2BD.%26aulast%3DHaaksma%26aufirst%3DC.%2BJ.%26aulast%3DHinz%26aufirst%3DB.%26atitle%3DContraction%2520of%2520myofibroblasts%2520in%2520granulation%2520tissue%2520is%2520dependent%2520on%2520Rho%252FRho%2520kinase%252Fmyosin%2520light%2520chain%2520phosphatase%2520activity%26jtitle%3DWound%2520Repair%2520Regen.%26date%3D2006%26volume%3D14%26spage%3D313%26epage%3D320%26doi%3D10.1111%2Fj.1743-6109.2006.00126.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurundkar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurundkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thannickal, V. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">1096</span>– <span class="NLM_lpage">1108</span>, <span class="refDoi"> DOI: 10.1172/jci66700</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1172%2Fjci66700" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=1096-1108&author=Y.+Zhouauthor=X.+Huangauthor=L.+Heckerauthor=D.+Kurundkarauthor=A.+Kurundkarauthor=H.+Liuauthor=T.-H.+Jinauthor=L.+Desaiauthor=K.+Bernardauthor=V.+J.+Thannickal&title=Inhibition+of+mechanosensitive+signaling+in+myofibroblasts+ameliorates+experimental+pulmonary+fibrosis&doi=10.1172%2Fjci66700"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1172%2Fjci66700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252Fjci66700%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHecker%26aufirst%3DL.%26aulast%3DKurundkar%26aufirst%3DD.%26aulast%3DKurundkar%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DT.-H.%26aulast%3DDesai%26aufirst%3DL.%26aulast%3DBernard%26aufirst%3DK.%26aulast%3DThannickal%26aufirst%3DV.%2BJ.%26atitle%3DInhibition%2520of%2520mechanosensitive%2520signaling%2520in%2520myofibroblasts%2520ameliorates%2520experimental%2520pulmonary%2520fibrosis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D1096%26epage%3D1108%26doi%3D10.1172%2Fjci66700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evelyn, C.
R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iniguez-Lluhi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merajver, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span> <span> </span><span class="NLM_article-title">CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2249</span>– <span class="NLM_lpage">2260</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-06-0782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1158%2F1535-7163.mct-06-0782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=17699722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVGltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=2249-2260&author=C.%0AR.+Evelynauthor=S.+M.+Wadeauthor=Q.+Wangauthor=M.+Wuauthor=J.+A.+Iniguez-Lluhiauthor=S.+D.+Merajverauthor=R.+R.+Neubig&title=CCG-1423%3A+a+small-molecule+inhibitor+of+RhoA+transcriptional+signaling&doi=10.1158%2F1535-7163.mct-06-0782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling</span></div><div class="casAuthors">Evelyn, Chris R.; Wade, Susan M.; Wang, Qin; Wu, Mei; Iniguez-Lluhi, Jorge A.; Merajver, Sofia D.; Neubig, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2249-2260</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Lysophosphatidic acid receptors stimulate a Gα12/13/RhoA-dependent gene transcription program involving the serum response factor (SRF) and its coactivator and oncogene, megakaryoblastic leukemia 1 (MKL1).  Inhibitors of this pathway could serve as useful biol. probes and potential cancer therapeutic agents.  Through a transcription-based high-throughput serum response element-luciferase screening assay, we identified two small-mol. inhibitors of this pathway.  Mechanistic studies on the more potent CCG-1423 show that it acts downstream of Rho because it blocks SRE.L-driven transcription stimulated by Gα12Q231L, Gα13Q226L, RhoA-G14V, and RhoC-G14V.  The ability of CCG-1423 to block transcription activated by MKL1, but not that induced by SRF-VP16 or GAL4-VP16, suggests a mechanism targeting MKL/SRF-dependent transcriptional activation that does not involve alterations in DNA binding.  Consistent with its role as a Rho/SRF pathway inhibitor, CCG-1423 displays activity in several in vitro cancer cell functional assays.  CCG-1423 potently (<1 μmol/L) inhibits lysophosphatidic acid-induced DNA synthesis in PC-3 prostate cancer cells, and whereas it inhibits the growth of RhoC-overexpressing melanoma lines (A375M2 and SK-Mel-147) at nanomolar concns., it is less active on related lines (A375 and SK-Mel-28) that express lower levels of Rho.  Similarly, CCG-1423 selectively stimulates apoptosis of the metastasis-prone, RhoC-overexpressing melanoma cell line (A375M2) compared with the parental cell line (A375).  CCG-1423 inhibited Rho-dependent invasion by PC-3 prostate cancer cells, whereas it did not affect the Gαi-dependent invasion by the SKOV-3 ovarian cancer cell line.  Thus, based on its profile, CCG-1423 is a promising lead compd. for the development of novel pharmacol. tools to disrupt transcriptional responses of the Rho pathway in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovpixrnu35wLVg90H21EOLACvtfcHk0likQRjZIwheAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVGltbs%253D&md5=6b58f9ac8c9f45e8efc1572d21b358bf</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.mct-06-0782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.mct-06-0782%26sid%3Dliteratum%253Aachs%26aulast%3DEvelyn%26aufirst%3DC.%2BR.%26aulast%3DWade%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DIniguez-Lluhi%26aufirst%3DJ.%2BA.%26aulast%3DMerajver%26aufirst%3DS.%2BD.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26atitle%3DCCG-1423%253A%2520a%2520small-molecule%2520inhibitor%2520of%2520RhoA%2520transcriptional%2520signaling%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D2249%26epage%3D2260%26doi%3D10.1158%2F1535-7163.mct-06-0782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcucci, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stassi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maria, R.</span></span> <span> </span><span class="NLM_article-title">Epithelial-mesenchymal transition: a new target in anticancer drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1038/nrd.2015.13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1038%2Fnrd.2015.13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=26822829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs12ht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=311-325&author=F.+Marcucciauthor=G.+Stassiauthor=R.+De+Maria&title=Epithelial-mesenchymal+transition%3A+a+new+target+in+anticancer+drug+discovery&doi=10.1038%2Fnrd.2015.13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Epithelial-mesenchymal transition: a new target in anticancer drug discovery</span></div><div class="casAuthors">Marcucci, Fabrizio; Stassi, Giorgio; De Maria, Ruggero</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">311-325</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The conversion of cells with an epithelial phenotype into cells with a mesenchymal phenotype, referred to as epithelial-mesenchymal transition, is a crit. process for embryonic development that also occurs in adult life, particularly during tumor progression.  Tumor cells undergoing epithelial-mesenchymal transition acquire the capacity to disarm the body's antitumor defences, resist apoptosis and anticancer drugs, disseminate throughout the organism, and act as a reservoir that replenishes and expands the tumor cell population.  Epithelial-mesenchymal transition is therefore becoming a target of prime interest for anticancer therapy.  Here, we discuss the screening and classification of compds. that affect epithelial-mesenchymal transition, highlight some compds. of particular interest, and address issues related to their clin. application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryjKwYq-FVDrVg90H21EOLACvtfcHk0likQRjZIwheAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs12ht7o%253D&md5=dd4ecd416aaeb73ba477836449079fb0</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2015.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2015.13%26sid%3Dliteratum%253Aachs%26aulast%3DMarcucci%26aufirst%3DF.%26aulast%3DStassi%26aufirst%3DG.%26aulast%3DDe%2BMaria%26aufirst%3DR.%26atitle%3DEpithelial-mesenchymal%2520transition%253A%2520a%2520new%2520target%2520in%2520anticancer%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D311%26epage%3D325%26doi%3D10.1038%2Fnrd.2015.13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbloom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez, S. A.</span></span> <span> </span><span class="NLM_article-title">Strategies for anti-fibrotic therapies</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1832</i></span>,  <span class="NLM_fpage">1088</span>– <span class="NLM_lpage">1103</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2012.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.bbadis.2012.12.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1832&publication_year=2013&pages=1088-1103&author=J.+Rosenbloomauthor=F.+A.+Mendozaauthor=S.+A.+Jimenez&title=Strategies+for+anti-fibrotic+therapies&doi=10.1016%2Fj.bbadis.2012.12.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2012.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2012.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DRosenbloom%26aufirst%3DJ.%26aulast%3DMendoza%26aufirst%3DF.%2BA.%26aulast%3DJimenez%26aufirst%3DS.%2BA.%26atitle%3DStrategies%2520for%2520anti-fibrotic%2520therapies%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2013%26volume%3D1832%26spage%3D1088%26epage%3D1103%26doi%3D10.1016%2Fj.bbadis.2012.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sisson, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajayi, I. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subbotina, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodi, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodansky, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibucos, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keshamouni, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, P. D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horowitz, J. C.</span></span> <span> </span><span class="NLM_article-title">Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">969</span>– <span class="NLM_lpage">986</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2014.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.ajpath.2014.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=25681733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2MXis1Smt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2015&pages=969-986&author=T.+H.+Sissonauthor=I.+O.+Ajayiauthor=N.+Subbotinaauthor=A.+E.+Dodiauthor=E.+S.+Rodanskyauthor=L.+N.+Chibucosauthor=K.+K.+Kimauthor=V.+G.+Keshamouniauthor=E.+S.+Whiteauthor=Y.+Zhouauthor=P.+D.+R.+Higginsauthor=S.+D.+Larsenauthor=R.+R.+Neubigauthor=J.+C.+Horowitz&title=Inhibition+of+myocardin-related+transcription+factor%2Fserum+response+factor+signaling+decreases+lung+fibrosis+and+promotes+mesenchymal+cell+apoptosis&doi=10.1016%2Fj.ajpath.2014.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Myocardin-Related Transcription Factor/Serum Response Factor Signaling Decreases Lung Fibrosis and Promotes Mesenchymal Cell Apoptosis</span></div><div class="casAuthors">Sisson, Thomas H.; Ajayi, Iyabode O.; Subbotina, Natalya; Dodi, Amos E.; Rodansky, Eva S.; Chibucos, Lauren N.; Kim, Kevin K.; Keshamouni, Venkateshwar G.; White, Eric S.; Zhou, Yong; Higgins, Peter D. R.; Larsen, Scott D.; Neubig, Richard R.; Horowitz, Jeffrey C.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">969-986</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Myofibroblasts are crucial to the pathogenesis of tissue fibrosis.  Their formation of stress fibers results in the release of myocardin-related transcription factor (MRTF), a transcriptional coactivator of serum response factor (SRF).  MRTF-A (Mkl1)-deficient mice are protected from lung fibrosis.  We hypothesized that the SRF/MRTF pathway inhibitor CCG-203971 would modulate myofibroblast function in vitro and limit lung fibrosis in vivo.  Normal and idiopathic pulmonary fibrosis lung fibroblasts were treated with/without CCG-203971 (N-[4-chlorophenyl]-1-[3-(2-furanyl)benzoyl]-3-piperidine carboxamide) and/or Fas-activating antibody in the presence/absence of transforming growth factor (TGF)-β1, and apoptosis was assessed.  In vivo studies examd. the effect of therapeutically administered CCG-203971 on lung fibrosis in two distinct murine models of fibrosis induced by bleomycin or targeted type II alveolar epithelial injury.  In vitro, CCG-203971 prevented nuclear localization of MRTF-A; increased the apoptotic susceptibility of normal and idiopathic pulmonary fibrosis fibroblasts; blocked TGF-β1-induced myofibroblast differentiation; and inhibited TGF-β1-induced expression of fibronectin, X-linked inhibitor of apoptosis, and plasminogen activator inhibitor-1.  TGF-β1 did not protect fibroblasts or myofibroblasts from apoptosis in the presence of CCG-203971.  In vivo, CCG-203971 significantly reduced lung collagen content in both murine models while decreasing alveolar plasminogen activator inhibitor-1 and promoting myofibroblast apoptosis.  These data support a central role of the SRF/MRTF pathway in the pathobiol. of lung fibrosis and suggest that its inhibition can help resolve lung fibrosis by promoting fibroblast apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG7V8_ausIX7Vg90H21EOLACvtfcHk0lgiib05t6ilVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXis1Smt7g%253D&md5=147984195b8821c88aefd8cc21c9ea10</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2014.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2014.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DSisson%26aufirst%3DT.%2BH.%26aulast%3DAjayi%26aufirst%3DI.%2BO.%26aulast%3DSubbotina%26aufirst%3DN.%26aulast%3DDodi%26aufirst%3DA.%2BE.%26aulast%3DRodansky%26aufirst%3DE.%2BS.%26aulast%3DChibucos%26aufirst%3DL.%2BN.%26aulast%3DKim%26aufirst%3DK.%2BK.%26aulast%3DKeshamouni%26aufirst%3DV.%2BG.%26aulast%3DWhite%26aufirst%3DE.%2BS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DHiggins%26aufirst%3DP.%2BD.%2BR.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DHorowitz%26aufirst%3DJ.%2BC.%26atitle%3DInhibition%2520of%2520myocardin-related%2520transcription%2520factor%252Fserum%2520response%2520factor%2520signaling%2520decreases%2520lung%2520fibrosis%2520and%2520promotes%2520mesenchymal%2520cell%2520apoptosis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2015%26volume%3D185%26spage%3D969%26epage%3D986%26doi%3D10.1016%2Fj.ajpath.2014.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiwen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikitorowicz-Buniak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed-Abdi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponticos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suki, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layne, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafyatis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. D.</span></span> <span> </span><span class="NLM_article-title">A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related Fibrosis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0126015</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0126015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1371%2Fjournal.pone.0126015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=25955164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Oju7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=X.+Shiwenauthor=R.+Strattonauthor=J.+Nikitorowicz-Buniakauthor=B.+Ahmed-Abdiauthor=M.+Ponticosauthor=C.+Dentonauthor=D.+Abrahamauthor=A.+Takahashiauthor=B.+Sukiauthor=M.+D.+Layneauthor=R.+Lafyatisauthor=B.+D.+Smith&title=A+Role+of+Myocardin+Related+Transcription+Factor-A+%28MRTF-A%29+in+Scleroderma+Related+Fibrosis&doi=10.1371%2Fjournal.pone.0126015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A role of myocardin related transcription factor-A (MRTF-A) in scleroderma related fibrosis</span></div><div class="casAuthors">Shiwen, Xu; Stratton, Richard; Nikitorowicz-Buniak, Joanna; Ahmed-Abdi, Bahja; Ponticos, Markella; Denton, Christopher; Abraham, David; Takahashi, Ayuko; Suki, Bela; Layne, Matthew D.; Lafyatis, Robert; Smith, Barbara D.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0126015/1-e0126015/20</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">In scleroderma (systemic sclerosis, SSc), persistent activation of myofibroblast leads to severe skin and organ fibrosis resistant to therapy.  Increased mech. stiffness in the involved fibrotic tissues is a hallmark clin. feature and a cause of disabling symptoms.  Myocardin Related Transcription Factor-A (MRTF-A) is a transcriptional co-activator that is sequestered in the cytoplasm and translocates to the nucleus under mech. stress or growth factor stimulation.  Our objective was to det. if MRTF-A is activated in the disease microenvironment to produce more extracellular matrix in progressive SSc.  Immunohistochem. studies demonstrate that nuclear translocation of MRTF-A in scleroderma tissues occurs in keratinocytes, endothelial cells, infiltrating inflammatory cells, and dermal fibroblasts, consistent with enhanced signaling in multiple cell lineages exposed to the stiff extracellular matrix.  Inhibition of MRTF-A nuclear translocation or knockdown of MRTF-A synthesis abolishes the SSc myofibroblast enhanced basal contractility and synthesis of type I collagen and inhibits the matricellular profibrotic protein, connective tissue growth factor (CCN2/CTGF).  In MRTF-A null mice, basal skin and lung stiffness was abnormally reduced and assocd. with altered fibrillar collagen.  MRTF-A has a role in SSc fibrosis acting as a central regulator linking mech. cues to adverse remodeling of the extracellular matrix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE_DfciSC9I7Vg90H21EOLACvtfcHk0lheqkkNWe9foQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Oju7bI&md5=e737b5705f7a08db7f95d9bea9e0b968</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0126015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0126015%26sid%3Dliteratum%253Aachs%26aulast%3DShiwen%26aufirst%3DX.%26aulast%3DStratton%26aufirst%3DR.%26aulast%3DNikitorowicz-Buniak%26aufirst%3DJ.%26aulast%3DAhmed-Abdi%26aufirst%3DB.%26aulast%3DPonticos%26aufirst%3DM.%26aulast%3DDenton%26aufirst%3DC.%26aulast%3DAbraham%26aufirst%3DD.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DSuki%26aufirst%3DB.%26aulast%3DLayne%26aufirst%3DM.%2BD.%26aulast%3DLafyatis%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DB.%2BD.%26atitle%3DA%2520Role%2520of%2520Myocardin%2520Related%2520Transcription%2520Factor-A%2520%2528MRTF-A%2529%2520in%2520Scleroderma%2520Related%2520Fibrosis%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0126015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treisman, R.</span></span> <span> </span><span class="NLM_article-title">Serum-regulated transcription by serum response factor (SRF): a novel role for the DNA binding domain</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">5421</span>– <span class="NLM_lpage">5432</span>, <span class="refDoi"> DOI: 10.1002/j.1460-2075.1994.tb06877.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1002%2Fj.1460-2075.1994.tb06877.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1994&pages=5421-5432&author=C.+S.+Hillauthor=J.+Wynneauthor=R.+Treisman&title=Serum-regulated+transcription+by+serum+response+factor+%28SRF%29%3A+a+novel+role+for+the+DNA+binding+domain&doi=10.1002%2Fj.1460-2075.1994.tb06877.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fj.1460-2075.1994.tb06877.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fj.1460-2075.1994.tb06877.x%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DC.%2BS.%26aulast%3DWynne%26aufirst%3DJ.%26aulast%3DTreisman%26aufirst%3DR.%26atitle%3DSerum-regulated%2520transcription%2520by%2520serum%2520response%2520factor%2520%2528SRF%2529%253A%2520a%2520novel%2520role%2520for%2520the%2520DNA%2520binding%2520domain%26jtitle%3DEMBO%2520J.%26date%3D1994%26volume%3D13%26spage%3D5421%26epage%3D5432%26doi%3D10.1002%2Fj.1460-2075.1994.tb06877.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutchings, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisabeth, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajeswaran, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorenson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruth, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsou, P.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leipprandt, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. D.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1744</span>– <span class="NLM_lpage">1749</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.02.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.bmcl.2017.02.070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1744-1749&author=K.+M.+Hutchingsauthor=E.+M.+Lisabethauthor=W.+Rajeswaranauthor=M.+W.+Wilsonauthor=R.+J.+Sorensonauthor=P.+L.+Campbellauthor=J.+H.+Ruthauthor=A.+Aminauthor=P.-S.+Tsouauthor=J.+R.+Leipprandtauthor=S.+R.+Olsonauthor=B.+Wenauthor=T.+Zhaoauthor=D.+Sunauthor=D.+Khannaauthor=D.+A.+Foxauthor=R.+R.+Neubigauthor=S.+D.+Larsen&title=Pharmacokinetic+optimitzation+of+CCG-203971%3A+Novel+inhibitors+of+the+Rho%2FMRTF%2FSRF+transcriptional+pathway+as+potential+antifibrotic+therapeutics+for+systemic+scleroderma&doi=10.1016%2Fj.bmcl.2017.02.070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.02.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.02.070%26sid%3Dliteratum%253Aachs%26aulast%3DHutchings%26aufirst%3DK.%2BM.%26aulast%3DLisabeth%26aufirst%3DE.%2BM.%26aulast%3DRajeswaran%26aufirst%3DW.%26aulast%3DWilson%26aufirst%3DM.%2BW.%26aulast%3DSorenson%26aufirst%3DR.%2BJ.%26aulast%3DCampbell%26aufirst%3DP.%2BL.%26aulast%3DRuth%26aufirst%3DJ.%2BH.%26aulast%3DAmin%26aufirst%3DA.%26aulast%3DTsou%26aufirst%3DP.-S.%26aulast%3DLeipprandt%26aufirst%3DJ.%2BR.%26aulast%3DOlson%26aufirst%3DS.%2BR.%26aulast%3DWen%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DKhanna%26aufirst%3DD.%26aulast%3DFox%26aufirst%3DD.%2BA.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26atitle%3DPharmacokinetic%2520optimitzation%2520of%2520CCG-203971%253A%2520Novel%2520inhibitors%2520of%2520the%2520Rho%252FMRTF%252FSRF%2520transcriptional%2520pathway%2520as%2520potential%2520antifibrotic%2520therapeutics%2520for%2520systemic%2520scleroderma%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D1744%26epage%3D1749%26doi%3D10.1016%2Fj.bmcl.2017.02.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haak, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchhoff, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. D.</span></span> <span> </span><span class="NLM_article-title">Optimization of novel nipecotic bis(amide) inhibitors of the Rho/MKL1/SRF transcriptional pathway as potential anti-metastasis agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3826</span>– <span class="NLM_lpage">3832</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.04.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.bmcl.2013.04.080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3826-3832&author=J.+L.+Bellauthor=A.+J.+Haakauthor=S.+M.+Wadeauthor=P.+D.+Kirchhoffauthor=R.+R.+Neubigauthor=S.+D.+Larsen&title=Optimization+of+novel+nipecotic+bis%28amide%29+inhibitors+of+the+Rho%2FMKL1%2FSRF+transcriptional+pathway+as+potential+anti-metastasis+agents&doi=10.1016%2Fj.bmcl.2013.04.080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.04.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.04.080%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DJ.%2BL.%26aulast%3DHaak%26aufirst%3DA.%2BJ.%26aulast%3DWade%26aufirst%3DS.%2BM.%26aulast%3DKirchhoff%26aufirst%3DP.%2BD.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26atitle%3DOptimization%2520of%2520novel%2520nipecotic%2520bis%2528amide%2529%2520inhibitors%2520of%2520the%2520Rho%252FMKL1%252FSRF%2520transcriptional%2520pathway%2520as%2520potential%2520anti-metastasis%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3826%26epage%3D3832%26doi%3D10.1016%2Fj.bmcl.2013.04.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evelyn, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocab, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harzdorf, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis
Showalter, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. D.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and prostate cancer cell-based studies of analogs of the Rho/MKL1 transcriptional pathway inhibitor, CCG-1423</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">665</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.bmcl.2009.11.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=19963382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2iur%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=665-672&author=C.+R.+Evelynauthor=J.+L.+Bellauthor=J.+G.+Ryuauthor=S.+M.+Wadeauthor=A.+Kocabauthor=N.+L.+Harzdorfauthor=H.+D.+Hollis%0AShowalterauthor=R.+R.+Neubigauthor=S.+D.+Larsen&title=Design%2C+synthesis+and+prostate+cancer+cell-based+studies+of+analogs+of+the+Rho%2FMKL1+transcriptional+pathway+inhibitor%2C+CCG-1423&doi=10.1016%2Fj.bmcl.2009.11.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and prostate cancer cell-based studies of analogs of the Rho/MKL1 transcriptional pathway inhibitor, CCG-1423</span></div><div class="casAuthors">Evelyn, Chris R.; Bell, Jessica L.; Ryu, Jenny G.; Wade, Susan M.; Kocab, Andrew; Harzdorf, Nicole L.; Showalter, H. D. Hollis; Neubig, Richard R.; Larsen, Scott D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">665-672</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We recently identified bis(amide) CCG-1423 (1) as a novel inhibitor of RhoA/C-mediated gene transcription that is capable of inhibiting invasion of PC-3 prostate cancer cells in a Matrigel model of metastasis.  An initial structure-activity relationship study focusing on bioisosteric replacement of the amides and conformational restriction identified two compds., 4g and 8, with improved selectivity for inhibition of RhoA/C-mediated gene transcription and attenuated cytotoxicity relative to 1.  Both compds. were also capable of inhibiting cell invasion with equal efficacy to 1 but with less attendant cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDgSeS9pYMp7Vg90H21EOLACvtfcHk0lipilOjZS-MVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2iur%252FO&md5=e931712238b9376b45c6e40daac3fda8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.056%26sid%3Dliteratum%253Aachs%26aulast%3DEvelyn%26aufirst%3DC.%2BR.%26aulast%3DBell%26aufirst%3DJ.%2BL.%26aulast%3DRyu%26aufirst%3DJ.%2BG.%26aulast%3DWade%26aufirst%3DS.%2BM.%26aulast%3DKocab%26aufirst%3DA.%26aulast%3DHarzdorf%26aufirst%3DN.%2BL.%26aulast%3DHollis%2BShowalter%26aufirst%3DH.%2BD.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26atitle%3DDesign%252C%2520synthesis%2520and%2520prostate%2520cancer%2520cell-based%2520studies%2520of%2520analogs%2520of%2520the%2520Rho%252FMKL1%2520transcriptional%2520pathway%2520inhibitor%252C%2520CCG-1423%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D665%26epage%3D672%26doi%3D10.1016%2Fj.bmcl.2009.11.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haak, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleton, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisabeth, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misek, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockwell, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Airik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krook, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhaegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawlor, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of Myocardin-related Transcription Factor pathway blocks bung metastases of RhoC-overexpressing melanoma</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-16-0482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1158%2F1535-7163.mct-16-0482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=27837031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsF2jtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=193-204&author=A.+J.+Haakauthor=K.+M.+Appletonauthor=E.+M.+Lisabethauthor=S.+A.+Misekauthor=Y.+Jiauthor=S.+M.+Wadeauthor=J.+L.+Bellauthor=C.+E.+Rockwellauthor=M.+Airikauthor=M.+A.+Krookauthor=S.+D.+Larsenauthor=M.+Verhaegenauthor=E.+R.+Lawlorauthor=R.+R.+Neubig&title=Pharmacological+inhibition+of+Myocardin-related+Transcription+Factor+pathway+blocks+bung+metastases+of+RhoC-overexpressing+melanoma&doi=10.1158%2F1535-7163.mct-16-0482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma</span></div><div class="casAuthors">Haak, Andrew J.; Appleton, Kathryn M.; Lisabeth, Erika M.; Misek, Sean A.; Ji, Yajing; Wade, Susan M.; Bell, Jessica L.; Rockwell, Cheryl E.; Airik, Merlin; Krook, Melanie A.; Larsen, Scott D.; Verhaegen, Monique; Lawlor, Elizabeth R.; Neubig, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-204</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Melanoma is the most dangerous form of skin cancer with the majority of deaths arising from metastatic disease.  Evidence implicates Rho-activated gene transcription in melanoma metastasis mediated by the nuclear localization of the transcriptional coactivator, myocardin-related transcription factor (MRTF).  Here, we highlight a role for Rho and MRTF signaling and its reversal by pharmacol. inhibition using in vitro and in vivo models of human melanoma growth and metastasis.  Using two cellular models of melanoma, we clearly show that one cell type, SK-Mel-147, is highly metastatic, has high RhoC expression, and MRTF nuclear localization and activity.  Conversely, SK-Mel-19 melanoma cells have low RhoC expression, and decreased levels of MRTF-regulated genes.  To probe the dependence of melanoma aggressiveness to MRTF transcription, we use a previously developed small-mol. inhibitor, CCG-203971, which at low micromolar concns. blocks nuclear localization and activity of MRTF-A.  In SK-Mel-147 cells, CCG-203971 inhibits cellular migration and invasion, and decreases MRTF target gene expression.  In addn., CCG-203971-mediated inhibition of the Rho/MRTF pathway significantly reduces cell growth and clonogenicity and causes G1 cell-cycle arrest.  In an exptl. model of melanoma lung metastasis, the RhoC-overexpressing melanoma cells (SK-Mel-147) exhibited pronounced lung colonization compared with the low RhoC-expressing SK-Mel-19.  Furthermore, pharmacol. inhibition of the MRTF pathway reduced both the no. and size of lung metastasis resulting in a marked redn. of total lung tumor burden.  These data link Rho and MRTF-mediated signaling with aggressive phenotypes and support targeting the MRTF transcriptional pathway as a novel approach to melanoma therapeutics.  Mol Cancer Ther; 16(1); 193-204. cpr2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNd4iHo1dIebVg90H21EOLACvtfcHk0liEQ1PPwzE4tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsF2jtw%253D%253D&md5=d26db3a495452bda8477c576239f5dbe</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.mct-16-0482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.mct-16-0482%26sid%3Dliteratum%253Aachs%26aulast%3DHaak%26aufirst%3DA.%2BJ.%26aulast%3DAppleton%26aufirst%3DK.%2BM.%26aulast%3DLisabeth%26aufirst%3DE.%2BM.%26aulast%3DMisek%26aufirst%3DS.%2BA.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DWade%26aufirst%3DS.%2BM.%26aulast%3DBell%26aufirst%3DJ.%2BL.%26aulast%3DRockwell%26aufirst%3DC.%2BE.%26aulast%3DAirik%26aufirst%3DM.%26aulast%3DKrook%26aufirst%3DM.%2BA.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26aulast%3DVerhaegen%26aufirst%3DM.%26aulast%3DLawlor%26aufirst%3DE.%2BR.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26atitle%3DPharmacological%2520inhibition%2520of%2520Myocardin-related%2520Transcription%2520Factor%2520pathway%2520blocks%2520bung%2520metastases%2520of%2520RhoC-overexpressing%2520melanoma%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2017%26volume%3D16%26spage%3D193%26epage%3D204%26doi%3D10.1158%2F1535-7163.mct-16-0482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haak, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsou, P.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruth, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span> <span> </span><span class="NLM_article-title">Targeting the myofibroblast genetic switch: inhibitors of Myocardin-Related Transcription Factor/Serum Response Factor-regulated gene transcription prevent fibrosis in a murine model of skin injury</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">480</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1124/jpet.114.213520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1124%2Fjpet.114.213520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=24706986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGltbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2014&pages=480-486&author=A.+J.+Haakauthor=P.-S.+Tsouauthor=M.+A.+Aminauthor=J.+H.+Ruthauthor=P.+Campbellauthor=D.+A.+Foxauthor=D.+Khannaauthor=S.+D.+Larsenauthor=R.+R.+Neubig&title=Targeting+the+myofibroblast+genetic+switch%3A+inhibitors+of+Myocardin-Related+Transcription+Factor%2FSerum+Response+Factor-regulated+gene+transcription+prevent+fibrosis+in+a+murine+model+of+skin+injury&doi=10.1124%2Fjpet.114.213520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury</span></div><div class="casAuthors">Haak, Andrew J.; Tsou, Pei-Suen; Amin, Mohammad A.; Ruth, Jeffrey H.; Campbell, Phillip; Fox, David A.; Khanna, Dinesh; Larsen, Scott D.; Neubig, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">480-486, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Systemic sclerosis (SSc), or scleroderma, similar to many fibrotic disorders, lacks effective therapies.  Current trials focus on anti-inflammatory drugs or targeted approaches aimed at one of the many receptor mechanisms initiating fibrosis.  In light of evidence that a myocardin-related transcription factor (MRTF)-and serum response factor (SRF)-regulated gene transcriptional program induced by Rho GTPases is essential for myofibroblast activation, we explored the hypothesis that inhibitors of this pathway may represent novel antifibrotics.  MRTF/SRF-regulated genes show spontaneously increased expression in primary dermal fibroblasts from patients with diffuse cutaneous SSc.  A novel small-mol. inhibitor of MRTF/SRF-regulated transcription (CCG-203971) inhibits expression of connective tissue growth factor (CTGF), α-smooth muscle actin (α-SMA), and collagen 1 (COL1A2) in both SSc fibroblasts and in lysophosphatidic acid (LPA)- and transforming growth factor β (TGFβ)-stimulated fibroblasts.  In vivo treatment with CCG-203971 also prevented bleomycin-induced skin thickening and collagen deposition.  Thus, targeting the MRTF/SRF gene transcription pathway could provide an efficacious new approach to therapy for SSc and other fibrotic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolPwXDfCVZd7Vg90H21EOLACvtfcHk0liEQ1PPwzE4tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGltbvM&md5=182922f94ffc7a990a3ed96d1d915db2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.213520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.213520%26sid%3Dliteratum%253Aachs%26aulast%3DHaak%26aufirst%3DA.%2BJ.%26aulast%3DTsou%26aufirst%3DP.-S.%26aulast%3DAmin%26aufirst%3DM.%2BA.%26aulast%3DRuth%26aufirst%3DJ.%2BH.%26aulast%3DCampbell%26aufirst%3DP.%26aulast%3DFox%26aufirst%3DD.%2BA.%26aulast%3DKhanna%26aufirst%3DD.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26atitle%3DTargeting%2520the%2520myofibroblast%2520genetic%2520switch%253A%2520inhibitors%2520of%2520Myocardin-Related%2520Transcription%2520Factor%252FSerum%2520Response%2520Factor-regulated%2520gene%2520transcription%2520prevent%2520fibrosis%2520in%2520a%2520murine%2520model%2520of%2520skin%2520injury%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D349%26spage%3D480%26epage%3D486%26doi%3D10.1124%2Fjpet.114.213520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldfine, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciaraldi, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emecan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzpatrick, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vokes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Chillaron, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patti, M.-E.</span></span> <span> </span><span class="NLM_article-title">Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">918</span>– <span class="NLM_lpage">929</span>, <span class="refDoi"> DOI: 10.1172/jci41940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1172%2Fjci41940" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=918-929&author=W.+Jinauthor=A.+B.+Goldfineauthor=T.+Boesauthor=R.+R.+Henryauthor=T.+P.+Ciaraldiauthor=E.-Y.+Kimauthor=M.+Emecanauthor=C.+Fitzpatrickauthor=A.+Senauthor=A.+Shahauthor=E.+Munauthor=M.+Vokesauthor=J.+Schroederauthor=E.+Tatroauthor=J.+Jimenez-Chillaronauthor=M.-E.+Patti&title=Increased+SRF+transcriptional+activity+in+human+and+mouse+skeletal+muscle+is+a+signature+of+insulin+resistance&doi=10.1172%2Fjci41940"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1172%2Fjci41940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252Fjci41940%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DW.%26aulast%3DGoldfine%26aufirst%3DA.%2BB.%26aulast%3DBoes%26aufirst%3DT.%26aulast%3DHenry%26aufirst%3DR.%2BR.%26aulast%3DCiaraldi%26aufirst%3DT.%2BP.%26aulast%3DKim%26aufirst%3DE.-Y.%26aulast%3DEmecan%26aufirst%3DM.%26aulast%3DFitzpatrick%26aufirst%3DC.%26aulast%3DSen%26aufirst%3DA.%26aulast%3DShah%26aufirst%3DA.%26aulast%3DMun%26aufirst%3DE.%26aulast%3DVokes%26aufirst%3DM.%26aulast%3DSchroeder%26aufirst%3DJ.%26aulast%3DTatro%26aufirst%3DE.%26aulast%3DJimenez-Chillaron%26aufirst%3DJ.%26aulast%3DPatti%26aufirst%3DM.-E.%26atitle%3DIncreased%2520SRF%2520transcriptional%2520activity%2520in%2520human%2520and%2520mouse%2520skeletal%2520muscle%2520is%2520a%2520signature%2520of%2520insulin%2520resistance%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26spage%3D918%26epage%3D929%26doi%3D10.1172%2Fjci41940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffield, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luster, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tager, A. M.</span></span> <span> </span><span class="NLM_article-title">LPA(1)-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1830</span>– <span class="NLM_lpage">1846</span>, <span class="refDoi"> DOI: 10.1096/fj.12-219378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1096%2Ffj.12-219378" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=1830-1846&author=N.+Sakaiauthor=J.+Chunauthor=J.+S.+Duffieldauthor=T.+Wadaauthor=A.+D.+Lusterauthor=A.+M.+Tager&title=LPA%281%29-induced+cytoskeleton+reorganization+drives+fibrosis+through+CTGF-dependent+fibroblast+proliferation&doi=10.1096%2Ffj.12-219378"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1096%2Ffj.12-219378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.12-219378%26sid%3Dliteratum%253Aachs%26aulast%3DSakai%26aufirst%3DN.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DDuffield%26aufirst%3DJ.%2BS.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26aulast%3DTager%26aufirst%3DA.%2BM.%26atitle%3DLPA%25281%2529-induced%2520cytoskeleton%2520reorganization%2520drives%2520fibrosis%2520through%2520CTGF-dependent%2520fibroblast%2520proliferation%26jtitle%3DFASEB%2520J.%26date%3D2013%26volume%3D27%26spage%3D1830%26epage%3D1846%26doi%3D10.1096%2Ffj.12-219378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu-Wai-Man, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer-Dene, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchings, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisabeth, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treisman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaw, P. T.</span></span> <span> </span><span class="NLM_article-title">Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">518</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-00212-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1038%2Fs41598-017-00212-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=28364121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A280%3ADC%252BC1cvjt12qsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=518&author=C.+Yu-Wai-Manauthor=B.+Spencer-Deneauthor=R.+M.+H.+Leeauthor=K.+Hutchingsauthor=E.+M.+Lisabethauthor=R.+Treismanauthor=M.+Baillyauthor=S.+D.+Larsenauthor=R.+R.+Neubigauthor=P.+T.+Khaw&title=Local+delivery+of+novel+MRTF%2FSRF+inhibitors+prevents+scar+tissue+formation+in+a+preclinical+model+of+fibrosis&doi=10.1038%2Fs41598-017-00212-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis</span></div><div class="casAuthors">Yu-Wai-Man Cynthia; Bailly Maryse; Yu-Wai-Man Cynthia; Lee Richard M H; Khaw Peng T; Yu-Wai-Man Cynthia; Treisman Richard; Spencer-Dene Bradley; Hutchings Kim; Larsen Scott D; Lisabeth Erika M; Neubig Richard R</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">518</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The myocardin-related transcription factor/serum response factor (MRTF/SRF) pathway represents a promising therapeutic target to prevent fibrosis.  We have tested the effects of new pharmacological inhibitors of MRTF/SRF signalling in a preclinical model of fibrosis.  CCG-222740, a novel MRTF/SRF inhibitor, markedly decreased SRF reporter gene activity and showed a greater inhibitory effect on MRTF/SRF target genes than the previously described MRTF-A inhibitor CCG-203971.  CCG-222740 was also five times more potent, with an IC50 of 5 μM, in a fibroblast-mediated collagen contraction assay, was less cytotoxic, and a more potent inhibitor of alpha-smooth muscle actin protein expression than CCG-203971.  Local delivery of CCG-222740 and CCG-203971 in a validated and clinically relevant rabbit model of scar tissue formation after glaucoma filtration surgery increased the long-term success of the surgery by 67% (P < 0.0005) and 33% (P < 0.01), respectively, and significantly decreased fibrosis and scarring histologically.  Unlike mitomycin-C, neither CCG-222740 nor CCG-203971 caused any detectable epithelial toxicity or systemic side effects with very low drug levels measured in the aqueous, vitreous, and serum.  We conclude that inhibitors of MRTF/SRF-regulated gene transcription such as CCG-222740, potentially represent a new therapeutic strategy to prevent scar tissue formation in the eye and other tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQWJMd8-qWYjNyzdcP07UmufW6udTcc2eYiA4SDO4fJG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvjt12qsg%253D%253D&md5=3eb899dd07f924253de149588b01e17d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-00212-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-00212-w%26sid%3Dliteratum%253Aachs%26aulast%3DYu-Wai-Man%26aufirst%3DC.%26aulast%3DSpencer-Dene%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DR.%2BM.%2BH.%26aulast%3DHutchings%26aufirst%3DK.%26aulast%3DLisabeth%26aufirst%3DE.%2BM.%26aulast%3DTreisman%26aufirst%3DR.%26aulast%3DBailly%26aufirst%3DM.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DKhaw%26aufirst%3DP.%2BT.%26atitle%3DLocal%2520delivery%2520of%2520novel%2520MRTF%252FSRF%2520inhibitors%2520prevents%2520scar%2520tissue%2520formation%2520in%2520a%2520preclinical%2520model%2520of%2520fibrosis%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D518%26doi%3D10.1038%2Fs41598-017-00212-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span> <span> </span><span class="NLM_article-title">Propylene oxide assisted one-pot, tandem synthesis of substituted-1,3,4-oxadiazole-2(3H)-ones in water</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">7978</span>– <span class="NLM_lpage">7983</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2012.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.tet.2012.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyjs77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=7978-7983&author=X.+Yanauthor=S.+Zhouauthor=Y.+Wangauthor=Z.+Geauthor=T.+Chengauthor=R.+Li&title=Propylene+oxide+assisted+one-pot%2C+tandem+synthesis+of+substituted-1%2C3%2C4-oxadiazole-2%283H%29-ones+in+water&doi=10.1016%2Fj.tet.2012.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Propylene oxide assisted one-pot, tandem synthesis of substituted-1,3,4-oxadiazole-2(3H)-ones in water</span></div><div class="casAuthors">Yan, Xu; Zhou, Shuo; Wang, Yuanqiang; Ge, Zemei; Cheng, Tieming; Li, Runtao</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">7978-7983</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">It has been developed for the synthesis of substituted-1,3,4-oxadiazole-2(3H)-one derivs. via a novel one-pot, tandem procedure assisted by propylene oxide.  The 5-substituted-1,3,4-oxadiazole-2(3H)-ones and 3,5-disubstituted-1,3,4-oxadiazole-2(3H)-ones were, resp., obtained from three-component reaction of acylhydrazines, carbon disulfide, and propylene oxide, and four-component reaction of acylhydrazines, carbon disulfide, propylene oxide, and org. halides.  The reactions were carried out using water as solvent in the presence of potassium phosphate to afford the expected products in good to excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRTfZSG8k9B7Vg90H21EOLACvtfcHk0lghgwAIivfcSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyjs77N&md5=331acc507f763c89a7bdeeba4c2d6afc</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2012.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2012.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGe%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DR.%26atitle%3DPropylene%2520oxide%2520assisted%2520one-pot%252C%2520tandem%2520synthesis%2520of%2520substituted-1%252C3%252C4-oxadiazole-2%25283H%2529-ones%2520in%2520water%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D7978%26epage%3D7983%26doi%3D10.1016%2Fj.tet.2012.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.-L.</span></span> <span> </span><span class="NLM_article-title">Oxadiazole derivatives containing 1,4-benzodioxan as potential immunosuppressive agents against RAW264.7 cells</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4895</span>– <span class="NLM_lpage">4902</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.06.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.bmc.2011.06.061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=4895-4902&author=J.+Sunauthor=N.+Caoauthor=X.-M.+Zhangauthor=Y.-S.+Yangauthor=Y.-B.+Zhangauthor=X.-M.+Wangauthor=H.-L.+Zhu&title=Oxadiazole+derivatives+containing+1%2C4-benzodioxan+as+potential+immunosuppressive+agents+against+RAW264.7+cells&doi=10.1016%2Fj.bmc.2011.06.061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.06.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.06.061%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DX.-M.%26aulast%3DYang%26aufirst%3DY.-S.%26aulast%3DZhang%26aufirst%3DY.-B.%26aulast%3DWang%26aufirst%3DX.-M.%26aulast%3DZhu%26aufirst%3DH.-L.%26atitle%3DOxadiazole%2520derivatives%2520containing%25201%252C4-benzodioxan%2520as%2520potential%2520immunosuppressive%2520agents%2520against%2520RAW264.7%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D4895%26epage%3D4902%26doi%3D10.1016%2Fj.bmc.2011.06.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, B. K.</span>; <span class="NLM_string-name">Audia, J. E.</span>; <span class="NLM_string-name">Gagnon, A.</span>; <span class="NLM_string-name">Harmange, J.-C.</span>; <span class="NLM_string-name">Naveschuk, C. G.</span></span> <span> </span><span class="NLM_article-title">Modulators of methyl modifying enzymes, compositions and uses thereof</span>. WO <span class="NLM_patent">2013075084 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=B.+K.+Albrecht&author=J.+E.+Audia&author=A.+Gagnon&author=J.-C.+Harmange&author=C.+G.+Naveschuk&title=Modulators+of+methyl+modifying+enzymes%2C+compositions+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DModulators%2520of%2520methyl%2520modifying%2520enzymes%252C%2520compositions%2520and%2520uses%2520thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D.-M.</span>; <span class="NLM_string-name">Sinz, C. J.</span>; <span class="NLM_string-name">Crespo, A.</span>; <span class="NLM_string-name">Wilson, J. E.</span>; <span class="NLM_string-name">McCracken, T.</span>; <span class="NLM_string-name">Xu, S.</span>; <span class="NLM_string-name">Li, H.</span></span> <span> </span><span class="NLM_article-title">Triazolyl pyrimidinone compounds as PDE2 inhibitors</span>. WO <span class="NLM_patent">2016145614 A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=D.-M.+Shen&author=C.+J.+Sinz&author=A.+Crespo&author=J.+E.+Wilson&author=T.+McCracken&author=S.+Xu&author=H.+Li&title=Triazolyl+pyrimidinone+compounds+as+PDE2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DD.-M.%26atitle%3DTriazolyl%2520pyrimidinone%2520compounds%2520as%2520PDE2%2520inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbas, C. F.</span></span> <span> </span><span class="NLM_article-title">Rapid, stable, chemoselective labeling of thiols with Julia-Kocienski-like reagents: A serum-stable alternative to maleimide-based protein conjugation</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">12592</span>– <span class="NLM_lpage">12596</span>, <span class="refDoi"> DOI: 10.1002/anie.201306241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1002%2Fanie.201306241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Wms7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=12592-12596&author=N.+Todaauthor=S.+Asanoauthor=C.+F.+Barbas&title=Rapid%2C+stable%2C+chemoselective+labeling+of+thiols+with+Julia-Kocienski-like+reagents%3A+A+serum-stable+alternative+to+maleimide-based+protein+conjugation&doi=10.1002%2Fanie.201306241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid, stable, chemoselective labeling of thiols with Julia-Kocienski-like reagents: A serum-stable alternative to maleimide-based protein conjugation</span></div><div class="casAuthors">Toda, Narihiro; Asano, Shigehiro; Barbas, Carlos F., III</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">12592-12596</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have developed a class of sulfone derivs. for applications in protein conjugation chem., and we have compared the newly synthesized conjugates to maleimide conjugates.  Methylsulfonyl-functionalized five-membered cyclic compds., such as phenyltetrazole or phenyloxadiazole, reacted rapidly and specifically with thiols in small mols. and proteins with exquisite chemoselectivity at biol. relevant pH values (pH 5.8 - 8.0).  Designer heteroarom. sulfones allowed for the selective introduction of a fluorophore and poly(ethylene) glycol chains (PEGylation), and provided protein conjugates with superior stability compared to maleimide-conjugated proteins in human plasma.  Given the speed, selectivity, and stability of the sulfone-cysteine reactions described herein, we anticipate that this "thiol-Click" approach will find broad application in peptide and protein chem. and for the development of antibody drug conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowJzWgExtAGLVg90H21EOLACvtfcHk0lj1aggTsnPBDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Wms7%252FF&md5=ef91e1e933d116482b9e886c94c6cdd0</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fanie.201306241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201306241%26sid%3Dliteratum%253Aachs%26aulast%3DToda%26aufirst%3DN.%26aulast%3DAsano%26aufirst%3DS.%26aulast%3DBarbas%26aufirst%3DC.%2BF.%26atitle%3DRapid%252C%2520stable%252C%2520chemoselective%2520labeling%2520of%2520thiols%2520with%2520Julia-Kocienski-like%2520reagents%253A%2520A%2520serum-stable%2520alternative%2520to%2520maleimide-based%2520protein%2520conjugation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D12592%26epage%3D12596%26doi%3D10.1002%2Fanie.201306241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adumeau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davydova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeglis, B. M.</span></span> <span> </span><span class="NLM_article-title">Thiol-reactive bifunctional chelators for the creation of site-selectively modified radioimmunoconjugates with improved stability</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1364</span>– <span class="NLM_lpage">1372</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.8b00081</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.8b00081" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvVKrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=1364-1372&author=P.+Adumeauauthor=M.+Davydovaauthor=B.+M.+Zeglis&title=Thiol-reactive+bifunctional+chelators+for+the+creation+of+site-selectively+modified+radioimmunoconjugates+with+improved+stability&doi=10.1021%2Facs.bioconjchem.8b00081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Thiol-Reactive Bifunctional Chelators for the Creation of Site-Selectively Modified Radioimmunoconjugates with Improved Stability</span></div><div class="casAuthors">Adumeau, Pierre; Davydova, Maria; Zeglis, Brian M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1364-1372</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Maleimide-bearing bifunctional chelators have been used extensively for the site-selective bioconjugation and radiolabeling of peptides and proteins.  However, bioconjugates obtained using these constructs inevitably suffer from limited stability in vivo, a trait that translates into suboptimal activity concns. in target tissues and higher uptake levels in healthy, nontarget tissues.  To circumvent this issue, phenyloxadiazolyl methylsulfones have previously been reported as alternatives to maleimides for thiol-based ligations, but these constructs have scarcely been used in the field of radiochem.  In this report, we describe the synthesis of two thiol-reactive bifunctional chelators for 89Zr and 177Lu based on a new, easy-to-make phenyloxadiazolyl methylsulfone reagent, PODS.  Radioimmunoconjugates created using these novel bifunctional chelators displayed in vitro stability that was higher than that of their maleimide-derived cousins.  More importantly, positron emission tomog. imaging in murine models of cancer revealed that a 89Zr-labeled radioimmunoconjugate created using a PODS-bearing bifunctional chelator produced a rate of uptake in nontarget tissues that is significantly lower than that of its analogous maleimide-based counterpart.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPceA_fJIlKrVg90H21EOLACvtfcHk0lj1aggTsnPBDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvVKrtbc%253D&md5=08abd0933d4965449c2bb8ed6f123544</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.8b00081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.8b00081%26sid%3Dliteratum%253Aachs%26aulast%3DAdumeau%26aufirst%3DP.%26aulast%3DDavydova%26aufirst%3DM.%26aulast%3DZeglis%26aufirst%3DB.%2BM.%26atitle%3DThiol-reactive%2520bifunctional%2520chelators%2520for%2520the%2520creation%2520of%2520site-selectively%2520modified%2520radioimmunoconjugates%2520with%2520improved%2520stability%26jtitle%3DBioconjugate%2520Chem.%26date%3D2018%26volume%3D29%26spage%3D1364%26epage%3D1372%26doi%3D10.1021%2Facs.bioconjchem.8b00081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farrukh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paez, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salierno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berninger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Campo, A.</span></span> <span> </span><span class="NLM_article-title">Bifunctional poly(acrylamide) hydrogels through orthogonal coupling chemistries</span>. <i>Biomacromolecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">906</span>– <span class="NLM_lpage">913</span>, <span class="refDoi"> DOI: 10.1021/acs.biomac.6b01784</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biomac.6b01784" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=906-913&author=A.+Farrukhauthor=J.+I.+Paezauthor=M.+Saliernoauthor=W.+Fanauthor=B.+Berningerauthor=A.+Del+Campo&title=Bifunctional+poly%28acrylamide%29+hydrogels+through+orthogonal+coupling+chemistries&doi=10.1021%2Facs.biomac.6b01784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Bifunctional Poly(acrylamide) Hydrogels through Orthogonal Coupling Chemistries</span></div><div class="casAuthors">Farrukh, Aleeza; Paez, Julieta I.; Salierno, Marcelo; Fan, Wenqiang; Berninger, Benedikt; del Campo, Aranzazu</div><div class="citationInfo"><span class="NLM_cas:title">Biomacromolecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">906-913</span>CODEN:
                <span class="NLM_cas:coden">BOMAF6</span>;
        ISSN:<span class="NLM_cas:issn">1525-7797</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Biomaterials for cell culture allowing simple and quant. presentation of instructive cues enable rationalization of the interplay between cells and their surrounding microenvironment.  Poly(acrylamide) (PAAm) hydrogels are popular 2D-model substrates for this purpose.  However, quant. and reproducible biofunctionalization of PAAm hydrogels with multiple ligands in a trustable, controlled, and independent fashion is not trivial.  Here, we describe a method for bifunctional modification of PAAm hydrogels with thiol- and amine- contg. biomols. with controlled densities in an independent, orthogonal manner.  We developed copolymer networks of AAm with 9% acrylic acid and 2% N-(4-(5-(methylsulfonyl)-1,3,4-oxadiazol-2-yl)phenyl)acrylamide.  The covalent binding of thiol- and amine-contg. chromophores at tunable concns. was demonstrated and quantified by UV spectroscopy.  The morphol., mech. properties, and homogeneity of the copolymd. hydrogels were characterized by SEM, dynamic mech. anal., and confocal microscopy studies.  Our copolymer hydrogels were bifunctionalized with polylysine and a laminin-mimetic peptide using the specific chemistries.  We analyzed the effect of binding protocol of the two components in the maturation of cultured postmitotic cortical neurons.  Our substrates supported neuronal attachment, proliferation, and neuronal differentiation.  We found that neurons cultured on our hydrogels bifunctionalized with ligand-specific chemistries in a sequential fashion exhibited higher maturation at comparable culture times than using a simultaneous bifunctionalization strategy, displaying a higher no. of neurites, branches, and dendritic filopodia.  These results demonstrate the relevance of quant. and optimized coupling chemistries for the performance of simple biomaterials and with sensitive cell types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9e33oc9sXt7Vg90H21EOLACvtfcHk0libH98qoTWB_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWksrs%253D&md5=e783b4dc21ccbae4926f6c5905a0b524</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.biomac.6b01784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biomac.6b01784%26sid%3Dliteratum%253Aachs%26aulast%3DFarrukh%26aufirst%3DA.%26aulast%3DPaez%26aufirst%3DJ.%2BI.%26aulast%3DSalierno%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DBerninger%26aufirst%3DB.%26aulast%3DDel%2BCampo%26aufirst%3DA.%26atitle%3DBifunctional%2520poly%2528acrylamide%2529%2520hydrogels%2520through%2520orthogonal%2520coupling%2520chemistries%26jtitle%3DBiomacromolecules%26date%3D2017%26volume%3D18%26spage%3D906%26epage%3D913%26doi%3D10.1021%2Facs.biomac.6b01784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saitoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunitomo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mol, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Textor, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, F.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and structure-activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3β</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2017</span>– <span class="NLM_lpage">2029</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.01.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1016%2Fj.bmc.2009.01.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=2017-2029&author=M.+Saitohauthor=J.+Kunitomoauthor=E.+Kimuraauthor=Y.+Hayaseauthor=H.+Kobayashiauthor=N.+Uchiyamaauthor=T.+Kawamotoauthor=T.+Tanakaauthor=C.+D.+Molauthor=D.+R.+Douganauthor=G.+S.+Textorauthor=G.+P.+Snellauthor=F.+Itoh&title=Design%2C+synthesis+and+structure-activity+relationships+of+1%2C3%2C4-oxadiazole+derivatives+as+novel+inhibitors+of+glycogen+synthase+kinase-3%CE%B2&doi=10.1016%2Fj.bmc.2009.01.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.01.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.01.019%26sid%3Dliteratum%253Aachs%26aulast%3DSaitoh%26aufirst%3DM.%26aulast%3DKunitomo%26aufirst%3DJ.%26aulast%3DKimura%26aufirst%3DE.%26aulast%3DHayase%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DUchiyama%26aufirst%3DN.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DMol%26aufirst%3DC.%2BD.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DTextor%26aufirst%3DG.%2BS.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DItoh%26aufirst%3DF.%26atitle%3DDesign%252C%2520synthesis%2520and%2520structure-activity%2520relationships%2520of%25201%252C3%252C4-oxadiazole%2520derivatives%2520as%2520novel%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%25CE%25B2%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D2017%26epage%3D2029%26doi%3D10.1016%2Fj.bmc.2009.01.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajicek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozasa, T.</span></span> <span> </span><span class="NLM_article-title">Regulation and physiological functions of G12/13-mediated signaling pathways</span>. <i>Neurosignals</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1159/000186690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1159%2F000186690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=19212140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhslyit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=55-70&author=N.+Suzukiauthor=N.+Hajicekauthor=T.+Kozasa&title=Regulation+and+physiological+functions+of+G12%2F13-mediated+signaling+pathways&doi=10.1159%2F000186690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation and Physiological Functions of G12/13-Mediated Signaling Pathways</span></div><div class="casAuthors">Suzuki, Nobuchika; Hajicek, Nicole; Kozasa, Tohru</div><div class="citationInfo"><span class="NLM_cas:title">Neurosignals</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-70</span>CODEN:
                <span class="NLM_cas:coden">NEURIQ</span>;
        ISSN:<span class="NLM_cas:issn">1424-862X</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Accumulating data indicate that G12 subfamily (Gα12/13)-mediated signaling pathways play pivotal roles in a variety of physiol. processes, while aberrant regulation of this pathway has been identified in various human diseases.  It has been demonstrated that Gα12/13-mediated signals form networks with other signaling proteins at various levels, from cell surface receptors to transcription factors, to regulate cellular responses.  Gα12/13 have slow rates of nucleotide exchange and GTP hydrolysis, and specifically target RhoGEFs contg. an amino-terminal RGS homol. domain (RH-RhoGEFs), which uniquely function both as a GAP and an effector for Gα12/13.  In this review, we will focus on the mechanisms regulating the Gα12/13 signaling system, particularly the Gα12/13-RH-RhoGEF-Rho pathway, which can regulate a wide variety of cellular functions from migration to transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod4qKQ3wyEQ7Vg90H21EOLACvtfcHk0libH98qoTWB_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhslyit7o%253D&md5=d57e621114e8e4f0ca58d2c89c2ed29d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1159%2F000186690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000186690%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DHajicek%26aufirst%3DN.%26aulast%3DKozasa%26aufirst%3DT.%26atitle%3DRegulation%2520and%2520physiological%2520functions%2520of%2520G12%252F13-mediated%2520signaling%2520pathways%26jtitle%3DNeurosignals%26date%3D2009%26volume%3D17%26spage%3D55%26epage%3D70%26doi%3D10.1159%2F000186690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span> <span> </span><span class="NLM_article-title">A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis</span>. <i>Lab. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">342</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1038/labinvest.2014.145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1038%2Flabinvest.2014.145" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=342-350&author=M.+Liangauthor=J.+Lvauthor=L.+Zouauthor=W.+Yangauthor=Y.+Xiongauthor=X.+Chenauthor=M.+Guanauthor=R.+Heauthor=H.+Zou&title=A+modified+murine+model+of+systemic+sclerosis%3A+bleomycin+given+by+pump+infusion+induced+skin+and+pulmonary+inflammation+and+fibrosis&doi=10.1038%2Flabinvest.2014.145"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.2014.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.2014.145%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DM.%26aulast%3DLv%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DR.%26aulast%3DZou%26aufirst%3DH.%26atitle%3DA%2520modified%2520murine%2520model%2520of%2520systemic%2520sclerosis%253A%2520bleomycin%2520given%2520by%2520pump%2520infusion%2520induced%2520skin%2520and%2520pulmonary%2520inflammation%2520and%2520fibrosis%26jtitle%3DLab.%2520Invest.%26date%3D2015%26volume%3D95%26spage%3D342%26epage%3D350%26doi%3D10.1038%2Flabinvest.2014.145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batteux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavian, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Servettaz, A.</span></span> <span> </span><span class="NLM_article-title">New insights on chemically induced animal models of systemic sclerosis</span>. <i>Curr. Opin. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">518</span>, <span class="refDoi"> DOI: 10.1097/bor.0b013e32834b1606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1097%2Fbor.0b013e32834b1606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=21857225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Ghu7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2011&pages=511-518&author=F.+Batteuxauthor=N.+Kavianauthor=A.+Servettaz&title=New+insights+on+chemically+induced+animal+models+of+systemic+sclerosis&doi=10.1097%2Fbor.0b013e32834b1606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">New insights on chemically induced animal models of systemic sclerosis</span></div><div class="casAuthors">Batteux, Frederic; Kavian, Niloufar; Servettaz, Amelie</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Rheumatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">511-518</span>CODEN:
                <span class="NLM_cas:coden">CORHES</span>;
        ISSN:<span class="NLM_cas:issn">1040-8711</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: To discuss the most recent published studies on chem.-induced animal models of systemic sclerosis (SSc) and to precise the important signalling pathways that lead to the initiation and progression of the disease in these models.  Recent findings: Environmental factors undoubtedly contribute to the initiation and the development of SSc.  Among those factors, bleomycin has been identified as a possible SSc-inducing substance in mice.  The bleomycin model mimics the inflammatory changes obsd. in the early phase of the disease.  This model has been extensively studied and has allowed identification of several key pathways activated in the human disease.  More recently, a new chem.-induced model of scleroderma has been developed in mice using daily intradermal injections of a soln. generating hypochlorous acid (HOCl)-model.  This HOCl-model recapitulates the whole spectrum of the human disease, as fibrosis, inflammation, autoimmunity and vasculopathy can be obsd. in mice and brought new arguments for a major role of reactive oxygen species in the induction of local and systemic fibrosis.  Summary: Chem. induced models truly develop a SSc-like disease and argue for a crucial role of ROS in SSc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXe1ozOLnA5rVg90H21EOLACvtfcHk0liddTbHsiwZ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Ghu7zE&md5=cd1d6fb1f8e903c2b5688e028d241b5e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1097%2Fbor.0b013e32834b1606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fbor.0b013e32834b1606%26sid%3Dliteratum%253Aachs%26aulast%3DBatteux%26aufirst%3DF.%26aulast%3DKavian%26aufirst%3DN.%26aulast%3DServettaz%26aufirst%3DA.%26atitle%3DNew%2520insights%2520on%2520chemically%2520induced%2520animal%2520models%2520of%2520systemic%2520sclerosis%26jtitle%3DCurr.%2520Opin.%2520Rheumatol.%26date%3D2011%26volume%3D23%26spage%3D511%26epage%3D518%26doi%3D10.1097%2Fbor.0b013e32834b1606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avouac, J.</span></span> <span> </span><span class="NLM_article-title">Mouse model of experimental dermal fibrosis: The bleomycin-induced dermal fibrosis</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1142</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-0404-4_11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1007%2F978-1-4939-0404-4_11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=24706279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns1yqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1142&publication_year=2014&pages=91-98&author=J.+Avouac&title=Mouse+model+of+experimental+dermal+fibrosis%3A+The+bleomycin-induced+dermal+fibrosis&doi=10.1007%2F978-1-4939-0404-4_11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse Model of Experimental Dermal Fibrosis: The Bleomycin-Induced Dermal Fibrosis</span></div><div class="casAuthors">Avouac, Jerome</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1142</span>
        (<span class="NLM_cas:issue">Arthritis Research</span>),
    <span class="NLM_cas:pages">91-98</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Relevant animal models are essential tools to investigate in depth the pathogenesis of autoimmune disease.  Systemic sclerosis (SSc) is an autoimmune connective tissue disorder that affects particularly the skin.  SSc is characterized by vasculopathy, immune disturbances, and fibrosis.  Expression of each of the three pathol. features varies among SSc patients leading to disease heterogeneity and variable organ manifestations.  Several animal models of SSc are available; however, some models display inflammation followed by fibrosis, whether some others primarily mimic autonomous fibroblast activation.  Here, we describe the mouse model of bleomycin-induced dermal fibrosis, which mimics early and inflammatory stages of SSc, and is widely used in SSc research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkovRIOPHT1LVg90H21EOLACvtfcHk0ljHaZtCzrWR4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns1yqt7w%253D&md5=b65f2e9afd44a63eeca75be498d6ac3d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-0404-4_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-0404-4_11%26sid%3Dliteratum%253Aachs%26aulast%3DAvouac%26aufirst%3DJ.%26atitle%3DMouse%2520model%2520of%2520experimental%2520dermal%2520fibrosis%253A%2520The%2520bleomycin-induced%2520dermal%2520fibrosis%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2014%26volume%3D1142%26spage%3D91%26epage%3D98%26doi%3D10.1007%2F978-1-4939-0404-4_11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khare, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghuwanshi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, R.</span></span> <span> </span><span class="NLM_article-title">Hydroxyproline: A potential biochemical marker and its role in the pathogenesis of different diseases</span>. <i>Curr. Protein Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">602</span>, <span class="refDoi"> DOI: 10.2174/1389203717666151201192247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.2174%2F1389203717666151201192247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=26916157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Grt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=596-602&author=A.+K.+Srivastavaauthor=P.+Khareauthor=H.+K.+Nagarauthor=N.+Raghuwanshiauthor=R.+Srivastava&title=Hydroxyproline%3A+A+potential+biochemical+marker+and+its+role+in+the+pathogenesis+of+different+diseases&doi=10.2174%2F1389203717666151201192247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxyproline: A Potential Biochemical Marker and Its Role in the Pathogenesis of Different Diseases</span></div><div class="casAuthors">Srivastava, Amit Kumar; Khare, Piush; Nagar, Hemant Kumar; Raghuwanshi, Navdeep; Srivastava, Rajnish</div><div class="citationInfo"><span class="NLM_cas:title">Current Protein and Peptide Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">596-602</span>CODEN:
                <span class="NLM_cas:coden">CPPSCM</span>;
        ISSN:<span class="NLM_cas:issn">1389-2037</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Hydroxyproline is a non-essential amino acid found in collagen and few other extracellular animal proteins.  It's two isomeric forms trans-4-hydroxy-L-proline and trans-3-hydroxy-L-proline play a crucial role in collagen synthesis and thermodn. stability of the triple-helical conformation of collagen and assocd. tissues.  Various abnormalities in hydroxyproline metab. have been shown to play key roles in the pathophysiol. and pathogenesis of different diseases.  The elevated level of hydroxyproline is obsd. in several disorders, e.g., graft vs. host disease, keloids, and vitiligo while its decreased level is a marker of poor wound-healing.  This review explores the potential of using hydroxyproline as a biochem. marker to understand the pathogenesis, mol. pathophysiol. and treatment of these diseases.  The review concludes with an outlook on the scope and challenges in the clin. implementation of hydroxyproline as a biomarker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC1dbwZRxvsrVg90H21EOLACvtfcHk0ljHaZtCzrWR4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Grt7%252FK&md5=ebb92a208f9d6b2992949942ed6a138f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.2174%2F1389203717666151201192247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389203717666151201192247%26sid%3Dliteratum%253Aachs%26aulast%3DSrivastava%26aufirst%3DA.%2BK.%26aulast%3DKhare%26aufirst%3DP.%26aulast%3DNagar%26aufirst%3DH.%2BK.%26aulast%3DRaghuwanshi%26aufirst%3DN.%26aulast%3DSrivastava%26aufirst%3DR.%26atitle%3DHydroxyproline%253A%2520A%2520potential%2520biochemical%2520marker%2520and%2520its%2520role%2520in%2520the%2520pathogenesis%2520of%2520different%2520diseases%26jtitle%3DCurr.%2520Protein%2520Pept.%2520Sci.%26date%3D2016%26volume%3D17%26spage%3D596%26epage%3D602%26doi%3D10.2174%2F1389203717666151201192247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palumbo-Zerr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramming, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelse, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distler, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schett, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distler, J. H. W.</span></span> <span> </span><span class="NLM_article-title">Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis</span>. <i>Ann. Rheum. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1136/annrheumdis-2014-207109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1136%2Fannrheumdis-2014-207109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=25858641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivV2ru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2016&pages=883-890&author=J.+Huangauthor=C.+Beyerauthor=K.+Palumbo-Zerrauthor=Y.+Zhangauthor=A.+Rammingauthor=A.+Distlerauthor=K.+Gelseauthor=O.+Distlerauthor=G.+Schettauthor=L.+Wollinauthor=J.+H.+W.+Distler&title=Nintedanib+inhibits+fibroblast+activation+and+ameliorates+fibrosis+in+preclinical+models+of+systemic+sclerosis&doi=10.1136%2Fannrheumdis-2014-207109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis</span></div><div class="casAuthors">Huang, Jingang; Beyer, Christian; Palumbo-Zerr, Katrin; Zhang, Yun; Ramming, Andreas; Distler, Alfiya; Gelse, Kolja; Distler, Oliver; Schett, Georg; Wollin, Lutz; Distler, Joerg H. W.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">883-890</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Background Nintedanib is a tyrosine kinase inhibitor that has recently been shown to slow disease progression in idiopathic pulmonary fibrosis in two replicate phase III clin. trials.  The aim of this study was to analyze the antifibrotic effects of nintedanib in preclin. models of systemic sclerosis (SSc) and to provide a scientific background for clin. trials in SSc.  Methods The effects of nintedanib on migration, proliferation, myofibroblast differentiation and release of extracellular matrix of dermal fibroblasts were analyzed by microtitre tetrazolium and scratch assays, stress fiber staining, qPCR and SirCol assays.  The antifibrotic effects of nintedanib were evaluated in bleomycin-induced skin fibrosis, in a murine sclerodermatous chronic graft-vs.-host disease model and in tight-skin-1 mice.  Results Nintedanib dose-dependently reduced platelet derived growth factor-induced and transforming growth factor-β-induced proliferation and migration as well as myofibroblast differentiation and collagen release of dermal fibroblasts from patients with and healthy individuals.  Nintedanib also inhibited the endogenous activation of SSc fibroblasts.  Nintedanib prevented bleomycin-induced skin fibrosis in a dose-dependent manner and was also effective in the treatment of established fibrosis.  Moreover, treatment with nintedanib ameliorated fibrosis in the chronic graft-vs.-host disease model and in tight-skin-1 mice in well-tolerated doses.  Conclusions We demonstrate that nintedanib effectively inhibits the endogenous as well as cytokine induced activation of SSc fibroblasts and exerts potent antifibrotic effects in different complementary mouse models of SSc.  These data have direct translational implications for clin. trials with nintedanib in SSc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDEbmgLqW_5LVg90H21EOLACvtfcHk0lgmK_e8zApXCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivV2ru7o%253D&md5=d8b6a3c431064917cb72c4f839aa55f4</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2014-207109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2014-207109%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DBeyer%26aufirst%3DC.%26aulast%3DPalumbo-Zerr%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DRamming%26aufirst%3DA.%26aulast%3DDistler%26aufirst%3DA.%26aulast%3DGelse%26aufirst%3DK.%26aulast%3DDistler%26aufirst%3DO.%26aulast%3DSchett%26aufirst%3DG.%26aulast%3DWollin%26aufirst%3DL.%26aulast%3DDistler%26aufirst%3DJ.%2BH.%2BW.%26atitle%3DNintedanib%2520inhibits%2520fibroblast%2520activation%2520and%2520ameliorates%2520fibrosis%2520in%2520preclinical%2520models%2520of%2520systemic%2520sclerosis%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2016%26volume%3D75%26spage%3D883%26epage%3D890%26doi%3D10.1136%2Fannrheumdis-2014-207109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium</span>. <i>BMC Pulm. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">63</span>, <span class="refDoi"> DOI: 10.1186/s12890-017-0405-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=10.1186%2Fs12890-017-0405-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=28420366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsl2qu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=63&author=Y.+Liuauthor=F.+Luauthor=L.+Kangauthor=Z.+Wangauthor=Y.+Wang&title=Pirfenidone+attenuates+bleomycin-induced+pulmonary+fibrosis+in+mice+by+regulating+Nrf2%2FBach1+equilibrium&doi=10.1186%2Fs12890-017-0405-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium</span></div><div class="casAuthors">Liu, Yuan; Lu, Fuai; Kang, Lirong; Wang, Zhihua; Wang, Yongfu</div><div class="citationInfo"><span class="NLM_cas:title">BMC Pulmonary Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63/1-63/11</span>CODEN:
                <span class="NLM_cas:coden">BPMMBB</span>;
        ISSN:<span class="NLM_cas:issn">1471-2466</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Oxidative stress is one of the important factors involved in the pathogenesis of idiopathic pulmonary fibrosis (IPF).  The equil. of Nuclear factor-erythroid-related factor 2 (Nrf2)/[BTB (broad-complex, tramtrack and bric-a-brac) and CNC (cap'n'collar protein) homol. 1, Bach1] dets. the expression level of antioxidant factors, further regulating the function of oxidn./antioxidn. capacity.  Pirfenidone (PFD) is one of two currently for IPF therapy approved drugs.  PFD regulates intracellular antioxidants, inhibits secretion of inflammatory cytokines and collagen synthesis.  However the mechanisms of its antioxidant effects remain elusive.  Methods: Effects of PFD treatment were studied in mouse lung fibroblasts (MLF) following induction by transforminggrowth factor beta 1 (TGF-β1) and in mice following bleomycin-induced lung fibrosis.  The mRNA and protein levels of oxidative stress-related factors Nrf2/Bach1 and their downstream antioxidant factors heme oxygenase-1 (Ho-1) and glutathione peroxidase 1 (Gpx1) were detd. by RT-PCR and Western blot.  Fibrosis-related cytokines interleukin-6 (IL-6) and myofibroblast markers type 1 collagen a1 (COL1A1) levels in supernate of MLF, serum, and bronchoalveolar lavage fluid (BALF) as well as malondialdehyde (MDA) in serum and BALF were detected by ELISA, reactive oxygen species (ROS) generation was measured by 2',7'- dichlorofluorescin diacetate (DCFH-DA) assay and lung pathol./morphol. alterations in mice were obsd. by HE and Masson to assess the antioxidant mechanism and therapeutic effects on pulmonary fibrosis induced by bleomycin.  Results: PFD inhibited Bach1 mRNA and protein expressions in mouse lung fibroblasts induced by TGF-β1 and lung tissues with pulmonary fibrosis induced by bleomycin.  Furthermore, it improved Nrf2, Ho-1 and Gpx1 mRNA and protein expressions.  After PFD treatment, COL1A1and IL-6 levels in supernate of MLF, serum, and BALF as well as ROS in lung tissues and MDA in serum and BALF from a mouse with pulmonary fibrosis were significantly decreased, and the infiltration of lung inflammatory cells and fibrosis degree were alleviated.  Conclusions: Theraputic effects of PFD for IPF were involved in Nrf2/Bach1 equil. which regulated the capacity of oxidative stress.  The study provided new insights into the antioxidant mechanism of PFD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4lesxVU9HjLVg90H21EOLACvtfcHk0lgmK_e8zApXCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsl2qu7g%253D&md5=23fb783bf5bdde2afe2ebeb7c196d447</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1186%2Fs12890-017-0405-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12890-017-0405-7%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DF.%26aulast%3DKang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DPirfenidone%2520attenuates%2520bleomycin-induced%2520pulmonary%2520fibrosis%2520in%2520mice%2520by%2520regulating%2520Nrf2%252FBach1%2520equilibrium%26jtitle%3DBMC%2520Pulm.%2520Med.%26date%3D2017%26volume%3D17%26spage%3D63%26doi%3D10.1186%2Fs12890-017-0405-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i139"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01772">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_48661"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01772">10.1021/acs.jmedchem.8b01772</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01772/suppl_file/jm8b01772_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01772/suppl_file/jm8b01772_si_001.csv">jm8b01772_si_001.csv (2.43 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01772&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01772%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-9" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01772" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799461a39382495","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
